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More than a quarter of the Australian population accessing healthcare services has diabetes. 
These consumers access health professionals who have varying levels of diabetes-specific 
knowledge and training, resulting in conflicting advice. However, conflicting health messages 
about diabetes care leads to consumer disengagement with health services. Primary care 
health professionals cite a lack of skills and confidence and inadequate time or access to 
practical resources as common barriers to delivering diabetes care.  
Competency frameworks are tools used to guide and standardise practice in stable clinical 
situations. However, national and international diabetes competency frameworks primarily 
focus on individual health topic areas and on one health professional discipline, which reduces 
consistency in training, consumer messaging and aspects of care. No diabetes framework 
exists in Australia that informs the whole workforce, nor are any capability-based frameworks 
to accommodate dynamic changes in healthcare. Thus, existing frameworks are unlikely to 
support workforce development adequately.  
Growing and changing demands for health professionals with diabetes capabilities and 
multidisciplinary Credentialled Diabetes Educators with prescribing capabilities warrant a 
more efficient means of developing the workforce to deliver diabetes education and care. A 
competent, flexible and adaptive health workforce is fundamental to increasing equitable 
access to safe, quality diabetes healthcare across the healthcare spectrum and areas of 
increasing remoteness in Australia. 
Aim 
To develop a capability-based framework by consensus for the Australian non-medical health 
professional workforce who provide diabetes education and care across the healthcare 
system. 
Method 
A 3-staged modified Delphi technique was used to gain agreement from a purposefully 
recruited panel of Australian diabetes health professional experts and academics from 
various disciplines and work settings. Stage I was a consultation phase to inform the Delphi 
survey development and included a semi-structured consultation group and a pilot Delphi 
survey. Qualtrics, a web-based platform, was used to conduct the pilot to validate the tool.  
Stage II involved the Delphi survey dissemination to the expert panel; it consisted of two 
phases, each with two rounds of questionnaires. The Delphi survey used 4- and 5-point Likert 
scales to determine consensus. Delphi survey Phase one sought to identify the health 
professional practice levels that signified a change in the breadth of knowledge and skills 
required to deliver diabetes care. Delphi survey Phase two sought to identify capabilities 
required for diabetes education and care and consensus on statements for each practice 
level. The capabilities were then mapped to the practice levels to draft a capability-based 
framework. 
Stage III of the Delphi technique involved a semi-structured focus group of expert diabetes 





professional training and peer organisations was performed to ensure the capabilities and 
statements would not impede health professional practice. 
Content analysis using emergent coding and no pre-specified number of major categories 
was used to analyse qualitative data from each Delphi stage. To determine quantitative data 
characteristics and consensus, frequencies and central tendency measures, including mean 
absolute deviation were calculated. An Expert Advisory Group was engaged for peer 
debriefing and cross-coding data to support the trustworthiness of the findings.  
Results 
Eighty-four expert diabetes health professionals were recruited from nursing and midwifery 
(n=60,71%), allied health (n=17,20%) and pharmacy (n=7,9%) disciplines. They were 
representative of varied Australian healthcare sectors and academia and from remote and 
metropolitan areas.  
In Delphi survey Phase One, seven health professional diabetes practice levels within the 
workforce were identified in order to deliver safe, quality diabetes care and gained 
consensus to inform the ‘Capability Framework’; these were aligned to seven corresponding 
stages of diabetes clinical competence. In Delphi survey Phase Two, nine capability areas to 
support the care were identified, along with three sets of underpinning attributes. Further, 
two to 16 statements attained consensus for each capability, 259 in total. The study also 
identified inconsistencies in how health professionals engaged in diabetes-related medicine 
management. Further, the study identified solutions to build the workforce’s capacity by 
expanding scope of practice and remuneration recommendations. 
Conclusion 
A rigorous systematic process of consultation and consensus combining evidence from the 
literature with real-world experience from experts in the field led to the development of the 
‘Capability Framework’, which addresses workforce enablers identified by the Australian 
National Diabetes Strategy. By guiding training to an appropriate level of diabetes clinical 
competence, the ‘Capability Framework’ provides a novel way to prepare health 
professionals to meet the needs of people with diabetes.  
The framework supports establishing consistent health professional curricula development 
across the nation, promoting diabetes education and care efficacy by reducing role boundary 
confusion that supports consumer engagement. By promoting multidisciplinary credentialling 
and recognising diversity, the ‘Capability Framework’ supports the entire workforce’s 
development and creates opportunities for shared understandings of evidence-based 
diabetes care across health professional disciplines.  
The framework addresses social and economic diabetes healthcare gaps by guiding remote 
area health professional training and assisting with workforce planning. However, consistent 
terms used to describe diabetes-related medicine management and diabetes health 
professionals’ involvement require clarification due to differences in Drug and Poisons 
Legislation nationwide. The findings from the study can inform diabetes policy, practice, 
education and research.  
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Following a University Research Week in 2018, design to question thinking, the researcher 
moved focus towards ‘capabilities’ and away from ‘competencies’; since then, data was 
analysed to identify capabilities. Hence, earlier working on documents sent to participants 
shown in the Appendices use the term competency-based. The wording ‘competency 
statements’ was not altered in the framework and other material to avoid confusion and for 
consistency in the data collection phase. However, statements referring to ‘capability 
statements’ are included as the thesis progressed and will be applied in future work.    
 
List of Figures 
7 
 
List of Figures  
 Title of figure Page 
2.1 The 2013 Australian Qualification Framework 57 
3.1 The theoretical underpinning of the framework for diabetes care 91 
3.2 Diagrammatic representation of the registered nurse standards for practice 93 
3.3 A scheme linking capability to competency, credentialling and mentoring 102 
3.4 Stages for modified Delphi technique 105 
3.5 Flow chart guiding data collection methods 107 
4.1 Process used by researcher to analyse qualitative data 119 
4.2 Consultation group members’ discipline 121 
5.1 Chronology of the recruitment period 146 
5.2 Screen display of Qualtrics email distribution feature 148 
5.3 All current roles held by panel members 152 
5.4 Models to describe practice levels to inform framework 153-154 
5.5 Cumulative ranking of models describing practice levels 170 
5.6 Healthcare professional practice levels to deliver diabetes care 173 
5.7 Stages of diabetes clinical competence associated with each practice level 174 
5.8 Delphi survey response rate 177 
5.9 Capabilities required to deliver diabetes care 184 





List of Tables 
8 
 
List of Tables  
 Table title Page 
1.1 Average annual healthcare costs of diabetes per person 16 
1.2 Healthcare providers eligible for Team Care Arrangements 19 
2.1 Search terms used to identify peered reviewed articles 31 
2.2 Studies that investigated the primary healthcare nurse’s role in diabetes 35 
2.3 Studies that investigated the pharmacist’s role in diabetes 38 
2.4 International differences to be recognised as a diabetes educator 46-48 
2.5 International competency frameworks for diabetes education and care 62 
2.6 
Competencies required by diabetes educators identified by different 
diabetes healthcare professional organisation 64 
2.7 Non-medical prescribing in Australia and internationally 70-72 
3.1 Search terms used to identify peered reviewed articles 83 
3.2 Benner’s stages of clinical competence 95 
3.3 Expert Advisory Group members 112 
4.1 Roles and work settings where participants were employed 122 
5.1 Timeline for Delphi rounds and Expert Advisory Group meetings 147 
5.2 Characteristics of participants in study 151 
5.3 Ranking of practice level models by Delphi participants 170 
5.4 Definitions for capabilities required to deliver diabetes care 185-186 
5.5 
Attributes required by healthcare professionals that underpin diabetes 
healthcare 187 
5.6 MAD of medium for statements under each capability 188 
5.7 Reasons participants provided for altering their initial ranking 191 
6.1 Focus group questions 197 
6.2 Minimum level of clinical competence in diabetes care required by roles 199 
6.3 Capability Framework for Diabetes Care: A guide to practice 200-219 
6.4 Selective health profession and training organisations contacted 222 
6.5 Stakeholders who responded to request for feedback 223 
6.6 Summary of stakeholder feedback 225-226 
Glossary of Terms 
9 
 
Glossary of Terms 
Capability-based learning: Learning strategies that include a combination of flexible and 
responsive and traditional learning pathways and encompasses learning contracts, and 
problem-based, situational and experiential learning in clinical learning environments as 
approaches to skills acquisition (Gardner et al., 2006). 
Delphi technique: A process that uses multiple rounds of coordinated, anonymous data 
collection to combine the shared knowledge and insight of a group of experts towards a 
consensus understanding (Hasson & Keeney, 2011).  
Focus group: a common method of collecting data on a topic or phenomena in 
qualitative health research because focus groups enable the accumulated views, 
experiences and beliefs, and important motivators of individual participants who have 
expertise in the topic under investigation to be explored (Nyumba et al., 2018). 
Gestational diabetes mellitus: glucose intolerance of variable severity with onset or first 
recognition during pregnancy (World Health Organization [WHO], 2019). 
HbA1c: a test used to diagnose and monitor diabetes: circulating blood glucose 
permanently bonds to haemoglobin in red blood cells and the amount of HbA1c formed 
is relative to the quantity of glucose in the blood over the preceding 3-months (d’Emden 
et al., 2015). 
Insulin dose advice: “providing advice on insulin dose based on factors such as meal 
planning, activity and blood glucose levels” (Queensland Health, 2017, p.5).  
Insulin titration: “alteration of insulin dose based on a written or verbal prescription that 
contains a specific structure to guide dosage; the structure may include a table or 
formula to calculate the dose required” (Queensland Health, 2017, p.5).  
Medicare: is a publicly funded universal healthcare scheme that provides Australians 
with access to some health services at low or no costs (Australian Government, 2020). 
Medicines DSME: structured education in partnership with the person with diabetes 
concerning their medicines and the manner each medicine impacts their diabetes 
management, safe storage, travelling with medicines, injection techniques (ADEA, 2012, 
2018a).  
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Non-medical healthcare professional: refers to a healthcare professional who is not a 
medical officer and is eligible for ADEA credentialling including, the Aboriginal and Torres 
Strait Islander health practitioner, accredited practising dietitian and exercise 
physiologist, and registered nurse, pharmacist, physiotherapist, podiatrist and midwife. 
Non-medical prescribing: prescribing rights “extended beyond the traditional remit of 
doctors and dentists to other health professionals” (Health Workforce Australia, 2013, 
p.1). 
Diabetes practice levels: a structure describing various levels of healthcare professional 
competence, work experience and skills, and scope of practice in diabetes care to 
perform their role safely 
Prescribing: “an iterative process involving the steps of information gathering, clinical 
decision-making, communication, and evaluation that results in the initiation, 
continuation or cessation of a medicine” (Health Workforce Australia, 2013, p.14). 
Type 1 diabetes: an autoimmune condition characterised by an absolute lack of insulin 
and risk of developing ketoacidosis; the onset is usually rapid, occurring at any age, 
however, usually in childhood or young adulthood (WHO, 2019). 
Type 2 diabetes: a genetic progressive chronic condition in which the body becomes 
resistant to insulin and its effects and gradually produces inadequate amounts of 






Abbreviation  Full term  
ADCES Association of Diabetes Care and Education Specialists  
ABS Australian Bureau of Statistics 
ACM Australian College of Midwives  
ACT Australian Capital Territory  
ACSQHC Australian Commission on Safety and Quality in Health Care  
ADA American Diabetes Association  
ADC Australian Diabetes Congress 
ADEA Australian Diabetes Educators Association 
ADIPS Australian Diabetes in Pregnancy Society 
AHP Allied health professional 
AHPRA Australian Health Practitioner Regulation Agency  
AHW Aboriginal health worker  
AIHW Australian Institute of Health and Welfare 
ANDS Australian National Diabetes Strategy 
APD Advanced practice dietitian  
APNA Australian Practice Nurse Association  
ASF Australian Standards Framework 
BC-ADM® Board Certified – Advanced Diabetes Manager 
BGL Blood glucose level  
BMI Body mass index 
BP Blood pressure  
CASP Course Accreditation and Standards of Practice Committee 
CDE Credentialled diabetes educator TM  
CGM Continuous glucose monitoring  
CNS Clinical nurse specialist 
COAG Council of Australian Governments 
CPD Continuous professional development 
CSII Continuous subcutaneous insulin infusion 
CSIRO Commonwealth Scientific and Industrial Research Organisation (Australian) 
DAA Dietetic Association of Australia 
DAFNE Dose Adjustment for Normal Eating TM 
DESMOND Diabetes Education and Self-Management for Ongoing and Newly 
Diagnosed TM 
DoH Department of Health 
DSME Diabetes self-management education  
DSN Diabetes specialist nurse  




eDM Electronic direct messaging  
GDM Gestational diabetes mellitus 
GDP Gross domestic product  
GLM Glucose-lowering medicine 
GP General practitioner PT 
GWG Gestational weight gain 
HbA1c Glycated haemoglobin  
HCP Healthcare professional 
HPPP Health Professional Prescribing Pathway 
HWA Health Workforce Australia 
IPT Insulin pump treatment 
JBI Joanna Briggs Institute 
KSA Knowledge, skills and attributes  
LDL Low-density lipoproteins  
MAD Mean absolute deviation  
NADC National Association of Diabetes Centres  
NDSS National Diabetes Services Scheme 
NHS National Health Service  
NMBA Nursing and Midwifery Board of Australia  
NMP Non-medical prescribing  
NP Nurse practitioner PT 
NPS National Prescribing Service  
NRHC National Rural Health Commissioner  
NSW New South Wales (state of Australia) 
PAID Problem areas in diabetes scale 
PBS Pharmaceutical Benefits Scheme  
PHCN Primary health care nurse TM 
PLS Plain language statement 
PSA Pharmaceutical Society of Australia  
QoL Quality of life 
QUM Quality Use of Medicine  
RCT Randomised control-trial 
RM Registered midwife PT 
RN Registered nurse PT 
SD Standard deviation 
SoP 
T1D 
Scope of practice 
Type 1 diabetes mellitus 
T2D Type 2 diabetes mellitus 
TCA Team Care Arrangement  
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Chapter 1: Background to the study  
1.1. Introduction 
I was just diagnosed with type 2 [diabetes] two months ago with an [Hb]A1C of 6.8 [%]. 
Overall, I feel super negative about the whole diagnosis and feel like it’s changed my 
outlook on life for the worse. But I’m trying! I have met with a Credentialled Diabetes 
Educator and I feel like she gave me conflicting information from what my GP [General 
Practitioner] had told me, and what I’ve read. (Anonymous, 2017) 
The quote was from a consumer accessing community support from a web-based 
blog. Despite accessing trained healthcare professionals (HCP), the consumer suggests 
the experience was not positive.  
The consumer had accessed peer support because she felt HCPs provided conflicting 
information. The lifelong demands of diabetes require the person living with diabetes 
to manage every aspect of their lives (Hendrieckx et al., 2020). Thus, consistent 
diabetes information among HCPs and access to appropriate, credible, and timely 
information by a knowledgeable and flexible health workforce trained to provide 
diabetes care is central to the support they require (Ng et al., 2017).  
Chapter 1 introduces the background to the study. It focuses on recent dynamic 
changes to diabetes healthcare policy, driving changes within the healthcare 
workforce and user expectations. It shows a need for change to develop a more 
competent, flexible and adaptive workforce to address future diabetes care needs. The 
study’s origins are then outlined, including a reflection about the researcher’s 
experience and role as a research instrument. The chapter concludes by outlining the 
thesis structure and provides a synopsis of each chapter. 
1.2. Diabetes increasing prevalence in Australia 
Diabetes is the fastest growing healthcare problem in Australia and globally 
(Australian Institute of Health & Welfare [AIHW], 2019), which creates an imperative 
for change to provide timely care sustainably. In Australia, the National Diabetes 
Services Scheme (NDSS) had 1.4 million people registered as of December 2020 
(Diabetes Australia, 2020). The NDSS is an Australia Government initiative that aims to 
enhance the capacity of people living with diabetes to self-manage through access to 
services, support and subsidised diabetes products (NDSS, 2020a). 
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Several types of diabetes mellitus (diabetes) exist, a chronic condition characterised 
by insulin deficiency or resistance causing hyperglycaemia and inflammatory 
responses, which affect normal cell function and growth, damaging blood vessels, 
nerves and organs (Craig et al., 2011). These are type 1 diabetes (T1D), T2D, hybrid 
forms of diabetes (e.g. ketosis-prone T2D), other specific types (e.g. monogenic 
diabetes) and GDM, and a prediabetes state (WHO, 2019).  
Diabetes is associated with reduced QoL, higher hospitalisation rates and mortality 
(AIHW, 2020a); common comorbidities are cardiovascular in origin, including renal 
disease and stroke, disability, depression, and vision impairment (AIHW, 2019). Also, 
diabetes-related hospitalisations accounted for 1.2 million episodes in 2017-18 
(AIHW, 2020a). Hence, when the diabetes consumer seeks care, the health workforce 
must be equipped to promote and support appropriate self-care. 
Up to 35% of consumers using healthcare services across Australia daily have diabetes 
(Bach et al., 2014; National Health Performance Authority, 2015). The rising incidence 
of T2D in youth and T1D in all age groups contributes to the increasing global 
prevalence of diabetes (WHO, 2019). Alarmingly, a genetic predisposition for T2D is 
seen in those as young as eight (Bell et al., 2020).  
Significantly, by 2030, diabetes will be the leading health condition burden in Australia 
(AIHW, 2019), when over half, primarily tertiary-based, CDE workforce reaches 
retirement age (ADEA, 2017a). More consumers requiring diabetes healthcare with a 
longer duration of diabetes and comorbidities will inundate the workforce. A mature 
and retiring diabetes-trained workforce will reduce the Australian health system’s 
capacity to deliver diabetes care and reduce diabetes complications. Consequently, 
traditional diabetes care and education solely delivered by diabetes educators may 
not meet consumer needs. 
1.2.1. Diabetes in Aboriginal and Torres Strait Islander populations  
Aboriginal and Torres Strait Islander populations have higher rates of diabetes than 
non-Indigenous Australians. AIHW (2017, 2020a) reported the age-standardised rate 
of diabetes for adult Indigenous Australians was 12.6% nationally and 27% in 
Northern Territory; respectively, 3.2 and 4.7 times higher than the non-Indigenous 
Australian’s rate. Aboriginal and Torres Strait Islander people residing in the Northern 
Territory have one of the highest rates of diabetes in the world (Burrow & Ride, 2016). 
Consequently, diabetes creates a significant burden to Indigenous Australians and 
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their communities and impacts the limited HCP workforce capacity to support 
diabetes care in rural, remote populations. 
A diagnosis of T1D and T2D in Aboriginal and Torres Strait Islander youth and younger 
adults presents earlier (Titmuss et al., 2019). Higher rates of hyperglycaemia and 
adverse pregnancy outcomes, increasing intergenerationally, are seen in pregnancies 
of Indigenous compared to non-Indigenous women: highest in regional and remote 
areas (Maple-Brown & Hampton, 2020).  
Furthermore, the hospital separation rate for Aboriginal and Torres Strait Islander 
people with T2D was 4.3 times that of all Australians (AIHW, 2020a): circulatory 
complications are the most serious complication leading to hospitalisation (Burrow & 
Ride, 2016). Moreover, life expectancy in Indigenous Australians is shorter. Diabetes is 
the second leading cause of death, with mortality rates eight times higher than non-
Indigenous Australians (Australian Bureau of Statistics [ABS], 2019).  
Hence, rates of diabetes are high, and the duration of diabetes is longer in areas of 
remoteness in Australia, where reduced access to healthcare services exists (National 
Rural Health Commissioner [NRHC], 2020a). Therefore, there is an immediate need to 
build diabetes capabilities within the Indigenous healthcare workforce to support 
culturally appropriate diabetes care. 
1.3. The human and financial cost of diabetes 
Ongoing healthcare needs create a potentially unmanageable cost burden to people 
living with diabetes, their families and the community. Diabetes can lead to diabetes-
related complications affecting people living with diabetes (Hendrieckx et al., 2020). 
Notably, some people have an increased genetic risk for complications (Prasad & 
Groop, 2015), a cost burden to the individual and the healthcare system.  
The Australian Diabetes, Obesity and Lifestyle study data of 6,000 participants was 
used to compare costs associated with diabetes to those of individuals with lower 
glucose intolerance levels (Lee et al., 2013). Lee et al. found that the annual direct-
person cost more than doubled in those with diabetes and higher in people with 
diabetes-related complications, see Table 1.1 on page 16. The annual cost of diabetes 
for Australians aged ≥30 years was $10.6 billion in 2005, including direct costs and 
Government subsidies (Lee et al., 2013).  
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Table 1.1 Average annual healthcare costs of diabetes per person (Lee et al., 2013) 






Normal glucose tolerance  A$1,446 A$452 A$3,361 
No complications of diabetes A$2,357 A$1,133 A$7,045 
Microvascular complications only A$3,051 A$1,716 A$7,391 
Macrovascular complications only A$5,826 A$638 A$7,250 
Micro- and macrovascular complications  A$5,935 A$3,693 A$9,327 
 
The excess cost of diabetes to individuals and the Government is substantial; recent 
Government direct diabetes healthcare expenditure estimates of $2.7 billion versus 
$989 million in 2008 suggest these costs are unchanged, and the economic burden that 
diabetes represents for the Australian economy is growing steadily (AIHW, 2019). 
Further, unpaid family support is an un-costed volunteer ‘workforce’. The increasing 
prevalence of diabetes adds to the human and financial burden, reducing the current 
diabetes-trained workforce’s capacity to support care. 
Men are twice as likely to fall into income poverty after developing T2D according to an 
analysis of a national, longitudinal survey comparing adults diagnosed with T2D to 
those who were not (Callander & Schofield, 2016); 27% of people with diabetes omit 
care because of the cost (Callander et al., 2017). According to Schofield et al. (2014), 
who used a multiple regression model based on the ABS surveys of disability, aging and 
carers, 38% of those aged 45 to 64-year with diabetes retired early and had incomes 
88% lower than their employed colleagues. Thus, earlier intervention may improve 
their living standards and delay diabetes-related complications. 
However, efforts towards reducing diabetes complications in Australia may be 
impeded without a diabetes competent workforce equipped with appropriate skills to 
support implementing self-care behaviours to manage diabetes. A national approach 
towards increasing the workforce’s capacity for diabetes care might prevent the loss 
of productive life years and reduce the human and financial costs of diabetes in a 
population with high healthcare expenses. 
Ventura et al. (2016) used a population survey via the NDSS of 18- to 75-year-olds to 
investigate how Australians managed their diabetes, their support, and the impact of 
diabetes on their lives. The survey included 2,342 adults living with T1D or T2D. Only 37% 
had accessed structured group diabetes education, 36% of those with insulin-treated 
Chapter 1: Background to the study 
17 
 
T2D showed moderate to severe depressive symptoms, and 24% of adults with T1D 
experienced moderate to severe depression or severe diabetes distress.  
Caring for a person with severe anxiety and depression or complications can be 
challenging and distressing for the whole family. Depressive states lead to reduced 
healthcare usage in those who require it most (Hendrieckx, 2020) and reduced QoL 
(Browne et al., 2017). Early assessment of emotional health by a diabetes-trained 
workforce may reduce the risk of disengagement and the trajectory to costly 
diabetes-related complications.  
The studies in this section suggest that the personal financial impact of diabetes is 
high, and access to structure diabetes education is inadequate. Diabetes is a costly 
condition, which requires investment in developing an approach to ensure that the 
healthcare workforce delivering care is diabetes-competent and skilled to use 
supportive communication styles to provide appropriate, timely healthcare 
sustainably. A diabetes competent workforce that provides consistent, structured 
diabetes education may support increased consumer engagement, reducing diabetes-
related complications through the support they provide.  
1.4. The Australian healthcare system 
The Australian healthcare system delivers State government-funded tertiary and some 
community services free to consumers; community and primary care services are 
Commonwealth-funded through Medicare. Medicare is a publicly funded universal 
healthcare scheme, providing Australians access to some health services at low or no 
costs (Department of Health [DoH], 2017). Consumers can access partial 
reimbursement of the costs of many primary services through Medicare or Private 
Health Funds and sometimes both.  
Only 44% to 53% of the Australian population has some level of privately-funded 
hospital or extras health cover respectively (AIHW, 2020b). Consumers who do not 
hold a Healthcare or Pension Card incur the total cost of axillary services such as 
diagnostic or dental; only a minimal Medicare reimbursement applies.  
Healthcare professionals need to be registered with the Australian Health Practitioner 
Regulation Agency or hold nationally recognised accreditation to access 
Commonwealth-funded Medicare payments. National registration in Australia is 
restricted to specific professions perceived as imposing greater risk to the public due 
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to their services (DoH, 2019a). Of the professions discussed in the thesis, it applies to 
all except dietitians and exercise physiologists. 
1.5. Health reform changing the landscape of diabetes care  
Driven by prevalence predictions, the Australian Government has continued to 
develop policies to better fund diabetes and other chronic conditions 
(Commonwealth of Australia (CoA), 2016). Thus, funding-driven health reform has 
changed the landscape of diabetes care provision in the past decade. However, policy 
direction must be supported by the alignment of appropriate, consistent diabetes 
healthcare workforce training. 
1.5.1. Changing Government policy and health reform 
The Australian Government commissioned Health Workforce Australia (HWA), a 
statutory authority, to ensure a responsive response to Australian healthcare needs in 
2010 (DoH, 2019a). HWA was a strategy to address the challenges of implementing 
change to develop a more skilled, flexible and innovative health workforce (HWA, 
2012). Next, the Government announced health reform; policies included Medicare-
incentivised models to fund primary and private services, redirecting diabetes health 
services from tertiary to primary care settings (Furler et al., 2017; NRHC, 2020a).  
The National Registration and Accreditation Scheme was developed recently to 
support the work of HWA (DoH, 2019a). The scheme aims to protect the public, 
facilitate workforce mobility across Australia and enable continuous development of a 
responsive, flexible and sustainable health workforce (DoH, 2019a). It considers HCPs 
‘cross-training’, an approach to health workforce reform. The current study provided 
an opportunity to identify relevant diabetes ‘cross-training’ requirements for the 
workforce and expand the scope of non-specific diabetes roles.  
A. Chronic Disease Management and Team Care Arrangements 
One policy initiative focused on the diabetes workforce was Chronic Disease 
Management-GP Services via Medicare. GP Management Plans act as a funding 
incentive for GPs to manage diabetes with generalist primary health care nurses 
(PHCN) and AHPs in a coordinated manner through Team Care Arrangements (TCA), 
see Table 1.2 on page 19 (DoH, 2017). However, primary care HCPs may not be 
appropriately trained to support the diabetes education role.  
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Table 1.2 Healthcare providers eligible for Team Care Arrangements 
Aboriginal and/or Torres Strait Islander health worker and practitioner  
Audiologist 
Asthma educator  
Chiropractor, Osteopath  
Diabetes educator  
Dentists, Dental therapists  
Dietitian 
Exercise physiologist, Physiotherapist  
Nurses (Practice nurse, enrolled nurse, community nurse) 
Occupational therapist  
Orthoptist, orthotist or prosthetist 
Podiatrist  
Psychologist, Mental health worker  
Speech pathologist 
 
The TCA requires a minimum of three collaborating healthcare providers to be 
considered a multidisciplinary team and is limited to five consultations per year: 10 
for Indigenous consumers. All generalist AHPs and Credentialled Diabetes Educators™ 
(CDE) who have a provider number are eligible (ADEA, 2019a; DoH, 2017). However, 
there is no requirement to demonstrate diabetes competence.  
B. Diabetes Care Project 
Another policy initiative that changed the landscape of diabetes care in Australia was 
the Commonwealth 2011 to 2014 Diabetes Care Project, a randomised cluster study. 
Two new healthcare models, including either two or five additional care elements for 
adults with T1D or T2D delivered through GP practices, were tested beside current 
models of care (DoH, 2015). The funding reform saw PHCNs as pivotal to coordinated 
diabetes care with generalist AHPs. It aimed to demonstrate the benefits of using a 
multidisciplinary approach, including diabetes educators, to provide care.  
However, the study’s findings suggest that skills and competence in managing diabetes 
of a wide range of generalist allied and nursing HCPs may not be adequate to 
individualise diabetes care appropriately to support extensive change. While the 
reduction in the mean primary endpoint HbA1c by 0.2% was statistically significant in 
the five-care elements intervention group (DoH, 2015), the result was not clinically 
meaningful when benchmarked against landmark studies where reductions in 
cardiovascular outcomes are associated with a change of -0.5 to -1.0% (Nathan et al., 
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2013). Also, uncertainty existed about the pilot study’s cost-effectiveness, despite 
preventable hospitalisations reductions offsetting the increased GP and AHP costs.  
Overall, the Diabetes Care Project identified that better care coordination and e-health 
communication tools are essential to address chronic conditions (Fountaine & 
Bennett, 2016). A generalist healthcare workforce more suitably trained for diabetes 
care, more able to individualise and coordinate care appropriately and as required, can 
support further improved health outcomes.  
Further, it was unclear whether the primary care AHPs and diabetes educators worked 
in isolation or were supported by diabetes services in the Diabetes Care Project. 
Linkages to larger diabetes centres enhance HCPs’ competence through collaboration 
with diabetes medical specialists and experienced diverse CDEs (DoH, 2015; Hicks, 
2017). A diabetes capability framework may support linkages between primary and 
tertiary care HCPs, building capacity for diabetes care. 
C. Health Care Home trial 
A Government Primary Health Care Advisory Group examined the complexity of 
managing chronic conditions and enabled infrastructure for the Health Care Home 
trial, a Diabetes Care Project report recommendation (Primary Health Care Advisory 
Group, 2016). Health Care Homes were implemented in mid-2017 in seven primary 
health networks for 12,000 patients to strengthen continued, coordinated, and 
multidisciplinary care and health outcome (Fountaine & Bennett, 2016).  
Health Care Homes practices receive a payment ranging from $591 to $1,795 per 
patient per annum, which is derived from assessing patient complexity and morbidity 
by a risk stratification tool, which predicts risk from data used for CSIRO modelling 
and validation (DoH, 2016). The payment system eliminated the requirement for 
numerous Medicare item numbers to reimburse health services and included a one-
off grant to support staff training and infrastructure. However, professional 
organisations voiced concern regarding compensation for practice change and 
business costs details paucity (Jackson & Hambleton, 2017).  
The program aims to provide flexibility by coordinating a team-based individualised 
approach to care and focusing on cost-shifting; evaluation is planned after June 2021. 
Given the Diabetes Care Project results, a compassionate, diabetes competent 
workforce may better individualise care coordination. 
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D. COVID-19 and future Government plans  
Unexpected changes can, however, precipitate a healthcare crisis requiring rapid 
adaptation by HCPs. By March of 2020, Australian States and Territories had 
announced a state of public health emergency, and the WHO (2020a) announced that 
the COVID-19 outbreak was a pandemic. 
People with diabetes were identified as a high-risk group for developing COVID-19 
(DoH-Health Direct, 2020); adverse outcomes, including death, were four-times higher 
in people with T2D and associated with obesity (Andrikopoulos & Johnson, 2020). 
Besides many reactive activities such as stockpiling medicines, consumer behaviour 
altered in response to the pandemic and diabetes services across the nation started to 
consult with clients virtually (Andrikopoulos & Johnson, 2020). However, there were 
delays in accessing usual services and increased presentations of severe 
complications, such as hyperosmolar hyperglycaemic state and diabetic ketoacidosis 
(Palermo et al., 2020).  
Healthcare professionals were required to adapt quickly to a new environment, which 
may not have met diabetes consumer needs. Government lobbying provided COVID-
19 Medicare-funded videoconference and telephone services to CDEs and AHPs to 
enable healthcare delivery (ADEA, 2020a). The Australian Government is considering 
continuing the telehealth arrangements after 2020 following receiving positive 
feedback from consumers and HCPs (Andrikopoulos & Johnson, 2020). 
The way diabetes education and care are delivered to people with diabetes may 
change forever due to COVID-19, and HCPs may need to adapt to new delivery 
models. The models may not include human touch, complete physical assessments or 
allow the clinician to note their client’s demeanour or body language. New essential 
capabilities may evolve to ensure the consumer receives safe, quality diabetes 
education and care.  
1.5.2. The impact of health reform on diabetes education and care 
Diabetes education and HCP support became linked to the 2010 healthcare policy and 
funding changes. Consequently, primary care HCPs with previously limited roles in 
diabetes care found themselves taking on greater responsibility for caring for people 
living with diabetes: expected to undertake activities and specialised diabetes care that 
was once performed by the diabetes educators or CDE (Hollis et al., 2014). Involvement 
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in managing and administering medications in the home and residential-aged-care 
facilities by non-HCPs also increased (Dunning, 2018). 
PHCNs readiness to support diabetes education roles requires exploration to ensure 
the risk of harm to people living with diabetes is reduced (Ashton, & Wynen, 2016; 
Hollis et al., 2014; Phillips, 2019). PHCNs’ training to deliver lifestyle counselling to 
promote engagement and support appropriate behaviour change (Phillips, 2019), and 
Medicare funding incentives for the time or resourcing required to deliver diabetes 
education, e.g. insulin initiation (Furler et al., 2017), may be inadequate.  
Conversely, Australian CDEs working in private practice are under-utilised based on 
data from appropriate Medicare Team Care Arrangement item numbers (Fenton, ADEA 
President, personal communication, June 10, 2020). Also, most CDEs with significant 
diabetes experience work primarily in tertiary settings (ADEA, 2017a). Thus, those with 
more diabetes expertise are less likely to care for people living with diabetes in these 
circumstances leading to inequities in care accessed.  
To build the healthcare workforce capacity for diabetes care, linking generalists with 
diabetes competent HCPs is essential. Pivotally because primary, community and 
tertiary healthcare settings differ regarding access to diabetes training and expertise 
and exposure to managing people living with diabetes (Hicks, 2017; Hollis et al., 2014). 
Hence, the care consumers receive can differ across the nation according to the 
expertise of the HCP they access (Phillips, 2019). 
Inconsistencies in the workforce’s diabetes training and differences in business models 
may reduce the quality of care. Medicare-incentivised programs encourage referral to 
generalist AHPs and pharmacists. While generalist HCPs can be experienced, they 
possess different business models for their private practices (National Association of 
Diabetes Centres [NADC], 2019a; Pharmaceutical Society of Australia [PSA], 2019a). 
They work in isolation, as part of the same profession or a multidisciplinary group. No 
Medicare incentivised programs for chronic conditions were identified that funded 
professional development for generalist AHPs or nurses; it is driven autonomously by 
individual HCPs.  
While some professions guide the role of their profession in diabetes (Dietitians 
Australia, 2018), it is unclear whether the primary care workforce is adequately 
prepared for the diabetes education and care they are expected to provide. 
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Specifically, diabetes care is complex medical management, and people often have 
multiple conditions that require managing. 
A. Preparedness of graduating health professionals for diabetes care 
One reason for the lack of HCP preparedness for their involvement in diabetes care 
may relate to HCP undergraduate courses. A national review of diabetes content in 
undergraduate Bachelor of Nursing programs found Australian universities provided 4 
to 21 hours (0.5%-2.5%) of diabetes-specific teaching across subjects (Allied Health 
Specialist Consultants, 2018). Further, the study found that students’ exposure to 
diabetes management during clinical practice varied and was unmonitored, despite 
diabetes’ National Health Priority status. 
Students gain experience and are mentored to perform assessments, decision-
making, and deliver care by implementing their learned knowledge (Ericsson, 2015; 
Faucher, 2016). Hence, a mismatch exists between the alignment of training and 
experience to support adequate skill development for basic competence in diabetes 
care. Disconcertingly, the report indicated that the: 
[Australian Nursing and Midwifery Accreditation Council (ANMAC) confirmed] there is 
currently no requirement for diabetes-specific content to be taught and this aspect is 
not assessed by ANMAC when accrediting courses. (Allied Health Specialist Consultants, 
2018, p.8) 
ANMAC sets national competencies for nurses; it influences Universities’ curriculum 
development. Therefore, undergraduate nursing and allied health curricula content 
require guidance about the breadth of knowledge and skills required to support a 
flexible, responsive healthcare workforce or enable appropriate scope of practice (SoP) 
expansion and build capacity for a diabetes competent workforce. A capability 
framework for diabetes care could identify the capabilities required by graduating 
nurses and allied health to build capacity for a diabetes competent workforce. 
1.5.3. Expanding scope of practice 
The SoP of all health disciplines is changing to accommodate the longer duration and 
increasing prevalence of chronic conditions, the current geographical spread of 
certain health professions that do not reflect population distribution, and changes in 
practices, e.g. reduced working hours (DoH-Health Workforce, 2018). Expanded scope 
of practice is defined by Young et al. (2015, p.250) as:  
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The introduction of any role or task that increases the current scope of a profession’s 
practice, where practitioners were previously prevented from doing so.  
Moreover, increasing the scope of generalist nurses, pharmacists and AHPs’ practice 
in diabetes care has altered the SoP of diabetes educators and CDEs who are 
becoming more proactive in managing medicines (ADEA, 2018a; Pyrlis et al., 2019).  
Medical shortfalls in certain rural and remote areas in Australia and populations of 
extreme disadvantage also exist; while numbers of doctors per capita have increased by 
44% since 2000, the medical workforce remains a Government concern (DoH, 2019b). A 
shortage of 109,490 nurses and 2,701 doctors by 2025 is predicted without further 
reform (Mason, 2013). Developing the non-medical workforce is imperative by 
developing diabetes capabilities to deliver quality primary and preventative care and 
population health initiatives and expanding SoP to address medical shortages. 
Activities towards expanding SoP in Australia to meet growing community needs, such 
as medication endorsement pathways, are notable on webpages of many HCP 
organisations such as nursing, podiatry, pharmacy and dietetics (Pharmacy Board of 
Australia, 2019; Podiatry Board of Australia, 2018; PSA, 2019a). Often they focus on 
medicines to enable timely consumer access. The skills of trained medication-endorsed 
HCPs can be harnessed for diabetes care.  
However, the risk to the diabetes consumer and the HCP through complaints or 
litigation requires mitigation. A national approach is required to align appropriate 
diabetes-specific training to changing SoP to ensure evidence-based care, and a 
capability framework should underpin this approach.  
ADEA considered the CDE well suited to a ‘semi-autonomous prescriber’ role 
following additional training and supervision in feedback to the proposed registration 
standard to endorse RN prescribers in partnership (ADEA, 2018a). A capability 
framework guiding diabetes care may identify a career structure to address the 
learning needs of CDEs seeking to expand their SoP with prescribing. 
Queensland Health (2016) policy enables AHPs to work to their full SoP to meet the 
needs of its large geographical area and remote communities. The State government 
promotes tasks that fall outside recognised SoP on the premise that the AHP is 
performing what they are educated, competent and authorised, consistent with their 
policy platform. For diabetes, the department saw no regulatory impediment to 
appropriately trained dietitians undertaking insulin titration as part of an extended 
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SoP (Queensland Health, 2014). However, inconsistent training across different 
disciplines and Australia can reduce the safety and quality of care and consumer 
engagement. 
The exponential growing diversification in diabetes practice skills and knowledge and 
the expanded SoP different health professions seek, supported by all Australian 
Government levels, creates a risk to quality, safe diabetes care, which is recognised 
internationally (Daly et al., 2019; Hick, 2019; Phillips, 2019). The constant generation 
of knowledge alters our understanding of diabetes pathophysiology and the 
management required and available. 
Hence, an appropriate level of diabetes competence among HCPs is paramount, 
primarily because the workforce drive is often not competency-driven. However, 
compounded by policy occurring faster than regulation and funding factors. These can 
create differences in practices and what the consumer can expect to receive. 
1.6. The problem - justification for the study 
Fundamentally many HCPs are underprepared for future diabetes healthcare needs. A 
gap among the expected standards, course requirements, training consistency, and 
capabilities for many HCPs supporting or taking a role in diabetes care in Australia 
exists (Alford, 2016). Essentially, a flexible and adaptive HCP workforce equipped to 
manage diabetes across the continuum of care and through transitions of care to 
increase equity in safe diabetes healthcare is needed (DoH, 2019c). 
Diabetes is a costly National Health Priority of increasing prevalence. The Australian 
National Diabetes Strategy 2016-2020 (CoA, 2015) identified the workforce as an 
enabler to improve access to equitable quality care; it emphasised: “high-quality, 
person-focused and integrated multidisciplinary teams spanning the health continuum 
is required to support all actions” (CoA, 2015, p.8). Thus, identifying the skills and 
knowledge required by all HCPs is paramount.  
In parallel to health reform, the number and complexity of available technologies and 
medicines used to manage diabetes have increased exponentially in the last decade 
(Gunton et al., 2016; Pyrlis et al., 2019). Furthermore, while the prevalence of T1D and 
T2D is increasing, an improved understanding of the pathophysiology of different 
diabetes types is driving healthcare change (AIHW, 2019; WHO, 2019).  
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More diabetes consumers access varied healthcare providers throughout the 
healthcare system who require more complex medicines regimens and use more 
diabetes technologies. The broader HCP workforce is not adequately prepared or 
resourced for these challenges and employer expectations (Ashton & Wynen, 2016; 
Phillips, 2019). Hence, the current Australian diabetes-trained workforce is unlikely to 
meet the needs of the diabetes consumer.  
Pivotal to HCP lack of preparedness for diabetes care is the limited diabetes-specific 
content in Australian undergraduate health degrees and inconsistencies in CDE 
postgraduate training. The higher demand for HCPs with diabetes and non-medical 
prescribing competencies warrants a more efficient way to develop the workforce. 
The diabetes-trained workforce requires the capacity to enable safe expansion in 
diabetes technology use and support medicines management.  
Better preparing the health workforce to deliver diabetes care by identifying relevant 
capabilities supports early detection and improves referral processes and triage 
points, improving access to care and reducing health costs. Further, it assists HCPs to 
appropriately increase their SoP to meet the healthcare needs of people living with 
diabetes in specific settings, such as remote settings.  
The information HCPs provide and the approach they take can engage or disengage the 
person accessing health services. Inconsistent or stigmatising health messaging to 
consumers with chronic conditions leads to disengagement (Hendrieckx et al., 2020). 
Consistency promotes engagement with and improves healthcare through improved 
consumer health literacy (Hendrieckx et al., 2020). A capability framework could 
improve consistency by guiding health curricula development across the nation.  
1.7. Research aim and question  
The research aim was: 
• To develop a capability-based framework by consensus for the Australian non-
medical HCP workforce who provide diabetes education and care across the 
healthcare system. 
The research objectives were: 
1. To identify and understand the different healthcare professional diabetes practice 
levels used to deliver diabetes care in Australia. 
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2. To identify the capabilities required to deliver quality, safe diabetes education 
and care. 
3. To increase the health workforce’s capacity to manage diabetes. 
The study’s overarching research question was: What capabilities are required across 
the healthcare workforce to deliver future diabetes education and care? 
1.8. Personal orientation to the study 
As an instrument within the research process, understanding the researcher’s 
orientation to the study is essential. Kayrooz and Trevitt (2005, p.280) stated: 
The researcher’s identity is rarely mentioned in many research texts, yet their age, 
gender, role, position and experience can profoundly affect the conduct of the research 
itself – particularly on stakeholder perceptions of bias.  
In the interests of transparency, I describe my orientation and share a broad overview 
of my experiences that could have influenced the study in unknown ways.  
As a Nurse Practitioner (NP) and CDE with 30-years’ experience in clinical and 
management settings, I support people who live with diabetes through assessment, 
diagnoses, prescribing, education and research. I have held diabetes leadership 
positions at state and national levels, as president and director of the Australian 
Diabetes Educators Association (ADEA), which credentials diabetes educators and 
Diabetes Australia board director, the national consumer advocacy organisation. 
Throughout my career, I have used mentorship and reflective practice to develop my 
skills, regardless of others seniority and sought opportunities for growth. 
I have represented diabetes nursing nationally for Ministerial advisory groups and 
Government-funded Pharmaceutical Benefits Scheme (PBS)reviews, such as the Post-
Market Review of Products Used in the Management of Type 2 Diabetes (T2D). As 
ADEA’s president, I approved and supported the Indigenous Educational Pathways 
Project, among others. Further, I have coordinated, designed, implemented and 
evaluated models of care to increase access to quality safe care in a rural, regional 
setting for people with diabetes.  
These positions provided me with a wealth of experience and understanding of the 
diabetes healthcare workforce and the settings in which diabetes care is delivered. 
Further, they gave me insight into the significant contribution HCPs make to people 
living with diabetes and the challenges diabetes educators face across the nation.  
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Disputes regarding professional role boundaries in diabetes care and SoP concerns are 
among the challenges the diabetes workforce faces. Lack of clarity leads to conflict, 
which has no place when providing safe, quality care. Over the past 25 years, I have 
been privy to many discussions debating the topic. 
My aim has always been to provide appropriate person-centred care to support 
consumers' goals, prevents or delays the progression of comorbidities and helps 
people achieve the best quality of life (QoL) possible. Some individuals have embraced 
the support, while others have arrived angry, disillusioned or disengaged. Ultimately, I 
have been in a position of privilege, where consumers have shared their stories. 
Besides personally learning from their storytelling, their words tell me we can do 
better. If we can do better, we should strive to do the best we can. 
The current study’s focus fits my keen interest in equitable access to high standards of 
safe quality care, regardless of the healthcare setting and individual consumer needs. 
The ways that potential biases were managed are discussed in Chapter 4. 
1.9. Thesis outline 
The thesis comprises eight chapters. Chapter 1 introduced the topic and issues. 
Chapter 2 provides a literature review about the diabetes workforce, how a health 
professional becomes an expert in diabetes, existing competency frameworks for 
diabetes and the competencies required for diabetes education and care, and 
medicine management in diabetes.  
Chapter 3 provides information about research methods for developing frameworks 
and building consensus, and the theoretical models underpinning the study. These 
informed the aims, objectives and research questions guiding the inquiry. Next, the 
systematic design of the modified Delphi technique used in the study and its three 
data collection methods is shared: Stage I, a pre-Delphi consultation, Stage two the 
Delphi survey and Stage 3, a post-Delphi Stakeholder appraisal. The chapter concludes 
with the processes used to ensure research rigour.  
Chapter 4 describes the pre-Delphi data collection period (Stage I) of the three-staged 
modified Delphi technique used in the study. It shares the study setting; the steps 
used for data collection, including participant sampling and data analyses. Lastly, the 
findings used to inform the framework design, Delphi questions and online survey 
platform.  
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Chapter 5 presents the Delphi survey data collection period (Stage II) and the findings, 
which led to the development of the draft ‘Capability Framework’. Namely, it 
incorporates the practice levels and the relevant capabilities and statements 
identified. Chapter 6 presents the post-Delphi appraisal period (Stage III), the data 
collection method and analyses. These findings finalised the framework. 
Chapter 7 provides information about workforce implications for delivering diabetes 
education and care identified from the findings. The study strengths and limitations 
follow. Chapter 8, the final thesis chapter, provides the recommendations regarding 
practical actions needed to safely enhance the role of HCPs to enable them to deliver 
safe, quality diabetes care. The chapter finishes with research recommendations and a 
thesis conclusion. 
1.10. Chapter summary 
By 2030, diabetes is expected to be the leading cause of disease burden in Australia, 
when over half the CDE workforce reaches retirement age. The prevalence of diabetes 
is high: diabetes impacts the person and their family physically, psychologically and 
financially. Diabetes care is everybody’s business. 
The Government has invested in expanding HCPs’ scope of practice to meet diabetes 
healthcare needs, focusing on non-medical prescribing. Simultaneously, the number of 
technologies and medicines available to people to manage their diabetes have grown 
exponentially, adding to the complexity of the care provided. Further, Government 
reform enables the passage of diabetes healthcare from tertiary to primary settings; 
however, undergraduate health degrees have inadequate diabetes content. Hence, 
care and education traditionally provided by diabetes educators are now offered by 
primary HCPs who can lack adequate training.  
Consequently, many diabetes care activities are occurring with little consideration 
towards developing the healthcare workforce’s capacity to meet the aims set by the 
Government. The current study aims to develop a capability-based framework by 
identifying the essential capabilities for different HCPs across the workforce. 
Understanding the capabilities HCPs require to support consistent practice and 
strengthening connections within the diabetes care workforce may enable a flexible, 
adaptable workforce.   
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Chapter 2: The healthcare workforce and competence in 
diabetes education and care 
2.1. Introduction to chapter 
The purpose of Chapter 2 is to provide an understanding of the existing research and 
debates relevant to the area of study gathered from a literature review. First, the 
research questions are listed, then the literature search strategy used, followed by 
information about the diabetes healthcare workforce focused on disciplines eligible for 
credentialling as CDEs, who can access Team Care Arrangements including: 
• Primary healthcare nurses 
• Pharmacists 
• Allied health professionals, i.e. dietitian, podiatrist and exercise physiologist 
• Aboriginal and/or Torres Strait Islander health practitioners 
• Midwives 
• Diabetes educators 
From this point on, these roles will be referred to as healthcare professionals (HCP) 
unless explicitly referring to a discipline. The chapter provides information about how a 
HCP develops diabetes expertise, role diversification and boundaries, and access.  
A historical account of the competency development movement in Australia and 
information about competency frameworks for diabetes education and care follows. 
Next, competencies required by the diabetes healthcare workforce to deliver safe, 
quality care are identified. Last, an overview of non-medical prescribing in Australia 
and internationally focusing on diabetes management are discussed.  
2.1.1. The research questions addressed in the chapter 
1. Which healthcare professionals support diabetes education or care? 
2. How do healthcare professionals currently become competent and experts in 
diabetes education and care?  
3. What capability or competency frameworks exist to inform diabetes education 
and care? 
4. What is the existing evidence about the capabilities or competencies 
healthcare professionals require to deliver diabetes education and care?  
5. What is known about diabetes-related medicine management? 
6. How are diabetes educators involved in medicine management in Australia? 
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2.1.2. Literature search strategy 
CINAHL and Medline Complete databases were used to identify peer-reviewed 
research articles written in English between 2009 and 2019, using the search terms 
listed in Table 2.1. The search period was chosen as it aligned with the decade of 
health reform described in Chapter 1. Article abstracts were reviewed to identify 
pertinent literature. Research articles were selected based on their thematic and 
content relevance to the inquiry; any concerning diabetes or diabetes education and 
the HCP role were obtained for detailed reading.  
A systematic narrative literature review was undertaken because no capabilities were 
identified. Also, the main objective of the review was not to formulate a well-defined 
question but to understand how to build the health workforce’s capacity for diabetes 
care. A narrative review provides a credible, evidence-based story that cites relevant 
existing literature addressing multiple questions, focusing on educating on a topic 
(Ferrari, 2015; Gregory & Denniss, 2018), supporting the content used in Delphi. After 
conferring with a librarian, three searches were undertaken to identify pertinent 
information to answer the six research questions listed in Section 2.1.1 on page 30. 
Table 2.1 Search terms used to identify peered reviewed articles 
Search 1 diabet* AND ‘health professional*’ OR ‘practice nurse*’ OR dietitian* OR 
dietician* OR podiatrist* OR ‘exercise physiologist*’ OR ‘Aboriginal health 
worker*’ OR midwi* OR physiotherapist* OR pharmacist* AND educat* 
Search 2 ‘diabet* educat*’AND capabilit* OR competenc* OR credential*  
Search 3 diabet* AND ‘non-medical prescrib*’ OR prescriber* OR ‘medicine 
management’ 
 
Search 1 was performed to identify literature about HCPs’ involvement in diabetes 
education and care (Research question 1). Search 2 was performed to identify 
literature relating to HCP capabilities, competencies and competence in diabetes care 
(Research questions 2 to 4). Search 3 identified literature about diabetes-related 
medicine management (Research questions 5 and 6). 
Search 1 including all HCPs, yielded an impractical number of references. Hence, the 
search was repeated separately for each profession listed, removing the term ‘health 
professional*’. Overall, this refined search strategy resulted in 171 articles for review. 
Of these, 16 were duplicates and 114 out of scope because they were not specific to 
Chapter 2: The healthcare workforce and competence in diabetes education and care 
32 
 
the HCP roles in diabetes; thus, 41 informed research question 1. Search 2 identified 
7,693 articles; the majority were out of scope because the search captured articles 
relating to ‘competence’ rather than describing competencies or focused on the 
consumer rather than the HCP role: 12 were obtained for further reading to inform 
research questions 3 and 4. To ensure relevant articles were not missed, the term 
competenc* was removed from Search 2 and rerun; however, no articles about 
diabetes capabilities for HCPs were identified. 
Last, Search 3 yielded 1,625 articles; 77 were duplicates, 1449 out of scope because 
they were not related to diabetes and more commonly about opioids, 99 were 
obtained for reading; however, the majority were not specific to diabetes or concerned 
medication aides, so 19 informed questions 5 and 6.  
Further, the Australian, Canadian, New Zealand (NZ), United Kingdom (UK) and the 
United States of America (USA) peer diabetes HCP organisations, the Australian Health 
Practitioner Regulation Agency, National Association of Aboriginal and Torres Strait 
Islander Health Worker and Practitioner and the National Prescribing Service websites 
were reviewed for grey literature concerning credentialing or certification processes, 
and competency and capability frameworks or prescribing. The review yielded 61 
documents, including 19 reports, 17 standards, 16 frameworks, six position 
statements/policies, and two consultations papers. Also, each diabetes organisation 
was asked to provide any information about the benefit or value of the diabetes 
educator role, which resulted in three reports. 
2.2. Healthcare professionals who support diabetes care 
Diabetes impacts healthcare across the continuum of care; consequently, diabetes 
education occurs in many healthcare settings and life-stages, including neonatal, 
paediatric, youth, adulthood, pregnancy, aged and palliative care (Dunning, 2017, Ng 
et al., 2017). Hence, all HCPs play an essential role in reviewing and discussing aspects 
affecting diabetes education and care.  
Specifically, all HCPs are likely to encounter people living with diabetes at critical time-
points in the person’s life. Critical time points when people are more likely to 
experience adverse events occur during the transfer of care and medication or 
treatment changes (ACSQHC, 2020a). Others include when disengaged adolescents or 
young adults with T1D have a health-related turning point, such as overcoming a 
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significant health scare (Ng et al., 2017). Ng et al. suggest these critical time-points are 
opportunities for HCPs to support engagement with care.  
Also, HCPs need to be competent in diabetes education across the care continuum to 
help address inequities in Australia’s healthcare system. Australia experiences 
workforce shortages across several health professions, including medical doctors, that 
are more critical in rural and remote areas and for more vulnerable populations (DoH, 
2019c). Demands for healthcare services will increase with an aging population and 
growing community expectations (NRHC, 2020a). Thus, HCPs need to be equipped to 
manage diabetes, support consumer engagement with health services and know when 
and how to refer in a clinically precise non-demeaning manner to ensure equity in safe 
diabetes healthcare (Dunning & Speight, 2019).  
The following sections describe the role of different disciplines in diabetes education 
and care in Australia.  
2.2.1. Primary health care nurses  
The largest health profession group involved in diabetes care is the primary 
healthcare nurse (PHCN); nurses overall account for half of all registered HCPs in 
Australia (AHPRA, 2020). General diabetes screening and management are 
undertaken in the primary care setting in Australia (AIHW, 2016). The AIHW (2016) 
defines primary care as entry-level, or the first contact people have with the 
healthcare system. Primary care relates to broad community-based services including, 
health promotion and prevention and treating and managing acute and chronic 
conditions (Australian Primary Health Care Nurses Association, 2019). 
PHCNs in Australia include Commonwealth-funded practice and public state-funded 
community nurses. They are well-positioned in the primary care setting to provide key 
aspects of diabetes education and care to a broader proportion of people living with 
diabetes and prediabetes than HCPs in other healthcare settings (Daly et al., 2019; 
Hollis et al., 2014). Yet, Australian and international literature suggest PHCNs may be 
inadequately trained to provide that care.  
A survey by Hollis et al. (2014) of 29 Australian PHCNs from multiple practices about 
their knowledge of diabetes founds deficits in basic knowledge, such as managing 
hypoglycaemia and insulin action, despite the majority recently completing a three-
day diabetes management course. Similarly, the UK iDEAL Group, an independent 
multidisciplinary panel of diabetes experts and consumers, confirm that deficits in 
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PHCNs’ diabetes knowledge are common (Phillips, 2019). Due to rapidly evolving roles, 
the group identified the need to keep PHCNs up to date to deliver evidence-based 
diabetes care wherever they practice. Daly et al. (2019) found that increasing diabetes 
skills in PHCNs can improve diabetes care, in a 10-year follow-up New Zealand survey 
of 1,363 PHCNs, including interviews of PHCNs and consumers.  
The level of access to training and time afforded to PHCNs in Australia is unclear, and 
pressures to deliver usual services with limited resources in environments under 
constant restructured have been identified by PHCNs as reasons for not fully engaging 
in training (Furler et al., 2017; Ismail et al., 2018). The National Association of Diabetes 
Centres’ (NADC) aimed to address gaps in PHCNs’ knowledge and skills in diabetes via 
its National Diabetes Care Course, which was reformatted for an online platform in 
2017 and promoted to the PHCN workforce (NADC, 2019a). However, the effects on 
practice are not yet known. 
The search strategy in this study identified seven RCTs investigating the PHCN’s role in 
diabetes management, see Table 2.2 on page 35. Two were conducted in Australia 
(Blackberry et al., 2013; Furler et al., 2017) and five internationally. Notably, only the 
study by Furler et al. found statistically significant improvements in HbA1c and two 
other health outcomes, including depression and quality of life, and it was the only 
study that included ongoing CDEs mentoring of PHCNs in the intervention.  
In the remaining six RCTs (Blackberry et al., 2013; Branda et al., 2013; Frei et al., 2014; 
Ismail et al., 218; Juuls et al., 2014; Van Dijk-de Vries et al. 2015), no benefit in the 
primary outcome HbA1c was observed concerning PHCN diabetes-related training; 
however, an improvement was found in one health outcome, either diabetes-related 
distress or a cardiovascular endpoint. Findings from a systematic review and quality 
appraisal of studies that measured the effects of PHCNs supporting the management of 
people with T2D found people with higher HbA1cs might derive greater benefits from 
support provided by PHCNs (Parker et al., 2016). 
The evidence overall, despite limitations including lack of validated survey tools (Hollis 
et al., 2014), an inadequate description of some research elements (Daly et al., 2019; 
Hollos et al., 2014) and selection bias (Furler et al., 2017) suggests PHCNs may currently 
lack the skills and knowledge to support diabetes education and care appropriately and 
effectively.  
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Sample Intervention Primary outcomes 
measures 
Proposed limitations  Country 
Blackber








PHCN with two-day of training delivered 
scheduled and structure telephone coaching on 
self-management, medicines and dosing. Advice 
and medicines intensification aligned with GP-
led treatment goals. 
No significant difference in: 
HbA1c, lipids, renal 
function, weight, BMI, QoL 
and depression scales. 
 
Intervention intensity and fidelity was compromised; hence, the 
findings do not align with the methods and fall short of 











Decision aide for discussions about statin and 
glucose-lowering medicine choices. 
No significant difference in 
HbA1c and LDL. 
The approach falls short of answering the study’s aim given the 
small sample size and measuring the intervention due to 











The ‘Stepping Up’ model trialled practice nurses 
mentored by CDEs, leading discussions with 
patients about managing insulin dosing with GP 
liaison. 
Statistically significant 
reductions in patients’ 
HbA1c, depression and QoL 
scales. No significance in 
physical health PAID 
psychometric evaluation. 
Selection bias was introduced as the control participants were 
recruited before randomisation, impacting their characteristics 
and thus the trustworthiness of findings. Although outcomes 
were attributed to the program, they may result from 








A six-day training course and a decision aide to 
support practice nurses for their role within the 
team. 
Blood pressure (BP) and LDL 
cholesterol improved. 
No statistically significant 
difference in HbA1c and LDL 
cholesterol. 
Risk of bias due to the inability to blind primary care physicians 












Practice nurses were trained in 6 psychological 
skills and delivered a 12-sessions program based 
on cognitive behavioural therapy or motivational 
interviewing versus standard care. 
No significance difference in 
HbA1c due to treatment or 
increase nurse contact time. 
The approach falls short of answering the study aim and 
measuring the intervention because repeated measures of 
HbA1c were not collected, and they failed to achieve a minimum 












A 16-hour self-determination, theory-based 
course and communication training undertaken 
by PHCNs delivered over ten months. 
No significant difference in 
HbA1c 
Total cholesterol level 
improved. 
Method issues - time allocation for nurses to sufficiently 













Three 8-hour education sessions followed by 
booster sessions to PHCNs to incorporate self-
management support into routine consultations. 
No statistical difference in 
HbA1c, PAID, QoL or self-
efficacy. 
The method falls short of addressing the aim given the low 
exposure to the complete intervention by participants. 
Netherlands 
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To manage the forecasted number of people with diabetes in Australia, increasing 
the capacity of the primary care workforce to deliver diabetes education and care is 
essential. It is essential to understand the knowledge and skills PHCNs require in 
their work setting to be diabetes competent. Also, the role CDE mentoring of PHCNs 
has in developing diabetes competence to increase workforce capacity.  
2.2.2. Pharmacists  
Pharmacists are one of the initial points of health contact for many people with 
diabetes and represent the fifth largest of Australia’s 16 registrable health professions 
(PSA, 2019b). Pharmacists are experts in medicines and have a primary responsibility 
to ensure medicines are used and dispensed safely and judiciously to achieve optimal 
health outcomes and economic objectives (PSA, 2019a). Pharmacists are an individual 
profession, given their unique medicines skill-set (PSA, 2019b). 
Two broad groups of pharmacists exist. Community pharmacists work more directly 
with consumers, and hospital pharmacists collaborate more with large healthcare 
teams (PSA, 2019b). Pharmacists’ clinical expertise is suited to educating 
consumers, monitoring and managing diabetes medication plans, particularly in 
people with T2D, and supporting medicine change in those who do not respond to 
or tolerate a medicine (Deters et al., 2018). 
Sentinel events of hyperglycaemia or hypoglycaemia often precede acute glycaemia 
presentations managed by ambulance services or emergency departments (Villani 
et al., 2017; Yan et al., 2018). Therefore, opportunities exist for a diabetes-
competent pharmacist workforce to reduce acute presentations by ensuring that 
discharge diabetes medicines are individualised and understood and that medicines 
plans are reviewed.  
The Australian Government identified community pharmacies as ideal venues for 
health promotion and diabetes screening (CoA, 2015), a stance supported by some 
literature. A 0.66% significant positive difference in HbA1c was identified in a 
systematic literature review and meta-analysis of 11 eligible RCTs that measured the 
outcomes of community pharmacists’ interventions for 640 people with diabetes 
(Deters et al., 2018). The quantitative analysis of the intervention elements 
identified that sending feedback to the physician, setting individual consumer goals 
and analysing the consumer’s medications reaped the effect on HbA1c values 
(Deters et al., 2018). However, the study did not account for differences in health 
system models, socioeconomic disadvantage or pharmacist training.  
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According to McNamara et al. (2020), pharmacist screening programs eased the 
appointment burden and are sustainable for detecting undiagnosed diabetes in 
Australia. Their feasibility project was an exploratory implementation study 
involving pharmacist training, screening intervention, and interviews with 388 
consumers and ten pharmacists from a range of community pharmacies. Moreover, 
a UK economic modelling study of community pharmacy screening, which included 
HbA1c screening of 336 consumers living in diverse social deprivation, identified 
pharmacists’ screening and care coordination as cost-effective (Wright et al., 2019).  
The search strategy for this thesis identified eight RCTs that investigated the 
pharmacist’s role in diabetes, see Table 2.3 on page 38. One was conducted in 
Australia relating to diabetes screening (Krass et al., 2017). Internationally, two 
concerned diabetes medication adherences (Erku et al., 2017; O’Connor et al., 2014) 
and the remaining five measured outcomes of diabetes education (Ali et al., 2012; 
Chen et al., 2016; Mehuys et al., 2011; Sarayani et al., 2018; Shao et al., 2017). The 
outcome of interest was a significant decrease in HbA1c in these five studies and 
pharmacists were diabetes-trained or CDEs in all. 
Despite limitations, including lack of transferability (Chen et al., 2016; Erku et al., 
2017), limited investigation of confounding variables (O’Connor et al., 2014; Shao et 
al., 2017), high drop-out rate (Saravani et al., 2018), and selection bias (Ali et al., 
2012), the evidence suggests pharmacists have a role in counselling and screening 
for diabetes, and individualising consumer goals and medication plans (Ali et al., 
2012; Chen et al., 2016; Krass et al., 2017; 2014; Saravani et al., 2018; Shao et al., 
2017). The pharmacist role in supporting diabetes medication adherence was 
variable (Erku et al., 2017; Mehuys et al., 2011; O’Connor et al., 2014). However, 
diabetes-specific accreditation models could promote greater improvements. 
The NADC aims to improve the quality and safety of pharmacy-based diabetes services 
through accreditation (NADC, 2017). The diabetes-specific accreditation model 
assesses clinical, governance and educational criteria. To qualify as a NADC diabetes 
pharmacy service, applicants must have completed the postgraduate certificate in 
diabetes education or, if not a CDE, the National Diabetes Care Course. Here, the 3-day 
NADC course is weighted equally to CDE credentialling, despite the difference in 
training; hence, the CDE status may not be valued. Currently, few Australian 
pharmacists are CDEs; thus, the quality of diabetes care may vary.  
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Intervention Primary outcomes 
measures 
Proposed limitations Country 
Ali et al., 
2012 




Monitoring/counselling by a community pharmacist on six 
occasions over 12-month, on pre-set topics about diabetes, 
its treatment and associated cardiovascular risk factors. 
Statistically significant reductions in 
HbA1c, BP, BMI, diabetes-related 
knowledge and QoL, and medication 
concerns. No differences in lipids. 
The pharma industry funded the study, 
and their approach failed to address bias, 






RCT  127 adults 
with T2D 
Single centre 
Personalised pharmacotherapeutic care plan and diabetes 
education to review the impact of pharmacist-led therapy 
management on medication adherence. 
Statistically significant increase in 
medication adherence at 3 and 6-
months and decreases in hospital 
admissions. 
A drawback concerned transferability of 
results: depends on consumers’  






RCT 100 adults 
with T2D 
One 421 bed 
hospital 
Pharmaceutical care provided by a certified diabetes-
educator pharmacist to elderly consumers with non-target 
glycaemic levels over 6 one-hour sessions to resolve drug-
related problems. 
Statistically significantly decrease in 
HbA1c after 6 months. No 
differences in medical expenses and 
hospitalisation rates. 
Results may not be transferable to the real 
world due to site-interaction effect; the 
intervention group was not blinded, 













Three sequential screening methods offered by pharmacies:  
Group A - risk assessment using a validated tool 
(AUSDRISK); Group B - AUSDRISK assessment followed by 
point-of-care HbA1c testing; Group C - AUSDRISK 
assessment followed by point-of-care blood glucose testing. 
Opportunistic screening cost 
effective and sustainable for 
detecting undiagnosed diabetes.  
Advantages include that it included 












Counselling focused on correct medication use, medication 
adherence and healthy lifestyle promotion. 
Statistically significance difference in 
HbA1c. 
The results were not sustained; at 18-






RCT 2,378 people 
with diabetes 
One scripted telephone call from a diabetes educator or 
clinical pharmacist to identify and address non-adherence 
to new medication assessed against the first medication fill 
within 60 days of the prescription and within 180 days. 
No difference in primary adherence, 
medication persistence, or 
metabolic markers. 
Challenges the outcomes of previous 
studies listed: although, intervention 
greater in other studies.  
United States 









Sixteen counselling telephone calls in 3-month by a 
diabetes-trained pharmacist working in an academic drug 
centre. 
Significant improvement in HbA1c in 
both groups at 3 and 9-months. 
Small improvement in lipid profile, 
adherence and self-care scores. 
Fidelity of results due to the high drop-out 




RCT 240 adults 
with T2D 
One hospital 
Extra pharmaceutical care from clinical pharmacists 
including two sessions focused on diabetes management 
i.e., proper use and precautions of GLMs and insulin, signs 
or symptoms of hypoglycaemia and healthy lifestyle. 
Significant improvement in 
metabolic markers including HbA1c, 
total cholesterol and BP. 
These investigations disregard the effects 
of confounding factors, e.g. the impact of 
other HCP education while inpatients.  
China 
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Insufficient practice hours with patients with diabetes and employer restrictions 
were identified as barriers to maintaining CDE credentials in a survey using a 
validated tool of 462 USA CDE pharmacists (36.2% response rate); hence, they were 
more likely to focus on dispensing in the community (Gonzalvo et al., 2018). A 
pathway for Australian pharmacists interested in diabetes to work towards CDE 
status exists; it provides a ‘road map’, sample scopes of practice and advice on 
remuneration (PSA, 2017). However, community pharmacists are privately funded, 
and it is unknown whether funding for ongoing diabetes education is easy to access.  
In summary, pharmacists in Australia can contribute to diabetes education and care 
concerning the increasing number and complexity of glucose-lowering medicines 
regimens to reduce adverse outcomes and acute glycaemia admissions. Evidence 
suggests that pharmacists play a role in reducing the adverse outcomes of diabetes 
augmented through appropriate diabetes-specific training. A focus on increasing 
pharmacist diabetes capabilities can increase workforce capacity for diabetes care. 
2.2.3. Allied health professionals  
Allied health professionals (AHP) also have an essential role to play in optimal 
diabetes care. Definitions of AHPs are inconsistent; until recently, a common 
feature has been HCPs who do not prescribe medicines (NRHC, 2020a). For this 
thesis, AHPs refers to professions eligible for Australian Diabetes Educator 
Association (ADEA) credentialling, including accredited practising dietitians (APD) 
and exercise physiologists (AEP), and registered podiatrists and physiotherapists. 
A. Dietitians 
Dietitians are involved in diabetes care through Team Care Arrangements and 
health promotion in primary care or as CDEs. A systematic literature review of RCT 
and non-RCT studies reporting outcomes of primary care dietitian intervention for 
obesity between 2000 to 2014 showed changes in diabetes and cardiovascular 
disease outcomes, including metabolic markers, weight and BMI compared to usual 
care (Howatson et al., 2015). Despite limitations to the review, including a lack of 
study quality appraisal and limited investigation of confounding variables, e.g. 
multidisciplinary care or medicines prescribed, these results still suggest APDs can 
play an essential role within the diabetes healthcare workforce.  
Dietitians have explored expanding their scope of practice (SoP) to include medicines 
in Australia and internationally (Stenner et al., 2018). An RCT of 118 adults with T2D 
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investigated the effectiveness of a dietitian-led telemedicine program supported by 
a CDE (Benson et al., 2019). A treatment protocol was initiated to titrate medicines 
combined with medical nutritional therapy to manage blood glucose, BP and lipid 
levels. Improvements were seen in aspirin and statin usage; however, no difference 
in HbA1c was identified. The protocol was not always adhered to, with nurses 
making medication changes independently; however, the findings remain indicative 
that dietitians can play a role in improving medicines adherence.  
B. Exercise physiologists and physiotherapist   
The role of exercise and diet in preventing T2D is established (Briggs Early, 2018). 
Accredited exercise physiologists (AEP) and physiotherapists play an important role 
in advising physical activity for people living with diabetes. AEP and physiotherapists 
are experts in movement and exercise to assist clients in managing chronic 
conditions, disability and injury (Exercise & Sports Science Australia, 2020), 
reducing pain and stiffness, increasing mobility and rehabilitation (Australian 
Physiotherapy Association, 2020).  
AEPs and physiotherapists often work in private practice in Australia, and very 
few are CDEs (ADEA, 2017a). However, an opportunity to harness their skills to 
better support individualised tailored diabetes care exists by working more 
closely with diabetes teams or becoming CDEs. Ultimately, physical activity 
barriers should not include diabetes, particularly in youth who are developing 
lifelong habits (Chetty et al., 2019).  
Research has shown that physiotherapists and AEP can play an important role in 
rehabilitation and preventative diabetes care. An RCT of an AEP-led education 
program about the impact of exercise on and managing glucose homeostasis in 32 
people with T1D found reduced exercise-induced hypoglycaemia (Piotrowicz, et al., 
2019). Two prospective studies also support the role of community physiotherapists 
(Higgs et al., 2016) and AEPs (Dunstan et al., 2006) in diabetes education and care.  
Higgs et al. examined a 12-week community-based physiotherapist-led lifestyle 
program in 36 adults with diabetes. Despite 30% attrition due to medical reasons, 
they reported statistically significant improvements in aerobic fitness, exercise 
behaviour and self-efficacy (Higgs et al., 2016). Dunstan et al. (2006), examined an 
AEP supervised twice-weekly resistance training program for 12-months in 57 
people with T2D. Participants were randomly assigned to a gym or their home, and 
significant reductions in HbA1c, lipids and BP were found.  
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Limitations of both prospective studies included lack of controls as comparators and 
drop-out bias. However, these studies suggest movement specialists are essential in 
diabetes education. Better diabetes-trained and integrated AEP and physiotherapists 
could afford extended benefits and delay diabetes-related complications.  
C. Podiatrists   
Podiatrists play a major role in managing high-risk foot conditions (McLean et al., 
2019). In Australia, diabetes-related amputation rates are a concern with rates 
greater than similar nations; more than 4,400 occur per annum, and incidence 
varies up to 10-fold across Australia (Van Netten et al., 2017). Podiatrists’ access to 
at-risk people with diabetes and multiple comorbidities means they have a vital role 
in health promotion while managing neuropathic ulcers, deformities and Charcot’s 
joints, foot infections and minimising the frequency of hospitalisation (Bullen et al., 
2019; McLean et al., 2019; NADC, 2018).  
A meta-analysis of prospective or retrospective cohort studies assessed the 
outcomes of including podiatrists in multidisciplinary teams (Blanchette et al., 
2020). Including a podiatrist in interventions on diabetic foot ulcerations and lower-
extremity amputations significantly reduced both outcomes. A limitation was that 
most studies included did not have controls as comparators. The data reflects best 
practices in multidisciplinary care (Fountaine & Bennett, 2016); even so, the 
successful outcomes were attributed to the podiatrist role. 
Podiatrists have an essential role in educating other HCPs about dermatological, 
neurological and vascular foot screening and identifying those at high-risk as a means 
of reducing diabetes-related foot complications (NADC, 2020). Programs such as 
FootForward support HCP training (NADC, 2020); however, few podiatrists are CDEs 
(ADEA, 2017a). An opportunity exists for better-personalised care by increasing 
diabetes competence within the podiatry workforce, including in Aboriginal and 
Torres Strait Islander communities where higher levels of adverse foot outcomes and 
smaller rural and remote communities exist (Chuter et al., 2019; NADC, 2020).  
2.2.4. Aboriginal and/or Torres Strait Islander Health Workers and 
Practitioners 
The Aboriginal and/or Torres Strait Islander Health Worker and Practitioner role is 
pivotal in supporting diabetes care to Indigenous Australians, given the higher 
prevalence in Indigenous communities (The Lowitja Institute, 2014). The Aboriginal 
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health worker (AHW) role emerged as a cultural broker who delivered a range of 
immunisation and health promotion services in the 1950s (Curtin Indigenous 
Research Centre, 2001). Their current role remains critical in environmental and 
mental health for Indigenous peoples and reducing anxiety related to accessing 
health services (Straw et al., 2019). As of 2020, there were 806 registered Aboriginal 
and/or Torres Strait Islander health practitioners in Australia (AHPRA; 2020). 
Culturally safe interventions have been shown to increase positive clinical outcomes 
for Indigenous people with diabetes and engagement with healthcare (Tremblay et 
al., 2019). Integrating more Indigenous HCPs in the workforce is key, according to 
Tremblay et al. (2019), who performed a rapid systematic literature review of seven 
studies that evaluated cultural safety between 2000 and 2018. The authors suggest 
that Aboriginal and Torres Strait Islander health workers and practitioners are more 
suited to modifying clinical environments to support cultural safety. 
Further, involving AHWs in consultations where diagnosis or medication changes 
enable culturally appropriate information sharing (Straw et al., 2019). These 
findings derived from a phenomenological study of Aboriginal adults with T2D in 13 
semi-structured interviews using yarning and an audit of 915 patients managed in 
two remote communities. The interviews were undertaken by AHWs known to the 
consumers; therefore, familiarity bias may have affected the results. However, 
participants suggested that involving AHWs provided consistent support and 
education by people who understood their unique situation and needs.  
Moreover, an RCT evaluating a culturally safe, AHW-led community model of 
diabetes care in 213 high-risk Indigenous people in 12 remote Indigenous Australian 
communities corroborated these findings. McDermott et al. (2015) identified 
significant reductions in mean HbA1c of 10.7% by -1% (p=0.02) and increased GP 
Management Plans uptake in the intervention group. However, differences in BP, 
lipid profile, BMI or renal function, and smoking rates were insignificant. Limitations 
included sampling bias as participants knew recruiters and a lack of information on 
the control conditions. Nevertheless, the outcomes of these studies demonstrate 
the benefits of increased access to appropriate healthcare enhanced by the AHW.  
Thus, an Indigenous workforce’s unique cultural expertise coupled with increased 
diabetes capabilities support delivering effective, equitable and culturally-
appropriate diabetes care. Promoting the Indigenous-specific credentialling 
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pathway (ADEA, 2018d) is essential and better multidisciplinary engagement is 
required to build workforce capacity.  
2.2.5. Midwives  
Diabetes is the most common medical condition in pregnancy (Irwin 2010), with the 
prevalence of GDM ranging from 8%-13% in different populations (Maple-Brown & 
Hampton, 2020; Moses et al., 2016). Adverse health outcomes for the mother with 
pre-existing diabetes include, e.g. diabetic ketoacidosis and deterioration of diabetes-
related complications, and the neonatal, e.g. macrosomia, stillbirth and prematurity 
(Rudland et al., 2020).  
Midwives provide care for women and new-borns across the childbirth trajectory 
(Australian College of Midwives [ACM], 2020). Therefore, they care for these women 
with high-risk pregnancies and neonates who are unwell, or monogenic neonatal 
diabetes (Irwin, 2010). Hence, midwives contribute to multidisciplinary teams 
delivering diabetes care and require current diabetes knowledge. 
Diabetes educators are expected to have specialised competence to deliver 
diabetes care in more complicated ‘high-risk’ pregnancies (Rudland et al., 2020). 
However, few midwives are CDEs (ADEA, 2017a); thus, non-CDE midwives can play 
essential roles. Midwives in maternity services can work in health-promoting ways 
by providing essential nutrition and physical activity advice during pregnancy to 
prevent excessive gestational weight gain and T2D (Arrish et al., 2017). Midwives 
working as extended postnatal care midwives, lactation consultants or in maternal 
and child health have a unique opportunity to follow-up with women post-GDM or 
a pregnancy complicated by diabetes (Watson et al., 2002).  
Australian midwives can also undertake limited prescribing activities (Small et al., 
2016), which provides an opportunity to assist with managing diabetes. However, 
only a small proportion of suitably educated midwives have taken on the role. Two 
studies, a mixed-methods analysis and an Australian survey, suggest midwife 
prescribers cite barriers, including the lack of public sector prescribing roles and the 
need for supportive professional relationships and mentoring (Fontein-Kuipers et al., 
2019; Small et al., 2016). The authors suggest they require theoretical, practical and 
logistic support because their context medicates their prescribing behaviour. 
Thus, midwives play a pivotal role in supporting pregnancies complicated by diabetes 
as autonomous practitioners, as CDEs or as part of a multidisciplinary team. A 
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diabetes competent midwifery workforce can support managing diabetes diagnosed 
in pregnancy and maternal obesity, reducing unhealthy gestational weight gain and 
neonates birth weights, and supporting diabetes prevention (Josey et al., 2019). 
The following section reviews the existing diabetes-trained workforce: experts in 
diabetes education and care. 
2.3. How healthcare professionals become experts in diabetes 
education and care - the diabetes educator workforce  
Diabetes educators are considered experts in diabetes education and care and have 
long been pivotal to the care (Child et al., 2017). The contribution of the diabetes 
teaching nurse in the early 1900s was described in Allen’s (2003) historical account of 
diabetes educators; notably, Joslin, the first doctor to specialise in diabetes in the 
USA, advocated for the empowerment of patients through their teaching. At the 
Diabetes Educator Journal launch, Dr Elliott Joslin remarked, “a well-trained nurse is 
of more value than the patient’s doctors” (Childs et al., 2017, chpt. 1, para. 5). In 
Australia, diabetes educators were nurses until the 1990s (Colagiuri & Ritchie, 1996). 
A diabetes educator is a HCP who provides diabetes self-management education 
(DSME) and care in partnership with the person living with diabetes. DSME is 
described as a continuous: 
Process of facilitating the knowledge, skill, and ability necessary for diabetes self-care 
… [it] incorporates the person’s needs, goals, and life experiences with diabetes and is 
guided by evidence-based standards. (Powers et al., 2016, p.70)  
Successful DSME requires the HCP to actively motivate and empower the person 
with diabetes to participate in their care. DSME personalises goals and improves 
clinical outcomes. For example, reducing HbA1c and blood pressure (Chatterjee et 
al., 2018) and medical costs (Beck et al., 2017), particularly when the HCP delivers 
structured DSME (Speight et al., 2016). Structure DSME is defined as: 
A planned … programme that is comprehensive in scope, flexible in content, responsive 
to an individual’s needs and adaptable to their educational and cultural background. 
(McDowell & MacRury, 2015, p.24) 
While DSME can appear as a simple task or topic orientated activity within Powers et 
al.’s definition: quality structured DSME requires diabetes educators to be cognizant 
of all elements needed to support individuals to engage in their self-care (Funnell & 
Piatt, 2017; McDowell & MacRury, 2015).  
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Making connections, holding a shared understanding of the language used, 
comprehending drivers of personal goals, appreciating and understanding different 
learning styles, using experiential learning in an empathetic and appropriate manner 
are some of these elements (Dunning, 2013, 2018; Fink et al., 2019). One way to 
ensure quality in DSME and care is by standardising how HCPs are trained to become 
experts in delivering DSME. 
2.3.1. Credentialling as a diabetes educator in Australia  
A professional development program to support the training of diabetes educators 
in conjunction with CDE credentialling was introduced in Australia in 1986, like 
international counterparts (ADEA, 1991). Hospital nurses primarily delivered 
diabetes education at this stage (Dunning & Manias, 2009). 
ADEA proposes that the process is designed to standardise education and 
competence in diabetes education and care; the CDE status reassures the consumer 
that they are accessing an expert in the field (ADEA, 2019b). The title Credentialled 
Diabetes Educator was registered as a trademark certification and the current 
credentialling program for Australia is described in Table 2.4 on pages 46 to 48. 
In Australia, a CDE is a HCP usually with postgraduate diabetes training, recognised 
by the ADEA (2017b, p.5) as having:  
Demonstrated experience and expertise in diabetes education and commitment to 
professional development and ongoing learning that meet the ADEA’s standards.  
Through the Course Accreditation and Standards of Practice Committee, ADEA 
accredits postgraduate diabetes education and management courses currently 
offered by eight universities in Australia (ADEA, 2018b). However, a limitation of the 
credentialling process is the lack of consistency of programs despite the ADEA’s role 
in accrediting postgraduate diabetes qualifications (ADEA, 2019a). Cooper (ADEA 
Education Project Officer, personal communication, May 29, 2020) reports: 
Varying education and competence regarding diabetes management, device training, 
insulin titration and medication management present issues within the Australian 
diabetes healthcare system and ADEA members.  
The project officer indicated that an expert reference group would appraise the CDE 
education standards, programs, and pathways in Australia in 2021. These steps to 
improve the standardisation of CDE education challenge the concept that all CDEs 
can provide consistent expert care and advice to people living with diabetes.  
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Table 2.4. International differences to be recognised or credentialled as a diabetes educator 







Credentialing as a 
Credentialled Diabetes 
Educator (CDE) by the ADEA.  
 
Credentialling as an 
Indigenous allied health or 
enrolled nurses, or AHWs and 
Aboriginal Health Practitioners 
Diabetes Educator. 
 
ADEA membership required.  
✓ 
Certification as a Certified 
Diabetes Educator (CDE®) by 
the Canadian Diabetes 
Educator Certification Board 
(CDECB). 
X 
Self-appraisal against the 2018 
National Diabetes Nursing 
Knowledge and Skills 
Framework developed by the 





competency frameworks is 
available for nurses, 
podiatrists, pharmacists and 




Certification as a Certified 
Diabetes Care and Education 
Specialist (CDCES) by the 
Certification Board for 




ADM®) offered by the 
Association of Diabetes Care 
and Education Specialists 
(ADCES) for those involved in 
adjusting medicines and 




Minimum a postgraduate 
certificate in diabetes 
education and care accredited 
by the ADEA. 
X /✓ 
Health Educators or Social 




encouraged for proficient 
diabetes nurse and 
Masters/PhD for specialist 
diabetes nurse. 
X 
Encouraged for those working 
at higher levels and non-
medical prescribers.  
X /✓ 
A Masters or higher degree is a 
requirement for BC-ADM® and 
is not reliant on having CDCES 
status. 
Hours of practice 
specified 
✓ 
1000 over 4-years maximum. 
✓ 





1000 over 4-years [500 for BC-
ADM®]. 
Exam X ✓ 
Initially 
X X ✓ 
Initially and each 5-years 
administered by the CDCES or 
ADCES for BC-ADM®. 
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Table 2.4. International differences to be recognised or credentialled as a diabetes educator (continue) 
 Australia Canada NZ UK USA 
Eligible disciplines ✓ 
Accredited or Registered: 
- Exercise Physiologist 
- Indigenous HCP 
- Medical Practitioner 
- Midwife 




- Practising Dietitian. 
 
✓ 
Any HCP registered and fully 
licensed with a regulatory 
body in Canada practising in 
the competencies listed for 
diabetes by CDECB. 
 
? 
No formal process. 
? 
No formal process. 
✓ 
Licensed:  
- Clinical psychologist 
- RN/NP* 
- Occupational therapists 
- Optometrist 
- Pharmacist* 
- Physical therapist 
- Physician* 
- Podiatrist. 
Registered or certified: 
- Dietitian /nutritionist 
- Physician assistant 
- Clinical exercise 
physiologist 
- Master certified health 
education specialist. 
HCP with a master's degree or 
higher in social work. 






20 per year. 
✓ 




15 in the 2-years prior 
examination from 
recognised providers. 






X X ✓ 
2-years 
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Table 2.4. International differences to be recognised or credentialled as a diabetes educator (continue) 
 Australia Canada NZ UK USA 
Mentoring required ✓ 
6-month mentoring program with 
CDE. 
X X 
Nurses are encouraged to 
access an online health 
mentor resource to meet 





levels in diabetes 
✓ 
3 levels of CDE – novice, experienced 
and expert. 
Nursing diabetes framework, which 
identifies 4 levels. 
X ✓ 
3 practice levels specific to 
nurses including: all nurses, 
proficient diabetes nurses 
and specialist diabetes 
nurses, which includes a 
post-registration pathway of 
short courses to higher 
degrees i.e. the SDN works 
towards a Masters or PhD. 
✓ 
4 practice levels specific to 
nurses and AHPs, e.g. for 
pharmacists:  
- foundation (<1000 days),  
- advanced stage 1 (1000 
days of practice),  
- advanced stage 2 (> 1000 
days)  
- mastery (>10 years of 
practice).  
For nursing:  
- unregistered practitioner  
- competent  
- experienced or proficient 




Para-professional levels 1-2 







Annually with 20-hours CPD and 
meeting learning goals.  
✓ 
Every 5-years by completing 
a credit portfolio and 250 
credits points in diabetes 
practice. 
X X ✓ 
Every 5-years by completing 
exam and 1000 practice 
hours in diabetes with 400 
within the last 12-months. 
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References: (Aotearoa College of Diabetes Nurses, 2014, 2018; ADCES, 2019, 2020; ADEA, 
2015a, 2017b, 2018c, 2018d, 2019b, 2020b; CDECB, 2017, 2020; CBDCE, 2020a, 2020b; 
TREND-UK, 2019a; UK Clinical Pharmacy Association, 2018). 
 
The credentialling process may also fail to meet the needs of HCPs delivering care in 
remote and rural areas where access to quality mentors may be limited: impacting 
the choice to become a diabetes educator and the expertise developed should the 
HCP undertake the process. The current study informs the ADEA review and a 
consistent national curriculum and identifies ways to strengthen mentorship 
relationships; current mentorship requirements are listed in Table 2.4 on page 48. 
Increasing healthcare access needs by diabetes consumers in the 1990s led to ADEA 
strategically deciding that other suitable disciplines could become eligible for CDE 
credentialling on application by their profession (ADEA, 2015b; King et al., 2017). 
Physiotherapy and midwifery were the last disciplines to become eligible for 
credentialling in 2015 (ADEA, 2015c). Also, increased access was expected when 
CDEs became able to register for Medicare chronic conditions rebates in 2004, 
enabling private practice (ADEA, 2004).  
The removal of Medication Management Review accreditation requirements by 
pharmacists to apply for CDE status in 2014 triggered an increase in pharmacists 
seeking to undertake CDE credentialling (Pharmacy Guild of Australia, 2014). Also, 
removing the barriers for different health professions to undertake CDE 
credentialling, saw growth in early career HCPs numbers and CDEs with different 
foundational training (ADEA, 2017a). 
2.3.2. Comparison of processes for recognition as a diabetes educator  
International differences in the requirements for recognition as a diabetes educator 
exist, which could identify additional capacity. These include the requirements for:  
• Recognition as a diabetes educator. 
• Hours of practice in diabetes education before applying for CDE status. 
• A postgraduate qualification. 
• Involvement in a mentoring program. 
• Maintaining CDE status. 
• Disciplines eligible for applying for CDE status. 
The current thesis focused on English speaking countries with similar healthcare 
systems, the UK, NZ and Canada. Also, the USA, because its CDE credentialling 
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program has similarities and was developed simultaneously to Australia. 
Like Australia, the USA and Canada opted for a rigorous certification process for 
diabetes educators; see Table 2.4 on pages 46 to 48. Once the HCP completes all 
elements of the designated process CDE status is attained. In Canada, it stands for 
Certified Diabetes Educator®, whereas the USA transitioned to Certified Diabetes Care 
and Education Specialist in 2020. The change in the title made to articulate better the 
SoP and capacity of diabetes educators beyond DSME and support, to drive change to 
innovative models of care in the health workforce (Pearson et al., 2019). 
The UK and NZ systems challenge the need to have credentialing processes. In 
contrast to credentialling, these countries encourage autonomous practice and 
advise HCPs to self-assess against relevant diabetes competency frameworks and 
provide tools to undertake the activity (Aotearoa College of Diabetes Nurses, 2018; 
TREND-UK, 2019a). The approach may reduce restrictions to nurses interested in 
diabetes becoming educators.  
However, the lack of consistent approaches to training and developing the UK 
diabetes specialist nurse (DSN) is a limitation raised by the Training Research and 
Education for Nurses in Diabetes (TREND-UK) organisation. Hicks (2017) indicated 
that DSNs had grown more autonomous without defined mentoring programs and 
growth in the specialisation of nurses from varying practice settings, both primary 
care and speciality units, often with limited experience.  
Thus, neither approach to becoming a diabetes educator, i.e. credentialling or self-
appraisal, is infallible. Guidance by one source of truth, a ‘living’ capability 
framework for diabetes may support consistency.  
Moreover, some Australian diabetes educators do not see the value of becoming a 
CDE. Despite the availability of a credentialling process, not all Australian diabetes 
educators are credentialled. Thus, the level of knowledge, competence and 
educational qualification of those not credentialled are unknown. PHCNs who have 
undertaken a three-day diabetes education short course do not meet the criteria 
for credentialling (Fenton, ADEA President, personal communication, June 9, 2020).  
No peer-reviewed literature indicates why HCPs working in diabetes do not become 
credentialled as a CDE. According to the ADEA (2017a) Workforce Survey common 
reasons diabetes educators with a postgraduate diabetes qualification do not 
choose to undertake or maintain credentialling include:  
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• Perceived lack of benefit if employed in the public sector.  
• Minimum Government reimbursement through Medicare for private practice.  
• Cost and time commitment to the credentialling/recredentialling processes. 
A capability framework promotes standardise training, including self-directed 
training across disciplines to build the health workforce’s capacity for diabetes care. 
2.3.3. Effectiveness of diabetes education by diabetes educators 
According to Deloitte Access Economics (2014), who performed a literature review 
to inform a cost-effectiveness analysis of diabetes educators to the Australian 
healthcare system, diabetes education is cost-effective, saving one quality-adjusted 
life-year for just $650. Further, over $16 was saved in healthcare system costs for 
every dollar spent on diabetes education. The authors used WHO modelling and 
definition for the analysis.  
However, few of the studies included in the analysis evaluated the effectiveness of 
diabetes educators per se. Instead, the focus was on the effectiveness of diabetes 
education. Also, it was unclear whether it was a systematic review because the 
report failed to provide a PRISMA, or the total number of articles identified. 
Deloitte Access Economics (2014) determined that the 2014 CDE workforce could 
care for 57% of people living with diabetes. The economic analysis demonstrated 
the benefits of having diabetes education experts; however, a better explanation of 
their approach to systematically managing literature would have improved the 
soundness of the results.  
Nevertheless, Lawler et al. (2019) substantiated these results in a hermeneutic 
interpretive literature review about the UK DSN workforce's impacts on health 
outcomes from 1990 to 2018. Lawler et al. found that DSN-supported services were 
associated with reductions in length of hospital stay and admissions, harm related 
to medicines errors, and increased consumer satisfaction and counselling. Though, 
Lawler et al. drew from grey literature and position statements that may not have 
been peer-reviewed.  
Ultimately, the diabetes educator workforce is one part of the healthcare 
workforce; CDEs are specialist expert resources that can be developed to meet 
future consumer needs. However, workforce numbers may not meet Australians’ 
growing diabetes healthcare needs. 
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2.3.4. Australia’s diabetes educator workforce 
Australia has a predominantly older and aging diabetes educator workforce. A 2017 
workforce survey compiling statistics about the employment status of diabetes 
educators in Australia, including 597 responses (29.8% response rate) of which 63% 
were CDEs, suggest 58% are aged 50 years or older (ADEA, 2017a). Only 16% of 
respondents were aged under 40 years. 
Nurses were the main respondents (84.9%), followed by dietitians (7.2%), midwives 
(7%) and a few pharmacists, physiotherapists and podiatrists (ADEA, 2017a). Also, 
the proportion of diabetes educators per person with diabetes varied across the 
nation: 1:13,000 people in Tasmania to 1:42,000 in NSW. An ideal ratio per 1,000 
people with diabetes may be 2.75 full-time equivalent diabetes educators, based on 
an Australian workforce model, calculating consultation time against diabetes 
clinical guidelines for 20 competencies relating to care coordination, for 26 patient 
attributes, e.g. diabetes type and complications (Segal et al., 2013).  
Diabetes educators worked primarily in tertiary or secondary outpatient settings; 
the survey revealed that the 25% employed in private practice had dual tertiary 
roles (ADEA, 2017a). Only 5% of privately-employed CDEs worked full-time, despite 
Medicare incentives. Thus, financial incentives may inadequately support 
employment and mobility of experienced diabetes HCPs from public-funded tertiary 
to primary settings. 
A recent ADEA strategy encouraged more AHPs, midwives and pharmacists to 
become involved in diabetes education (ADEA, 2019a). The study and the 
framework support the move to multidisciplinary credentialling, increasing the 
capacity for diabetes care in the workforce and setting the standards for diabetes 
education and care, which could, reduce role boundary confusion. 
A. United Kingdom’s diabetes educator workforce 
Compared to the UK, Australian data show a much lower diabetes educator to 
consumer ratio. TREND-UK (2019b) workforce survey identified over 18,000 DNSs in 
a national employment register, i.e. 0.58 DNSs for every 1,000 people living with 
diabetes in the UK (Hicks, 2019). Increasing numbers of clinicians with diabetes skills 
is dire in Australia because HCPs provide much remote area healthcare. 
However, unlike the UK survey, the Australian workforce survey did not capture the 
whole workforce. Moreover, TREND-UK identified greater workforce dispersion 
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than Australia; 49% worked in tertiary settings, 36% were community nurses and 
15% worked across both settings (Hicks, 2019). The more significant expansion into 
the primary care setting in the UK compared to Australia may relate to differences 
in funding and primary care models integral to the National Health Service (NHS).  
The difference implies an under-utilised resource or highlights compounding factors 
such as geographical distances between services in Australia, i.e. PHCNs may not 
feel supported to undertake the role. Lastly, 117 titles used for diabetes educator 
nursing roles were identified . TREND-UK (2019b) suggests using only two titles: the 
DNS and senior DNS, the latter holding a non-medical prescribing qualification and 
willing to work towards a Master’s degree creating opportunity to expand care.  
B. United States of America’s diabetes educator workforce  
Compared to the USA, Australia has lower rates of dietitians working towards 
becoming CDEs. Based on a survey examining diabetes education practice of 4,696 
diabetes educators (14.7% response rate) from two USA member organisations, 
diabetes educators were primarily female (95%), and their primary discipline was 
nursing (48%), nutrition (38%), and pharmacy (7%) (Rinker et al., 2018). Most 
(82.6%) held a CDE credential and 3.8% a BC-ADM®, and 13.6% had neither. 
Increasing diabetes-related skills and competence in the Australian dietitian 
workforce may support building capacity for diabetes care. A capability framework 
may identify relevant skills required and create a career structure to encourage 
more work towards CDE status, increasing workforce capacity. 
2.4. Diversification of diabetes expert roles and boundaries 
With the rise in diverse HCPs disciplines becoming involved in diabetes care to meet 
the needs of Australians, role boundary concerns between disciplines have risen 
(ADEA, 2016). A systematic literature review of the Australian diabetes educator 
workforce suggests a gradual movement of the nursing dominant towards an 
interdisciplinary diabetes educator workforce and role flexibility (King et al., 2017). 
The authors noted evidence of role boundary delineation related to ADEA’s: i) 
response to the competency movement, ii) insulin being listed as a Schedule 4 
medicine, iii) Medicare Benefits Schedule expansion to include CDEs, and iv) ADEA’s 
changing governance and culture.  
Chapter 2: The healthcare workforce and competence in diabetes education and care 
54 
 
Another systematic literature review about role boundaries identified that when a 
staff shortage or Government precedent drove role changes, the profession 
impacted responded by attempting to protect their established role and ‘their’ 
boundary (King et al., 2015). However, diabetes care is multidisciplinary, and 
Australia is characterised by large geographical areas or communities of remoteness, 
which impacts access. The National Rural Health Commission (NRHC) found rural 
AHPs:  
Covered an extended scope of work using generalist and specialist skills to meet 
diverse community needs with limited infrastructure [in Australia]. Skill areas included 
paediatrics, Indigenous health, chronic conditions, health promotion and prevention, 
primary healthcare and health service management. (NRHC, 2020a, p.62) 
These findings suggest, HCPs often adapt to the diverse needs of their community, 
particularly in rural and remote areas.  
Leggat’s (2014) literature review using the job characteristics model to analyse 
proposed HCP scope of practice solutions suggests that specialisation can negatively 
impact quality and safety due to the current health workforce structure. In 
Australia, this is particularly pertinent to the health workforce in rural remote areas 
(NRHC, 2020a). Leggat (2014) suggests there was no evidence for the current 
organisation of HCP roles and that the allocation of specific tasks is a historical 
accident. However, the report did not provide details of the systematic approach to 
managing literature.  
Regardless, little modification of the HCP workforce has occurred to meet changing 
healthcare needs of Australia’s ageing population, clinical advances and 
technological revolution, which changes the way healthcare is provided (NRHC, 
2020a). There is a need to develop a capability framework that supports different 
health professions to deliver diabetes education and care: minimising barriers 
impacting HCP role and SoP development, to promote access. 
2.5. Differences in access to diabetes healthcare 
Diabetes impacts healthcare across the continuum of care and multiple settings, 
e.g. emergency departments, oncology, occupational therapy, mental health units, 
foot clinics, general practice and schools (Dunning, 2017, 2018; Furler et al., 2017). 
Hence, people with diabetes access care throughout their lives, in many settings 
from a range of HCPs resourced differently.  
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Developing a diabetes competent workforce is required to ensure people have 
increased access to appropriate DSME and support at the point of care and across 
the healthcare continuum (Ng et al., 2017). HCPs’ lack of diabetes knowledge, 
interpersonal and self-management skills in the general practice setting was 
associated with increased diabetes distress in a cross-sectional survey of 178 people 
with T1D (Mohn et al., 2015), and decreased motivation for self-care in a qualitative 
study using semi-structured interviews of 23 T2D consumers from across 11 
practices (Grohmann et al., 2017). Thus, a gap between HCP competence and 
consumer expectations for safe care exists. 
Jan Alford, an experienced CDE involved in developing Australia’s credentialling 
program and accreditation for postgraduate qualifications in diabetes stated:  
The diabetes educator role is becoming more problematic as the environment in 
which we do business changes rapidly. Tertiary services continue to struggle to 
identify their role in the patient journey. At the same time, those in primary care, … 
are not necessarily being resourced with an appropriately skilled workforce … the 
model of care will need to look different in the future. (Alford, 2016, p.17) 
Alford (2016) proposed that some HCPs had skills and knowledge deficits to deliver 
diabetes care competently. Also, Alford identified the need to consider ways other 
health professions and roles, such as practice nurses, pharmacists and midwives, fit 
into a model for diabetes care. Alford stated: 
The battle will be to ensure that all the players work together to ensure the individual 
skills we have worked to develop as educators are not lost but are used to enhance 
the care of the most important people in this space, our patients. (Alford, 2016, p.17) 
To respond to an increasingly culturally diverse population, all HCPs need to develop 
knowledge and skills in diabetes care. Moreover, Australia has significant nuances, 
which affect care; it is multicultural and has areas of considerable remoteness where 
numbers of HCPs are low, access to healthcare is limited, and the prevalence of 
diabetes is high (AIHW, 2019; DoH, 2019b).  
For example, people with T1D residing in remoteness areas are less likely to start 
insulin pump therapy due to their perceived lack of diabetes-expert support (AIHW, 
2012; NRHC, 2020a). In Australia, 21,074 consumers used insulin pumps in 2012 
versus 26,496 in 2019: accounting for 21.3% of people living with T1D in Australia 
(NDSS, 2020b). However, despite over a third of people with T1D residing in outer 
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regional to very remote areas of Australia, only 8% of insulin pump usage is 
undertaken by those residing in these areas of remoteness (NDSS, 2020b).  
Identifying ways to engage better and meet the diabetes training needs of HCPs 
working in all settings, including very remote and outer regional Australia, is 
essential. The study provides an opportunity to meet these needs; to build capacity 
within the health workforce for diabetes care. 
2.6. Capability or competency frameworks to inform diabetes 
education and care 
One way to build workforce capacity is through competency frameworks. 
Competency frameworks are a structure for HCP training to meet a set level of 
competence. Their strength is that they guide scopes of practice, setting objective 
standards for HCPs to ensure a standardised approach to excellence (Simmons et 
al., 2015). The following section provides a historical account of the Australian 
framework and information about existing competency frameworks’ strengths and 
weaknesses for diabetes education. No capability framework was identified.  
2.6.1. Historical account of the move towards competency standards 
Competency standards were a Training Reform Agenda initiative to increase 
industry competitiveness and support Australia’s economic recovery as the 
Government pre-empted the 1990 recession (Colagiuri & Ritchie, 1996). Pivotally, 
the basis for curriculum development became enterprise-driven rather than 
priorities set by individual trainers.  
The National Training Board, an Australian Government statutory body of 1989, 
transformed assessment to a competency rather than skills-based approach by 
introducing an Australian Standards Framework (ASF) to guide developing industry 
competency standards (Colagiuri & Ritchie, 1996). It became the agreed 
endorsement tool for regulating Australian education and training systems and 
included eight competency levels that industry standards must align (Colagiuri & 
Ritchie, 1996).  
HCP registration boards adopted profession-specific competency frameworks to 
measure clinical competence (Sutton & Arbon, 1994). Then, a Government imposed 
1993 deadline saw competency documents develop across the nation, e.g. dietitians 
and nursing in 1993, and podiatrists in 1994 (Colagiuri & Ritchie, 1996).  
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By 1995, the ASF nomenclature changed to the Australian Qualification Framework 
(AQF), which underpinned the national qualifications system and encompassed 
higher education, vocational education and training, and schools. The current AQF 
has ten competency levels, see Figure 2.1, which describe the complexity of the 
qualification attained and the autonomy graduates require to demonstrate success 












2.6.2. Origins of the Australian diabetes competency framework  
The economic reforms of the 1990s also instigated diabetes competencies 
development in Australia, beginning with the document titled The Role of the 
Diabetes Nurse Educator (ADEA, 1989). It coincided with the initiation of the ADEA 
credentialling program and focused on developing nursing roles as diabetes 
educators. Next, the document entitled National Standards of Practice for Diabetes 
Educators recognised the competencies required to deliver diabetes education and 
the diverse profession and experiences of diabetes educators (ADEA, 1991). 
However, it did not specify different health professions and only nurses were 
eligible for credentialling.  
Later, ADEA’s (1994) publication National Guidelines for the Safe Practice of Diabetes 
Nurse Educators focused on preparing the ‘diabetes nurse’ for the ethical and legal 
dilemmas they may face in the practice setting. These three papers laid the foundation 
for the first national diabetes educator competency framework in Australia. 
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Colagiuri and Ritchie (1996, p.30) provided an account of the method used to 
develop the 1996 National Core Competencies for Diabetes Educators and indicated 
that diabetes education practice required a complex combination of: 
Clinical knowledge and skills, educational expertise, competence in counselling and 
behaviour modification techniques, analytical and problem-solving ability, and 
familiarity with health promotion principles and strategies.  
The authors did not reference the description of practice; it is unclear whether it is 
based on their personal experiences or obtained as part of the development 
process. Along with many essential skills, the authors claimed that non-
pharmacological intervention carried out by diabetes educators was a significant 
and integral component of diabetes care. Colagiuri and Ritchie (1996, p.30) stated 
diabetes educators take on several clinical procedures and assessments, including: 
Insulin dosage adjustment, or dietary assessment and prescription, measurement of 
capillary blood glucose and assessment of visual acuity, peripheral vascular status and 
peripheral sensation … interpret[ing] the results of laboratory assessment of glycaemic 
control and lipid balance and advising the patient about methods for correcting 
abnormalities. [Also] … be adept at foot assessment, understand the physiology of 
wound healing and be familiar with current recommendations for ulcer dressings.  
Colagiuri and Ritchie (1996) suggested that competencies were a quality assurance 
tool that aimed to ensure consistency in products and services by aligning the 
profession’s training and education on clear performance levels centred on the ASF. 
There was no measure or mention of adaptability to ensure the diabetes workforce 
could respond to a rapidly evolving health system. 
The inaugural competency framework for diabetes educators was developed by an 
initial literature review of competency development and guiding Government 
publications, a Consensus Development Conference (CDC) that explored issues for 
diabetes educators and identified the statements, and a survey of ADEA members 
to ascertain their training and qualifications (Colagiuri and Ritchie, 1996).  
Nurses accounted for 80%, dietitians 12%, podiatrists 5% of the 307 responses by 
diabetes educators who completed the survey, representing a 41% response rate and 
reflective of the membership (Colagiuri and Ritchie, 1996). Sixty members attended 
the CDC from diverse practice settings, identifying how the competency standards 
could be used and monitored. However, the method lacked anonymity, and dominant 
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personalities can influence discussions in large groups, creating difficulty working 
towards consensus as communications become monologue (McMillan et al., 2016).  
Colagiuri & Ritchie (1996, p.35) indicated that the draft set of competencies were: 
Listed against the function of [the] diabetes educators arbitrarily divided into five 
main units of competency to reflect the key elements of the educator’s role: clinical, 
educational, health promotion, service management and professional accountability.  
This suggests a haphazard process. The competencies were forward to ADEA members 
and relevant HCP organisations for appraisal: following amendments, a consensus was 
obtained via the ADEA 1995 annual general meeting by member voting.  
The Australian National Core Competencies for Diabetes Educators’ launch 
coincided with diabetes listing as a National Health Priority Area in 1996, and three 
years later, the first National Diabetes Strategy 2000-2004 was endorsed by 
Ministers to maintain momentum, guide funding allocation and for structural 
reorganisation (Colagiuri et al., 1998). However, implementation was unfunded 
(Colagiuri, A-Professor Sydney University, personal communication, May 29, 2020). 
2.6.3. Inclusion of different disciplines 
From these historical beginnings, diabetes education competencies in Australia 
changed from a nursing focus to encompass other disciplines. King et al. (2017) 
systematic literature review offers an interpretation of the evolution. King et al. 
explored the sociology of podiatry and the role and SoP of diabetes educators and 
identified role boundaries concerns. The authors suggest that language used by the 
ADEA altered over time to become more allied health inclusive. Simultaneously, 
despite ADEA espoused desire for inclusiveness, their documentation did not always 
reflect the change and a nursing focus dominated.  
For example, dietitians, podiatrists, psychologists and social workers were 
recognised as HCPs delivering personalised care to people with diabetes in the 
1996 National Core Competencies for Diabetes Educators (King et al., 2017). 
Nevertheless, King et al. noted that role delineation continued to exist between 
disciplines because the document described a competent diabetes educator as:  
One who maintains and applies clinical skills appropriate to the educator’s clinical 
discipline and their specialist function, for example, nurses: insulin dosage adjustment 
or correct injection technique, dietitians: diabetes dietary prescription, podiatrists: 
wound management. (ADEA, 1996, p.3) 
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However, given that ADEA is a ‘member’ organisation and works for its members, 
a limitation of the interpretive study assessing ADEAs inclusiveness of other 
disciplines was the lack of a broader account of ADEA’s strategic and operational 
imperatives that led the strategic decision-making. According to Colagiuri and 
Ritchie (1996), accommodating differences between disciplines and practice 
settings was problematic. Little progress has been made in Australia to articulate 
the competencies for diabetes educators from different disciplines to ensure 
appropriate training. Findings from the current study enable a move towards 
consistent, appropriate diabetes training, which can clarify the role of all 
disciplines. 
A strength of the current National Competencies for Credentialled Diabetes 
Educators is that it outlines the minimum competencies required of all CDEs 
irrespective of their primary discipline (ADEA, 2017b). The version includes a three-
level ‘novice to expert’ progression of competence and recognises diabetes 
educators come to their role with various skills, experience and exposure to training. 
Information in the framework suggests a group of expert diabetes educators 
updated the competency statements (ADEA, 2017b); however, the method used was 
not described.  
A more person-centred and evidence-based focus promoting diversity in diabetes 
educator roles were key changes to the ADEA’s (2017b) five practice domains:  
• Clinical practice 
• Education and counselling 
• Research and quality improvement 
• Management and administration 
• Leadership and advocacy
Limitations concern the lack of clarity about SoP. Information in the competency 
framework recommends that all CDEs work within their SoP and adhere to relevant 
legislation related to authority to practice (ADEA, 2017b). However, there are no 
recognised distinctions between HCPs from different professions. Further, the 
framework did not identify capabilities to enable an adaptive diabetes workforce. 
The current study creates an opportunity to identify essential capabilities for the 
whole healthcare workforce to support consistency in training and increase 
workforce capacity.  
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2.6.4. Indigenous diabetes practitioners competency framework 
The National Core Competencies for Aboriginal and/or Torres Strait Islander 
Diabetes Health Workers and Diabetes Health Practitioners, includes a process to 
support diabetes credentialling for Aboriginal and/or Torres Strait Islander health 
practitioners (ADEA, 2018d). A strength of the framework was that it was designed 
and endorsed by a collaboration between an Indigenous AHP and an AHW 
organisations with ADEA to address the needs of Indigenous communities. 
Despite this collaboration, a possible limitation of the framework relates to cultural 
appropriateness. Culturally inappropriate health services have contributed to 
persistent health inequalities for Indigenous people; academics reviewing cultural 
training suggest that to improve healthcare services’ efficacy for Indigenous 
Australians, requires a cultural safety model (Downing et al., 2011).  
To date, negligible numbers of Indigenous health practitioners have undertaken 
diabetes-specific credentialing (ADEA, 2019a). Hence, more progress is required 
towards training Aboriginal and/or Torres Strait Islanders health workers and 
practitioners to deliver diabetes care. Therefore, a paucity in diabetes healthcare 
access for Aboriginal and Torres Strait Islander consumers endures (Tremblay et al., 
2019).  
In summary, gaps exist in the current competency frameworks in diabetes 
education and care in Australia that the current study will address. These concern 
the capabilities all HCPs require, including those who are not CDEs, those from 
other disciplines other than nursing, and CDEs expanding their SoP. 
2.6.5. International diabetes competency frameworks  
International frameworks for delivering diabetes education and care reviewed for 
this thesis were competency-based and varied across countries; variations relate to 
the number of practice or competence levels identified, and the HCP/s included in 
the framework, see Table 2.5 on page 62. The current literature search identified 
that internationally, competency frameworks exist for most non-medical HCPs.  
In contrast, no Australian framework was found that described diabetes 
competencies for generalist allied HCPs who access Team Care Arrangements to 
deliver diabetes care, see Table 1.2 on page 19; neither HCPs who identify as 
diabetes educators but are not credentialled as CDEs.  
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Table 2.5. International competency frameworks for diabetes education and care 
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References for Table 2.5: AADE, 2016a, 2016b; Aotearoa College of Diabetes Nurses, 2018; ADEA, 
2017b, 2018d, 2020b; Beck et al., 2017; Canadian Diabetes Association, 2014; CDECB, 2020; UK 
Clinical Pharmacy Association, 2018; Diabetes UK, 2013; Dietitians Board of NZ, 2016; McCardle et 
al., 2019; Public Health England, 2017; TREND-UK, 2019a). 
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As used in the UK, a limitation of multiple frameworks to guide different disciplines 
in diabetes is inconsistency in training across professions. Moreover, there is a risk 
of reduced relevancy because diverse organisations’ priorities drive ongoing 
reviews. Australia requires an increasingly flexible and mobile diabetes workforce to 
meet the growing healthcare of all Australians across the nation (NRHC, 2020a). The 
geographical dispersion of varied HCPs and distances between services requires 
consideration. Hence, a single national capability-driven diabetes framework that 
captures all HCPs supports aligning training with policy driving diabetes care and 
national strategies: enabling an appropriate expansion of SoP guided by relevant 
training.  
A strength of the USA competency framework is its inclusiveness of multiple 
professions; roles and responsibilities of multiple levels of diabetes educators and 
paraprofessionals are delineated to create a career pathway. Yet, it is unclear 
whether the USA model has improved health outcomes through increased access; 
further, the USA and Australian health systems are markedly different. 
Australian diabetes-related competencies frameworks do not differentiate between 
other generalist HCPs, only multidisciplinary CDEs or nurses. The National Diabetes 
Nursing Education Framework 2020, a career structure for nurses working in 
diabetes in Australia, aligns with the UK diabetes nursing model and includes four 
SoP levels: foundational, proficient, specialist and expert (ADEA, 2020b). Yet, using 
the nursing framework in parallel with the CDE national competency document in 
Australia risks increasing role boundaries concerns and could reduce consistency in 
diabetes training across disciplines.  
The current study provided an opportunity to identify a fit-for-purpose framework 
that accommodates Australia’s nuances and healthcare system: enabling 
identification of relevant capabilities to build future capacity within the health 
workforce for diabetes. 
2.7. Competencies for diabetes education and care  
Internationally, competencies HCPs require to deliver diabetes education and care 
are generally health-topic specific, such as hyperglycaemia (AADE, 2016b; Aotearoa 
College of Diabetes Nurses, 2018; Canadian Diabetes Association, 2014; McCardle et 
al., 2019; McLaughlin et al., 2017; TREND-UK, 2019a). Conversely, Australian 
competencies for CDEs focus on practice domains (ADEA, 2017b).  
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However, in all cases, the competencies do not systematically connect or identify 
capabilities required to meet consumer needs, a limitation that impedes flexibility 
and growth in workforce capacity (Wheelahan, 2017). The essential competencies 
identified by the current literature review are listed in Table 2.6 on page 64, 
identified from competency frameworks. 
A systematic literature review of Australian and international publications using the JBI 
tool, identified the following core competency areas for diabetes educators: DSME, 
teaching and clinical skills, pathophysiology and epidemiology knowledge, and cultural 
competency (Alharbi et al., 2019). These were drawn from 22 identified publications, 
six of which were grey literature. The authors concluded that an international 
assessment tool for assessing diabetes educators’ competencies is required.  
However, Canadian and American nurses and AHPs use self-assess tools to measure 
performance against set competency statements before the HCP undertakes the CDE 
examination (AADE, 2016b; CDECB, 2020). Equally, assessment tools for self-appraisal 
against diabetes competency areas are also used in the UK and NZ, with options for 
advancement in pay scales (Welsh Academy for Diabetes Nursing, 2020; Aotearoa 
College of Diabetes Nurses, 2018).  
Although this process can help motivate practitioners to identify areas of weakness 
and seek appropriate education, a limitation is that competency is self-reported 
against self-selected courses that may or may not meet consumer or HCP needs. The 
current study provides opportunities to align relevant training nationally to support 
consistent consumer advice, diabetes education and care. 
2.7.1. The healthcare professional as a health coach 
All HCPs should be competent health coaches to enable better uptake of consumer 
advice about diabetes (Speight, 2013). A high-quality systematic literature review of 
41 RCTs using PRISMA and adjusting for confounders found that motivational 
interviewing conducted by HCPs reduced diabetes distress and improved glycaemia in 
6,650 participants with diabetes (Sturt et al., 2015). 
Speight, an Australian behavioural researcher (2013, p.16-17), suggested that HCPs 
behaviour is a dominant element that shapes every consumer consultation, stating: 
Consultations are not designed to enable clinicians to focus on the individual's concerns 
and challenges, yet doing so creates a positive, trusting relationship and identifies 
areas of diabetes self‐care where there is most to gain.  
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To support her stance on health coaching as a core competency, Speight (2013, p.13) 
indicates that clinicians’ behaviour is unlikely to become a focus of clinical practice 
unless clinicians, healthcare organisations and policymakers accept that behaviours 
of both people living with diabetes and clinicians are the main causative factors of 
diabetes outcomes.  
Speight’s statement disregards that the average person with diabetes would only be 
in the presence of a HCP 0.2% of the year based on eight health consultations 
annually. However, other literature identified may corroborate the HCP’s impact. A 
mixed-methods study using semi-structured interviews with 23 diabetes consumers 
from 11 primary care sites found that consumers expressed enhanced motivation to 
improve their self-care when trusting relationships were built through supportive 
discussions with HCPs (Grohmann et al., 2017). 
HCPs require the ability to orientate teaching styles and approaches according to 
individual consumers (Fink et al., 2019). To personalise care, Dunning (2018, p.47) 
suggests that HCPs require the ability to: 
• Listen ‘like a dog’. 
• Be creative and open-minded and have self-knowledge. 
• Reflect in and on their values, attitudes, beliefs and practice to enhance their 
skills and insight. 
• Promote inclusive collaboration. 
Essentially, all HCPs would benefit from receiving training and developing 
competence in health coaching and motivational interviewing and assessment skills 
to recognise clinical symptoms and ascertain patient emotional health (Hendrieckx et 
al., 2020). Identifying interpersonal competencies is critical, and reflection in and on 
practice is also essential to provide safe, quality care (Rolfe & Gardner, 2005). The 
current study can potentially identify the DSME skills generalist HCP require to tailor 
their discussions with consumers.  
The following section reviews diabetes-related medicine management in Australia 
and how diabetes educators are involved in medicine management. 
2.8. What is known about diabetes medicine management?  
Australian communities require timely, equitable access to evidence-based healthcare 
and medicines management (DoH, 2000). The Australian Government listed Quality 
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Use of Medicines and Medicine Safety as the 10th National Health Priority, recognising 
the benefits and risks associated with managing medicines (COAG, 2019). 
2.8.1. Medicine management  
The UK’s National Health Service defined medicine management as:  
An evidence-based approach to prescribing, which balances the safety, tolerability, 
effectiveness, cost and simplicity of treatments. Good medicines management means 
that patients receive better, safer and more convenient care. (NHS, 2017) 
Employing a more descriptive definition, the Australian Pharmaceutical Advisory 
Council (2005) describes medication management as a cycle including: 
• Deciding appropriate treatment and whether to prescribe a medicine/s. 
• Recording and reviewing a medicine order/prescription. 
• Issuing or dispensing a medicine/s. 
• Providing medicine information. 
• Distributing and storing medicines. 
• Administering a medicine/s. 
• Monitoring the response. 
• Transferring verified information. 
The latter suggests a comprehensive intervention that can incorporate many HCPs, 
while neither definition explicitly includes other essential skills listed in the QUM 
standards, such as cessation of medicines in polypharmacy (National Prescribing 
Service [NPS], 2021). Hence, medicine management encompasses administering 
medicines, prescribing wisely, monitoring medicines efficacy and supporting people 
to take their medications correctly. Therefore, there are opportunities for different 
HCPs to support medicine management in ways beyond simply prescribing. 
Identifying how the diabetes workforce, particularly CDEs and Aboriginal and Torres 
Strait Islander health practitioners, can further support medicine management is 
essential. An imperative exists due to high rates of poor diabetes medicines 
adherence generally (Polonsky & Henry, 2016) and morbidity and mortality 
experienced by Indigenous Australians (ABS, 2019).  
 
Furthermore, increasing workforce skills to undertake medicine management safely, 
including advice, administration or prescribing in rural, regional areas where 
workforce gaps exist, can increase healthcare access across Australia (Zhou et al., 
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2019). A capability framework may guide the diabetes healthcare workforce’s 
training to improve medication adherence among people with diabetes, which is 
important because chronic conditions could be alleviated by enhancing medication 
adherence (Langloh de Dassel et al., 2017).  
A. Non-medical prescribing. 
Non-medical prescribing (NMP) is when the right to prescribe is extended to health 
professionals other than medical doctors. NMP is not a new concept in Australia and is 
one element of medicine management. Midwives and NPs gained access in 2010 to the 
Pharmaceutical Benefits Scheme, an Australian Government initiative that provides 
subsidised access to selected essential medicines for Australians (Nissen & Kyle, 2010).  
The Pharmaceutical Society of Australia (2010) recommended in 2010 a prescribing 
framework to support the Government initiative, guiding registration, professional 
development and indemnity insurance, practice support and evaluation. In response, 
the National Prescribing Service released a prescribing competency framework in 
2012 (NPS, 2021). COAG endorsed the Health Professionals Prescribing Pathway 
Project in 2013 to provide regulatory oversight and support a nationally consistent 
implementation approach to NMP (HWA, 2013). However, progress to implement 
NMP has been slow. The Australian Health Practitioner Regulation Agency did not 
request submissions from varied disciplines national boards to approve endorsement 
concerning scheduled medicines under the National Law until 2018 (ADEA, 2018c), 
and despite active Governmental interest to pursue the expansion of NMP, until 
recently there was limited evidence to support a national implementation approach.  
In 2021, the National Prescribing Service updated the essential competency areas, 
focusing on understanding the consumer and their needs and management options: 
prescribing safely, effectively and professionally; agreed medicines plan and 
communicating agreed treatment decisions; and reviewing treatment outcomes 
(NPS, 2021). Arguably, these essential competency areas should be included in any 
framework designed to build the capacity of the diabetes educator workforce, 
including the proposed capability framework.  
2.8.2. Complexities of medicine management in diabetes  
Medicine management in diabetes is a complex skill (Stewart et al., 2017). A narrative 
review of international prescribing practices of independent non-medical prescribers in 
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diabetes suggests prescribing can be high-risk and error-prone, with many influencing 
factors (Cope et al., 2016). However, the authors did not describe their approach to 
managing the literature systematically.  
The rapid development of novel new medicines has led to polypharmacy in people 
with chronic conditions, increasing the risk of drug interactions and adverse effects 
(Picton et al., 2016). In diabetes management, increasing numbers and classes of 
glucose-lowering medicines targeting different tissues and organs involved in glucose 
homeostasis and cardiovascular systems have increased the complexity and the need 
for monitoring (Gunton et al., 2016). Picton et al. included interviewed 34 
prescribers, conducted focus groups involving primary healthcare professionals, and 
performed a 12-month retrospective analysis of prescribed medications to conclude 
that safe prescribing is challenging when prescribing for people with multiple chronic 
conditions and increases in medication with novel mechanisms of action use 
compounded drug-drug and disease-drug interactions.  
Diabetes technologies such as insulin pumps have also inundated the diabetes 
market, intensifying medicine management for people living with diabetes (Pyrlis et 
al., 2019; Xu et al., 2015). The Australian Commission on Safety and Quality in Health 
Care (2020b) indicate insulin is a high-risk medicine even when prescribed 
appropriately and is in the top three medicine-related reasons for hospital 
admissions. Thus, the growing complexity of both medicines and delivery devices 
increases the risks of medication errors. A capability framework guiding diabetes 
care needs to consider diverse roles and accommodate medicine management 
capabilities because more CDEs are increasing their SoP into medicine management.  
2.8.3. Training required to undertake a non-medical prescribing role 
To obtain NMP qualifications, HCPs need to undertake focused programs to develop 
medicine management competence. These programs differ across countries 
regarding education, practice experience and mentorship, see Table 2.7 on pages 70 
to 72, and in most instances, a postgraduate qualification is required. Until recently, 
only nurses, midwives and pharmacists had the authority to prescribe medicines; 
however, varying degrees of NMP rights have extended to other disciplines such as 
podiatrists and dietitians in many healthcare systems in Australia, Canada and NZ 
(Maier, 2019). 
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Table 2.7. Non-medical prescribing in Australia and internationally  
















- 3-years fulltime experience at 
advanced practice level. 
- Master’s degree. 
- 300-hour internship. 
- Any medicine within their SoP 
and PBS requirements. 
RN (supply schedule 
medicines rural & remote) / 
Midwife – prescribe scheduled 
medicines 
- 3-years fulltime experience. 
- Completing a Nursing and 
Midwifery Board of Australia 
(NMBA) approved program of 
study leading to scheduled 
medicines endorsement. 
 
Most Australian jurisdictions 
authorise RNs to supply and 
administer scheduled medicines 
according to protocol without 
the need for endorsement 
(NMBA, 2018).  
✓ 
Differences with many 
jurisdictions. 
Independent Prescriber 
Framework for RN Prescribing 
in Canada (2015) working 
toward Independent Prescriber. 
- 3-years clinical experience. 
- RN prescribing education 
program. 
- Internship.  
Midwife 
Against a formulary.  
Nurse Practitioner 
NP independently diagnose 
and treat health conditions 
have limited prescribing 
authority. 
RN authorized prescriber 
May counsel in insulin dose 
adjustment within parameters 
(e.g., dosage range, specific 
instructions) of a provided 
prescription by a medical 
officer.  
✓ 
In NZ 3 levels of nurse 
prescriber exist: 
Nurse Practitioner 
- 4-years fulltime experience 
in a specific area. 
- Master’s degree. 
- Passing an assessment 
against NP competency 
area. 
- 300-hours clinical 
supervision. 
- Any medication within SoP. 
Designated/Delegated 
Prescriber  
Registered nurses in 
community setting for chronic 
conditions or Pharmacists can 
apply following:  
- Undertaking a pharmacy 
practicum. 
- Minimum of 40-day/year of 
practice in a supervised 
prescribing relationship. 
- Limited schedule of 
medicines.  
Midwives 
Within scope of practice. 
✓ 
Independent Prescriber  
Nurse or Midwife 
independent prescriber 
(V300) 




- Pharmacology and 
numeracy exams. 
- Any medicine within their 
competence. 
Community practitioner 
nurse or Midwife prescriber 
(V300) 
- 1-year of clinical practice. 
- Community practitioner 
nurse prescribing course. 
- Formulary. 
  
May apply for 
‘Supplementary Prescriber 
(V100/V150) 
- 1-year of clinical practice. 










• Qualified at postgraduate 
level as an Advanced Practice 
RN (APRN) including NP, 
Nurse Anaesthetist or 
Midwife. 
• Have applied for additional 
credentials for ‘prescriptive 
authority’. 
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Table 2.7. Non-medical prescribing in Australia and internationally (continue) 









Nurse Practitioner  
? 
Credentialing for ‘insulin 
advice’. Dietitians and nurses 
who are either a CDETM, or a 
DAFNE facilitator or have 
completed a postgraduate degree 
in diabetes can provide insulin 
advice via local credentialing. 
DAFNE facilitator training: 
• Observe a DAFNE course. 
• Attend 2-day workshop. 
• Deliver a 5-day DAFNE 
course with supervision.  
X 
 





Registered nurses who 
recognise themselves as a 
Diabetes Specialist Nurse (self–
assessment via competency 
statements.  
? 
Insulin dose adjustment 
policy 
NHS Diabetes specialist and 
cystic fibrosis dietitian after: 
- Attendance to DIANE 
(Diabetes Insulin Adjustment 
for Normal Eating).  
- Work at a band 6 or above. 
- Minimum of 3-years post-
registration training.  
- One year in the field of 
diabetes or cystic fibrosis. 
X 
 










Medication administration by 
Aboriginal and Torres Strait 
Islander health practitioners 
varies between States and 
Territories’ legislation regarding 
handling, possession and 
administration of medications. 
Isolated practice authorisation 
can gain authorisation to use 
scheduled medicines under a 
drug therapy protocol. 
, 
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Table 2.7. Non-medical prescribing in Australia and internationally (continue) 


























Podiatrists or podiatric surgeons 
may apply for medicines 
endorsement after: 
Pathway A: 
Completing an approved 
qualification for endorsement for 
scheduled medicines. 
[N/A at 6/2020] 
Pathway B: 
Completion of: 
- Qualification in podiatric 
therapeutics. 
- 15 online case studies.  
- 150-hours of supervised practice 
over 12-months. 
- Portfolio of evidence. 
 
Pharmacists  
- Continue therapy on certain 
scheduled drugs if a medical 
officer provided a previous 
repeat. 
- Prescribing rights for Pharmacist 
Only Medicines (Schedule 3). 
[As above re ‘insulin advice’ in 
Queensland] 
✓ 
Differences with many 
jurisdictions. 
 
Independent prescriber /  
Collaborative prescriber 
Pharmacists with 
prescribing rights are 
approved to prescribe 
independently or in 
collaboration with a 




CDEs may practice insulin 
dose adjustment under 
medical directive in 
compliance with the 
College of Dietitians of 
British Columbia standards 






- Undertake a Prescriber 
Training Course (Course 
comprises 15-20 hours pre-
course learning followed by 
a one-day academic 
workshop). 
- Endorsement by the NZ 
Dietitian Board. 
- A diagnosis by a MO. 
- Can prescribe vitamins and 




Pharmacists can prescribe. 
- Postgraduate Diploma in 
Clinical Pharmacy qualification. 




Podiatrists can prescribe from 
a list of medicines applicable to 
their clinical practice.  
✓ 
Independent Prescriber 
Pharmacists may apply for 
prescribers’ rights after: 
• 2-years of practice experience. 
• Attain of an accredited 
independent prescriber 
qualification at university ( 6-
months) Master’s level. 
• Identified a clinical or 
therapeutic practice area. 
Other AHPs (including 
physiotherapists and podiatrists): 
• 3-years post-registration. 
• Attain an advanced 




dietitians and physiotherapists 
may apply: 
- Accredited course.  
- According to 
protocol/clinical 
management plan. 
- Following medical officer 
diagnosis.  
✓ 
Independent Prescriber  
Florida is the only state 
permitting independent 
Pharmacist prescribing from a 
limited list of medications.  
 
Collaborative Drug Therapy 
Management 
Recognised in 25 states; 
Pharmacists in partnership 
with a medical doctor prescribe 
within Collaborative Drug 
Therapy Management Clinics 
and a formal agreement.  
Differences exist; patient or 
population-specific, or 
statewide protocol to 
unrestricted category which is 
the least restrictive. 
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References for Table 2.7: (Aboriginal and Torres Strait Islander Health Practice Board, 2020; 
American College of Clinical Pharmacy, 2015; Australian College of Nurse Practitioners, 2018; 
Australian Nursing and Midwifery Accreditation Council, 2019; British Dietetics Association, 
2017; Budge & Snell, 2013; Canadian Nurses Association, 2015; College of Dietitians of British 
Columbia, 2012; Cope et al., 2016; Davidson & Russell, 2018; Dietitian Board NZ, 2016; 
General Pharmaceutical Council, 2019; Heck et al., 2015; HWA, 2013; Maier, 2019; National 
Association of Aboriginal and Torres Strait Islander Health Worker and Practitioners, 2016; 
National Alliance of State Pharmacy Associations, 2018; National Health Service, 2017; 
National Health Service - Grampian, 2018; NMBA, 2019; Nursing & Midwifery Council, 2019; 
OzDAFNE, 2020; Podiatry Board of Australia, 2018; Podiatrists Board NZ, 2019; Queensland 




In the USA, in contrast to Australia, to undertake medication adjustments and treat 
and monitor acute and chronic complications, additional training is required by 
experienced CDEs to gain Board Certified-Advanced Diabetes Management® 
certification, see Table 2.4 on page 46 to 48. However, the exam does not include 
pharmacotherapy, and it is not stipulated as a requirement of the Master’s degree. 
Only registered nurses, dietitians and pharmacists are eligible. 
In the UK, prescribing competencies are incorporated into undergraduate nursing and 
pharmacy degrees in preparation for future prescribing roles (Nursing and Midwifery 
Council, 2019). Further, prescribing qualifications can be undertaken by nurses and 
pharmacists after one year or two respectively, of graduating, see Table 2.7 on pages 
70 to 72. Moreover, prescriber training is Government-funded, a strategy to increase 
the numbers of practising prescribers (Courtenay et al., 2018). Thus, most UK diabetes 
nurses and pharmacists providing medicine advice have undertaken relevant 
pharmacotherapy postgraduate training (TREND-UK, 2019b). These factors represent 
potential strengths to the management of diabetes in the UK but also fundamental 
differences to the Australian context, despite the recent shift towards NMP.  
Pharmacotherapy includes the principles of pharmacology, pharmacokinetics, 
pharmacodynamics and the therapeutic uses and effects of medicines required to 
undertake medicine management (Cardiff, 2017), and safe, effective and judicious 
prescribing requires the successful integration of a range of clinical and assessment 
skills and pharmacotherapeutic knowledge (NPS, 2021). Given identified gaps in 
training, frameworks and mentorship, Australian HCPs could be better prepared for 
medicine management roles in diabetes, particularly CDEs.  
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A. Educational preparedness of diabetes educators for medicine management  
Despite their importance to diabetes management in Australia, diabetes educators 
may not be supported by appropriate education and training in medicine 
management, including prescribing. Internationally, evidence suggests that health 
outcomes of NMP in diabetes are based on populations managed by HCPs with 
postgraduate training in pharmacotherapy (Abutaleb, 2015; Courtenay et al., 2015; 
Tabesh et al., 2018). In contrast, Australian postgraduate degrees in diabetes include 
negligible pharmacotherapy training (ADEA, 2018a).  
In Queensland, Australia, education required to prepare nurses and dietitians seeking 
to be credentialed to provide insulin dose advice includes holding a postgraduate 
degree in diabetes education or being accredited as a Dose Adjustment for Normal 
Eating (DAFNE) facilitator or be a CDE (Queensland Health, 2017). DAFNE and CDE 
training are seen as equivalent, and neither includes education in pharmacotherapy. 
Other States and Territories of Australia do not promote this practice.  
The majority of Australian CDEs are nurses (ADEA, 2019a). According to the NMBA 
(2019), nurses are highly involved and appropriately trained to administer medicines. 
In a multicentre time and motion study, nurses were observed by an independent 
researcher to spend the highest proportion of the day, over one-fifth, managing 
medicines (Holmqvist et al., 2018). NMBA (2019) suggest nurses hold relevant skills to 
support future NMP roles because most Australian jurisdictions authorise and enable 
registered nurses to supply and administer scheduled medicines safely according to 
protocols without endorsement.  
CDEs preparedness for a medicine management role is vital, particularly given a UK 
audit that identified an increase in serious incidents and death linked to an increase in 
independent GP practice-based UK pharmacist prescribers (Pharmaceutical Defence 
Association, 2019). A combination of different skills is essential.  
 
According to Cope et al. (2016), who performed a narrative literature review of NMP 
in the UK over 20 years, nurses have shown greater skills in physical assessment, 
diagnosis and interpretation of laboratory results than pharmacists, who in turn 
showed superior pharmacology knowledge in diabetes. The skills demonstrated by 
both are essential; thus, it suggests incorporating a focus on diagnostic and medicine 
management skills into a capability framework for diabetes better prepare CDEs by 
improving their physical examinations, diagnostic skills, and care delivered.  
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The capability framework can promote consistency in how CDEs are involved in 
medicine management to reduce risk and increase safe diabetes care access. 
2.9. How diabetes educators are involved in medicine 
management in Australia 
Diabetes educators support medicine management by educating consumers and 
providing advice regarding glucose-lowering medicines or their adjustment or 
prescribing (ADEA, 2015d). Nurse CDEs often initiate and adjust insulin doses or 
algorithms on insulin pumps and glucose-lowering medicines (GLM), according to local 
protocols, aligned with relevant State or Territory Drug and Poisons Legislation (ADEA, 
2018c; NSW Government, 2013). Access to prescribing qualifications has enabled the 
development of nurse-led clinics to provide more timely care (Cope et al., 2016). In 
Australia, however, approximately 80 nurse practitioners who specifically worked in 
diabetes were endorsed in 2020 to prescribe (ADEA, 2020b).  
2.9.1. Adjusting or advising on insulin doses  
Traditionally, insulin dose adjustments formed part of the SoP of diabetes educators in 
Australia, predominantly nurses working in well-supported tertiary settings (Colagiuri 
& Ritchie, 1996; Dunning & Manias, 2009). However, different medicine management 
practises have emerged because of legislative changes, and the numbers of CDEs from 
different disciplines other than nursing have increased.  
A. The impact of policy change concerning insulin scheduling in Australia  
In 2020, nurse diabetes educators faced uncertainty regarding their continued 
involvement in adjusting insulin doses and managing glycaemic levels. The Therapeutic 
Goods Administration identified insulin as a high-risk medicine, and it became a 
Schedule 4 medicine, i.e. by prescription only (CoA, 2000). No peer-reviewed literature 
was identified to explain the change.  
However, when insulin was rescheduled, medicine management was seen as part of 
the existing SoP of nurses, e.g. administration of medicines. The change was evidenced 
in researcher-collected field notes from discussions in 2017 to 2019 with diabetes 
services managers from regional and metropolitan areas working in 2000 in NSW, 
Victoria, South Australia and Tasmanian. The policy change posed additional problems 
because a precedent existed. Insulin adjustment would be expected of a nurse 
diabetes educator by consumers and multidisciplinary colleagues. Therefore, the 
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practice continued with formalised protocols authorised by their employing 
organisations and mentorship supporting insulin dose adjustments in ambulatory care. 
B. Increasing CDE disciplines involvement in insulin dose adjustment  
More recently in Australia, increasing numbers of allied health and pharmacist CDEs, 
have begun managing insulin doses, and more CDEs generally have commenced 
working outside tertiary centres (ADEA, 2018b). Issues of role boundaries delineation 
have increased with different disciplines managing insulin doses (ADEA, 2016). 
Analysis of this researcher’s field notes suggests that diabetes educators, including 
nurse CDEs from community settings, increasingly report being uncomfortable 
providing insulin dose advice if they lack expertise and mentorship. Further, allied 
health CDEs wish to increase their involvement in managing insulin because it is 
witnessed as a practice of their nursing colleagues and would help to increase 
healthcare access. 
Stewart et al. (2017) suggests that differences in training, mentorship and experience, 
and resourcing can reduce safe, quality care, which is pertinent to the CDE workforce 
because undergraduate training differs between disciplines, and more have started 
working in primary care where resourcing differs. However, the current study 
represents an opportunity to identify ways to meet the needs of all CDEs looking to 
increase their SoP to address consumers needs by guiding the safe expansion of 
workforce capacity.  
C. Approaches to and confusion about managing insulin 
Different practices for managing insulin have arisen with increasing numbers of 
disciplines involved, including ‘insulin dose advice’, ‘insulin titration’ and ‘prescribing’ 
(see Glossary on pages 9-10) and can vary across jurisdictions.  
Understandings about the insulin dose advice practice are not congruent across 
Australian diabetes groups, and this discrepancy can lead to unsafe medicines 
practices (ACSQHC, 2020b). Queensland Health policy supports local credentialing of 
public sector nurses and APD to advise on insulin doses to meet the state’s large 
geographical and very remote community’s needs (Queensland Health, 2017). 
Queensland Health (2017, p.7) identify insulin as a Schedule 4, prescription-only 
medicine; however, state clinicians providing insulin dose advice are:  
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Neither prescribing nor administering insulin and therefore RNs and APDs who are 
educated, competent and authorised to give insulin dose advice to consumers do not 
require a regulatory endorsement.  
In contrast, the ADEA (2018b, p.11) appear to understand insulin dose advice to be 
prescribing in partnership, as they stated:  
This model [designated prescriber] is currently being rolled out in Queensland. RNs 
working in diabetes can apply for ‘credentialing’ (different to ADEA CDE status) to 
provide advice on dose adjustment for insulin.  
Similar incongruences exist for insulin dose adjustment. Dietitians Australia (2018) 
updated Role Statement for Accredited Practising Dietitians Practising in the Area of 
Diabetes indicated insulin dose adjustment are not areas of practice usually 
undertaken by a dietitian working in diabetes. The Queensland policy does not align 
with that statement, creating further confusion.  
The ADEA (2012) Initiating Insulin in the Ambulatory Care Setting standards sets the 
standard for eligible CDEs for their involvement in managing insulin doses. The 
standards indicate consideration to factors such as meal planning, activity, intercurrent 
illness, age, active microvascular disease and BGL targets when following any 
‘structured formula’ to alter or titrate insulin doses. The ADEA (2012, p.12) suggest 
insulin titration is prescribing in their standards: 
Initiation of insulin therapy, dose titration, dose adjustment and alteration of doses 
following a protocol are all prescribing practices.  
Hence, insulin dose advice and insulin titration practices align with the definition of 
prescribing. Moreover, Drug and Poisons Legislations do not use the term insulin 
‘titration’ or ‘advice’. 
A reason for the confusion may relate to Australian Drug and Poisons Legislations, 
which notably do not include a statement that either allows or forbids changes to the 
instructions given to a consumer regarding a prescribed medication after it has been 
dispensed. Regarding nursing, Simpson (Executive Director of Statewide Hospital 
Pharmacy in Tasmania, personal communication June 10, 2020) explained: 
Rather than a purely regulatory issue, it is a SoP issue. Changes to medicines by nurses 
have become an accepted practice in nursing over 50 years as an extension of the standing 
order regulation afforded to the administering nurse or midwife, although this practice is 
not necessarily clearly defined or enabled in policy or practice framework.  
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The quote suggests involvement in medicine management by health professions is 
related to SoP; hence, they must be appropriately trained and mentored. The current 
study may assist in better understanding the ways that HCP are involved in diabetes 
medicine management, and a capability framework for diabetes could improve 
consistency in training and practice. 
2.9.2. Non-medical prescribing and CDEs 
Adding to the complexity surrounding the involvement of CDEs in medicine 
management is the fact that there are differences in foundational training and 
experience across disciplines eligible for credentialling. Prescribing endorsement is 
related to the HCP’s primary discipline in Australia; Credentialled Diabetes Educator 
status alone does not enable NMP, neither does ADEA regulate NMP (ADEA, 2015d).  
Nationally, legislation differs regarding the type of HCP who can administer, hold, supply 
and prescribe Schedule 4 medications. For example, NSW public diabetes nurses can 
hold insulin stock and supply a small quantity, Queensland and Victorian endorsed 
nurses can supply medicines under protocol in rural and isolated services and many 
states, registered nurses can adjust medication according to protocols to stabilise 
diabetes (AHPRA, 2017; NSW Government, 2013).  
Regulatory oversight can be implemented to enable NMP by CDEs via changes to Drug 
and Poisons Legislation and AHPRA registration; however, these changes do not address 
CDEs from self-regulated accredited HCP disciplines. Drug and Poisons Legislations do 
not recognise some health professions because they are not required to be registered 
under the National Law. Simpson (Executive Director of Statewide Hospital Pharmacy, 
Tasmania, personal communication March 6, 2019) indicated: 
HCPs not listed within Poisons Acts from the state where they practice, e.g. a speech 
pathologist, are excluded from prescribing. HCPs not listed must seek individual guidance 
from their accrediting health profession organisation and insurance coverage.  
Accredited practising dietitians and exercise physiologists eligible for CDE status are 
not included in Australian legislation regulating the administration or prescribing of 
medicines (ADEA, 2015d). Neither do they have Boards established under the National 
Law; hence, no legal requirement to be registered with AHPRA.  
The AHPRA helps protect the public by regulating Australian registered health 
practitioners with oversight from relevant Boards (AHPRA, 2020). AHPRA only 
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regulates those health professions deemed to pose an increased risk to public safety 
because of the types of activities they provide. The AHPRA regulates certain health 
professions eligible for credentialling as a CDE, but not CDEs specifically. No legislation 
or regulations was identified that covers the CDE role in medicines management 
explicitly.  
According to Stewart et al. (2017), who performed a systematic literature review to 
assess the quality of studies investigating the implementation of NMP in different 
countries, some HCPs may not have adequate training in health assessment, 
pharmacotherapy, and QUMs to provide advice safely. Clinical governance and 
escalation processes to guide practice and mechanisms for monitoring incidents 
following adverse medication outcomes or errors are required by CDEs to include NMP 
as part of their professional SoP due to differences in foundational training of 
disciplines eligible for CDE status in Australia (NPS, 2021; PSA, 2010).  
Moreover, understanding the differences between other countries’ health systems and 
how they prepare their NMP workforce requires consideration to align SoP changes in 
Australia. Policy changes in NMP are occurring faster than regulation changes; this 
thesis can provide advice and solutions to increase diabetes medicine management in 
Australia.  
A. Differences in Australian Drug and Poisons Legislation 
A further issue adding to the complexity of CDEs involvement in NMP are multiple 
Australian State or Territory Drug and Poisons Legislation with prominent variations in 
nomenclature, including differences concerning how disciplines can be involved (AHPRA, 
2017). All legislation recognises the Poisons Standard Schedules; however, use different 
terminology to describe them (Hope & King, 2015).  
A framework to enable national medicines legislation exists with the formation of 
AHPRA: yet, HCPs continue to be regulated differently across Australia. Tooms (2017) 
suggests a singular national Drug and Poison’s Legislation linked to the Pharmaceutical 
Benefits Scheme would align with strategic and policy changes, identifying efficiencies. A 
single policy can reduce inconsistencies in CDE medicine mentoring and training.  
2.9.3. Gaps addressed by diabetes medicine management capabilities  
Capabilities to support medication adherence is vital. A literature review by Polonsky 
and Henry (2016) found diabetes medication adherence rates of between 41.2% to 
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67.9% in adults with T2D. Contributory factors included perceived treatment efficacy, 
hypoglycaemia and complexity of medication regimen.  
Evidence drawn from three systematic literature reviews of RCT and non-RCT 
(Abutaleb, 2015; Tabesh et al., 2018; Weeks et al., 2017), two comparative studies 
(Budge & Snell, 2013; Courtenay et al., 2015) and one quasi-experimental study (Carey 
et al., 2008) reviewing NMP in diabetes, identified health benefits in addition to 
addressing healthcare gaps. Limited prescribing by nurse and pharmacist diabetes 
educators have shown: increased medication adherence (Weeks et al., 2017), 
improvements to metabolic markers and health-related quality of life (Abutaleb, 2015; 
Budge & Snell, 2013; Weeks et al., 2017), improved access to diabetes medicines 
(Budge & Snell, 2013), higher patient satisfaction (Budge & Snell, 2013; Courtenay et 
al., 2015; Weeks et al., 2017), reduced hospital length-of-stay (Carey et al., 2008) and 
comparable results to doctors (Abutaleb, 2015; Tabesh et al., 2018; Weeks et al., 
2017). 
Combining the skills of both nurses and dietitians in a Canadian insulin adjustment 
program found a decrease in HbA1c and an increase in consumer satisfaction and HCP 
skills and expertise (Blekaitis & Wylie, 2016). The study did not, however, discuss the 
randomisation process or the complexity of patients recruited. 
Health gains can be achieved through promoting NMP. Harnessing the expertise and 
skills of diabetes-trained HCP can support QUM in people with diabetes through 
increasing workforce capacity. These elements should be considered in a whole 
workforce framework to guide diabetes education and care. 
2.9.4. Approaches to addressing medicine management gaps  
Implementation of NMP has been inconsistent and evidence suggests deficits in 
diagnostic training, mentorship, practice support and continuing professional 
development (Cardiff, 2017; Courtenay et al., 2018). A scoping review of UK, 
Australian, Canadian and NZ literature from 2003 to 2018 found common barriers to 
implementing NMP, included inadequate diagnostic training and support from 
authorities and insufficient reimbursement or funding (Zhou et al., 2019). Courtenay et 
al. (2018), who used a Delphi technique with 55 experts identified clinical supervision, 
interprofessional relationships, continued professional development, involvement in 
developing NMP protocols, study leave, linking NMP qualifications to job 
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specifications, and a consistent strategic approach to implementing and progressing 
NMP were priorities for promoting national NMP consistency.  
An Australian Government-funded project sought to promote consistency in assessing 
student prescribing competence in various health professions. According to Cardiff et 
al. (2018), who surveyed 12 physiotherapists and seven pharmacists following a 
National Prescribing Service-aligned AHP prescribing training program, development 
and delivery were challenging because both the needs of the individual practitioner 
and those of the profession require attention. 
Experts, such as CDEs, could suitably increase their role in supporting QUM, increasing 
the workforce’s capacity to provide accessible diabetes healthcare. Evidence suggests 
that an opportunity exists to improve adherence to diabetes medicines regimens. The 
current study created an opportunity to identify diabetes HCP current understanding 
of NMP to drive future appropriate training and research. A capability framework 
provides an opportunity to align ongoing training, mentorship and continuing 
professional development with any move towards including NMP capabilities in CDEs, 
other than NPs. Approaches to improving the adoption of QUM should be considered 
part of a workforce capability framework implementation.  
The preceding section ends the literature review. The literature review resulted in 
several research questions presented at the beginning of the three data collection 
methods chapters, in Sections 4.2, 5.2 and 6.1.1.  
2.10. Chapter summary  
Structured diabetes self-management education (DSME) contributes positively to the 
person living with diabetes by improving their health outcomes. To deliver DSME, HCPs 
require a plethora of skills and empathy because of the lifelong demands consumers 
with diabetes face and their increased risk of diabetes-related distress. 
Literature suggests HCPs contribute to diabetes prevention and health outcomes 
through health promotion and supporting the uptake of self-care strategies and 
medications; outcomes are greater when HCPs are mentored or diabetes-trained. 
Moreover, complementing different HCPs unique skill-sets with diabetes capabilities 
can create opportunities for improved access. However, despite their role in diabetes 
healthcare, many HCPs are not eligible to become credentialled as a CDE, nor seek to. 
Identifying ways to ensure these HCPs are diabetes competent is essential. 
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In Australia, a rigorous process exists for credentialling diabetes educators that 
recognise their expertise. However, existing diabetes frameworks in Australia to guide 
practice include only CDEs, nurses and Indigenous health practitioners. Moreover, they 
are competency-based, which aligns training to stable conditions; however, healthcare 
environments are dynamic. To increase consumer access to quality care, a framework 
to guide the relevant diabetes training requirements across a broad range of HCP 
disciplines to promote consistency is imperative.  
Diabetes healthcare is complex and integrated; coordinated care is vital for optimal 
health outcomes for people managing their diabetes. As professional practice changes 
and evolves, the capabilities HCPs require to deliver care change. Notably, workforce 
growth is hampered because competencies for HCPs in diabetes tend to focus on a 
health problem rather than the HCP developing capabilities. Fostering capacity in the 
diabetes workforce by developing flexibility in training approaches to ensure HCPs are 
competent in diabetes care, trained consistently and supported by strengthening 
connections with CDEs, may assist in meeting the future healthcare needs of people 
living with diabetes. 
Last, diabetes educators are expanding their SoP, primarily into medicine 
management. An appropriately trained CDE workforce is a solution to increase 
medicines access and promote medication adherence. However, defining SoP 
concerning involvement in medicine management for those eligible for CDE status in 
Australia is complex due to inconsistency in State and Commonwealth legislation, 
regulation and relevant training. Notably, access to appropriate training and ongoing 
mentoring of those working towards NMP by current prescribers are considered 
imperative. The research undertaken in this study aims to guide relevant curricula, 
capability framework development and policy.  
Next, the methodology ascertained as most beneficial to undertake the study is 
explained.  
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Chapter 3: Methodology  
3.1 Chapter introduction 
The purpose of Chapter 3 is to provide information about methods for developing 
consensus on a topic and a rationale for choosing the Delphi technique to conduct the 
study. Also, the evidence that informed the approach to data collection is shared. 
Next, the theories applied to the study that focus on clinical competency, expertise, 
and capability approach education are discussed. These theories informed both the 
research and the design of the capability framework. The chapter provides a 
conceptual framework to explain how the topic was explored. Last, the approaches 
taken to manage ethical and methodological integrity and ensure rigour are discussed. 
3.1.1. The research questions addressed in the chapter 
1. What is the best methodology to develop a capability or competency framework 
by consensus? 
2. What are the conceptual and theoretical frameworks that inform this study?  
3.1.2. Literature search strategy 
CINAHL and Medline Complete were searched to identify peer-reviewed research 
articles written in English between 2008 and 2018 on consensus methodologies used 
in diabetes, specifically those identifying competencies or capabilities. Two searchers 
were undertaken to identify information to inform the study method. Search 1 
identified studies using consensus methodologies in diabetes, and Search 2 identified 
studies using Delphi to identify capabilities or competencies in diabetes, see Table 3.1. 
Table 3.1: Search terms used to identify peered reviewed articles  
Search 1 diabet* AND Delphi OR 'consensus development conference' OR ‘RAND 
appropriateness method’ OR ‘nominal group technique’ 
Search 2 diabet* AND competenc*OR capabilit*AND Delphi 
 
Search 1 resulted in 319 articles, including 20 duplicates. On reading abstracts, 271 
were deemed out of scope because they did not relate to diabetes, and 28 articles 
were obtained for further reading, of which one was assessed eligible as it was the 
only one related to the workforce. The reference lists of the 28 articles were review 
for relevant research articles to inform the consensus methods discussion.  
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Next, Search 2 yielded 227 articles, including ten duplicates. Most, 208 were out of 
scope as they did not include Delphi and nine were obtained for further reading; 
however, they were not eligible because they did not pertain to diabetes and 
healthcare professional roles (HCP). Further, grey literature obtained from peer 
diabetes HCP organisations, as discussed in Chapter 2 on page 32 was also included. 
3.2. Consensus building methodologies  
Evidence suggests consensus approaches are used to identify core competencies, skills, 
attributes, priorities or guidelines (Diamond et al., 2014; Foth et al., 2016). Consensus 
research methods aim to enhance decision-making, synthesise professional expert 
opinion, or provide some means of measurement where there is a lack of empirical 
evidence or controversy (Waggoner et al., 2016).  
A consensus research method was appropriate for the current study because the 
literature review in Chapter 2 identified no articles concerning diabetes capabilities 
and role boundary concerns in diabetes among Australian HCPs. Several consensus-
building research methods were appraised to determine their suitability for the 
current study, including the Nominal Group Technique (NGT), RAND appropriateness 
method (RAM), Consensus Development Conferences (CDC) and Delphi technique. 
3.2.1. Nominal group technique 
The Nominal Group Technique (NGT) is a way of organising small group 
communication to generate and prioritise ideas to resolve issues: often used to elicit 
healthcare priorities (McMillan et al., 2016). NGT comprises a group of up to a 
maximum of seven participants. Participants are asked to brainstorm solutions to an 
issue independently, and then, using a ‘round-robin’ approach, consecutive 
contributions of a solution with a short explanation are shared (McMillan et al. 2016). 
Duplicated solutions are eliminated, and participants proceed to rank the solutions in 
order of importance.  
However, the literature suggests NGT may not be a discrete consensus method 
because its primary aim is not consensus (Waggoner et al., 2016). Regardless, 
consensus naturally occurs because the group prioritises ideas during the process.  
Given the number of disciplines involved and various settings within the current study, 
a small group NGT would not capture all relevant information from varied disciplines 
to inform the whole workforce. Further, given role boundary concerns (ADEA, 2016), 
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the method would lead to dominance bias and not reflect genuine workforce 
capabilities. Because of these limitations, the method was considered unsuitable for 
the current study and not used. 
3.2.2. RAND appropriateness method 
RAND appropriateness method (RAM) is an alternate consensus method, and it 
includes three rounds. In the first round, a core expert panel, e.g. surgeons, conducts a 
systematic review and lists indications for a medical intervention and its definitions. In 
the second round, another panel of experts review the pertinent information and 
independently rate the benefit-to-harm ratio of the procedures listed on a scale of 1 to 
9 (Foth et al., 2016). The core panel synthesises results, and then in the third round, 
the expert panel meet face-to-face to review the list of interventions against clinical 
scenarios with a moderator. After discussing areas of disagreement, they rate the list 
on a 9-point Likert scale again.  
Fundamental to creating efficient and equitable healthcare services and systems is 
understanding the appropriateness or necessity of care. Appropriateness refers to the 
relative weight of the benefits and harms of a medical or surgical intervention. RCTs 
often do not report on the benefits of many procedures; hence, RAM is more suited to 
attaining consensus on the ‘appropriateness’ of medical intervention or their quality 
indicators (Foth et al., 2016). 
Foth et al. (2016) suggest the RAM method is a hybrid of the Delphi technique and NGT 
combined. Given that the literature review in the current study did not reveal any 
capabilities for diabetes, it was impossible to develop a list of capabilities for the first 
RAM round. Hence, the method had little utility for the current study and was not 
used. 
3.2.3. Consensus development conference 
The Consensus Development Conference (CDC) is another consensus method used to 
finalise priorities. A selected panel are brought together who listen to experts 
presenting available data (Waggoner et al., 2016). The data presented is a summary of 
the authors’ review of literature and interviews with topic experts. Consensus is 
formalised through the ensuing discussions between CDC participants.  
For example, Colagiuri and Eigenmann (2009) used the method by bringing together a 
group of expert diabetes educators to develop a national consensus position on the 
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desired goals, outcomes and indicators of diabetes patient education. The list of 
outcomes and indicators were developed from a literature review, interviews with key 
opinion leaders and a focus group with people with diabetes (Colagiuri & Eigenmann, 
2009). However, while a continuous, systematic collection of opinions is described, the 
CDC had over fifty participants; thus, there was a risk of dominant personality bias 
impacted by the diversity of disciplines involved.  
Variations in planning CDCs have been cited (Waggoner et al., 2016); outcomes may be 
influenced by biases of specific personalities, the efficiency of the moderator and other 
variations. Given these limitations, the CDC was considered unsuitable and not used in 
the current study. 
3.2.4. Delphi technique 
Last, the Delphi technique enables a group of ‘experts’ to explore a complex issue/s 
and move towards consensus without influence by individual participants (Hsu & 
Sandford, 2007). The Delphi technique had utility for the current study because it was 
identified as the preferred consensus-building method when identifying HCP 
competencies and research priorities (Foth et al., 2016; McMillan et al., 2016). In the 
Delphi technique, opinions converge following a series of carefully designed 
questionnaires interspersed with a summary of participants’ feedback, which each 
participant reviews privately (Keeney et al., 2010).  
The RAND Corporation developed the Delphi method or technique in the late 1950s as 
a forecasting system to address military problems. Military experts were asked to give 
their opinion on the probability, frequency, and intensity of possible enemy attacks 
(Keeney et al., 2010). Then, the feedback was shared as statements to all the military 
experts anonymously, which they then ranked independently. The process was 
repeated several times until a consensus emerged; an anonymous summary of others’ 
rankings was provided with each iteration.  
The anonymity offered by the Delphi technique prevents individual participants from 
dominating discussions and eliminates group pressures to conform (Wilkes, 2015). 
Other features that ensure information is captured accurately and without influence 
are reviewing the groups’ ranked data with controlled feedback, allowing participants 
to modify their views because they better understand others’ perspectives (Waggoner 
et al., 2016). Notably, Delphi engages large numbers of participants from 
geographically diverse locations and conveniently obtains a rapid response to a 
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research question (Ginn, 2018), enabling access to a more representative group for the 
current study. 
The literature suggests differences between e-Delphi and online Delphi (Ginn, 2018); 
however, these appear to be related to delivery. An e-Delphi uses a survey tool forward 
to panellists via email. In contrast, a web-based Delphi survey involves panellists 
entering data into an online survey instrument (Helms et al., 2017).  
Delphi has since had various modifications (Diamond et al., 2014). For example, many 
Delphi studies in the literature search used an NGT before the Delphi technique, such 
as Oosterkamp et al. (2016), who aimed to gain consensus among orthodontists on 
264 clinical practice statements to reduce variability in preventative measures for 
managing white spot lesion. Oosterkamp et al. also provided the orthodontist experts 
with articles from a systematic literature review at the brainstorming round before the 
consensus rounds. Ultimately, any modification requires thoughtful consideration 
because it can influence the intrinsic knowledge drawn from the Delphi experts.  
Dietitian Australia used a modified Delphi to develop competency standards for 
dietitians (Palermo et al., 2016). The process was modified by including focus groups to 
explore the emerging purpose and function of the role before the Delphi survey was 
disseminated.  
However, attaining consensus from a Delphi study does not mean that the correct 
answer has been found (Waggoner et al., 2016). Enabling participants to elaborate on 
their opinions strengthen consensus by allowing participants to discuss issues (Keeney 
et al., 2010). Thus, opportunities for feedback and elaboration coupled with the Delphi 
technique were essential considerations for the current study.  
The CDC, RAM and NGT were deemed unsuitable for the study because the influence 
of specific personalities, and variations and logistics in planning and conducting the 
groups would create bias (McMillan et al., 2016). Hence, the Delphi technique was 
determined as the consensus methodology of choice and used in the current study. 
3.3. Rationale for using Delphi technique 
Given that no evidence existed, and opinions were likely to be diverse because the 
framework would describe SoP, the Delphi technique was selected as an appropriate 
research method to identify evidence and reach consensus about capabilities for 
diabetes in the current study. Australian HCPs have raised professional boundaries 
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concerns regarding activities different diabetes-trained HCPs undertake (Fenton, ADEA 
President, personal communication, June 9, 2020). Given the diversity of HCPs and role 
boundary confusion in diabetes in Australia, a consensus method offering anonymity 
enabling people to ‘speak’ freely had utility.  
It was vital that information generated and collected be managed with minimal impact 
on opinions or pressure towards participants to conform to the ‘norm’ to support sound 
findings. Further, it allowed collecting opinions from HCPs working in geographically 
remote areas; therefore, better representation of the healthcare workforce would 
capture Australia’s health service nuances created by remoteness. 
The three-staged modified Delphi technique used in the current study provided a 
sequential method to move towards consensus. Individual Delphi participants were 
anonymous to each other and the supervisors throughout the study. According to 
Flanagan et al. (2016), anonymity enabled by Delphi allowed participants to share their 
opinion freely without their attitude or thoughts being impacted by or on others. Thus, 
evaluation of each decision was on its merit informed by experts, and individual 
opinions did not dominate the consensus process.  
These methodological elements captured a better understanding of clinical competence 
in diabetes and what is required to develop expertise; further, an indication of potential 
motivators and utilitarian drivers of HCPs to diabetes healthcare.  
3.4. Delphi technique to attain consensus in diabetes  
Peer-reviewed literature concerning competency-based frameworks to guide HCPs to 
deliver diabetes education and care are sparse; most exists in grey literature. Further, 
the approach used to gain consensus is often not explained, such as the recent An 
Integrated Career and Competency Framework for Adult Diabetes Nursing by TREND-
UK (2019a). Information within the UK framework suggests a consensus document and 
mentions review by several diabetes-related organisations; however, the process for 
consensus is not described. While the current literature search did not identify Delphi 
studies to identify diabetes competencies or capabilities, articles relating to other 
health fields were identified. 
While qualitative research methodologies are used to explore why or how a 
phenomenon occurs, develop a theory, or describe the nature of an individual’s 
experience, quantitative methodologies address questions about causality, 
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generalisability, or magnitude of effect (Sekayi & Kennedy, 2017). Delphi does not fit 
into either of these definitions as it seeks consensus. However, although commonly 
perceived as a quantitative method because of its focus on statistical consensus, a 
modified and open-ended Delphi technique enables qualitative data to be collected 
that captures the experts ‘words’ and facilitates an albeit small understanding of 
participant experiences (Sekayi & Kennedy, 2017). 
Based on a systematic literature review to determine guidelines for consensus methods 
by Waggoner et al. (2016), the current study design included unambiguous inclusion 
criteria, multiple and rigorous statistically analyses to ensure the results genuinely 
reflected consensus and a predetermined definition of consensus to address the authors 
recommendations. However, Waggoner et al. did not use a validated tool such as JBI to 
appraise the studies. Nevertheless, articles identified in the current literature search 
pertaining to Delphi also identified the sample size as a crucial study element. 
3.4.1. Delphi sample size 
Systematic literature reviews by Foth et al. (2016) regarding consensus methods 
employed in nursing and Waggoner et al. (2016) concerning consensus about elements 
of consensus methods informed the sample size in the current study. Specific sample 
sizes for each data collection method in each Delphi stage are discussed in Chapters 4, 
5 and 6.  
Studies often chose convenience samples of participants, depending on the availability 
of experts and resources (Hsu & Sandford, 2007). However, sufficient numbers of 
expert participants for an adequate sample size concerns the stability of participants’ 
responses, which is fundamental to ensure consensus (Akins et al., 2005).  
Akins et al. suggest response characteristics of small expert panel groups can be stable 
compared to larger sample sizes when the knowledge areas are well defined and within 
the panels’ expertise. Foth et al. (2016) suggest that when participants are homogenous, 
a sample size of ten to 15 is considered adequate for each area of expertise; Waggoner 
et al. (2016) suggested smaller numbers of five to 11 for consensus.  
Peer-reviewed articles identified by the researcher, which used the Delphi technique 
to develop competency statements in a health-field, had varied sample sizes ranging 
between eight and 60. However, they could be higher and often concerning one 
discipline or nursing group, e.g. paediatric nursing (Courtenay et al., 2018; Helms et al., 
2017; Moser & Korstjens, 2018; Hsu & Sandford, 2007).  
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3.4.2. Measuring consensus in Delphi studies  
A predetermined definition of consensus before embarking on Delphi was essential 
(Waggoner et al., 2016). The following literature informed the definition for consensus 
and the Likert scale for the current study, described in Chapter 5 as it pertains to 
Delphi Stage II. 
Hsu and Sandford (2007) recommend that consensus is attained when 80% of 
participants’ votes fell within two categories on a seven-point Likert scale. Other 
literature indicated that at least 70% of Delphi participants need to rate three or higher 
on a four-point Likert scale, and the medium is 3.25 or higher to achieve consensus 
(Hsu & Sandford, 2007).  
In contrast, Hsu and Sandford (2007) proposed the stability of participants’ responses 
in successive iterations, as a more reliable measure of consensus, due to identified 
inadequacies of percentage measurement. Thus, it was essential to have a continuous 
high response rate throughout the Delphi data collection methods, the systematic 
method towards consensus.  
The number of response options was as important as the number of items to maintain 
participant engagement through the Delphi technique. To avoid bias in Delphi studies, 
attention to the number of items carried over to subsequent rounds was another 
essential consideration because too many items increase participant disengagement 
and impede consensus (Hasson & Keeney, 2011).  
Further, short Likert scales with 4 to 5 options were considered more valuable 
because longer scales increase panel member decision-making and burnout (McMillan 
et al., 2016). Given the potential number of items needed to be ranked for varied 
disciplines and work settings, the two issues identified by Hasson & Keeney (2011) and 
McMillan et al. were essential considerations for the current study. 
3.5. Theoretical frameworks that inform the study 
Several theories helped to understand essential concepts pertinent to conducting the 
research and develop the capability framework structure. The framework’s focus was 
to increase workforce capacity in diabetes by guiding training for a flexible workforce. 
Theories were divided into three categories: clinical competence, expertise and 
capability, see Figure 3.1 on page 91. Benner’s stages of clinical competence, Ericsson’s 
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theory of expertise, and Sen’s capability approach theory were used as the theoretical 
framework to guide the research.  
 
 
Figure 3.1: The theoretical underpinning of the framework for diabetes care 
Marcum (2012, p.112) explored the notion of virtue in medicine and noted: 
Caring without competence often leads to harm, while competence without caring is 
often inhumane.  
The quote suggests a unique therapeutic connection between the two concepts; caring 
for people with diabetes by HCPs without competence may not provide safe quality 
care or enable critical human connections. Human connections are essential to caring 
conversations and personalised care and assessing satisfaction with care (Hendrieckx 
et al., 2020). 
To identify the critical capabilities the diabetes healthcare workforce requires to 
develop a diabetes competent workforce; it is helpful to understand how competence 
and competency are defined. 
3.5.1. Descriptions of the terms: competence and competency  
Health literature defines ‘competence’ in several ways and the terms ‘competence’ 
and ‘competency’ are often used interchangeably; thus, the term could be considered 
nebulous. Therefore, before introducing the theories guiding the study, an 
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The Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health 
defined competence as:  
A principle of professional practice, identifying the ability of the provider to administer 
safe and reliable care consistently. (Miller & O’Toole, 2005) 
Miller-Keane’s definition is focused on ‘ability’ and implies repeatability within a 
context of not causing harm. In a general healthcare context, ‘safe’ means evidence-
based and ‘reliability’ means the care is trustworthy.  
Roget’s Thesaurus lists the following synonyms for competency: capability, proficiency, 
aptitude, expertise, skill, ableness, mastery, artistry, ability, capacity, adeptness 
(Kipfer, 2011). These synonyms imply qualities and attributes that draw on personal 
behavioural assets of inventiveness and flexibility in approaches to caring that could be 
relevant to the HCPs’ ability to demonstrate competency in diabetes education and 
care. 
Moreover, Roach (cited in Marcum, 2012, p.112), a nursing theorist, takes a more 
specific approach and defined competency as: 
The state of having the knowledge, judgment, skills, energy, experience & motivation 
required to respond adequately to the demands of one’s professional responsibilities.  
The definition starts to link qualities to legal and moral duties of the HCP’s role and 
includes the concepts of energy and motivation. Regarding the HCP and diabetes, the 
definition alludes to the HCP having qualities of enthusiasm and inspiration and an 
awareness of their motives within the decision-making processes during diabetes 
education. However, the definition does not incorporate a consumer aspect to 
consider their role within decision-making encounters.  
In contrast, the Nursing and Midwifery Board of Australia’s (NMBA) (2016) perception 
of competency is broad and principle-based and competency within its ‘standards of 
practice’ is described as a: 
Unique combinations of skills, knowledge, attitudes, values, abilities, confidence and 
capability of the individual nurse or midwife in the performance of their professional 
duties.  
Nurses’ competency domains: critical thinking, therapeutic engagement and 
capabilities are important when assessing, planning, improvising and evaluating care. 
The NMBA draws attention to the premise that all competency standards are 
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interconnected: each complementing or supporting the other, see Figure 3.2. No 
standard is unique on its own; all standards depend on each other to form a whole. 
Hence, information included in the current study’s framework had to explain how 
competency develops. Here, competency involves a cluster of actions combined with 
analytical thinking while maintaining a therapeutic relationship to provide care 
competently. 
 
Figure 3.2. Diagrammatic representation of the registered nurse standards for 
practice. [Reference: NMBA, 2016] 
 
The NMBA practice standards suggest that being competent means a nurse needs to 
meet all competency areas in their entirety to enable them to deliver safe care. If the 
same premise is used in the current study and framework design context, HCPs cannot 
learn a new task and be considered competent without considering capabilities in 
several other assessment and analytical actions.  
During discussions of ADEA case studies for a webinar series focused on increasing 
competence in CDEs, an Australian expert nurse practitioner and CDE stated: 
The problem with diabetes education as a whole - we [diabetes educators] break it up 
into little tasks, and many CDEs cannot see past the tasks. (Robins, NP, personal 
communication, May 15, 2017)  
Similar to the NMBA standards, Robins’ (2017) view suggests that being capable of 
undertaking a task well does not automatically indicate competence: conferring that 
other traits or qualities are required to deliver diabetes education and care. 
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The importance of personal qualities or traits was confirmed by Vazirani (2011, p.121); 
to understand competency models, he described the work of McClelland, a human 
motivation theorist:  
[The] best predictors of outstanding on-the-job performance were underlying, enduring 
personal characteristics [that he] called competencies.  
Vazirani (2011) suggested that competencies are best described as an iceberg. 
McClelland proposed that knowledge is at its peak, followed by skills and self-concept, 
whereas competencies such as traits and motives sit way below the surface.  
According to Ericsson (2015), academic aptitude and sound knowledge are seldom 
predictors of performance. Thus, the current study needed to identify relevant 
attributes to underpin the capabilities identified. Also, it was essential to include 
theoretical frameworks that underpinned the behaviours desired to develop HCP 
competence in diabetes education and care. Literature about ‘competence’ or 
‘competency’ highlighted several associated terms, including experience, mentoring 
and expertise, which identified the theories guiding the study. 
3.5.2. Benner’s stages of clinical competence  
Benner’s stages of clinical competence informed the current study because it described 
how an individual, through experience gains new skills and knowledge from a novice to 
the expert stage. The information assisted with the identification of practice levels and 
their relevant stages of clinical competence. 
Benner, a nursing theorist, adapted the five-stages of adult skill acquisition identified by 
Dreyfus in operational fields of work to evaluate the progress to clinical competence in 
nursing (Benner, 1984). While Benner’s work is an old study, it remains widely cited and 
relevant. Benner’s (2004) theory as a model to inform practice about how clinical 
competence is developed suggests, initial abstract principles and rules are combined 
with past experiences to alter the perception of the situation.  
Benner (1984) describes how new HCPs are initially task-focused and inflexible, which 
provide them with the ‘basics’; however, as they gain more experience and become 
more attached to a task, commitment and aptitude increase. Therefore, as confidence 
increases, knowledge and skills move from abstract to analytical to intuitive decision-
making, and judgement becomes more flexible, see Table 3.2 on page 95. Benner 
(2004) also indicates that sharing knowledge and previous experiences among HCPs 
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openly and authentically supports the process. However, unlike Dreyfus, Benner (1984) 
suggested timeframes for progress through the five stages from novice to expert.  
 
Table 3.2 Benner’s stages of clinical competence (Adapted from Benner, 2004) 
Stage Experience  Cues  Confidence Knowledge Discretionary 
Judgement 








Prior experience in 
actual situations 












Competent Working in same or 











Proficient  Much experience – 
perceives situation as 
whole [3-5 years] 
None 
required  
Confidence  Analytic Flexible 
Expert Operates from a 
thorough 
understanding of the 
total situation in its 












Benner's theory proposed that greater use of intuition was linked to higher clinical 
competence. Based on Benner’s (1984, 2004) theory, clinical competency is an 
amalgamation of practical and theoretical knowledge; clinically, expert HCPs would 
demonstrate the intuitive ability to efficiently make critical clinical decisions while 
quickly grasping the nature of a situation as a whole.  
 
The health literature suggests that Benner’s stages of clinical competence can be used 
to describe competency frameworks for nurses and allied health working in diabetes 
care. TREND-UK utilised a similar model to describe a competency framework for UK 
diabetes nursing (TREND-UK, 2019a). TREND-UK identified four levels of proficiency:  
• Unregistered practitioner 
• Competent nurse 
• Experienced or proficient nurse 
• Senior practitioner or expert nurse 
However, the use of ‘senior’ practitioner does not align with Benner’s theory that 
seniority in the workforce does not make a HCP competent or expert (Benner, 1984). 
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Benner’s theory strengthens the premise that an expert is not the HCP who has 
worked the longest or held the highest position; instead, the HCP who provides the 
best care through their intuitive and committed approach, focusing on continual 
development and professional growth, see Table 3.2 on page 95. 
Understanding the theory’s applications and how experience works towards 
developing competence informed the data analysis process, including stages of clinical 
competence, to better tailor the framework to diabetes workforce training needs. In 
particular, because the framework aimed to target HCPs working across the health 
spectrum with different levels of experience. Benner’s stages of clinical competence 
have been validated in professions other than nursing, demonstrating that it applies to 
any adult learning scenario (Chitty & Black, 2011). Therefore, a framework for diabetes 
education and care needs to identify and consider levels of clinical competence and 
experience and define them.  
While experience is necessary to develop clinical competence, it alone is insufficient to 
create diabetes expertise; expertise influences clinicians' clinical judgment and quality 
of care; a measure of their clinical competence (Benner, 1984). Expertise develops 
when a clinician tests and refines theoretical and practical knowledge in actual clinical 
situations. The work environment is a social system that impacts work performance, 
language used, and interactions; many of these are influenced by role models and 
mentors, who play a role in developing expertise. 
3.5.3. Ericsson’s theory of expertise 
Ericsson’s theory informed the current study by explaining how expertise is developed 
and assisted with the framework’s design and guiding information. The theory advised 
on essential considerations to combine with the framework to promote expertise. 
Ericsson’s (2015) position infers that many years of employment in a diabetes educator 
role do not inevitably mean that time spent working as a diabetes educator translates 
into expertise. Employment duration and experience are purely indications that the 
diabetes educator has worked in a role for a long time.  
Ericsson’s theory suggests that in the pursuit of expertise, quality trumps quantity of 
experience and values the learner’s general ability to process and integrate 
improvements in targeted skills (Ericsson et al., 2007a; Wang & Zorek, 2016). As HCPs 
are first introduced to new tasks, novices focus on understanding the activity with the 
rules provided and avoiding mistakes; Ericsson (2015) suggests the goal is to attain an 
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appropriate level of mastery to become an expert. To attain mastery, Ericsson et al. 
(2007a, p.E59) indicate that: 
Merely encountering patient conditions and situations is not experience; 
experience involves nurses reflecting on encountered circumstances to refine 
their moment-to-moment decision-making at an unconscious, intuitive level. 
A framework for diabetes care needs to identify ways to embrace and support these 
learning encounters and guide activities, such as reflection. However, Ericsson (2015, 
p.1472) suggested that elements that create differences in professional expertise are 
not well understood: 
Nobody becomes an outstanding professional without experience, but extensive 
experience does not invariably lead people to become experts.  
Albeit Ericsson asserts that consistently and overwhelmingly, the evidence shows that 
experts are always made, not born, and not an outcome of the duration of practice 
(Ericsson et al., 2007b). Moreover, the development of genuine expertise requires 
effort, sacrifice and honest self-assessment and by engaging in deliberate practice within 
tasks beyond the HCPs level of competence and comfort (Ericsson & Harwell, 2019). 
Deliberate practice is unanimous with the acquisition of expertise in a wide array of 
skill-based disciplines, including chess, music, sports, and healthcare (Ericsson, 2007a). 
Mastery is achieved in targeted areas through repeated cycles of focused practice and 
self-editing, with each cycle emphasising one or more aspects of the desired skill 
(Wang & Zorek, 2016).  
Fundamental to deliberate practice, the development of expertise requires reflection 
in and on practice to improve approaches to undertaking an activity, rather than 
simply performing a task repetitively until mastered (O’Connell et al., 2016). The 
reflection entails timely self-critique to determine what actions are required for future 
development to increase capacity (Ericsson, 2015). The final framework design needs 
to provide information to guide the HCP with these principles.  
Mentoring or coaching is a form of deliberate practice; Ericsson and Harwell (2019) 
indicate they are essential for developing expertise. Problem-solving concepts can be 
tried, challenged and tested within these relationships, so the safest approach is 
ultimately engaged (Ericsson, 2015). Mentoring can be lifelong; Woods and Murfet 
(2015) discussed the benefits of mentorship well into their diabetes career, and the 
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research approaches taken to enhance further the diabetes care they deliver clinically 
as nurse practitioners in different healthcare settings.  
Significantly, Faucher (2016) indicated that if the individual does not invest but 
abandons principles of deliberate practice during their career, the halted development 
can cause mastery to decline. Thus, HCPs need a well-informed coach to guide them 
through deliberate practice and help them learn how to coach themselves (O’Connell et 
al., 2016). Ericsson (2015) suggests, this self-aware learning and evaluation method is 
then applied to develop expertise as a lifelong learning process  
Therefore, the framework needs to guide mentoring opportunities for all HCPs in 
diabetes. Mentoring currently forms part of the CDE credentialling process in Australia; 
however, understanding mentoring and its influence on ongoing competence beyond 
the credentialling process may be pivotal to building diabetes capacity within the 
workforce. 
Although Benner’s (1984) suggests the HCP is an expert when they have worked in a 
similar area for greater than five years by drawing on their experience and intuitive 
grasp of reality, like Ericsson (2018), she notes that it is not only the passage of time 
that creates expertise but also how interactions are scrutinised for improved 
understanding. Therefore, more workforce capacity can be harnessed for diabetes care 
by promoting and supporting mentoring via the framework.  
Notably, rural and remote diabetes and primary care HCPs may not have the 
opportunity for repeated deliberate practice, access to specific diabetes patient cases 
or adequate mentoring support. Ericsson et al. (2007a) suggest that HCPs in different 
settings will essentially never encounter the same patients with the same diagnostic 
and treatment problems, making the comparison of patient outcomes problematic as a 
measure of individual clinical performance. The fundamental premise of the expert-
performance approach is that it is possible to identify representative tasks of sufficient 
difficulty that capture the essential activities associated with superior performance in 
everyday life (Ericsson et al., 2007a; Ericsson & Harwell, 2019).  
Deliberate practice is essential for those taking on roles in the diabetes workforce 
because proficiency and expertise, which enables independent practice, comes from 
relevant training and education and mentoring with ‘experts’. Access to mentoring 
provides valuable learning opportunities that facilitate patient case discussions, 
identifying and mitigating clinical risk. Therefore, the framework needs to guide 
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strategies to support appropriate deliberate practice to increase workforce capacity 
and competence in diabetes, particularly for those working in rural and remote areas.  
3.5.4. Sen’s capability approach theory  
Sen’s capability approach is another important theory that informed the current study 
by providing an alternate way to educator HCPs. Specifically, integrating Sen’s theory 
ensured the framework guided HCP adaptability, given that healthcare is not stable 
and consistent. Moreover, the study focused on isolating capabilities to increase 
flexible training and workforce capacity rather than identifying competencies. 
While the original premise of Sen’s theory was evaluating and assessing individual 
well-being and social arrangements to the design of policies, elements within the 
capabilities approach theory have been studied and used in educational theory and 
practice (Hinchliffe & Terzi, 2009; Saito, 2003). Sen’s capability approach theory 
focuses on the freedom the individual has to conduct their lives so that they feel fit to 
align with what they value, which supports well-being (Robeyns & Fibieger Byskov, 
2020). In education, learnings from Sen’s theory can increase an individual's capacity, 
translating to increased workforce capacity, which aligns with the study’s objectives. 
Specifically, Robertson (2015) suggests that Sen’s capability approach offers career 
theory when combined with a life-career developmental approach. Specifically, it can 
describe ways of working consistently with educational approaches (human capital) to 
develop the economy. Lozano et al. (2012) indicate that the emphasis of the capability 
approach lies in the freedom that a person has: not simply in the external evaluation of 
the situation. In terms of education or the health system, capabilities could be 
understood as the set of real opportunities students or HCPs can be by considering 
what they have reason to value.  
The capability approach is a personal utilitarian approach with two specific elements: 
functioning and agency (Lozano et al., 2012). From a functional perspective, this may 
relate to reading and writing, physical and mental state. However, from an agency 
perspective, this relates to a person's ability to pursue the goals that one values and 
are important for the life the individual wishes to live; individuals are happiest and 
perform better when they are more satisfied (Lozano et al., 2012).  
Agency implies an active participatory role in planning and conducting one’s life. Sen 
suggests that it is intrinsically important for individual freedom and instrumental for 
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collective action and democratic participation (Lozano et al., 2012). Workforce capacity 
can be drawn from agency. 
Therefore, the framework needs to incorporate capability-based learning. Lozano et al. 
(2012) suggest that promoting the concept of agency in education can:  
1. Educate people to reason on personal decisions and preferences. 
2. Enhance people’s capacities to reflect critically on their surroundings and work 
environment and envisage changes. 
3. Cultivate capacities to realise such changes in practice.  
Hence, education using the capability approach aims to expand people’s agency 
(empowerment) to be the authors of their own lives (Robertson, 2015). 
Lozano et al. (2012), who undertook a four-fold DeSeCo analysis to identify the 
differences between competence and capability, suggest: 
• Competence derives from a functional sphere - the functional facility to solve 
complex problems that turn a series of elements such as knowledge and skills 
into competencies. 
• Capabilities derive from an ethical and normative sphere - the opportunity to 
choose an action, choice or behaviour. 
Thus, the capability approach is broader and not demand-orientated; HCPs are guided 
by the freedom to choose and develop, thus giving rise to autonomy. 
Elements of the capability approach theory also align with McClelland's theory of 
human motivation that suggests that every person has one of three motivators: the 
need for achievement, affiliation, or power (Rybnicek et al., 2019). Thus, different 
people are motivated differently; a framework guiding practice needs to consider that 
not all HCPs will wish to develop in their career in the same ways as others.  
Developing a means of ‘tapping’ into what drives a HCP to give them more satisfaction 
and meaning in life can increase workforce capacity. Lozano et al. (2012) suggest that 
individuals with a strong need for affiliation do not like to stand out or take a risk; they 
value relationships over success. However, those motivated by achievement and 
power require opportunities to use these motivators to create innovative healthcare.  
Vazirani (2011) suggests that knowledge and skills can become obsolete in a rapidly 
evolving world. Moreover, the enduring competencies that are submerged, the 
motives and traits, significantly impact how a person performs in their role. Vazirani 
(2011, p.124) indicates that McClelland’s theory suggests that competencies are: 
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Underlying characteristics of people that indicate ways of behaving or thinking, 
which generalizes across a wide range of situations and endure for long periods. 
Focusing on competency-based training nonetheless has its limitations for developing 
the diabetes workforce, an objective of the study. Wheelahan (2017, p.640-643) 
identified the following limitations of competency-based training that it: 
• Is tied to specific workplace healthcare roles and discipline requirements. 
• Ties learning outcomes to descriptions of work as it currently exists. 
• Does not provide adequate access to underpinning knowledge. 
• Is grounded on the one-dimensional view that learning processes are identical 
with the skills to be learnt.  
• Is based on a notion of the professional as the supervised worker.  
Therefore, for the current study, these limitations prevented accessing the full 
potential of individual HCPs and thus our ability to build capacity within the workforce. 
Burcharth et al. (2017) suggest that these limitations do not support HCPs working in a 
dynamic environment where organisational transformation and research continually 
change the way they do things nor recognise the benefits of autonomous practice, 
which enable innovation. While competencies concerning skills and knowledge are 
easy to teach and learn, the framework needs to consider promoting HCPs developing 
self-concept to anticipate opportunities and valuable traits and motives to develop 
capacity within the diabetes healthcare workforce. 
Competency-based training supports the ability to reflect learnt skills rather than 
adapt and utilise the learnt knowledge and skills in the healthcare environment. To 
increase workforce capacity for diabetes care, identifying the relevant ‘enduring 
personal characteristics’ is essential. Moreover, by ensuring the framework includes a 
capability approach and promotes HCP’s agency there is potential to build workforce 
capacity in diabetes education and care. 
While safety and quality will always be at the forefront of healthcare decision-making, 
opportunities lie for building workforce capacity by enabling barriers to be removed 
and allowing individual HCPs to grow through motivation and agency drivers. 
Therefore, the capability framework needs to include a capability-based learning 
approach. 
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3.6. Capability-based learning  
Capability-based learning offered an alternative to competency-based learning in the 
current study. Capability-based learning enables flexible learning pathways that 
consider increasing complexity, and a wide variety of learning resources and mentored 
self-directed learning (Gardner et al., 2006). Poor dispersion of different HCP roles in 
remote areas in the Australian settings, increases the need for a flexible, adaptable 
diabetes workforce with skills to practice at advanced and extended levels (NRHC, 
2020a).  
The nature of healthcare is dynamic and unpredictable (O’Connell et al., 2014), 
requiring generalist HCPs and diabetes educators to work within unfamiliar clinical 
situations. Capability-based learning encompasses competency and, “extends beyond 
the technical skills implied by competence to emphasise the components of 
adaptability to change, lifelong learning and self-efficacy” (Brunner et al., 2018, p.2); 











Competency statements are used to assess stable and predictable situations in 
healthcare: they are task-oriented, focusing on the technical and procedural 
components of an activity or interaction (Australian Public Service Commission, 2018). 
Conversely, capability-based learning integrates learning and practice with adaptability 
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Capable learners can respond to changing clinical situations creatively and flexibly 
(Australian Public Service Commission, 2018). The capable HCP is not paralysed but 
copes with the unknown and moves beyond competency when faced with unfamiliar 
problems (O’Connell et al., 2014). Moreover, they are motivated by achievement, 
allowing increased innovation and workforce capacity (Vazirani, 2011). 
Frameworks to guide diabetes practice are often competency-based; however, 
focusing on capabilities promotes continuous self-development rather than assessing a 
skill at a specific moment (Brunner et al., 2018). Capabilities provide an opportunity to 
develop and expand capacity within the workforce to address future diabetes 
healthcare needs. Also, by meeting HCPs needs for agency and connecting with their 
motivating drivers, a framework that promotes capacity can stimulate consideration of 
HCP roles boundaries while also enforcing the appropriate guidance on training. 
Wheelahan (2017, p.645) indicated:  
Capacity arises from the interrelationship between personal, social and working lives, 
which means learning for work needs to go beyond work. 
The capability approach starts with the HCP delivering diabetes care and not the 
specific diabetes technical skills, which imply competence. The capability approach 
identifies the social, economic, and cultural capabilities required to achieve a range of 
outcomes (Wheelahan, 2017). 
Capability consists of the combination of skills, knowledge, attributes, values, self‐
efficacy and potential for development. The capability-based culture encourages lifelong 
learning that enables individuals to adapt to change and move beyond a skill-focus to 
achieve a particular outcome (Nagarajan & Prabhu, 2015). Hence, capability is the 
product of learning and experience and represents proficiency. Identifying the essential 
capabilities for different practice levels can guide individual HCPs in flexible learning and 
appropriate mentored self-directed learning. 
Healthcare organisations and services need to be designed for the potential of its HCPs 
and their capabilities, not the limits of their expertise (Australian Public Service 
Commission, 2018). Given the importance of promoting life-long learning and 
mentoring and the traits that support developing expertise, a need to focus on 
capability-based learning exists. A capability framework can increase the diabetes 
workforce’s flexibility and responsiveness, which support addressing anomalies in SoP 
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and increase workforce mobility and capacity for safe, quality diabetes education and 
care. 
The theories informed the conceptual design of the study. The study design, 
chronology of data collection methods against research questions and methodological 
integrity are discussed in the following sections. 
3.7. Research design 
The study used a three-staged modified Delphi technique consisting of a combination 
of the following data collection methods: 
• Stage I: A pre-Delphi survey consultation. 
• Stage II: An online Delphi survey, which encompassed two phases. 
• Stage III: A post-Delphi survey stakeholder appraisal process. 
The researcher intended to reach a consensus among key stakeholders about 
capability statements for the diabetes workforce across the spectrum of healthcare 
settings in Australia. In addition, we aimed to identify capabilities relevant to the 
diabetes workforce drawn from these statements.  
The Delphi technique was administered in three stages and was modified by 
introducing a pre-Delphi consultation stage to understand current workforce issues 
and opportunities (Diamond et al., 2014), see Figure 3.4 on page 105. Further, a post-
Delphi survey appraisal of the developed framework by relevant stakeholders. Also, 
the study was guided by an Expert Advisory Group (EAG), an independent group of 
researchers, to support validation. In particular, the approach was taken to: 
• Ensure no competencies were overlooked. 
• Move toward identifying capabilities that allow capacity growth. 
• Manage the volume of data expected at each data collection method. 
 
A detailed description of each data collection method and analysis procedure used for 
each stage is described individually in the chapters pertaining to the study stage, 
including the sampling and recruitment procedures used and decision-making points. 
Both quantitative and qualitative data was collected Chapter 4 (Stage I), Chapter 5 
(Stage II) and Chapter 6 (Stage III). Throughout the stages, the participant ‘words’ are 
constantly featured. 
 









The inclusion criteria that informed the sampling processes for data collection 
methods in the next three chapters, is described in the next section. 
3.7.1. Inclusion criteria for participant samples  
Healthcare professionals with greater than five years post-registration experience and 
were either: 
• A Credentialled Diabetes Educator (CDE) for five years or more. 
• In a position whose focus of employment for the past five years or more was 
diabetes education and care or/and research. 
Moser and Korstjens (2018) suggest that choosing experts with experience about the 
topic or phenomenon under investigation is more likely to produce rich, in-depth data. 
A. How an expert was determined – developing the inclusion criteria  
The researcher devised criteria from Benner’s (1984) model of clinical competence and 
Ericsson’s theory of expertise to identify clinical and academics HCP, expert in and 
cognizant of current issues that influence diabetes education and care, to canvas their 
views. Benner’s theory changed the perception of the term expert; the expert was the 
nurse who provided “the most exquisite nursing care” rather than the most senior 
nurse (Benner, as cited in Orsolini-Hain & Malone, 2007, p.160). Benner often used 
timeframes for movement from one level of clinical competence to the next; she 
considered expertise a process learnt over time in any field. An expert was more likely 
to have five years or more experience in one area.  
Delphi technique  
• Pre-Delphi 
Consultation Group
• Pilot Delphi survey 
Stage I
• Phase I online Delphi 
survey [2 rounds]
• EAG peer debriefing
• Phase II online Delphi 
survey  [2 rounds]
Stage II • Post-Delphi Focus 
Group review
• Peer health profession 
training and regulatory 
appraisal 
Stage III
Figure 3.4: Stages for modified Delphi technique 
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Moreover, Benner (1984) and Ericsson (2015) warn that expertise is not denoted by a 
clinician’s seniority or from the duration of time in a position. Personal growth through 
deliberate practice is also key to expertise, including mentoring and reflective practice 
(Ericsson & Harwell, 2019). Therefore, the inclusion criteria for the current study 
required an element of routine deliberate practice. 
The credentialling process for working towards the designation of CDE in Australia 
required completing a diabetes postgraduate degree, six months of mentoring by an 
experienced CDE mentor, 1000 clinical hours in diabetes and the HCP was required to 
demonstrate ongoing learning (ADEA, 2019b). Twelve monthly recredentialling 
requirements also encourage CDEs to demonstrate reflection on learning from set 
goals. Thus, the CDE had both experience and verified deliberate practice.  
It was also essential to capture the input of other diabetes educators who are not 
credentialled but who are an important part of the health care system because their 
ideas may differ from CDEs. A relevant mentorship program was not identified; 
therefore, years of experience would need to be considered. According to Ericsson and 
Harwell (2019), teachers with ten years were identified as experts. The inclusion 
criteria identified ensured that participants knowledgeable and dedicated to diabetes 
education, care and research were recruited.  
3.8. Chronology of data collection methods 
Delphi technique is a systematic method to reach consensus. A consultation group 
including diabetes HCPs met to discuss diabetes workforce issues to initiate the Delphi 
technique and develop the survey questions. The flow chart guided the study and 
chronology of data collection methods, including all its stages, is illustrated in Figure 
3.5 on page 107; guided the study and described how each data collection method 
would inform the following data collection activity. 
3.9. Ethical considerations 
The National Statement on Ethical Conduct in Human Research informed the 
consideration of ethical issues in human subjects in this doctoral research (National 
Health and Medical Research Council [NHMRC], 2018). Ethics approval was sought and 
gained through Deakin University in July 2018 and allocated reference EAG-H 
102_2018. The study was conducted in compliance with the study protocol and the 
NHMRC guidelines.  




Literature review about capabilities and 
competencies for diabetes education and 
the workforce.
Formation of research questions and 
conceptualising proposed framework.
STAGE I: Pre-Delphi Consultation 
Apply for and gained Ethics Approval.
Conduct Consultation Group to verify diabetes workforce 
issues to guide Delphi survey and framework.
Pilot test of Qualtrics platform and Delphi survey.
STAGE II: Recruitment Phase
Experts identified via research 
criteria and invited to participate. 
Plain Language Statement and online 
survey link forward to interested 
participants.
STAGE II: Delphi Survey Phase 1 (Round 1)
Initial questionnaire consisting of three sections: (1) a brief 
overview of the Delphi technique, (2) demographic questions, 
(3) three open-ended questions asking participants about 
existing health professional practice levels, the basic or 
fundamental and advanced knowledge, skills and attitudes 
(KSA) required by health professionals to provide diabetes care 
and diabetes medicine management.
STAGE II: Content analysis
Analysis of data for categories and 
repetition, and the language of the 
expert panel to identify health 
professional practice levels. 
Models identified to be reduced to 4-
6 and tested with EAG.
STAGE II: Delphi Survey Phase 1 (Round 2)
A second questionnaire consisting of: (1) a summary of expert 
panel comments and (2) 4-6 models to describe the 
Framework's structure for preferred ranking between 1 
(preferred) to 4. 
A third questionnaire if required for ranking.
Stages of clinical competence linked to practice levels, then 
finalised with EAG. The model achieving consensus for 
the Framework shared with the panel.
Consensus of model for framework
STAGE II: Delphi survey Phase 2 - Identification of Capabilities and statements
Content analysis of KSA for diabetes education and medicine management identified in Phase 1, Round 1. 
Major categories identifies broad capabilities and sub-categories identifies capability statements.
Peer debriefing and member validation by Expert Advisory Group.
Confirm the appropriateness of capability statements' position and recommend any omissions.
STAGE II: Delphi Survey Phase 2 (Round 1)
Initial questionnaire presenting (1) a summary of analysis process and (2) the capability statements, listed 
under each of the practice levels that gained consensus and relevant capability identified during thematic 
analysis. 
Panel invited to rank importance of each statement on a 5-point Likert scale: 1 (not important) to 5 
(essential). 
STAGE II: Delphi  Survey Phase 2 (Round 2) 
A second questionnaire consisting (1) a summary of Delphi panel comments and (2) capability statements 
that did not reach consensus but achieved > 40%. Panel invited to rank these again. 
A third questionnaire if required for ranking.
Draft Capability Framework finalised
STAGE III: Stakeholder Consultation 
Draft Capability Framework forward for appraisal to:
1. Focus Group at the Australasian Diabetes Congress; the 
information gathered to inform the final draft.
2. Health professional peer and training organisations 





Figure 3.5: Flow chart guiding data collection methods 
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3.9.1. Informed consent 
All HCPs who participated in any study stage were provided with a relevant PLS 
describing the study and inviting their consent. Moderators highlighted the topic of 
consent during the group introductions. Interested participants implied informed 
consent by commencing surveys; those who attended the groups signed a consent 
form. 
3.9.2. Confidentiality 
No participants’ names were recorded, or identifiable information shared, to maintain 
confidentiality. Instead, a unique identification number was allocated to each 
participant on Qualtrics, the web-based survey platform used and saved on the Deakin 
server.  
Then ‘anonymize responses’ was selected to disassociate the email address from 
responses to preserve anonymity. Delphi survey participants only saw summaries of 
amalgamated information. The unique ID number enabled verification of Delphi group 
consistency and breadth anonymously, and characteristics of those participants who 
had contributed to attrition.  
Participants were asked not to share or discuss study material because it may impede 
opinion and to maintain participant confidentiality. Any hard copy information had the 
following recorded: ‘This document is confidential and Deakin University property. No 
part of the document may be transmitted, reproduced, published, or used without 
prior written authorisation from the institution’. 
3.9.3. Data management  
A password protected computer, survey platform and email address were used to 
conduct surveys. The surveys and the data remain the ownership of the user, i.e. 
Deakin University. After the study, the account with Qualtrics will be deleted. For 
further information, refer to the Qualtrics Security Privacy Statement 
http://qualtrics.com/privacy-statement/ (Qualtrics, 2019).  
Data exported to Excel was stored on Deakin University’s system, which offers high-
level security and anti-virus programs to maintain data integrity. The network enabled 
remote access as a distance PhD research student and data were backed-up regularly. 
Any printed copies of data used were locked in a filing cabinet in the researcher’s 
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private office, which is also routinely locked. Data will be destroyed five years following 
the publication of study results, as per Deakin policy.  
Audiotapes from the pre-Delphi and focus groups were sent to Pacific Transcription at 
https://www.pacifictranscription.com.au/research/. Pacific Transcription (2020) 
provides legal, medical and research transcription services. Pacific Transcription holds 
ISO 9001 certification: an internationally recognised standard for quality management 
systems. All documents are purged from Pacific Transcription server one month after 
transcription payment to maintain security and confidentiality.  
3.10. Methodological integrity 
The researcher incorporated several approaches to support research rigour and ensure 
methodological integrity, including method, data and investigator triangulation; 
reflexivity; peer-debriefing; simple cross-coding; reflective journaling; an Expert 
Advisory Group (EAG) and audit trail. The researcher sampled and engaged in the 
research setting over a prolonged period to allow familiarity to develop and ensure 
data was contextualised.  
Each data collection method was regularly evaluated against two composite processes 
as described by Levitt et al. (2017):  
• Fidelity to the subject matter, i.e. the researcher, maintained faithfulness to 
participant words and the concepts conceived, and the results were grounded 
in the data collected. 
• Utility in achieving research goals, i.e. the researcher continued to monitor the 
study progress against the research questions and study aim. 
3.10.1. Method, data and investigator triangulation  
Triangulation was used by including multiple research methods, data sources and 
investigators concerning the topic under investigation to overcome the intrinsic biases 
of qualitative research (Noble & Smith, 2015). Triangulation enhances validity and 
produces more comprehensive findings by converging information and perspectives 
from different sources (Noble & Smith, 2015). In the current study it also allowed 
consensus to be checked repeatedly. 
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The researcher applied triangulation by using multiple: 
• Data collection methods, including. consultation group, pilot group, Delphi 
survey and external stakeholder appraisal. 
• Data sources, including literature review, Delphi expert panel, health profession 
regulatory and training organisations, and the EAG. 
• Researchers, including the supervisory team, EAG and independent 
Biostatistician and moderators to apply different approaches to check the 
meaning of the data generated from the study, i.e. reflexivity, peer-debriefing, 
cross-coding, audit trail and reflective journaling. 
In the next section, each approach is defined, including describing how each added rigour 
to manage both quantitative and qualitative data.  
A. Reflexivity 
Reflexivity refers to critical self-reflection on one’s biases, preferences and theoretical 
inclinations, and the critique of practice on practice (Rolfe & Gardner, 2005; Woods & 
Murfet, 2015). The researcher applied reflexivity to the research process and 
relinquished her research agenda, i.e. the researcher reflected on her practice and 
research study decisions and reflected on the ways the study decisions influenced each 
step of the research process.  
The researcher understood she was a crucial instrument throughout the study as 
described by Hall and Roussel (2017). She used reflexivity throughout the study 
process, including the design phase, development of data collection tools, participant 
recruitment and sampling methods, content analysis and interpretation of findings; to 
identify when findings or processes may have been tainted by the researcher’s 
personal or intrinsically linked professional biases. The researcher was aware of 
personal viewpoints and experience and reported these potential biases to the 
methodological process, to the research team, and the EAG, as Noble and Smith (2015) 
encouraged.  
B. Peer-debriefing 
Peer debriefing allows research and content expert peers to review and assess data 
generated to explore study aspects and provide critical reviews (Janesick, 2007). The 
researcher applied peer-debriefing by allowing critical auditing of findings, e.g. 
checking emerging categories from the group transcripts with the supervisory team 
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and EAG and assessing the final report to identify whether the researcher had over or 
under‐emphasized a point or missed a legitimate point. 
The researcher held a position of ‘empathic neutrality’ by showing respect, openness, 
sensitivity and responsiveness during peer debriefing to allow understanding to come 
from neutrality without judgement (Noble & Smith, 2015). The non-judgemental 
approach was demonstrated through discussions with supervisors, engaging with 
other researchers, the study participants and the EAG, and a reflective journal 
throughout the study. Hall and Roussel (2017) state that validity occurs when the 
researcher is fully transparent and their biases are fully integrated, becoming 
transparent throughout the study, which the researcher has attempted. 
C. Simple cross-coding 
Cross-coding refers to a process to re-check data to determine whether both parties, e.g. 
the researcher and the supervisory team or EAG, agreed with the researcher’s 
categorisation of data (Elliott, 2018). The researcher used cross-coding when data was 
ambiguous, and peer-debriefing did not result in a consensus.  
Simple cross-coding was used for developing consensus on the overarching findings 
around capabilities and their definitions or specific competency statements. The EAG, 
a virtual group of diabetes experts and academics, reviewed aggregated data and the 
definition provided or phrase developed to explain the competency statement to 
determine whether they agreed with the researcher’s categories.  
D. Reflective journaling 
Journaling was used in conjunction with the supervision discussions as described by 
Austin and Sutton (2014) to encourage the researcher to question their beliefs, check 
assumptions, personal agendas or attachments and to develop strategies to maintain 
neutrality. Reflection allowed the researcher to identify their worldview on diabetes 
education and care, and workforce and the process focused on questioning, which 
created mindfulness to support the maintenance of neutrality.  
E. Audit trail 
An audit trail was maintained with reflective journaling, which enabled field notes, 
emerging thoughts and potential biases to be noted. It provided a chronological 
account of methodological and analytical decision-making points and the reasoning 
behind them (Koch, 2006). The researcher used the audit trail to examine the research 
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process and the draft ‘Capability Framework’ as the product of the study to determine 
findings’ trustworthiness. 
F. Expert Advisory Group 
EAGs are panels, which consists of topic experts from whom researchers aim to obtain 
unbiased, balanced and objective evaluations through technical and explanatory 
guidance, or consensus regarding the study’s findings. Using an EAG was an approach 
to identify whether findings made sense and were a realistic, accurate and trustworthy 
account of the data collected.  
An EAG was convened by the researcher including independent researchers and HCPs 
in diabetes education and care and research from different disciplines, see Table 3.3. 
Further, two members were also Delphi panel members and more familiar with the 
survey and expectations for panel members. EAG members acknowledged their 
conflicts of interests and decision were made based on the majority.  
 
Table 3.3: Expert Advisory Group members 
Qualifications and roles Current employer 
PhD, Advanced Practising Dietitian, Consumer and 
Academic.  
University–Human nutrition 
CDE, MNg, Nurse Practitioner, Midwife, CDE  
Held roles in academia as course coordinator for 
diabetes education degrees and leadership roles in 
ADEA and ADIPS. 
District health service 
Private practice  
Senior Clinical Nurse Adviser, CDE  
Held leadership roles nationally in ADEA. 
Not-for-profit aged care service and 
healthcare provider / Private practice  
PhD, BA(Psych), Post-doctoral Research Fellow and 
Behavioural Scientist. 
University–Behavioural science  
CDE, BA, Lecturer, unit chair for a graduate 
certificate of diabetes education and Academic. 
University–Nursing  
 
G. Member checking 
Member checking refers to a system to explore results trustworthiness; results 
credibility validated by returning data or results to participants to check that findings 
resonate with their experiences and for accuracy of meaning (Birt et al., 2016). Fifteen 
Delphi participants indicated an interest in becoming virtual ‘member checking’ group 
participants. 
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Stage II required a high level of engagement by the Delphi panel because Delphi survey 
Phase One generated a large volume of data. Consequently, member checking was not 
used due to the risk of overburdening panel members and not contributing to Delphi 
Phase Two. The external EAG, whose members met the study inclusion criteria, was 
utilised to assess whether the researcher’s findings resonated with the data collected 
and intended meanings as a substitute. 
To that end, the reflective journal and reflexivity were used to avoid inaccurately 
presenting the data received, and data was not manipulated to fit with a prior 
perception of truth. 
3.11. Chapter summary  
Literature about achieving consensus identified the Delphi technique as the best 
option for the current study’s methodology. The technique enables a systematic 
approach to explore a complex issue with a group of experts and move towards 
consensus despite opinions being diverse and without influence. Theories on clinical 
competence and expertise were aligned with the capability approach to understand 
the research topic and plan the framework’s development to increase the health 
workforce capacity for diabetes care.  
The theories underpinning the study’s methodology suggest that competence 
develops through experience and genuine mentorship; expertise is developed through 
engagement in deliberate practice where scenarios can be practised and critiqued by 
others. It was identified that competency-based training in specific skills might be 
problematic in a rapidly evolving health environment where workforce flexibility and 
adaptability is required to provide appropriate, safe diabetes care. Moreover, because 
a competency-based focus provides important indicators for the technical aspects of 
care for the same discipline in stable situations, which align with the intentions of the 
Training Reform Agenda to increase the productivity of the Australian industry.  
In contrast, capability-based learning was identified as moving beyond competencies 
and promoting lifelong learning and self-efficacy, fostering an increase in healthcare 
capacity delivered by the HCP. The study provides an opportunity to identify ways to 
harness the full potential of HCPs by isolating the capabilities, which enable HCPs to be 
adaptable and flexible to varied diabetes clinical situations.  
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The conceptual framework informed by Benner, Ericsson and Sen’s theories included a 
three-staged modified Delphi technique to identify HCP practice levels and the 
capabilities required to develop a ‘Capability Framework’ for the diabetes workforce. 
Findings from each data collection method informed the next Delphi round or stage. As 
research rigour was paramount, various strategies were implemented to ensure the 
validity of the conclusions drawn at each stage to inform the next stage.  
The researcher sought to be reflexive, committed to the process and engaged in self-
questioning and understanding; peer debriefing with the EAG and supervisors aided 
the researcher to explore all aspects of the research process to ensure truth. 
Triangulation of both data sources and review processes employed guaranteened 
methodological integrity and fidelity of the data generated.  
The three stages designed to address the research aim are now presented in individual 
chapters: Chapter 4 presents the pre-Delphi consultation period (Stage I), Chapter 5 
the Delphi survey phases (Stage II), and Chapter 6 the post-Delphi appraisal (Stage III). 
The thesis presents all the decision-making points to ensure full disclosure and 
transparency and the researcher’s strategies to systematically manage high volumes of 
data and decrease potential bias.   
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Chapter 4: STAGE I - Pre-Delphi Consultation 
4.1. Chapter introduction 
The purpose of the pre-Delphi Consultation (Stage I) was to understand the current 
diabetes workforce issues and the knowledge and skills required to support diabetes 
workforce development. The information gathered informed the content and design of 
the Delphi survey and proposed capability-based framework.  
The following activities were undertaken during the pre-Delphi stage: 
• Consultation with a group of diabetes education experts. 
• Development of the web-based online survey. 
• Development of the Delphi survey questions. 
• A pilot test for face validity of the Delphi survey.  
The process to undertake each activity, including sampling and recruitment are 
discussed. Next, the analyses and results, including the information that informed 
Delphi technique Stage II are shared. 
4.2. Research questions guiding the pre-Delphi Consultation 
1. What are the issues currently impacting the diabetes workforce? 
2. What are the current skills, education and training needs of healthcare 
professionals in diabetes? 
3. What is the current understanding and acceptance of non-medical prescribing? 
4.3. Pre-Delphi consultation group  
The pre-Delphi consultation group activity enabled the researcher to understand issues 
impacting workforce development and identify any further valuable information to 
enhance the Delphi survey and framework. Further, the consultation process enabled 
the researcher to focus the Delphi questions to collect only essential information from 
Delphi survey participants.  
4.3.1. Participant sampling population and selection  
The sampling population was Australian nurses and AHPs employed to deliver diabetes 
education and care to or for people living with diabetes in a clinical, management or 
educational role. Education roles included clinical educators who educated HCPs or 
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consumers and academics involved in diabetes workforce training and professional 
development.  
To ensure a heterogeneous and representative sample was recruited, proportions of 
HCP disciplines established through the ADEA member survey were applied (ADEA, 
2017a). It was anticipated that the sampling frame would comprise nurses primarily, 
and up to a fifth would be from allied health disciplines because this figure 
represented the spread of disciplines identified in the 2017 ADEA member survey. The 
primary discipline of CDEs was nurses (83%), and the remainder were dietitians (10%), 
pharmacists (5%) and membership from podiatrists and midwives were low (ADEA, 
2019a). 
Physiotherapists were the last HCP group eligible for CDE credentialling in late 2015 
(ADEA, 2015c), and the National Core Competencies for Aboriginal and Torres Strait 
Islander Diabetes Health Workers/Diabetes Health Practitioners was introduced in 
August 2017 (ADEA, 2018d). Therefore, these last two disciplines were unlikely to meet 
the study’s inclusion criteria. 
4.3.2. Pre-Delphi consultation group recruitment strategy 
A sample target of 15 to 20 was set to collect quality dialogue and diverse opinions 
from different disciplines working in various settings with consideration for dropouts 
(McMillan et al., 2016). The consultation was held at the 2018 Australasian Diabetes 
Congress (ADC), an ideal venue given that many diabetes experts from across the 
nation attended. It enabled the researcher to access different HCP disciplines and 
experts engaged in diabetes education, care and research. The professional conference 
organiser company advertised the pre-Delphi consultation group to conference 
registrants.  
An advertisement was also provided to the ADEA, who disseminated it three times via 
direct email between July and August 2018. The advertisement linked the Plain Language 
Statement (PLS) and a survey to register interest; see Appendix 1 and Appendix 2 on 
pages 290 and 292. Survey Monkey, a cloud-based survey development tool, enabled 
information to be collected to determine meeting of inclusion criteria and other 
characteristics; the question included: 
• Are you currently employed in a role with a diabetes focus and held the 
position or similar work for at least the past five years? 
• What is your current role in diabetes care? 
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• How many years have you worked as a registered healthcare professional? 
• What is your primary discipline? 
• What is your current role in diabetes care? 
• What is your age group? <30 years, 30-50 years or > 50 years? 
Interested HCPs were emailed material about the consultation groups, i.e. a PLS that 
contained a consent form, meeting details and venue map. Further, information was 
collected on those who dropped out. 
4.3.3. The method used for the pre-Delphi consultation group 
A moderator using a semi-structured approach guided discussions in the pre-Delphi 
consultation group to enable the researcher to explore different opinions and 
fundamental diabetes workforce issues with participants without stifling the 
conversation (Gill et al., 2008). The independent moderator who did not influence the 
study or its design, supported research rigour by reducing the impact of the 
researcher’s preconceived ideas or theories on participants (Gill et al., 2008)  
The moderator was an experienced CDE who had previously held leadership roles in 
diabetes education; chosen because her views about the topic were not widely known, 
and she was personable and sensitive. The researcher and moderator met three weeks 
before the group to review the Moderator Instructions and discuss the process, see 
Appendix 3 on page 296. The researcher’s supervisors reviewed the interview 
questions to ensure the meaning was clear. 
The Moderator Instructions guided the moderator’s role within the session. She 
collected consent forms and asked the group the following seven focused questions: 
1. What do you think are the current key workforce issues in diabetes education 
and care? 
2. What do you think healthcare professionals need to know and be skilled at in 
the current climate? 
3. Do you think that there are different training or educational needs according to 
a work setting? 
4. What are your thoughts on NMP? Does it have a place in the Australian 
healthcare system? 
5. What do you think are the risks and benefits of NMP? 
6. What do you see as being the barriers to NMP? 
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7. Internationally non-medical prescribing has been long-standing in some 
countries; however, differences in the healthcare professional able to be 
endorsed to prescribe and the level to which they are permitted to prescribe 
exist. Do you have any thoughts on this for the Australian setting? 
The researcher took notes regarding the environment, participant engagement and 
body language and summarised issues emerging from the conversation. Summaries of 
the conversation were reported to the group during the session to obtain general 
agreement that the summary represented what was said, and the researcher’s 
interpretation of key concepts was correct.  
An overall summary of ‘next steps’ closed the session. The 95-minutes long audiotape, 
which included the voices of the facilitator, researcher and fifteen interviewees was 
transcribed verbatim.  
4.4. Data analysis of consultation group information 
Each data collection method in the Delphi technique informs the next, so data analysis 
regularly coincided with each Delphi Stage. Both quantitative and qualitative data were 
collected during the study drawn from the pre-Delphi consultation period (Stage I), the 
Delphi survey (Stage II) and the post-Delphi appraisal (Stage III). The data analysis 
section discusses the ways quantitative and qualitative data drawn from the pre-Delphi 
consultation group were managed. 
4.4.1. Analyses of qualitative data 
 The researcher undertook content analysis to identify patterns or ideas and categorise 
information within the qualitative data. Hsu and Sanford (2007) suggest that the data 
analysis method researchers use in Delphi studies is often chosen based on personal 
preference. Also, researcher bias could be increased by the researcher’s close 
immersion with the data collected and its interpretation. Therefore, data analysis 
procedures were aligned to answering the study’s research questions. The researcher 
also undertook activities within the analysis period to promote methodological 
integrity, as discussed in Chapter 3. 
The researcher used an inductive approach and emergent coding; the steps taken are 
shown in Figure 4.1 on page 119. NVivo was used to create word clouds to identify 
word frequency, the diabetes experts’ ‘language’. Then the researcher repeatedly 
listened to and read the transcripts and made contextual notes. 




Figure 4.1: Process used by researcher to analyse qualitative data 
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The researcher started highlighting key reoccurring sub-categories on the second 
reading by merging closely related data identified and managed data on Microsoft 
excel. Those related to each other were grouped into major categories.  
As an approach to coding data, emergent coding allowed developing data categories 
from participants’ words, which priori coding would not enable as categories are 
developed before analysing the text (Blair, 2015). It was essential to use the experts’ 
words to inform the Delphi technique and reduce researcher impact. Repetition of 
similar words or of similar meaning enabled data saturation to be achieved. These 
categories were then critically reviewed and cross-coded by two researchers from the 
supervisory team, and then explanatory notes were applied to each. 
The literature regarding diabetes education and care and medicine management 
competencies informed and guided the initial coding. Creating rules to coding prior 
content analysis is important (Erlingsson & Brysiewicz, 2017); those developed for the 
current study included: 
• Level of analysis used was word sense, phrase or sentences of similar meaning. 
• Flexibility in the coding process with no predefined number or list of concepts. 
• Concepts would be coded for their content not frequency. 
• Concepts would be developed in alignment with study questions and aims as they 
emerged into categories. 
• The EAG and supervisory team would support testing categories for relevancy, 
applicability, duplication or need for further condensing. 
4.4.2. Analyses of quantitative data  
Statistics from the quantitative data were used to identify the basic features, i.e. 
response rate and describe the characteristic of study participants. Descriptive 
statistics calculated included measures of central tendency including the mean (the 
sum of all the values divided by the total number) and medium (the figure that divides 
the distribution into two equal halves or the 50th percentile) (Kaliyadan & Kulkarni, 
2019). Also, measures of dispersion including the variance (the average squared 
deviation of each number from the mean of a data set) and standard deviation [SD] 
(the square root of the variance) (Kaliyadan & Kulkarni, 2019), were calculated to 
describe proportions of categorical variables such as participants’ demographic 
characteristics. Next, analysed data was prepared for reporting. 
Chapter 4: STAGE I - Pre-Delphi Consultation 
121 
 
4.5. Results of the pre-Delphi consultation group 
The pre-Delphi consultation group involved a face-to-face gathering of expert diabetes 
HCPs undertaken before the Delphi survey. The conversation between 15 CDEs who 
met the inclusion criteria was lively and robust.  
4.5.1. Participants’ characteristics  
Twenty individuals who had reviewed the PLS completed a survey monkey 
questionnaire to register and met the inclusion criteria. Fifteen of the 20 individuals 
who indicated their interest to participate attended the Pre-Delphi Consultation. 
Eight (53%) participants were from nursing (RNs and NPs), and seven (47%) were from 
allied health disciplines, see Figure 4.2. They were an experienced group: ten (67%) 
had greater than 20 years of experience as a HCP, and three (20%) had ten to 20 years 
of experience. Allied health participants were those with less experience. Five 
participants withdrew from the consultation group because of competing conference 
commitments, including an Aboriginal and Torres Strait Islander engagement manager 
and two midwives.  
 
 
Figure 4.2: Consultation group members’ discipline  
 
Participants often held multiple roles; 27 roles were listed in all, see Table 4.1 on page 
122. Also, the participants were employed in various work settings. Seven (47%) were 
aged between 30 to 50 years, and eight (53%) were aged greater than 50 years, see 
Table 5.2 on page 151. All participants were female, but one. 
The findings are presented under three headings, findings to inform: the framework, 
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Table 4.1: Roles and work setting where participants were employed   
Role held  No.  Work settings No. 
Pharmacist  4  Community/Primary care 4 
CDE / Diabetes Educator  13 
 
General Practice/Private 8 
Dietitian 3 
 
Rural/Remote setting  1 
Aboriginal/TSI health practitioner 0 
 
Metropolitan / urban setting  2 
Academic 3 
 
Regional setting  3 
Nurse Practitioner 2 
 
Hospital setting  3 
Practice Nurse 1 
 
Aboriginal communities 2 
Manager of diabetes service 1 
 
University  3 
Total positions held  27 
 
Total locations for work         26 
 
 
4.5.2. Findings to inform the framework  
A. Confusion about and self-regulating scope of practice  
The Pre-Delphi Consultation findings supported the need to explore further the scope 
of practice (SoP) of diabetes educators and the different disciplines eligible for 
credentialling as a CDE. Participants expressed concerns about the challenges 
associated with autonomous decision-making by individual HCPs for determining 
personal SoP. Participants indicated that the lack of clarity about SoP among diabetes 
educators from different disciplines created: 
• Difficulties for identifying role boundaries delineation between disciplines. 
• Potential unsafe practices in diabetes care.  
Several participants voiced the need for greater clarity about the role of different CDE 
disciplines in diabetes care and education by creating clear boundaries and articulating 
the ways each discipline can be involved. One participant indicated:  
I think another barrier is setting the boundaries. We can't say everybody can do 
everything, so the challenge is where we put the [CDE] boundaries. We end up arguing 
about where the boundaries are, so we say it's all too hard and go back to square one. 
(CDE, community pharmacist) 
Although participants discussed the issue in terms of ‘boundaries’, core to their 
discussion was the need to clearly understand which diabetes-related activities each 
individual HCP could support and manage, given their discipline-specific foundational 
knowledge and training. Another participant indicated: 
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There's lots of gaps [in competencies] and SoP frameworks within ADEA. For example, if 
you are a pharmacist CDE, these are the kind of skills and competencies [you should 
meet]. If you're a dietitian CDE, these would be the activities to go with your expertise. If 
you're a nurse, it's going to be different again. I wouldn't go out and say I'm going to be 
a specialist dietitian and profess to have specialist dietetic skills - [I] certainly have 
fundamental skills - because I'm not a dietitian. (CDE, tertiary NP) 
Several participants suggested, as shared above, that despite attempts by peer HCP 
organisations to set and clarify SoP or create a delineation between roles, which 
deliver diabetes management, these were inadequate. Pharmacists and nurses were 
those who raised the topic within the group.  
A few participants suggested that workforce capacity is impeded without a better 
understanding of different CDEs disciplines roles. For example, one stated:  
How do we develop the workforce to better help people with diabetes if we've got - 
many allied health professionals that can become CDEs? If we're unclear about our scope 
of practice … we can't define the scope of practice as any allied health professional, 
whether it's a CDE or not? Then how do we know how to develop that [role]? (CDE, 
private pharmacist) 
The impediment to the growth of workforce capacity appeared to be expanding SoP 
without creating delineation between disciplines. Half the participants indicated that 
with the trend towards more collaborative practice, it was essential to understand 
differences in practice between disciplines to appreciate what specific professions can 
bring to care. However, one participant challenged the discussion and stated: 
If [the CDE] been through their diabetes assessment management course, a mentoring 
phase and they've had years working as only a diabetes educator, are they working as a 
CDE, or are they still working as an exercise physiologist? (CDE, tertiary dietitian) 
The quote above questions the perception of the CDE role overall. However, several 
participants expressed that role delineation was essential because of their concern 
that the CDE role was subject to political influence. One participant said:  
The problem is that the Government would like … a cheaper workforce. They want a 
cheaper person, who isn't as highly qualified and trained, to do as many things as 
possible. If we're not careful, we're undercutting our professions, and our expertise and 
speciality, by having a generic health worker. (CDE, tertiary RN) 
Participants’ perceptions about Government policy promoted conversations, which 
suggested that to meet policy some HCPs addressed healthcare gaps without 
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necessarily having the competence to undertake the activity safely. Many participants 
indicated that work setting often determines individual SoP. One community 
pharmacist CDE said: 
If you were an isolated clinician, yes, the onus is up to you to regulate what you believe 
your skills are, and maybe have that [competency] framework to use as a guide. If you 
work in a service, I’d hope that there would be other people, experienced, to guide and 
support you. 
The participant’s comment suggests the supportive role of other HCPs when 
developing SoP is important: mentoring is discussed later in the chapter. 
Many participants indicated that the exposure and training accessed by the HCP might 
not be adequate to provide safe care in certain circumstances when the expansion of 
scope is driven by health service needs rather than the skills of the HCP or the wishes 
of consumers. One participant discussing the impact of limited experience and 
competence said:  
Especially if you are going to use just the terminology of CDE ... would you want an 
exercise physiologist that sees a diabetes person once every God knows how often, that 
does have the title, CDE, to be prescribing medications? Insulin is classed as a dangerous 
drug. Should everybody be prescribing that? [Do they] Have enough - experience and 
understanding and knowledge about what you're doing, and confidence, to actually do 
it, and competence? (CDE, tertiary and private practice NP) 
The quote suggests that infrequent exposure and experience with many diabetes care 
activities by different disciplines could impact patient safety. Participants discussions 
suggest that some HCPs may not self-determine their SoP appropriately as they 
evolved their role.  
A few participants indicated that while CDEs had been trained and credentialled, their 
employers sometimes curtailed certain practices by diabetes educators because they 
understood these activities were outside the discipline’s SoP. These employer actions 
reaffirmed a perception that many HCPs are not able to self-regulate their SoP. For 
example, one participant said: 
Some CDE are not employed in the acute care, or palliative care area hence would not 
require those skills. Some employers of CDE will not allow them to review [pump and 
CGM] downloads, or adjust insulin, stating it is not part of their role and should only be 
done by Medical staff. (CDE, community RN) 
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A few participants suggested that national registration by the Australian Health 
Practitioner Regulation Agency (AHPRA) was a significant defining aspect of expanding 
scope of practice because it offered a higher level of oversight and safety. For example, 
a primary care pharmacist CDE stated: 
We have all these different health professionals involved in diabetes. Some are 
registered, and others are self-regulated. Those registered have been identified as 
adding an increased risk to the community due to the activities they are involved in, e.g. 
administering or dispensing medicines, managing wounds. Others that are self-regulated 
do not have the same level of scrutiny.  
Several participants suggested that clinical governance by individual health profession 
organisations was not of the same standard or rigour as AHPRA. These discussions 
tended to occur when medicines or diabetes technology were discussed and included 
the need for awareness of personal liability. 
Another, a constant thread throughout the discussion concerning SoP was the concept 
of exposure and relevant mentoring. 
B. Access to quality mentoring 
The Pre-Delphi Consultation findings suggested incorporating a mechanism for ongoing 
mentoring in varied diabetes areas to support quality diabetes care. Participants 
expressed concern about access to and the quality of mentoring. Their discussions 
suggest that supporting quality mentoring in diverse diabetes care areas through the 
framework would be imperative. 
Most participants attributed differences in health workforce competence to deliver 
diabetes education and care to the individual professional’s access to mentorship in 
diabetes, as described by one participant:  
There are vast differences between practice levels and expertise in diabetes 
management dependent on workplace exposure to all types of diabetes care. The ability 
to manage certain levels of diabetes care with competence requires consistent exposure 
and regular mentoring. (CDE, tertiary dietitian) 
While the quote above conveys the value the participant placed on mentoring, several 
participants also suggested deficits in competence derived from limited or narrow 
mentorship. Narrow mentorship was perceived to be related to the skills, knowledge 
and experience of the mentor. Most participants agreed that the quality of mentoring 
could determine HCP capabilities. As one participant described: 
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If someone has done a postgraduate [diabetes] course, and then, has done [1000 hours 
of clinical] time and experience, and been mentored to become a CDE, they’re really 
mentored partly by the skills and the experience of the person who is their mentor. I 
guess, the areas in, which … you’re getting experience and exposure. (CDE, tertiary RN) 
Moreover, a few participants indicated that inadequate access to quality mentoring 
could lead to unsafe practices. One participant raised their concern by describing a 
CDE who may have worked only with people with T2D: 
It concerns me that a CDE would think, I've now got to go and work in a new area, such 
as pregnancy, and I'm assuming I have to assume skills to work in that setting. To me, 
that is quite dangerous and reckless. (CDE, tertiary dietitian) 
The participant’s concern focused on HCPs being assigned clinical activities with which 
they are unfamiliar or not yet competent. Many participants identified that mentoring 
was often population-specific, e.g. paediatric, pregnancy or T2D. They suggested this 
population-specific mentorship caused workforce limitations as the diabetes HCP’s 
skills may not be transferable to another diabetes setting. Therefore, access to 
mentoring in diverse areas of diabetes care via the framework was essential to enable 
diabetes workforce mobility. For example, one NP indicated: 
You can’t just move into other areas. Particularly areas considered specialities or 
vulnerable populations, e.g. paediatrics, elderly, pumps, gestational. (CDE, tertiary NP)  
A few participants raised concern about ‘unrealistic’ learning goals created for 
mentoring, by those seeking credentialling as a CDE. These participants suggested 
learning plans did not align with the HCP’s novice status in diabetes and towards 
developing diabetes self-management skills. An example provided was the HCP 
training to become a CDE who was unskilled in the basics of DSME but had listed 
learning about medicine management. One participant stated: 
The applications that we're getting are beyond what would be logical for anybody to be 
doing at that level. [The mentee] not being able to choose then what evidence should be 
put against what activities [learning goals listed] they think they're doing. (CDE, tertiary 
RN). 
Alternatively, the example could suggest that medicine management is an essential 
skill new graduating CDEs desire and require to deliver care. Most participants 
indicated they live in a rapidly changing technological world, which hindered their 
ability to maintain a sound understanding of diabetes technology to support safe 
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diabetes care and mentor others. To enable consumer-focused care, participants said 
they needed to keep abreast of these new technologies and medicines. As described 
by one participant: 
Keeping up to date [with technology and resources] is difficult because you get your 
favourite resource, start using it and understanding it but then a new resource comes 
out. It depends on whose around to keep you informed. (CDE, primary RN) 
The discussions about mentoring suggest the framework needs to promote and enable 
different diabetes educators to connect and gain regular access to quality mentorship 
in diverse diabetes care areas, regardless of their remoteness, to maintain competence 
in a rapidly evolving health space.  
4.5.3. Findings to inform the survey 
A. Scope of practice 
The Pre-Delphi Consultation findings confirmed the need to examine scope of practice. 
Given the concerns raised about SoP described in Section 4.5.2.A, page 122, the survey 
needed to direct participants to consider elements of regulation, training, qualification, 
work settings and credentialling. The findings suggest the survey should encourage 
participants to consider these elements when describing practice levels. Furthermore,  
the Delphi survey allows anonymity, which may shed further light on the issue of SoP. 
B. Medicine management and non-medical prescribing 
The Pre-Delphi Consultation findings confirmed the need to examine understanding of 
medicine management and prescribing among diabetes educators and how they 
support medicines management. Participants expressed concern about the way some 
diabetes educators are involved in medicine management. Further, participant 
discussions suggested a lack of collective understanding of ‘non-medical prescribing’ 
(NMP) among diabetes educators. The findings suggested the survey should explore 
participants’ understanding of and the ways HCPs support medicine management.  
Pharmacy and dietitian participants were unclear about the term ‘non-medical 
prescribing’. When the topic was discussed they used phrases such as “prescribing a 
nutritional formula”, “giving advice on exercise and nutrition” or “giving advice about 
medication against a protocol or standing order”. A few participants believed NMP 
meant the person providing the advice was not a HCP, e.g. “non-medical would 
indicate that you're not trained in it - health and taking medical assessments”. 
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Simultaneously, many participants indicated most undergraduate HCP programs and 
postgraduate diabetes degrees offered negligible medicines training. Overall, there 
was general confusion about medicine management; participants used multiple terms 
to discuss NMP, believing it interchangeable. For example, one participant shared that: 
The Council of Deans is talking about it, in terms of introducing it [NMP] as a core 
curriculum item within undergraduate nursing, so that when they graduate, they would 
have that skillset. The debate is whether it comes as undergraduate nursing, or it should 
be postgraduate nursing. (CDE, academic RN) 
In responding to the participant another indicated:  
Very limited medications that they're able to administer, which is a better word than 
prescribe. It's more accurate. (CDE, primary RN)  
Moreover, the participant focused on the task rather than the practice of prescribing 
and what is entailed.  
NMP was also described as an extension of collaborative discussions with a medical 
officer. A few participants suggested the collaboration potentially offered safer care. 
For example, one said: 
I think nurse practitioners, one of our things is to work in collaboration with doctors. I 
might just flick a message to the GP, and say, have you ever thought about using this 
medicine, or can we do this. I'm not prescribing per se, but you're getting that 
collaborative practice and, therefore, you're reducing the risk. To me, that's the best way 
if you're worried about treading on someone's toes, or there's controversy. (CDE, tertiary 
and private NP) 
The quote above could also suggest the independent prescriber can struggle with their 
involvement in NMP decision-making given a NP can prescribe autonomously. When 
discussing NMP, the conversation often gravitated to insulin and dose titrations in 
diabetes. Participants linked the use of insulin to formularies to demonstrate the 
differences between prescribing and administering. A few participants indicated that 
specifically providing advice on a change in dose of insulin was prescribing. In contrast, a 
few participants indicated, teaching consumers self-titration skills was DSME:  
You can teach them, as a CDE, how to self-titrate. You're not telling them how much 
insulin to take, because that's prescribing, when you tell them you've got to increase it by 
two, four, six, or eight. If you teach them how to self-titrate, you've done your job as a 
CDE. (CDE, tertiary RN) 
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Further, a community pharmacist CDE indicated that they could not provide written 
insulin dose suggestions on a piece of paper for a GP when requested by consumers 
“because that’s technically prescribing”. Last, involvement in NMP by those not 
endorsed to do so was viewed as a litigation risk by some. Another community 
pharmacist CDE indicated:  
We've got the issue that the only people who can prescribe insulin and prescribe doses 
are nurse practitioners, endocrinologists and GPs. If you adjust an insulin dose and those 
three people don’t sign if off, and something happens - to quote my insurance company, 
it's all fun and games until someone gets into trouble.  
Although the term ‘non-medical prescribing’ was not well understood several 
participants suggested an increase in focus of NMP could lead to improved access for 
the consumer. One highlighted a current strategy: 
At the Nurses' Board level and around accreditation of our graduate nursing programs, 
there's a discussion about that at the moment, specifically, with the idea that registered 
nurses could, what they're calling, prescribing. It's actually about administering 
something based on standing order. (CDE, tertiary RN) 
Again, the quote suggests that although the Nursing and Midwifery Board of Australia 
consultation paper, which the participant referred to, focuses on increasing NMP, the 
participants continued to focus on ‘actions’, i.e. administering. The survey should 
identify information to better understand medicine management and prescribing by 
the diverse diabetes workforce to better tailor the framework and guiding policy.  
C. Diversity and training of healthcare professional disciplines  
The Pre-Delphi Consultation findings confirmed the importance of diverse disciplines 
providing diabetes education and care and the need to explore relevant practice levels. 
Participants expressed that different disciplines brought different communication 
styles and culture to diabetes care, which supported consumer health literacy. 
Simultaneously, that difference HCPs required different levels of diabetes training. The 
findings suggest that the survey should explore the diversity required for diabetes 
education and care. 
Several participants suggested that different disciplines’ capacity for different 
approaches to diabetes care was a positive reflection of the health workforce’s 
adaptability. One participant stated:  
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The language a pharmacist would use would be different from a language a nurse would 
use. I do believe there need to be different things for different places. 
The differences among HCPs’ communication styles appeared related to individual 
disciplines and were not related to SoP. Instead, SoP was discussed as an essential 
element to support care; a concatenation of skills, cultural considerations, words used, 
and appropriate settings and how these elements are combined to deliver care. For 
example, another participant stated:  
Our job is an educator; to teach people about diabetes. … I'm thinking our job is to – 
[understand] does Fred Smith understand me? If he doesn't understand me, perhaps my 
Aboriginal health worker should have a yarn to Fred Smith, because they're going to use 
a language set slightly different from mine. I don't have much experience with other 
cultures, apart from Caucasians. (CDE, primary care RN) 
The discussions suggest that different discipline-specific skills and communication styles 
support health literacy. The importance of diversity became evident when discussed in 
terms of care provided to Aboriginal and Torres Strait Islander people. In these cases, 
the ability to consider the cultural context to support diabetes care was considered 
imperative:  
They've [different disciplines] had training that's more relevant to their knowledge, 
skillset and things like that. For me, training needs to suit the individual ... An Aboriginal 
health worker may not have had the educational opportunities that somebody else 
might have had, but they've got a burning desire to help people. Do we need a PhD or 
letters behind our name before we can save that client? (CDE, primary care and 
Indigenous communities RN) 
The emphasis was not on higher qualifications but the HCP’s discipline-specific training 
and skills. Despite the concerns about SoP, the discussion moved away from SoP and 
became more about the distinct contribution of different disciplines and recognition of 
the individual profession’s influence on healthcare.  
Several participants suggested that having many HCPs involved in diabetes care was 
both a barrier and an advantage; the impediment was the level of knowledge 
concerning diabetes care that the HCP held. However, most participants agreed that 
diabetes knowledge could not be held by one group alone because the prevalence of 
diabetes and complexities of care continues to grow. One participant stated: 
Everybody who provides a health service of some kind is going to see people with 
diabetes. Many of them need to know more about how to advise them or care for them. 
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It goes right from high-level medical specialists, CDEs, those caring for disabled and 
elderly people in nursing homes. There's just a huge range of professionals carers. (CDE, 
primary care RN) 
While recognising the diverse workforce and indicating that most HCPs require more 
diabetes training, several participants indicated the level of diabetes training for HCPs 
should be tailored to their roles. One participant said:  
There are different levels of knowledge people need to care for people with diabetes. We 
need to focus on their expertise. What you would expect of a practice nurse or carer is 
different. They need to know a little bit about diabetes and what's important for them to 
care for that patient: whereas the pharmacist, nurse, and dietitian need more. Then 
you've got nurse practitioners on top of that, who must be over everything. If there are 
gaps in those, they need addressing. (CDE, tertiary dietitian) 
Identifying the diversity of practice levels via the survey could assist in identifying the 
HCP learning gaps, which require addressing. Many participants indicated specific 
knowledge and skills are required to deliver diabetes education and care and to 
mobilise the workforce to deliver diabetes care. However, they reported a deficit 
existed across the workforce spectrum.  
Several participants suggested specific skills by all HCPs could support diabetes-specific 
knowledge deficits. For example, one participant indicated: 
Irrespective of what discipline people come from, or the place in which they work. 
Fundamentally, one of the things that the person [HCP] has to do when talking with a 
person with diabetes is having excellent conversational and assessment skills. Because it 
doesn't matter if they don't know what that person needs, or what the answers to their 
questions are. At least if they know how to collect the information in a detailed way. 
(CDE, academic RN) 
The participant suggests that sound diabetes assessment and communication skills by 
all HCP can increase improved diabetes access. Several participants indicated gaps in 
areas they identified as ‘speciality areas’, which included vulnerable populations. For 
example, one participant said: 
Once you are a CDE there's a big gap with things like insulin pump therapy, people with 
progressed T2D, GDM, working with paediatrics, working with the elderly, and palliative 
care. Once you're a CDE, the onus is on the person who is a CDE to work out where their 
discipline is. It's up to the person who is the CDE to then move that forward with training. 
(CDE, private practice pharmacist) 
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The participant suggested that the responsibility for developing these additional 
unique skills and knowledge, when relevant, remained with the diabetes educator.  
Moreover, most participants suggested that developing specialised knowledge to care 
for vulnerable populations depended on the HCPs’ work setting and was not an 
outcome of postgraduate training in diabetes. A few participants said that speciality 
areas required more defined training and viewed them as smaller craft areas where 
HCPs had unique in-depth knowledge:  
It looks, to me, like a matrix or tree, where you start with the basics, and then, as you 
come up, you branch out into different areas of expertise and, so, the knowledge 
increases and expands as people go up. That's where the knowledge does vary. The top 
end of the area of expertise. (CDE, tertiary/academic dietitian) 
The participant suggested some HCPs require broad knowledge and other very 
population-specific skills. Therefore, the survey should explore what denotes a 
difference in the training needs of different HCPs. The discussions suggest that a 
framework for diabetes care should include diverse roles and disciplines to increase 
workforce capacity.  
4.5.4. Findings for policy advice 
A. Drug and Poisons Legislations and terminology used 
The Pre-Delphi Consultation findings confirmed the need to improve consistency 
across Drug and Poisons Legislations about how HCP can be involved in medicine 
management. Participants expressed concerns about inconsistencies between 
Australian States and Territories regarding the manner HCPs can support medicines 
management. They recommended nationwide consistency in Drug and Poisons 
Legislation and improved clarity about the medicine management practices HCPs can 
support. 
When discussed, participants often talked about nurses and the differences between 
State and Territory Drug and Poisons Legislation concerning the use of standing orders:  
That's [standing orders/administering vaccines] different state-to-state as well in the 
terminology of it, but it's not considered prescribing. (CDE, community pharmacist) 
Participants indicated the differences in legislation made it more difficult for peer 
organisations such as ADEA to provide specific standards.  
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The issue we've got is the legislation, it states that insulin can be provided in this 
manner, although it's different in each State. (CDE, tertiary RN)   
Furthermore, many participants reported that inconsistency in legislation across 
Australia between States and Territories created problems for mentoring particularly 
in the private sector. Often the mentor was unfamiliar with the Drug and Poisons 
Legislation from the State where the mentee resided: 
You’re mentoring someone working towards CDE from Victoria but I’m working in NSW 
and the Poison’s Act differ. I don’t know what the person should follow for Victoria. (CDE, 
tertiary and private NP) 
Improving consistency about medicine management across Drug and Poisons Legislation 
nationally, including amendments to medication once prescribed, supports 
standardisation of CDE training. Moreover, it can support workforce mobility.  
B. Non-medical prescribing supporting healthcare access 
The Pre-Delphi Consultation findings suggest NMP is a workforce solution. Participants 
expressed that NMP by HCPs knowledgeable about diabetes management and 
medicines supports an appropriate increase and timely access to healthcare. They 
recommended that an alternate level of CDE who could prescribe should be 
considered. 
Several participants identified a well-trained CDE could be an asset in primary care:  
Our GPs will rely on CDEs to be up to date. You've got to remember; they know a little 
bit about a multitude of diagnoses and not a hell of a lot about one condition. (CDE, 
primary care NP) 
The participant recognised the specialty skills the CDE brings to care. Several indicated 
that access to CDEs was already considered beneficial by their medical colleagues to 
support appropriate care, for example: 
I work in private practice alongside 10 GPs and they always come around to me to ask 
about the best treatment options for their patients. They feel confident that I am more 
up-to-date about all the diabetes medicines. I consider the patients’ other conditions and 
their job etc. (CDE, private practice RN) 
Many participants suggested access to diabetes management could be improved by 
offering insulin titration advice or DSME. Participants provided examples of when 
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consumers have accessed their care and been on the same insulin dose for a long 
duration despite having above target glycaemia. For example: 
To me, the benefits are that person comes to see us. Clearly, you can see their issue is 
around their insulin dose. They're waking up to a [BGL of] 10, and they're on 10 units 
tonight and have been for the last three years because no-one's ever noticed that. They 
get the right [insulin] advice promptly. To me, it's better for the client. It's all client-
centred care. (CDE, tertiary care RN) 
The quote suggests that providing DSME or advice about changes to diabetes 
medicines provided consumers with meritorious service. The comment, like others, 
suggests that consumers accessed the diabetes educator as they identified the HCP 
held the knowledge and skills that they required to support their care.  
Moreover, given the CDEs expertise, a few participants suggested that a higher CDE 
role could be considered that could support medicine management:  
I think ADEA need to consider a higher qualification than CDE … A CDE is a diabetes 
educator. I understand a lot of people who are CDEs are much more than CDEs. They 
know about medications. They're diabetes managers. They could run a diabetes service, 
all sorts of things. I think we need to recognise that additional layer of expertise, which 
could well be a little bit like nurse practitioners, where it's got a specialty attached to it. 
It's sort of a specialist CDE. (CDE, primary pharmacist) 
The findings suggest that consistency in policy about medicines supports improving 
training in healthcare. Further, seeking policy change to enable a NMP CDE may be 
beneficial. 
C. Remuneration for private sector Credentialled Diabetes Educators 
The Pre-Delphi Consultation findings suggest the private sector diabetes educator 
workforce requires improved remuneration by Government to enable viable business 
models. Moreover, several participants suggested growth of the diabetes workforce 
was hampered by funding impediments, which did not allow for the growth of the 
private diabetes educator workforce to care for people with diabetes in primary care. 
These recommendations were primarily made by pharmacists and by NPs employed in 
private practice.  
Participants reported discrepancies in remuneration for disciplines providing diabetes 
education and care, and indicated these inconsistencies prevented working fulltime in 
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private practice. One participant suggested consultations were not delivered judiciously 
according to consumer needs, which impacted on access to funding by other disciplines:  
In the GP practice I work, they have finally agreed that the diabetes educator will now 
access some appointments over the podiatrist getting all five [Team Care Arrangement] 
visits. Nobody from now on will get all five visits to only the podiatrist … Because I work 
in rooms where they’re getting their toenails cut. He's [the podiatrist] moving at such a 
pace that he's earning four times as much as I earn. (CDE, community and private 
practice pharmacist)  
Several participants noted that the appropriateness of referral processes was essential 
to build viable businesses, but they continued to note that the capacity for business 
development required appropriate funding. Two participants indicated that despite 
the Government’s interest in improving diabetes education and support accessed 
through pharmacies, an impetus did not exist as remuneration was negligible. For 
example, one said: 
Pharmacy doesn't have direct access to any funding from Medicare. If we're going to 
provide diabetes services in pharmacy, we have no monetary incentive to do so. Not that 
we'd withhold that [consumer information], because of that, but it's a big gap in 
community pharmacy. (CDE, community and private practice pharmacist) 
Last, a couple of participants suggested no financial incentive to undertake and access 
professional development when working in private practice existed. Moreover, 
mentoring within the private sector was challenging, limiting their capacity to build 
skills within the primary care workforce.  
Even though there are lots of opportunities, many organisations or when you are in 
private practice, basically, you're doing a lot of one-to-one. You don't have the 
opportunities, always, to be mentoring - or [working] fully private practise, there's no 
opportunity to build workforce. (CDE, primary care RN) 
Business development in the private sector requires appropriate remuneration to 
increase healthcare access delivered by diabetes educators.  
Next, the Delphi survey questionnaire was developed, informed by the Pre-Delphi 
Consultation findings. 
4.6. Development of the Delphi survey questions 
Findings relating to scope of practice, medicine management and NMP and HCP 
diversity and training requirements were carried over to inform the Delphi survey 
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questions. These were considered along with the findings from the literature review 
and the study’s methodological unpinning. 
Traditional competency-based studies using Delphi technique create content for the 
first-round from the literature, which participants then rank (Keeney et al., 2010). 
Initially, a draft set of Delphi questions and lists of practice levels and statements for 
ranking were derived from the literature. However, peer-reviewed literature about 
frameworks for diabetes was largely international or grey material and competency-
based; the skills and knowledge list created reflected an international context and 
focused more on T2D.  
It became apparent that the ‘list’ for the Delphi survey would not capture the 
Australian diabetes education expert’s ‘voice’, nor were they capability-based. Thus, 
the practice levels identified could differ from the Australian context. Further, the 
traditional Delphi approach could stifle new content that could create a current list of 
capabilities and a more comprehensive list of statements for all practice levels.  
Capturing the expert Australian diabetes workforce voice was important to ensure the 
study captured Australian healthcare context nuances. Providing an opportunity for 
diabetes HCP experts to list their words would enable a better understanding of how 
the Australian diabetes workforce interprets and made sense of their experiences in 
providing diabetes education and care.  
Consequently, the research team determined the capabilities, and their statements 
should derive from knowledge, skills and attributes (KSA) data generated from the 
Delphi participants. Therefore, ensuring the capability-based framework had an 
Australian context and used the ‘language’ of Australian diabetes experts to increase 
the relevance of the final product. The Delphi survey included a section asking 
demographic questions and then three following focused question:  
1. What ‘diabetes healthcare professional practice levels’ for diabetes education 
and care currently exist within the Australian healthcare system?  
2. List the basic or fundamental and advanced KSA required to enable non-
medical health professionals to support diabetes education and care for people 
with diabetes?  
3. Provide a brief definition of medicines management and list the essential 
knowledge and skills non-medical healthcare professionals require to be 
involved in medicines management? 
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Participants were provided with the following definition for diabetes healthcare 
professional practice levels: Practice levels describe levels of HCPs competence, work 
experience and skills, and scope of practice in diabetes care. The first Delphi survey 
questionnaire tool is seen in Appendix 4 on page 300. Further, participants were asked 
to consider registration, credentialling, academic level attained, experience, disciplines, 
generalists, specialists and various work settings in their answer.  
The researcher was conscious that the approach would create a longer survey time 
and more work for participants. Keeping the number of rounds and their lengths to a 
minimum was vital moving forward because responder fatigue and attrition are 
common with longer rounds (Keeney et al., 2010). The initial preparations of the web-
based survey platform used to deliver the Delphi survey are described next.  
4.7. Development of the web-based online survey  
The Qualtrics web-based survey platform was used to develop and circulate the four 
Delphi survey rounds electronically as an email link to individual consenting participants. 
The web-based survey tool automatically-collected data after the survey responses were 
submitted. The researcher met with experts who had used the web-based survey 
platform. 
The following features were set in the web-based survey platform for the study:  
• An ‘expiration date’ four weeks after opening. 
• ‘Save and continue’ enabling the Delphi participant to respond at their 
convenience and adequate time to think about the questions and issues. 
• ‘Back button’ so responses could be altered. 
• ‘Add display logic’ algorithm for specific questions so the new question was only 
shown if their response required more information.  
Setting features improve the participant’s experience and decrease fatigue because they 
reduce reading time in one sitting (Akins et al., 2005). Also, ‘force answer’ was set for 
demographic and ranking questions to ensure data completeness.  
The web-based survey platform’s survey options used, including those to protect 
anonymity and the authenticity of responses are seen in Appendix 5 on page 307. Other 
features were also set in the email distribution section. These included weekly reminder 
messages to respondents who had not completed their survey and a thank you email 
once submitted to Qualtrics. The web-based survey platform enabled access to HCPs in 
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all areas of Australia and was the key instrument delivering the Delphi survey to panel 
participants.  
The web-based survey platform’s data analysis features such as predictive modelling 
reduce the pre-processing steps to prepare data for analysis (Ginn, 2018). For example, 
the web-based survey platform indicates the number of completed surveys submitted 
and displays ‘current response rate’ on request. The program enabled design and survey 
distribution, data review and analyses, and viewing reports from selected responses 
with simple analysis online, during the study. 
Once the web-based survey was prepared, the Delphi survey pilot test followed, to 
ensure features and questions supported the Delphi technique and addressed the 
study’s aims. 
4.8. Pilot test of the Delphi survey  
Conducting a pilot provided an opportunity to inform the survey design and validate the 
data collection instrument to establish whether respondents interpreted items as the 
researcher intended (Brace, 2010). It provided an opportunity to test Delphi survey 
questions, the web-based survey platform and its features including, estimating the time 
taken to complete the questionnaire. The pilot test was undertaken to enhance the 
questionnaires’ face and content validity and trustworthiness of results obtained (Brace, 
2010). Testing the questions and wording for ongoing Delphi rounds to ensure their 
meaning was clear, occurred with the research team and the EAG. 
4.8.1. Recruitment to the pilot test 
Recruitment occurred during the first two weeks of July 2018 to identify individuals for 
the Delphi pilot. Purposeful recruitment was used to identify seven HCPs with 
expertise in diabetes and from different disciplines and work settings. Potential 
participants were emailed and invited to volunteer their time to trial a questionnaire 
and provide feedback for the study.  
4.8.2. Process undertaken for the Delphi survey pilot  
Following ethics approval, the pilot Delphi survey was forward to pilot participants in 
September 2018 and was open online for two weeks. Survey details and link, and a PLS 
was forwarded directly via email to the seven individuals who indicated an interest to 
participate, see Appendix 6 on page 308 and Appendix 7 on page 312.  
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The researcher kept discussions with pilot participants to a minimum to mimic the 
level of information, which would be accessible to future Delphi panel participants. 
Consent was implied when each participant completed the questionnaire. They were 
asked to provide feedback about the time taken to complete the survey, readability, 
usability and format, and the clarity of instructions. The pilot group tested the first 
survey in preparation for Delphi survey Phase One (Round one).  
4.9. Analyses of pre-Delphi pilot data 
The analysis involved reviewing participant information regarding the survey tool and 
process for similar feedback and context. Participant feedback concerning the 
demographic data was scrutinised to identify whether any demographics had been 
missed. Lastly, responses to the Delphi questions were reviewed to identify whether 
they captured the intended information required. Quantitative data was managed in 
the same manner as the pre-Delphi consultation group data, used to describe the 
participants' characteristics.  
4.10. Pre-Delphi survey pilot results  
The pilot test supported establishing the web-based survey platform features in 
preparation for the Delphi survey and enabled the researcher to refine the Delphi 
survey questions before use in Stage II. Improvements would allow the Delphi panel to 
have a better experience; therefore, more likely to answer questions. Three areas 
were improved as a result of the pilot and these related to the: 
• Survey look and flow. 
• Question format. 
• Survey length and duration. 
The findings for each issue are discussed next. 
4.10.1. Survey pilot participants’ characteristics 
The pre-Delphi pilot panel included seven female diabetes-specialist HCPs. A diabetes 
specialist podiatrist and dietitian, and CDE aged less than 30 years with diabetes 
experience ranging between five and ten years. Further, it included a nursing CDE, a 
diabetes nurse practitioner, a midwife CDE, and a nursing academic CDE with over 20 
years of experience in diabetes education and care. 
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4.10.2. Findings to validate the Delphi survey and its design 
Feedback from pilot participants enabled questionnaire refinement for Delphi survey 
Phase One in Stage II. The feedback targeted three areas: survey look and flow, 
question formatting and survey duration discussed individually.  
A. Survey look and flow  
Survey flow was the most common general feedback. Participants suggested adding a 
‘progress bar’ so responders could determine their progress and how much time the 
survey may take. Also, the ‘save and continue’ feature allows the participant to 
continue the survey at different times.  
Participants also recommended it would be helpful for the responders to receive a 
copy of their responses at the survey completion. It provided an opportunity for 
participants to review personal comments and remind themselves of their thinking in 
earlier rounds. Lastly, while maintaining ‘force answer’ feature for demographic 
questions, to encourage participant engagement it was recommended to remove the 
feature from the Delphi questions so the responder could more easily navigate through 
the questions, moving back and forward. 
B. Question formatting 
Responses to Delphi questions captured desired information. Participants indicated the 
demographic questions were sound, clear and open-ended and suggested the 
following:  
• To add ‘academic’ and ‘diabetes educator’ to the question ‘What is your 
profession?  
• To add a query about credentialling as a CDE and medicine management in the 
demographic section.  
Further participants recommended separating question 3 into sub-questions. 
Therefore it was altered to: 
• 3A) Describe medicines management? 
• 3B) What essential knowledge and skills do you think non-medical healthcare 
professionals require to be involved in medicines management? 
• 3C) Tell me what you understand by the term ‘non-medical prescribing’? 
No other suggested changes: however, an important survey attribute supporting 
engagement level is duration.  
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C. Survey length and duration  
Although not raised by the pilot participants, the length of time to complete the survey 
could be an issue; it depended on the amount of detail the participant contributed. 
Pilot participants took between 45-57 minutes to complete the survey and provided 
detailed information to all questions. Despite trying to reduce the time allocated for 
each survey, the first round of Delphi survey Phase One was lengthy, in part because 
the individual needed time to consider all relevant skills and knowledge.  
The introduction to the Delphi survey was changed to better indicate the time it would 
take to complete the survey, which provided future participants with an opportunity to 
determine whether they had adequate time to complete the survey. It was altered to: 
‘the survey will take 30-60 minutes to complete depending on the level of detail you 
wish to provide’. Wording in the PLS was altered to reflect timing to 15 and 60 minutes 
because follow-up Delphi rounds would be shorter.  
In conclusion, the pre-Delphi pilot found that questions overall did collect the intended 
information. Participants who undertook the pilot survey provided helpful information 
to improve the survey to increase engagement. 
4.11. Chapter summary  
Chapter 4 described Stage I, the pre-Delphi consultation period, which included 
findings from two data collection methods, namely a pre-Delphi Consultation with 
diabetes HCPs and a pilot of the Delphi survey. The collective results guided the 
framework’s development and informed the design and content of the Delphi survey. 
Stage I was one part of the consensus strategy to systematically work towards an 
agreement about the information contained in the framework. 
In summary, the Pre-Delphi Consultation highlighted several important considerations 
concerning the health workforce to deliver diabetes care and NMP. Firstly, that 
mentoring, and health workforce diversity were critical attributes. Conversely, that 
while much knowledge and expertise existed, there was also confusion impacting on 
workforce development. Clarity concerning scope of practice and non-medical 
prescribing in diabetes care, especially for CDE, was needed. The issues or 
considerations identified from the pre-Delphi Consultation informed the Delphi survey 
questions to help develop a framework to guide the health workforce that delivers 
diabetes education and care.  
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Lastly, the pre-Delphi pilot enabled improving features of the web-based survey 
platform to meet researcher needs, encourage engagement, and refine questions to 
ensure they elicit the correct information required. Results from the pre-Delphi survey 
pilot were used to validate and improve the clarity, flow and utility of the proposed 
Delphi survey. The interpretation of data collected from the pre-Delphi activities (Stage 
I) prepared the researcher and data collection tools for Stage II, the Delphi survey.   
Chapter 5: STAGE II – Delphi survey phases 
143 
 
Chapter 5: STAGE II – Delphi survey phases 
5.1. Chapter introduction 
Stage II of the study used a Delphi survey conducted in two phases; each involved two 
sequential rounds of feedback, see Figure 3.4 on page 105. The purpose of Stage II was 
to address the study’s research questions and gain consensus on different framework 
aspects.  
Stage II consisted of the following activities: 
1. Administration of the Delphi survey Phase One, Round one and two. 
2. Consultation with an Expert Advisory Group (EAG) for peer debriefing and 
member validation. 
3. Administration of the Delphi survey Phase Two, Round one and two. 
The purpose of conducting Delphi survey Phase One was to identify the practice levels in 
the Australian healthcare context that signify a change in the level of knowledge or skills 
the HCP requires to deliver diabetes education and care. The results identified a model 
that informed the capability-based framework. 
The purpose of conducting Delphi survey Phase Two was to isolate the broad 
capabilities and relevant statements for each practice level identified in Phase One to 
complete the capability-based framework. An online Delphi data collection method 
was chosen to accommodate participant dispersion across Australia: living in 
remoteness or isolation a nuance of Australia.  
The chapter starts with the research questions guiding the stage. Then, information 
about the rationale for the survey sample size and strategies adopted to recruit 
participants is provided. After that, information describing the data collection 
procedures used in the two Delphi survey rounds conducted in each phase, analyses of 
data obtained, including how the EAG supported peer debriefing, and the findings are 
shared last. 
5.2. Research questions guiding Stage II 
1. Phase 1: What healthcare professional diabetes practice levels are used to 
deliver diabetes care in Australia?  
2. Phase 2: What are the capabilities required to deliver diabetes education and 
care?  
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5.3. Participant sampling and sample size 
The same sampling strategy used for the pre-Delphi Consultation in Stage I was also 
used in Stage II, see Section 4.3.1 on page 115. Literature about competency studies and 
the research aim and questions were used to determine the sample size: a minimum 
panel size of 40 participants. The researcher assumed significant variations between 
expert opinions and variability due to employment setting, remoteness, HCPs’ scope of 
practice (SoP) and differences between disciplines to determine the sample size. 
A larger sample size was chosen to ensure the study:  
• Captured the breadth and range of opinions of different disciplines.  
• Allowed for participants attrition. 
• Maintained rigour by increasing the likelihood of a minimum 70% response rate 
at the conclusion of all Delphi survey rounds (Hasson & Keeney, 2011). 
One consequence of larger panel sizes is the large quantity of data generated, 
negatively influencing the analysis period (Hasson & Keeney, 2011). Strategies for 
managing the potential volume of data in the study included reviewing responses for 
data saturation, peer debriefing with the EAG and an adequate response rate, i.e. 
greater than 70% of participants in each round. 
5.3.1. Recruitment strategies and timeframes for the Delphi survey 
The Delphi survey recruitment period lasted 11-weeks from July to September 2018. A 
combination of purposeful and snowball sampling methods was used to recruit HCPs 
to the study. These methods are useful to engage information-rich experts well-versed 
in diabetes education and generate a cohort reflecting the range of HCPs delivering 
diabetes care (Moser & Korstjens, 2018).  
A recruitment target of 60 participants was set to allow for non-starters and dropouts. 
The purposeful sample aimed to recruit expert:  
• CDEs of all disciplines and various employment settings  
• Primary health care nurses  
• Diabetes nurse practitioners  
• Academics with a research focus in diabetes education and care  
Open recruitment was used to reduce potential selection bias due to the purposeful 
sampling approach. An invitation email including an advertisement for the study, see 
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Appendix 8 on page 313, was circulated in August 2018 to seven peak HCP organisations 
for the different disciplines eligible for CDE credentialling including the:  
• Australia Diabetes Educators Association (ADEA) 
• Australian College of Midwives (ACM) 
• Australian College of Nurse Practitioners (ACNP) 
• Australian Podiatry Association (APodA) 
• Australian Practice Nurse Association (APNA) 
• Dietetic Association of Australia (DAA) 
• Pharmaceutical Society of Australia (PSA) 
Each organisation advertised the research in their regular membership emails. The 
recruitment period chronology and response rate is presented in Figure 5.1, page 146. 
An invitation to participate in the study was advertised to over 12,000 HCPs, and 57 
(0.48%) indicated an interest in being involved. The percentage was benchmarked 
against levels of engagement with the advert by ACM members; although 42.8% 
opened the email, opening the actual research advertisement had a click rate of 0.40% 
(ACM Media, personal communication, December 10, 2018). 
The researcher reviewed participants’ demographic data collected in the web-based 
survey platform as the recruitment period progressed to ascertain the breadth of 
disciplines recruited. Demographic data were checked for those actively influencing 
diabetes workforce development, e.g. academics because their opinion brings vital 
information on innovative practice in the diabetes workforce.  
Targeted recruitment included AHP diabetes interest groups to recruit AHPs who were 
underrepresented, i.e. the National Association of Diabetes Centres Foot Network, 
Lower Hume Primary Care Partnership - Diabetes AHP Working Group and the 
Pharmaceutical Society of Australia CDE Leadership Group. To ensure the sample size 
was adequate, data saturation was monitored; that is, when participants’ feedback 
provided no new insights (Saunders et al., 2018) and the AHP distribution was similar 
to ADEA membership, recruitment stopped. The recruitment period achieved 95% of 
the participant recruitment goal. 
5.4. Stage II: Delphi survey Phase One 
Activities to this point, including the literature review on consensus methods and the 
pre-Delphi period (Stage I) informed the final Delphi survey and its two phases. The 
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Figure 5.1: Chronology of the recruitment period 
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objective of Delphi survey Phase One was to identify the practice level model to 
inform the capability-based framework: the broad groupings that signify the varying 
levels of knowledge and skills different HCPs require to deliver diabetes education 
and care in the Australian healthcare system, requiring a different level of training. 
The following section describes the process used for Delphi survey Phase One 
(Round One), scoring and determining consensus. 
5.5. Delphi survey Phase One (Round One) 
The purpose of Delphi survey Phase One (Round one) was to gather information to: 
• Identify diabetes practice levels.  
• Describe diabetes HCPs’ role in, and their understanding of, medicine 
management and NMP. 
Further, Round one, gathered information about the basic and advanced 
knowledge, skills and attributes (KSA) HCPs require to deliver diabetes care and be 
involved in medicine management. Activities in Phase One worked towards 
achieving consensus of the practice levels; the knowledge and skills information 
collected was left for content analysis at the beginning of Delphi survey Phase Two. 
5.5.1. Process for Delphi survey Phase One (Round One)  
The Delphi survey was disseminated over twelve months, see Table 5.1. The process 
included an analysis period and EAG peer-review in-between each round. The first 
two rounds were part of Phase One; the second two rounds were part of Phase Two.  
 
Table 5.1: Timeline for Delphi rounds and Expert Advisory Group meetings 
DELPHI STAGE  Delphi round Date open Date closed  Length of time  
STAGE II     
PHASE 1 Round 1 20/09/18 01/11/18 6-weeks 
 Round 2 12/12/18 22/01/19 6-weeks  
PHASE 2 Round 1 17/06/19 14/07/19 4-weeks 
 Round 2 22/07/19 16/08/19 4-weeks 
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An email list of HCPs who indicated an interest in participating in the Delphi survey 
was created as a contact in the ‘Compose Email’ feature of the online survey 
platform. Distributed emails contained an introduction to the round and were sent 
out in batches during the recruitment period. The researcher reviewed data to 
ascertain saturation of ideas and diversity of panel members by working in ‘batches’.  
 
‘Anonymised responses’ was engaged in the web-based survey platform, which de-
identified data collected to protect participants’ privacy. A screen display of survey 
platform distribution features to illustrate ways the researcher managed incoming 
communication, reminders and thank you messages is provided in Figure 5.2. 
 
 
Figure 5.2: Screen display of Qualtrics email distribution feature 
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Round One comprised an introduction to the survey, 13 demographic questions to 
capture Delphi participant characteristics and three open-ended questions to 
capture diabetes workforce information as described in Chapter 4 (Sections 4.6 and 
4.10.2[B]). The Round One data collection tool is seen in Appendix 4 on page 300. 
A. Response rate 
The researcher monitored response rates via the web-based survey platform, which 
calculated these statistics daily once completed questionnaires were submitted. To 
maintain an adequate sample size for consensus and support research rigour, when 
the response rate was lower than 70% for the survey round, the researcher added 
‘closing soon’ to the title of reminder emails to prompt a participant reply.  
B. Reminders  
Reminders were sent out weekly after the initial invitation and two days before the 
end of each round. They were sent to ‘unfinished respondents’ only; the Qualtrics 
system recognised those who had not yet submitted their responses. Each reminder 
stated the time the survey had been opened, the researcher contact details and a 
link to the survey. The email was sent directly from the web-based platform 
because it was set up with a feature to thank participants on completions and send 
reminders. Once the demographic data was reviewed to ensure completeness of 
the data and group diversity, the survey was closed in preparation for data analysis. 
The following section describes the analysis of diabetes practice levels to identify what 
signalled an increasing requirement for skills and knowledge to deliver diabetes care.  
5.5.2. Analyses of Delphi survey Phase One (Round One) data 
The analysis period aimed to identify four to six models describing diabetes practice 
levels for ranking to attain consensus to inform the framework. The KSAs identified 
in Round One were carried over to Delphi survey Phase Two for content analysis to 
identify major and sub-categories: the relevant capabilities and their statements to 
support the diabetes workforce.  
A. Qualitative data analysis 
Following Phase One (Round One), content analysis of qualitative data followed the 
same process as demonstrated in Figure 4.1 on page 119. It concerned data drawn 
from question one, to elicit diabetes practice levels to inform a model for the 
‘Capability Framework’; also, questions 3A and 3C to understand participants' 
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comprehension of medicine management, see Appendix 4 on page 300. The 
supervisory team and EAG cross-checked models and merging of models. 
B. Quantitative data analysis 
In Round One, counts and percentages of participant demographic data were 
undertaken to identify the Delphi participants’ characteristics and diversity. 
5.5.3. Results of Delphi survey Phase One (Round One) 
Fifty-seven HCPs indicated they were willing to participate in the study. The following 
section outlines their characteristics and the outcomes of Round One. 
A. Characteristics of the Delphi expert panel 
Fifty-four participates were from ADEA or its sub-committees: 95% of the recruitment 
sample. Forty respondents (70%) were recruited from ADEA electronic direct-
messaging (eDM), six (11%) from fortnightly news emails, six (11%) from Course 
Accreditation and Standards of Practice Committee (CASP), and two (4%) from ADEA 
member shares to AHPs, see Figure 5.1 on page 146.  
Fifty-two of the 57 potential participants marked the consent box, acknowledging 
they read and understood the Plain Language Statement, and commenced the 
Delphi survey. Only the characteristics of fifty people are discussed below because 
two participants only completed the demographic questions.  
Thirty-nine (78%) respondents were nurses, and eleven (22%) allied HCPs, see Table 
5.2 on page 151; five nurses did not start the survey. Nearly half the participants 
held more than one role and reported working in multiple settings; the fifty 
participants listed a total of ninety-three separate roles, see Figure 5.3 on page 152.  
No participant indicated they were an Aboriginal and Torres Strait Islander health 
practitioner, although some HCPs reported working in Aboriginal and Torres Strait 
Islander communities; no physiotherapists responded. Advertising through APNA 
did not recruit primary care nurses or experienced enrolled nurses. 
Participants included a diverse representation of the diabetes health workforce; 
70% (n=35) were older than 50 years, see Table 5.2. Further, they were an 
experienced group of experts; most (n=30, 60%) worked as a HCP for over 30 years. 
All participants were female, but one. The majority (n=45, 90%) had a postgraduate 
or higher research degree, and often this was diabetes-related (n=42, 84%). Most 
(n=39, 78%) indicated they were involved in medicines management. 
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Discipline   n %  n %  n %  n %  n %  n %  n % 
Aboriginal & Torres Strait 
Islander Health Worker 
0 0 
0 0 0 0 0 0 0 0 0 0 0 0 
Dietitian 2 13 3 20 5 10 5 11 5 13 5 14 1 25 
Exercise physiologist 0 0 0 0 1 2 1 2 1 3 1 3 0 0 
Nurse 10 67 8 53 39 78 33 75 29 73 27 73 2 50 
Physiotherapist  0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Pharmacist 0 0 4 27 2 4 2 5 2 5 2 5 1 25 
Podiatrist  1 7 0 0 2 4 2 5 2 5 2 5 0 0 
Psychologist/Behavioural  2 13 0 0 1 2 1 2 1 3 0 0 0 0 
Gender  n %  n %  n %  n %  n %  n %  n % 
Female 15 100 14 93 49 98 43 98 39 97 37 100 4 100 
Male 0 0  1 7 1 2 1 2 1 3 0 0 0 0 
Years of practice  n %  n %  n %  n %  n %  n %  n % 
> 5 - 10 years 0 0 0 0 4 8 4 9 4 10 4 11 0 0 
>10 - 15 years 2 13 3 20 2 4 2 5 2 5 2 5 0 0 
> 15 - 20 years 0 0 0 0 8 16 8 18 8 20 6 16 0 0 
> 20 years 6 40 2 13 6 12 4 9 3 8 4 11 2 50 
> 30 years 7 47 10 67 30 60 26 59 23 58 21 57 2 50 
State/territory of practice  n % n %  n %  n %  n %  n %  n % 
ACT / NSW 3 20 3 20 14 28 11 25 10 25 7 19 1 25 
Northern Territory  0 0 1 7 2 4 2 5 2 5 2 5 0 0 
Queensland  0 0 1 7 6 12 6 14 6 15 6 16 1 25 
South Australia  0 0 3 20 4 8 4 9 3 8 2 5 1 25 
Tasmania  4 27 1 7 3 6 3 7 3 8 2 5 0 0 
Victoria 8 53 4 27 15 30 13 30 11 28 12 32 1 25 
Western Australia  0 0 2 13 6 12 5 11 5 13 6 16 0 0 
Employment locality 
(all)  n %  n %  n %  n %  n %  n %  n % 
RA1 – Major cities  3 20  33   32    31   2 50 
RA2 – Inner regional  4 27  20   27    28     
RA3 – Outer regional  6 40  27   19    19   2 50 
RA4 – Remote  2 13  13   12    11     
RA5 – Very remote  0 0  7   10    11     
Age group  n %  n %  n %  n %  n %  n %  n % 
< 30 years 2 13 0 0 1 2 1 2 1 3 1 3 0 0 
> 30 - 50 years 9 60 4 27 14 28 11 25 10 25 9 24 1 25 
> 50 years 4 27 11 73 35 70 32 73 29 73 27 73 3 75 
Employment sector  n %  n %  n %  n %  n %  n %  n % 
Primary (including community) 2 13  25  25    28   1 25 
Tertiary/Hospital (inc out-pts) 5 34  52  47    54   2 50 
Research/University 6 40  15  18    13   0 0 
Private practice 2 13  8  10    5   1 25 
Highest qualification  n %  n %  n %  n %  n %  n %  n % 
General nurse training (Hosp) 0 0 0 0 2 4   1 3   0 0 
Bachelor’s degree 0 0 0 0 3 6   1 3   0 0 
Postgraduate Degree 6 40 11 73 29 58   25 63   3 75 
Clinical Masters   2 13 1 7 10 20   7 18   0 0 
Masters (Research) 1 7 3 20 4 8   4 10   1 25 
PhD or Doctorate 6 40 0 0 2 4   2 5   0 0 
Degree in diabetes    n %  n %           n % 
Yes postgrad    15 100 42 84          3 75 
Involved with medicines       n %           n % 
Yes      39 78          3 75 
Maybe      5 10          1 25 
No      6 12          0 0 
 




Figure 5.3: All current roles held by panel members 
 
The expert Delphi panel was representative of the settings in which Australian 
diabetes educators’ work and all States and Territories, and areas of remoteness, 
see Table 5.2 on page 151. Area of remoteness was an essential characteristic to the 
richness of data because Australia has many remote areas where the prevalence of 
diabetes is high, health resourcing is low and adaptive services are often created 
(Skinner et al., 2013). Half of the HCPs (48%) were employed in tertiary hospitals, 
including outpatient specialist services, and some had dual roles. Thus, the 
characteristics of the expert participants reflected the current diabetes expert HCP 
workforce, which captures the diversity of the Australian healthcare context.  
B. Results from the recruitment process  
More participants were recruited from electronic-Direct Messaging when the email 
title recorded the study and contained only information concerning the study. 
When the study invitation was disseminated in eBulletins with other organisational 
material, there was negligible recruitment through ADEA or other organisations, see 
Figure 5.1 on page 146.  
C. An Australian model of diabetes healthcare professional practice levels  
Thirty-four individual models were initially identified based on the terms and HCP 
titles participants (n=47) provided in Delphi survey Phase One (Round one). 
Participants were asked to describe the current HCP practice levels for diabetes 
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education and care within the Australian healthcare system. Three tertiary-employed 
nurse CDEs indicated they did not understand the question. Participants provided 
varying explanation to describe the varied different practice levels within Australian. 
Due to the similarity of roles and focus, the 34 models were merged into eight models. 
The eight models were further reduced into four models by adding an additional 
practice level. Key features of the models were identified and listed, see Figure 5.4.  
 
Figure 5.4: Models to describe practice levels to inform framework 
 




Figure 5.4: Models to describe practice levels to inform framework (continued) 
 
The four models, which described diabetes practice levels were similar in terms of 
HCP roles and disciplines included. However, they differ in terms of HCPs’ 
employment settings and focus. Specifically, four different foci were identified:  
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• A Nursing focused model, which was a career pathway for nurses in 
diabetes. Years of experience and working towards credentialling as a CDE 
were described as important. The model only focused on nursing. 
• An Australian Health Practitioner Regulation Agency (AHPRA) focused model 
differentiated between HCPs who were AHPRA registered and those who 
were not, and SoP was related to the HCP’s primary discipline. Practice levels 
were often related to the type of postgraduate qualifications the HCP held. 
• A Multidisciplinary focused model, which was a pathway from HCPs with 
broad generalist knowledge to those with diabetes-specific expertise. As 
scope in diabetes increased, it signified an increase in acuity of patient type 
the HCP managed and complexity of care. The model highlighted the 
essential contribution of all different disciplines and roles. 
• A Work setting focused model that described changes in SoP in terms of the 
HCPs’ work setting. Work settings concerned remoteness and the model 
recognised differences between services provided in tertiary centres, e.g. 
specialised diabetes care versus primary care, e.g. general practice and 
pharmacy. The model recognised that the HCP delivering the same service 
may be similar or different due to work setting, e.g. rural remote versus 
metropolitan. 
 
Once the key models describing the HCP practice levels were identified, they were 
forwarded to the Delphi survey Phase One (Round two) participants.  
5.5.4. Results regarding diabetes educators and medicine management  
Participants’ descriptions of their role in, and their understanding of, medicine 
management and NMP resulted in an interpretation of the ways the diabetes 
workforce is involved with medicines and their shared understanding. 
A. Delphi panel members’ roles in managing medicines  
Four practices emerged from the question regarding participants’ roles in medicines 
management that explained their involvement: 
i. Collaborative medicine management. 
ii. Diabetes medicine self-management education. 
iii. Ambulatory care insulin stabilisation. 
iv. Prescribing and deprescribing medicines. 
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Each practice identified is defined and explained in the next section using 
descriptive quotes from participants.  
i. Collaborative medicine management 
Collaborative medicine management was a common practice listed by most 
participants. Collaborative medicine management concerned indirect medicines 
management by the HCP through providing advice and discussing GLMs with the 
consumer’s GP or treating medical team. Participants’ comments suggested that 
optimising care was the basis for the practice. Further, the onus and final 
responsibility for decision-making concerning diabetes medicines remained with the 
prescriber. For example, one participant said: 
I am always reviewing current medicine regimens and their suitability in the individual's 
circumstances and efficacy of dose ... I also liaise with doctors to provide a professional 
opinion in the suitability of medicines and initiation of more aggressive therapy to 
support lifestyle interventions which can be slow to adopt and implement [by the 
consumer]. (CDE, primary care nurse) 
Many participants said they had unique knowledge regarding diabetes medicines 
and used their knowledge to promote best practice care through the consumer’s 
primary caregiver. They described their confidence and ability to review current 
medicine regimens and suitability by considering the individual's situation, e.g. 
employment type or living alone and the dose efficacy considering comorbidities. 
They indicated their practice was a supportive and complementary role to medical 
practitioners. One participant said: 
I see my role as a supportive role for the diabetes team. I have a good understanding 
T1D and T2D medication management, including insulin titration and flexible insulin 
therapy. This enables me to identify when there needs to be a change in 
insulin/medication regimen based on the effectiveness of controlling BGLs. This will 
then be discussed with other team members to assist with providing optimal 
glycaemic control. (CDE, tertiary APD) 
Many participants suggested their practice supported coordinating care, for 
example notifying the prescriber of medicine side effects. One participant stated:  
[I] identify if the individual is experiencing side effects and review dose advised and 
communicate [these symptoms] to the prescriber. (CDE, primary care RN)  
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Several participants suggested the collaborative medicine management practice 
was broader than focusing on diabetes alone and could extend beyond insulin and 
oral and injectable GLM. Moreover, collaborative medicine management could 
include discussions or advice to manage diabetes comorbidities, including 
cardiovascular, antibiotic and anti-inflammatory medicines. For example, one 
participant explained their role also involved: 
Reviewing the patient’s adherence to antibiotics for ulcer management and diabetes 
medication and linking [the] patient with specialists if [they are] not already involved 
[in care]. (CDE, tertiary podiatrist)  
Collaborative medicines management was discussed regarding targeting the metabolic 
conditions associated with diabetes to reduce the risk of and manage diabetes-related 
complications. For example, a private practice APD CDE indicated she: 
Provided advice to GPs regarding medication options for clients to improve diabetes 
management for [reducing] BGLs, plus if identified, not being addressed for blood 
pressure, cholesterol, kidney function, neuropathy and erectile dysfunction.  
However, several participants described collaborative medicine management in 
broader terms and indicated their practice could be more extensive and included 
reviewing clinical guidelines and policies, and reporting drug reactions, as one 
participant described: 
Collaborative involvement in quality use of medicines, including people with diabetes, 
their families/carers and health professionals regarding medication access and 
formulary management, medication information, policy/procedure/guideline 
development medication history. (CDE, tertiary pharmacist) 
Moreover, many participants suggested the collaborative medicine practice was 
important during transition of care and considered safety. One respondent wrote: 
Also, reviewing education of medication safety, monitoring medication use and 
outcomes, adverse drug reaction, reporting understanding how medicines are being 
used, and issues in practice regulatory considerations facilitating transitions of care or 
shared care. (CDE, tertiary pharmacist) 
In summary, participant responses coded under the collaborative medicine 
management practice suggested a relationship between the HCP, the prescriber 
and the consumer.  
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ii. Diabetes medicines self-management education 
Diabetes medicine self-management education was another common practice most 
participants reported. Diabetes medicines self-management education concerned 
providing tailored self-management education regarding diabetes medicines, e.g. 
GLM and teaching insulin self-administration and titration steps to the consumer. 
Several participants suggested that the onus and responsibility for decision-making 
concerning diabetes medicines rested with the consumer; it was unclear whether 
participants thought it rested with the prescriber too. Many participants indicated 
that consumers could be empowered by making better choices concerning diabetes 
medicines to suit their lifestyle.  
Most participants indicated they provided relevant information to support consumers 
and their families to self-manage medicines, specifically if the consumer voiced 
concerns regarding medicines or BGL reaching targets. An example of diabetes 
medicines self-management education concerning diabetes medicines by one 
participant included:  
Providing general information to people with diabetes and their families on the types of 
medicines used in diabetes management, their mode of action and possible side effects. 
A pharmacist checks this information. Also, providing advice on the risks of consuming 
alcohol while using insulin and seeking their doctor’s advice on potential interactions 
between their medication and alcohol. (Academic, dietitian, CDE) 
Participants descriptions suggested the exchange of information about diabetes 
medicines self-management education was also undertaken to evaluate care; the 
practice included glycaemic review with the consumer. For example, a primary care 
CDE nurse indicated: 
[I] review efficacy [of diabetes medicines] through evaluation of pre- and post-
prandial blood (or sensor) glucose values, pre- and post-activity and during times of 
illness or stress.  
When describing the diabetes medicines self-management education practice, 
participants often described a person-centred focus to empower the consumer to 
enable self-management. They discussed the importance of equipping the consumer 
with relevant skills, knowledge and resources, as one CDE described:  
Being able to read and understand a prescription, learning and knowing how this 
medication is going to fit into the person with diabetes's life, being able to explain the 
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benefits and possible consequences of taking the medication, limiting cost, ensuring 
access to medication, setting up prompts or reminders [on phone or meter] to 
encourage the individual to take the medication as prescribed, using tools such as 
Webster packs or Memoir pens, storage of medications, teaching and assessing 
administration of medication, timing of medication, things/medications that need to 
be avoided because of this medication, reporting and managing side effects, review of 
effectiveness of the medication. (CDE, primary care RN) 
Diabetes medicines self-management education also focused on ensuring the 
consumer understood how to self-manage the medicines they required due to 
diabetes-related complications or current changes in BGLs due to intercurrent 
illness. The practice concerned teaching the consumer factors to consider when 
adjusting medicines. For example, one participant indicated she would: 
Ensure clients understand medication options based on individual situations, e.g. 
home BGLs, eGFR, contraindications. (CDE, private practice APD) 
In this context, the focus was on improving the consumer’s understanding through 
DSME rather than advice to a secondary person such as a GP. 
The diabetes medicines self-management education practice was also related to 
teaching the consumer specific skills such as injecting and teaching them how to use 
their medicines, including storing oral and injectables. An academic nurse who 
worked as a private practice CDE said she: 
[I] taught people to self-administer injectable medications and to self-titrate insulin … 
[and] how diabetes medicines work, adverse and side effects or hypoglycaemia, when 
and how to take them.  
Several participants who described diabetes medicines self-management education 
suggested the onus of insulin titration remained with the consumer empowered to 
improve their healthcare because of the education.  
Many participants’ roles in diabetes medicine management extended beyond DSME 
and incorporated adjusting consumer’s medicines dosage as discussed next. 
iii. Ambulatory care insulin stabilisation 
Ambulatory care insulin stabilisation was another common practice highlighted by 
many participants. Participants from different disciplines described teaching about 
administering insulin and supporting to initiate insulin treatment in the ambulatory 
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setting instead of hospital settings. The practice included providing specific advice to 
consumers, i.e. the quantity of insulin dose adjustment required to stabilise BGLs.  
Responsibility for decision-making was unclearly stated compared to the two 
practices discussed previously. However, it appeared that the onus for decision-
making remained with the diabetes educator, who provided the advice with authority 
provided by a registered prescriber.  
The practice of stabilising insulin doses related to both forms of insulin delivery, i.e. 
injections and insulin pumps. Participants often linked managing insulin doses to a 
formal arrangement with a doctor or by following hospital guidelines. For example, 
one private practice APD CDE indicated that her role involved: 
Insulin initiation and titration in accordance with approved GP or specialist guidelines. 
The practice appeared to be related only to insulin because no other medicines 
were mentioned and a connection to a prescriber was sometimes discussed 
regarding adjusting insulin doses. For example, a primary practice CDE nurse said:  
My role involves titration of insulin, with authority from the prescribing/managing 
medical professional. 
However, the practice was related to stabilising blood glucose levels by identifying 
the correct insulin dose. Another tertiary CDE nurse described the practice of 
managing insulin pump therapy as: 
Reviewing patient’s glycaemic control and adjust[ing] insulin therapy by making 
adjustments to pump rates according to our diabetes centre guideline. 
Participants indicated they consider activities that could impact BGLs when 
adjusting insulin doses to stabilise diabetes in the ambulatory care setting. For 
example, one participant indicated their role also included:  
Advising on the importance of monitoring BGLs to evaluate the impact of medicines, 
especially insulin, and to seek an Exercise Physiologist/CDE advice on self-adjustment 
of insulin to accommodate exercise and of a Dietitian/CDE on self-adjustment of 
insulin to accommodate variations in food consumption. (Academic, dietitian, CDE) 
Participants did not always identify whether they followed a protocol or instructions 
endorsed by a prescriber when involved in the ambulatory care insulin stabilisation 
practice. Many participants indicated they followed a ‘formulary’; however, no 
further elaborating details were provided.  
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Five participants disagreed with diabetes educators involvement in the ambulatory 
care insulin stabilisation practice. One indicated:  
Good collaborative discussions are all that is required to manage consumers’ diabetes 
medicines.  
Their responses suggested the ambulatory care insulin stabilisation practice 
amounted to prescribing, which they indicated was a practice best performed by 
endorsed prescribers only.  
iv. Prescribing and deprescribing  
Prescribing and deprescribing were the last common practices that several 
participants portrayed. Responses by those listing prescribing included 
recommending a new medicine or a change in medicine to a consumer and ordering 
the medicine through a prescription after a comprehensive assessment.  
A primary care NP CDE indicated her involvement in medicine management 
consisted of being: 
Involved in prescribing new GLMs, changing dosing or administration times, ceasing 
GLMs, ordering and reviewing relevant pathology to safe medicine management and 
direct input into revision of hospital policies related to GLMs.  
Deprescribing included the cessation of medicines no longer required for 
management or due to side effects or other comorbidities. Most participants said 
the onus and responsibility for decision-making regarding prescribing and 
deprescribing remained with the prescriber. Nurse practitioner participants were 
most likely to describe this practice. Many participants did not elaborate on their 
responses except to record the word ‘prescribe’. 
Overall, responses from participants when asked to describe their role in medicine 
management highlight diversity in how expert diabetes HCPs are involved in 
medicine management. There were differences, despite HCPs working at the same 
level as a CDE.  
The next section summarises the results of the subsequent Delphi survey question, 
i.e. how participants described the term ‘medicine management’. 
Chapter 5: STAGE II – Delphi survey phases 
162 
 
B. Medicine management 
Participants were asked to describe the term medicine management to enable the 
researcher to understand better how HCPs interpret the term. Responses revealed 
the following three different descriptions:  
i. Medicine management involves titrating medicines, primarily insulin or nurse-
initiated drugs. 
ii. Medicine management is a legislative endorsement to prescribe. 
iii. Medicine management is a complex process focused on pharmacotherapy.  
Each description is discussed in more detail in the next section. 
i. Titrating medicines  
Many participants interpreted medicine management as adjusting medicines doses, 
primarily insulin, to manage diabetes. At times, titrating medicines concerned a HCP 
autonomously commencing a medicine, such as nurse-initiate medication. For 
example, one tertiary CDE midwife said:  
Medication management involves initiating or ceasing medication and explaining 
options to patients and rationale for choosing one option over another and then 
titration to achieve optimal management and quality of life. 
Several participants stated they understood medicine management to involve 
providing general advice including dosage, to either the consumer or the service 
delivering the care. For example, an academic podiatrist CDE stated:  
This is an area of diabetes care practice that involves providing direct or general 
guidance to clients/service users about their medication administration. This would 
include dosage, mechanism of delivery and timing. 
Often participants described medicine management as an activity to support 
optimising treatments to reach targets. 
ii. Legislative endorsement to prescribing  
Many participants interpreted medicine management as the legislative endorsement 
to prescribe autonomously by the HCP. When participants described medicine 
management, they focused on the HCP’s ability to write and provide a prescription. 
For example, one private practice APD CDE said medicine management is:  
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Non-medical health practitioners, e.g. nurse practitioners endorsed to write 
prescriptions for clients to obtain medications for which a script is required. I don't 
support non-medical HCPs having prescribing rights.  
The APD also wrote that she did not support NMP: a comment made by six 
participants made overall. 
Under this interpretation, most participants’ descriptions indicated the term 
included HCPs who are authorised or certified by their organisation to follow set 
protocols to provide timely care. These descriptions were added to the legislative 
endorsement for prescribing definition because at times participants indicated an 
organisational endorsement was required, which could have been linked to 
legislative criteria. One participant’s description indicated: 
Any HCP who does not hold a medical degree. Many HCPs make medication decisions 
according to specialist courses, e.g. Mobile Intensive Care Ambulance Paramedic. As 
an Intensive Care nurse, I was certified to cannulate and use IV medications according 
to the cardiac rhythm needs of the patient being resuscitated. There was a written 
protocol followed and practised for these situations. (CDE, primary nurse & midwife) 
In these cases, the legislative endorsement to prescribe was not apparent; some 
participants’ descriptions indicated the HCPs employing organisation provided the 
endorsement. Individual organisational endorsement could suggest differences in 
how HCPs are endorsed. Four participants either did not understand the question or 
their descriptions focused on lifestyle prescription. 
The responses suggest differences in describing the term could depend on where 
the HCP practises and their training. Also, that HCPs required specific sound skills 
and knowledge to be involved in medicine management. 
iii. Complex process focused on pharmacotherapy  
Some participants interpreted medicine management as a complex process centred 
on assessing the use, benefits and adverse effects of medicines and tailoring 
medicines to meet therapeutic goals and for optimal diabetes care; ultimately, a 
definition of pharmacotherapy (Cardiff, 2017). A CDE, primary care NP explained 
why she felt medicines needed to be well understood, stating: 
This [medicine management] is a complex process, which involves the health 
professional understanding the pharmacodynamics and pharmacokinetics of the drugs 
the person is prescribed, the possible side effects, drug interactions, metabolism and 
Chapter 5: STAGE II – Delphi survey phases 
164 
 
elimination and the importance of renal function to the mechanism of action of the 
drug. The process is not limited to dose titration of insulin. Many drugs are prescribed 
for diabetes patients and having a smattering of understanding of these drugs is not 
medicines management.  
Pharmacists, nurse practitioners and some general nurses were more likely to 
describe medicine management in this manner.  
An in-depth understanding of the consumer’s overall health and interplay between 
medicines was considered important for decision-making in medicines. Other 
participants highlighted risks to the consumer when HCPs involved in medicine 
management had minimal knowledge about medicines. 
Several participants recorded that it was important for the HCP to understand 
motivators and consumer-specific issues. For example, a primary pharmacist CDE stated:  
Understanding of the [consumers’] motivations for taking or refusing to take the 
medication, the disease process you are treating and why … [and] how to improve 
adherence to correct timing of medication and economic cost to the individual.  
Overall, some participants described medicine management as a complex process 
focused on pharmacotherapy: an approach consisting of a series of tasks, events or 
relationships. 
C. Understanding of the term ‘non-medical prescribing’ by Delphi panel 
Delphi survey Phase One (Round one) asked participants to define the phrase ‘non-
medical prescribing’. Their definitions fell into three categories of understanding: 
i. A legislative endorsement 
ii. An extension to scope of practice  
iii. Using complementary medicine  
i. Non-medical prescribing as a legislative endorsement description 
More than half the participants provided definitions of varying detail that defined 
NMP as a legislative endorsement. Their responses indicated it was an activity 
afforded to eligible Australian Health Practitioner Regulation Agency (AHPRA) 
endorsed HCPs other than medical doctors, registered to prescribe medication 
autonomously. Participants stated that several HCP disciplines could obtain 
legislative endorsement, including pharmacists, nurses, midwives and podiatrists, as 
illustrated in the quote below:  
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Prescribing rights that have been extended beyond the traditional remit of doctors 
and dentists to other health professionals as a way to improve the quality of services 
to clients, while maintaining client safety to increase client choice and to improve 
access to healthcare. Include nurse practitioners, optometrists and midwives. 
Medicines should be prescribed following the relevant medicines’ formulary 
requirements and only if they are within the scope of practice of that health 
professional. (Primary and tertiary CDE RN) 
When participants provided more detail in their response, they generally listed two 
points. Participants described NMP as 1) providing a prescription for the medicine 
and 2) indicated it was legislated by individual States and Territories Drug and 
Poisons Legislation. For example, a PHCN diabetes educator said:  
[The] provision of scripts by registered prescribers who are not a [medical] doctor to 
the public. This prescriber is accredited to prescribe in a specified discipline and bound 
by differing state and federal laws, regulations and restrictions. 
Further, participants indicated some practices required HCPs to follow medicines 
formularies that could be rigid, or drug class-related, could include providing 
supplementary medicines or could include rural and remote standing orders. One 
described the variation as: 
NMP is [a] term that has various meanings across different settings currently many 
HCPs other than medical officers can prescribe - ophthalmologist - some nursing in 
rural and remote on set schedules - standing orders - vaccination by pharmacist. HCPs 
are only [permitted] to prescribe within their scope of practice. NMP can be - 
independent - supplementary only. (CDE, primary and tertiary care NP) 
At times, legislative endorsement was not mentioned in the participants’ definitions. 
Moreover, their definitions suggested prescribing was an extension of SoP. 
ii. Non-medical prescribing as an extension to scope of practice 
Several participants did not include endorsement or legislation within their 
definition of NMP and their feedback focussed on an extension to scope of practice 
(SoP). In most cases, responses centred on managing insulin, as described in the 
following quotes:  
[NMP] would be the prescribing of medications, which includes insulin titration, by 
people who have not received medical training, within their current scope of practice. 
(Exercise physiologist, primary care diabetes educator) 




[NMP involves] health professionals who are not registered medical doctors selecting 
a suitable medication to address the patient's problem and providing instructions on 
dosage amounts, times, frequency and conditions. (Academic APD CDE) 
Several participants suggested the NMP definition included the requirement for 
ongoing assessment and documentation to guide practice; one RN indicated:  
Assessment of medication being taken by a person with diabetes. Initiation of 
medication in partnership with a medical practitioner via a legal titration order 
ensures that medication is appropriate and adjusted promptly assessing if the patient 
is taking medication as prescribed. (CDE, tertiary RN) 
In a few instances, insulin dose adjustment was discussed as ‘secondary 
prescribing’; it was unclear whether the action was called secondary prescribing 
because a new prescription was not required or resulted from another mechanism. 
For example, an academic podiatrist CDE defined NMP as: 
Where a member of a healthcare profession, but not a medical officer, prescribes a 
medication for an individual (primary) or adjusts the dose of medication (secondary) 
independently of a medical officer. 
A few participants who defined NMP as an extension of SoP stated it in terms of a 
task, as demonstrated in the next two examples: 
The ability to assist patients to use their medications to achieve the intended 
outcomes and avoid undesirable outcomes. (Academic, dietitian, CDE)  
AND 
Advice is given to manage or alter medications for a particular individual. (PHCN, 
diabetes educator) 
Participants who worked in the primary care setting were less likely to describe NMP 
as a complex decision-making process, compared to those from tertiary settings.  
Two participants suggested that regulation by AHPRA was pivotal to an extension to 
SoP. One participant raised her concern by indicating: 
I am concerned that AHPs who may not be AHPRA regulated are being included with 
RNs and midwives. I would expect a midwife or RN in the hospital setting to 
administer medication but not an AHP. Similarly, for performing BGL monitoring, I 
would consider this beyond the scope of AHPs. (CDE, tertiary RN) 
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Last a few participants understood NMP to be using complementary medicine. 
iii. Non-medical prescribing as a concept of using complementary medicine 
A few more participants understood NMP to be a set of practices centred on the 
using complementary medicine as a substitute to conventional medicines. One 
primary nurse CDE/Midwife indicated that she refers to complementary medicine 
when discussing ways to lower BGLs with consumers and stated: 
[NMP includes] ‘health shops’ prescribing herbal medications, some with minimal 
oversight and training and only testimonials as "evidence" of effectiveness. 
A few described NMP as consumers who may self-medicate or self-manage their 
medicines without recommendations from their doctor.  
Fifteen percent (n=7 participants), representing nursing (n=4) and allied health 
(n=3), indicated they did not know what the term meant and related it to different 
activities such as dietary advice or consumers accessing advice about medicine via 
the internet. For example, a primary care CDE nurse indicated: 
Never heard of this term but guessing it means people using Dr Google or non-
evidence-based opinion as to what medicines to take.  
Three participants shared their thoughts rather than providing a definition, and 
these concerned the: lack of national consistency for NMP; perception that a 
multidisciplinary approach provided better outcomes for consumers and the 
importance of mutual respect among health professions. For example, one private 
practice APD CDE indicated that NMP was not required because:  
Good communication and mutual respect are all that is needed between non-medical 
and medical practitioners if medication changes are required.  
These comments suggest that NMP is not supported by all, including those who may 
benefit from role expansion.  
Overall, content analysis of responses to Delphi survey questions concerning 
medicine management and NMP revealed several key terms are used 
interchangeably. Moreover, many respondents interpret some terms such as 
administration, prescribing, titration and medicine [insulin] advice to mean the 
same thing. These data indicate confusion about the terms and a lack of a shared 
understanding.  
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These results concluded Delphi survey Phase One (Round One). The next section 
discusses the Delphi survey Phase One (Round Two) and its outcomes.  
5.6 Delphi survey Phase One (Round Two) 
The rationale for Delphi survey Phase One (Round Two) was to achieve consensus 
on the preferred model to inform the ‘Capability Framework’ that appropriately 
described HCP diabetes practice levels within Australia. The following sections 
discuss the data collection method used in Round Two, data analysis and the final 
results. Next, the diabetes-specific clinical competence identified for each practice 
level are defined. Following, information about Delphi survey Phase Two is shared, 
including a discussion about the knowledge and skills information collected in Phase 
One but carried over for content analysis in Phase Two. 
5.6.1. Process for Delphi survey Phase One (Round Two) 
All panel members who completed Round One were emailed and invited to 
complete Round Two. Those (n=5) who did not start the survey after three 
reminders were not emailed in Round Two. Round Two was available for six weeks.  
Round Two participants received a summary of anonymous aggregated consensus 
opinions developed through content analysis, see Appendix 9 on page 314. Further, 
four pictorial models as seen in Figure 5.4 on pages 153-154, which described HCP 
diabetes practice levels needed to deliver diabetes education and care.  
Round Two included four questions, which aimed to identify panel members’ area 
of remoteness, sought agreement on terms used and rank the models in order of 
preference, see Appendix 9. There was also an opportunity for Delphi panel 
members to explain the reasoning for their preferred choice to inform the 
capability-based framework. 
Once the data collection period was over, analyses of the data collected commenced.  
5.6.2. Analyses of Delphi survey Phase One (Round Two) data 
A. Qualitative data analysis 
Qualitative data pertained to information collected in the comments sections within 
the Delphi survey round. Following review, patterns of common feedback were 
elicited to understand the reasons for the preferred model chosen: to identify if any 
relevant information informed adjustments to the model or ‘Capability Framework’. 
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Further, to better define the diabetes practice levels, participant feedback to 
questions about practice levels and skills and knowledge from Round one, see 
Appendix 4 on page 300, were scrutinised for words and their meanings to describe 
the level of diabetes clinical competence required for each practice level. 
B. Quantitative data analysis – the meeting of consensus  
Descriptive statistics, including measures of central tendency, i.e. mean, medium, 
standard deviation (SD) and variance, and accumulative percentages were calculated 
to describe responses to ranking and preferred positioning and to identify consensus 
for the model to describe practice levels. The definition of consensus used for ranked 
data was: ≥75% accumulative votes within two more favourable (retained) or least 
favourable (rejected) categories on the 4-point polling and a medium of ≤1.75. 
Further, counts and percentages, were collected to describe categorical variables 
such as participants’ characteristics and response rate.  
The researcher and supervisor met with Deakin University Biostatistician in 2019 to 
review statistical approaches to data analysis and determine whether additional 
rounds to Delphi survey Phase One would be required. An additional round to rank 
the models was not included because it risked achieving the same results and 
increase participant dropout.  
The next section reports the Delphi survey Phase One (Round Two) findings. 
5.7. Results of Delphi survey Phase One (Round Two) 
The four models identified in Round one that could describe the Australian diabetes 
practice levels required, were forwarded to participants for ranking in Delphi survey 
Phase One (Round two). Several nurses dropped out, see Table 5.2 on page 151. 
However, the sample remained representative. 
5.7.1. Consensus model to inform the capability-based framework 
Model three, the multidisciplinary focused model gained consensus as the model to 
inform the capability-based framework. Although Models one, two and three were 
similarly ranked in position one, see Table 5.3 on page 170, Model 3 was ranked as 
the second preference by half the participants.  
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Table 5.3: Ranking of practice level models by Delphi participants  




 % No. % No. % No. % No. Mean  Medium MAD No. 
Model 1 32.6% 14 23.3% 10 16.3% 7 27.9% 12 2.40 2 1.0 43 
Model 2 30.2% 13 20.9% 9 34.9% 15 14.0% 6 2.33 2 0.9 43 
Model 3 30.2% 13 48.8% 21 16.3% 7 4.7% 2 1.95 2 0.6 43 
Model 4 7.0% 3 7.0% 3 32.6% 14 53.5% 23 3.33 4 0.7 43 
 
 
Model four achieved consensus for the least preferred; Models one and two did not 
achieve consensus. One participant answered all the questions but did not fully 
complete the ranking; therefore, this individual’s responses were not included. 
The mean of Model three was the lowest at 1.95 (SD 0.81, variance 0.65) and the 
closest to the prime number one preferred polling position: however, not ≤1.75. 
Model four’s mean was the highest at 3.33 (SD 0.88, variance 0.78), and closest to the 
least preferred polling position. Models three and four had smaller SD and variances 
than the other models; these findings suggested there was more congruency in the 
results and positioning. 
An accumulated ranking of Model three reached 79% (n=34) when preferred 
positions one and two were combined, see Figure 5.5. Similarly, Model 4 
accumulative ranking reached 86.1% (n=37) when the least preferred positions of 
three and four were combined. Models 1 and 2 did not achieve 75% or more within 
the accumulative results of the two more preferred versus the two least preferred 
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A. Delphi participants’ explanations for choosing their preferred model  
Many participants indicated that Model three was more inclusive of multiple 
disciplines. Many participants indicated that the model’s characteristics, such as the 
different levels of knowledge associated with the different roles alongside different 
work settings were important. Finally, several participants suggested that Model 
three was more transferable across the whole healthcare system. For example, one 
CDE primary carer RN suggested:  
[Model 3] encompasses other disciplines and holds a logical format without being 
exclusive, therefore, being applicable in both metro and remote areas.  
Other participants suggested that recognising the development of various diabetes 
educator roles was important. One participant described: 
[Model three] is an inclusive model and recognises the value of the range of CDE 
eligible professions. Model three also highlights the various specialist areas of 
diabetes educator practice. (Academic, podiatrist, CDE). 
Participants who chose Model three suggested that it recognised that many HCPs had 
a role in diabetes education and care, which was considered important. However, 
some feedback suggested a lack of shared understanding. One participant said: 
I think Model three best describes what happens in practice, but my only concern is 
the comment is that a specialist CDE (paediatrics) would be downloading CGM 
routinely and I think that this technology will be used widely; also, insulin adjustment 
would be happening routinely ... so, I question the need for the final category [Level 7: 
Advanced Management CDE or Nurse Practitioner]. (RN CDE, tertiary and academic) 
The comment suggests the participant may consider the CDE, nurse practitioner and 
a future non-medical prescriber role interchangeable. The comment may also 
suggest a lack of understanding of the scope of a NP role.  
The main reasons participants indicated that they did not choose Model three were 
because it did not include the Aboriginal and Torres Strait Islander health 
practitioner or healthcare assistant roles. Often, these participants chose Model 
two as their preferred option.  
A few participants indicated that diabetes education should only include those with 
AHPRA registration. These participants chose Model two as their preferred option. 
Three nursing participants (7%) indicated that diabetes care was best suited to the 
nursing field. When explaining why they selected the nursing-focused model, their 
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feedback included the nurse’s intrinsic knowledge and skills about pathophysiology, 
assessment, medicines and connecting with the consumer. One participant said: 
As a Diabetes Educator, you need a nursing background to gain fundamental 
knowledge of anatomy and physiology. Also, you gain and have knowledge of 
medication used to treat various illnesses, health conditions and complaints. You 
learn and gain assessment and treatment skills from a holistic approach that are 
not taught or gained with other allied health professions such as podiatry, 
dietetics or pharmacy with a narrower focus during their training or work 
placement. It is imperative that people providing diabetes assessment, education 
and care have these skills and knowledge, and nurses are best placed to provide 
this. (CDE, tertiary RN) 
Participant responses did not list other skills such as nutrition, communication or 
education skills. However, several participants indicated that undergraduate 
training better prepared nurses for clinical assessment and management. One 
participant indicated: 
I have answered these questions with an RN in mind. I am not in a position to state 
what an AHP would be expected to do as they don’t undertake the same level of 
clinical assessment or clinical management in their training. (CDE, tertiary RN) 
Five participants (11%) indicated that Model one was more inclusive because it 
identified a career pathway and provided clarity and direction for nurses. 
Participants who ranked Model two, the Australian Health Practitioner Regulation 
Agency (AHPRA) focused model as their preference indicated it would best meet the 
healthcare needs of Australians living with diabetes. Two indicated that independent 
national regulation assured better healthcare, e.g. one participant stated: 
AHPRA registrations reassures there is professional oversight and accountability 
within the profession. (CDE, tertiary RN) 
Some participants found Model two more suitable because it included more health 
providers within the healthcare system. Several participants indicated that they 
preferred the AHPRA-focused Model two because it included those not registered 
through AHPRA and drew attention to the difference. One tertiary RN CDE 
recorded: 
[Model two is] the most inclusive model and includes at its basic level, a vast 
number of workers who care for people with diabetes as an adjunct to their 
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primary care of people, e.g. carers and patient care assistants, who require basic 
diabetes training to assist the person/people with diabetes they are caring for. 
Despite many participants choosing Model one and two, most discussed Model 
three favourably, even when they did not choose it as their preferred model to 
inform the framework. Model three was chosen on consensus as the specific HCP 
diabetes practice levels to inform the capability-based framework. 
5.7.2. Healthcare provider diabetes practice levels 
Seven HCP diabetes practice levels signifying a progressive change in the level of skills 
or knowledge required by the healthcare provider to deliver safe quality care were 
identified. Diabetes practice and clinical competence levels were cross-checked with 
the Expert Advisory Group (EAG). The diabetes practice levels are listed as tiers and 
illustrated in Figure 5.6. 
The practice levels start at a foundational level, which requires healthcare providers 
have a broad and fundamental understanding of many health conditions, including 
diabetes. At the other end of the spectrum, healthcare providers work as 
autonomous practitioners at an advanced level of practice with narrow but 
specialised expertise in diabetes care.  
 
              
Figure 5.6: Healthcare professional practice levels to deliver diabetes care 
Tier 1
• Assistant in Nursing, Personal Care Assistant, Allied Health Assistant, Aged Care 
Worker, Health Care Assistant, Aboriginal and Torres Strait Islander Health Worker 
Tier 2
• Generalist Nurse, Generalist Allied HCP, MidwifePT, Enrolled Nurse, Aboriginal 
and Torres Strait Islander Health Practitioner 
Tier 3
• Primary Healthcare NursePT, primary healthcare Allied HCP or Pharmacist, 
Community Nurse or Practice Nurse, or Midwife
Tier 4
• Diabetes Educator (Nurse or Allied HCP) or Diabetes Aboriginal and Torres Strait 
Islander Health PractitionerPT
Tier 5
• Credentialled Diabetes EducatorTM [Novice-Experienced] - Nurse, Midwife, 
Pharmacist or Allied HCP
Tier 6
• Specialist Credentialled Diabetes Educator [Expert] - Nurse, Midwife, Pharmacist 
or Allied HCP
Tier 7
• Advanced Management Credentialled Diabetes Educator [Non-medical prescriber 
or Prescriber in Partnership] or Nurse PractitionerPT
Chapter 5: STAGE II – Delphi survey phases 
174 
 
Diabetes practice levels one to three focused on awareness and supportive roles in 
diabetes care, whereas practice levels four through to seven were diabetes-specific 
roles. All positions were regarded essential and complementary to safe, quality 
diabetes care in the Australian healthcare context. Practice levels were associated 
with a minimum level of diabetes clinical competence and are discussed next. 
5.7.3. Seven stages of diabetes clinical competence 
Participants used a range of words to describe the differences between each diabetes 
practice level and the minimum levels of clinical competence in diabetes education and 
care within each practice level. These words were examined through content analysis 
for repetition, synonyms and words describing an increase in competence to ascertain 
the level of diabetes clinical competence needed for each practice level identified. The 
stages of diabetes clinical competence were derived from participants’ feedback using 
the terms they used to explain individual HCP roles in different settings.  
Stages of diabetes clinical competence are related to the HCP practice levels (tier) 
illustrated in Figure 5.7 and set a minimum expected standard for diabetes 
education and care. 
 
 
Delphi participants’ and the EAG’s feedback suggested that a generalist HCP could 
be experienced and have extensive clinical skills. However, HCPs strengthen their 
diabetes knowledge and skills as their experience managing diabetes and access to 
diabetes mentors and specialists increases. Therefore, some HCP’s level of diabetes 
clinical competence may not meet that required within their practice level to 
provide care considering all diabetes consumer needs and nuances. Simultaneously, 
an individual, generalist HCP, may have more in-depth diabetes-related capabilities 
than the minimum expected level due to their interest or professional development 
accessed. Therefore, they could meet capability statements within their role’s 

















Figure 5.7: Stages of diabetes clinical competence associated with each 
diabetes practice level 
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As the diabetes practice levels increase from one to seven, HCP roles listed signify an 
increase in the quantity of and complexity of people with diabetes managed and a 
need for a more in-depth understanding of diabetes education and care. Participants’ 
and the EAG’s feedback suggested that stages of diabetes clinical competence move 
from a foundational level where routine tasks are completed under supervision and 
direction, to increasing autonomy and shared decision-making, to mastery of 
decision-making in complex diabetes cases using intuition and experience. That is, 
reflexivity, instinctively reflecting on their actions to become self-aware and engaging 
in continuous quality improvement to improve practice or services. 
Participants and the EAG feedback suggested that a HCP who moves from one level to 
another, for example, a practice nurse working towards becoming a CDE, should 
already meet the capability statements in all the practice levels below level five. Figure 
5.7 on page 174, depicts the transition between the stage of clinical competence 
required to provide diabetes care and education related to each practice level.  
Through the content analysis of participants’ information and EAG’s feedback, the 
seven stages of diabetes clinical competence were defined as follows: 
• Foundational level (Practice level 1): the individual who works at a 
foundational level provides care to a wide variety of consumers with a broad 
range of medical conditions. They have some basic knowledge and skills to 
support diabetes care under close supervision to deliver or perform routine 
tasks and procedures.  
• Practised level (Practice level 2): the HCP who works at a practised level 
provides care to varied consumer groups and a broad range of conditions. The 
generalist HCP with a broad scope of practice is involved in aspects of diabetes 
care and has basic diabetes care skills.  
• Experienced level (Practice level 3): the HCP who works at an experienced level 
provides care to a broad consumer group with complex healthcare needs and a 
broad range of conditions. The experienced generalist HCP has gained more 
focused involvement to deliver aspects of diabetes care and has started to work 
towards developing competencies in diabetes over several years. 
• Proficient level (Practice level 4): the HCP who works at a proficient level 
provides diabetes care to a varied consumer group with a limited range of 
medical conditions, primarily diabetes. Their scope of practice is narrowing, and 
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they use advanced skills to promote shared decision-making with people living 
with diabetes. 
• Advanced level (Practice level 5): the HCP who works at an advanced level has 
advanced competencies in diabetes care. They extend and develop their 
competence through mentoring and extensive experience in the speciality area 
of diabetes. Their scope of practice is focused on diabetes and they see people 
with many types of diabetes: a varied and broad consumer group with diabetes.  
• Expert level (Practice level 6): the advanced practice HCP who works at an 
expert level to provide care to a specific diabetes consumer group, e.g. 
paediatrics or pregnancy. The HCP has highly advanced practice and focuses on 
a speciality area in diabetes. Their scope of practice and diabetes consumer 
group are narrow focused on their speciality. 
• Master level (Practice level 7): the Master HCP uses intuitive reflectivity in 
complex care and has mastered many health and diabetes care elements. They 
have a broad set of advanced practice assessment and clinical skills to 
complement a narrow scope of practice. They identify and utilise expertise for 
specific complex consumer cases and work within a defined scope of practice 
and consumer group. 
The next section lists the participant response rate for each Delphi round 
throughout the Delphi survey. 
5.7.4. The response rate for each Delphi questionnaire 
The experts were highly involved in completing each Delphi round questionnaire. 
The Delphi survey maintained a response rate of over 70% throughout the study, 
which Hasson and Keeney (2011) indicated supports research rigour, see Figure 5.8 
on page 177. 
Flanagan et al. (2016) explained that the Delphi study only commences once 
participants qualify as an ‘expert’ and the first round is disseminated to those who 
agreed to take part. Therefore, the figure of fifty instead of fifty-seven was carried 
forward to determine response and dropout rates.  
 

















Figure 5.8: Delphi survey response rate 
An examination of the characteristics of those who did not complete the survey 
revealed five of the ten nurses who dropped out, worked in private practice. They 
did not overly represent other characteristics of interest such as higher education, 
area of remoteness or years of experience.  
Participants who were not a Credentialled Diabetes Educator (CDE) also explained 
why they had not pursued the status. Of the seven (14%) not credentialled; four 
indicated that they were in the process of undertaking credentialling and the 
remainder reported challenges gaining adequate practice hours to meet the 
credentialing criteria, despite having completed a postgraduate degree in diabetes. 
5.8. Expert advisory group recommendations 
After completing the Delphi survey Phase One the EAG reviewed Model 3 and the 
feedback, and several decision points and iterations were made. The initial version of 
the model presented to the EAG had eight practice levels, see Model 3 in Figure 5.4 
on page 154. A health assistant practice level was added to the beginning of the 
model because participants’ feedback indicated that the absence of these roles was 
why they did not rank Model 3 as their preferred option.  
Round 1  
57 participants invited 
52 started the survey  
• 41 completed the survey 
• 6 partially completed the survey 
including Delphi questions 
• 2 only consented and answered 
several demographic questions* 
• 3 did not complete all the research 
questions 
• 5 did not start the survey 
50/57 (88%) 
 
Round 1  
48 participants invited 
40 started the survey  
• 36 completed the survey 
• 4 partially completed the survey  
• 2 opted out 




Round 2  
46 participants invited 
37 started the survey  
• 36 completed the survey 
• 1 partially completed the survey  
• 2 opted out 




Round 2  
48 participants invited 
44 started the survey  
• 41 completed the survey 
• 3 partially completed the survey  
• 3 opted out  
• 1 overseas 
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The EAG considered capability statements that were merging and provided the 
following feedback once listed against the then eight practice levels: 
(1) The number of practice levels may not be manageable concerning 
implementing the capability-based framework and its influence.  
(2) To add the non-diabetes trained Aboriginal and Torres Strait Islander health 
practitioner to diabetes practice level, including health assistants. 
(3) To amalgamate the practice nurse, community nurse and Aboriginal and 
Torres Strait Islander diabetes health practitioner roles because there was 
little difference in the capability statements. 
(4) To split practice level 5 into [A] and [B] to acknowledge the three ADEA CDE 
levels (novice, advanced and expert); the expert CDE to be captured in 
practice level 6. 
(5) To add the midwife role because it was absent in the model compared to 
other models. 
(6) Recommended that the advanced management CDE not be defined, as a 
title may evolve because the role did not currently exist within the 
Australian healthcare system.  
(7) Improved terms were required to describe medicine management, given 
that the participants’ feedback often related to the HCP’s roles in medicines 
management in this field. 
(8) To include the certificate IV Aboriginal and Torres Strait Islander health 
practitioner in diabetes practice level two, as they are often medication 
endorsed and move the diabetes-specific role from practice levels three to 
four to prevent impediment to practice in medicines management and to 
ensure adequate diabetes skills development.  
5.8.1. Finalising the model to inform the framework 
The model to inform the ‘Capability Framework’ was finalised by adding the 
relevant stage of diabetes clinical competence to each diabetes practice level. In 
February 2019, participants were sent an email, see Appendix 10 on page 321, 
summarising the process to date and the decision to move forward with Model 3 
for the framework. The email concluded Delphi survey Phase One; subsequently, the 
researcher moved into Phase Two.  
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Delphi survey Phase Two focused on identifying the capability areas required to 
deliver diabetes care and their associated capability statements that inform each 
diabetes practice level. Phase Two commenced with the content analysis of the 
basic and advanced skills, knowledge and attributes information that was carried 
over. The next section discusses the Delphi survey Phase Two and its outcomes.  
5.9. Stage II: Delphi survey Phase Two 
The purpose of Delphi survey Phase Two was to finalise the framework: to identify 
the essential capabilities required to deliver diabetes education and care and gain 
consensus about the specific capability statements for each diabetes practice level 
that participants identified in Phase One.  
 
Stage II-Phase Two included three data management or collection activities, including: 
• A data analysis and review period: to identify essential capabilities required 
to deliver diabetes education and care and allocate relevant capability 
statements to agreed diabetes practice levels for ranking. Further, to 
identify the attributes that underpin the capabilities identified. 
• Round one Delphi survey questionnaire: to enable ranking of capability 
statements and to add omissions.  
• Round two Delphi survey questionnaire: to enable ranking of capability 
statements that had not reached consensus and finalise the ‘Capability 
Framework’ in preparation for Stage III, the post-Delphi appraisal period. 
5.9.1. Analysis of data to identify capabilities and statements 
The preliminary data analysis for Delphi survey Phase Two took place from 
November 2018 to May 2019 and concerned analysis of the basic and advanced 
knowledge, skills and attributes identified in Delphi survey Phase One for diabetes 
care and medicine management. The EAG supported constant peer debriefing and 
appraisal between rounds; its members roles are listed in Table 3.3 on page 112.  
The EAG was instrumental in minimising researcher bias and applying Delphi 
panellists’ ‘words’. Consensus meetings occurred regularly between the researcher, 
supervisors and the EAG, who met on four occasions before administering Delphi 
survey Phase Two (Round one), see Table 5.1. on page 147. Further peer debriefing 
and cross-coding occurred between the meetings via email as required until 
consensus was reached. 
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Content analysis followed the same pattern as shown in Figure 4.1 on page 119. It 
was helpful to assimilate broadly related information into groups due to the sheer 
volume of written data to identify essential capabilities: sentences from 
participants’ responses that concerned different aspects of care. These were 
reviewed against word clouds as these provided overarching terms for these major 
categories, e.g. DSME, medicine or counselling. Once essential capabilities were 
reviewed for suitability and gained consensus via consensus meetings, then data 
was split into basic and advanced skills and analysed separately. 
Next, the lists of data under each major category were coded into sub-categories, 
which identified relevant statements for each capability. These related to similar 
concepts and used the ‘words’ Delphi experts provided. When relevant, sub-
categories were merged or moved between a major category due to the capability 
statement’s focus. Statements derived from respondents’ ‘basic’ information were 
allocated to practice levels one to three, and ‘advanced’ information to practice 
levels four to seven.  
The EAG reviewed the capability statements and their performance cues, i.e. 
examples of how these capabilities might be demonstrated. The EAG identified 
duplicate statements and omissions. Finally, the researcher, supervisors and the 
EAG reviewed the final statements for completeness and comprehension. 
The data was also scrutinised for attributes listed and words relating to attributes, 
which participants had included in their responses about skills. Again, these were 
managed by developing sub-categories, which were merged into major categories. 
The EAG also advised changes to the model that reached consensus within Stage II 
to refine the practice levels due to similarity of capability statements required or 
potential for impeding practice. The findings are combined and are discussed in 
Section 5.11 and sub-sections with those from Round One, which is discussed next. 
5.10. Delphi survey Phase Two (Round One) 
The rationale for Round one was to begin the consensus process to determine the 
relevant capability statements for each practice level identified. Participants were 
presented with the capability statements identified from the content to initiate 
ranking. The following sections describe the sample and process used to gain 
consensus, the findings of Round One and conclude with a summary. 
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5.10.1. Process for Delphi survey Phase Two (Round One) 
Delphi survey Phase Two (Round One) was available for four weeks. The survey was 
disseminated and managed via the web-based survey platform as described in 
Phase One. The survey was presented to the panel members in levels representing 
each diabetes practice level. Each level had a list of between two to 16 statements 
listed under the capability identified to deliver diabetes education and care. 
Participants were asked to rank the importance of each statement listed under each 
diabetes practice level; see the introduction in Appendix 11 on page 323. The 
ranking used a Likert scale with five choices including: 
1. Not important. 
2. Little important. 
3. Somewhat important. 
4. Very important. 
5. Essential.  
At the end of each diabetes practice level, there was an opportunity to provide 
feedback and suggest additional items for consideration in the next round. On closing 
the survey, the researcher then began analysis to determine levels of agreement. 
A. Delphi panel members 
Delphi participants were invited to complete Phase Two and the two Delphi survey 
rounds unless they indicated a desire to withdraw from the study. Participants 
implied consent by continuing the survey; ten nurses had dropped out or withdrew. 
However, the Delphi panel remained representative of various disciplines, all areas 
of Australia, remoteness and different work settings, see Table 5.2 on page 151.  
B. Delphi questionnaire content 
Two hundred and eighty-eight statements were listed under the relevant nine 
capabilities identified during content analysis as major categories. The information 
presented to the Delphi participants was representative of the initial draft 
capability-based framework, see Table 6.3 on pages 200 to 219.  
The following sections discuss data analysis of data collected from the current 
Delphi round. Next, the findings are shared. 
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5.10.2. Analyses of Delphi survey Phase Two (Round One) data 
A. Definition for meeting consensus 
The literature review informed the definition of consensus, which for ranked data 
was: ≥75% accumulative votes within two more favourable categories, e.g. 
‘essential/very important’ (retained) or least favourable, e.g. ‘a little important/not 
important’ (rejected) on the 5-point Likert scale and a medium of ≥3.5. 
B. Statistical analyses of ranking and demographic data 
Descriptive statistics including measures of central tendency (mean, medium, 
standard deviation [SD]) and variation, and accumulative percentage were calculated 
to describe proportions of categorical variables such as participants’ demographic 
characteristics, response rate and agreement as defined by Kaliyadan and Kulkarni 
(2019) in Stage I. Accumulative percentages of the positioning of participants 
responses on the 5-point Likert scale were more likely to demonstrate a ‘general 
agreement’ to assess consensus.  
The accumulative percentages of positions five with four and positions one with 
two on the 5-point Likert scale of importance were calculated for ranking 
statements. Statements that had an accumulative percentage of 75% or above were 
retained or rejected.  
When opinions were broad, e.g. concerning medicines capability, variances and SDs 
were affected by extremely high or low values on the 5-point Likert scale; Hutchings et 
al. (2005) suggests central tendency measures do not capture where the majority sit 
on the topic in these circumstances. Hence, the mean absolute deviation (MAD) from 
the median was calculated to measure participant disagreement and data spread; it is 
the average of absolute deviations from a central point, ignoring data outside of a 
trend (Hutchings et al., 2005).  
The level of agreement was categorised into MAD thirds (low >0.75, moderate 0.48-
0.75, high <0.48): the average distance of participants' ratings from the group's median 
rating (Hutchings et al., 2005). For items ranked according to medians; 4–5 defined 
strong, 3-3.5 moderate and 1–2.5 weak support, on the 5-point Likert scale. 
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C. Ranking and consensus of capability statements 
Following Delphi survey Phase Two (Round One), a consensus meeting was held in 
July 2019 where the EAG, researcher and supervisors reviewed the capability 
statements and all items included in the Round One questionnaire. Items that had 
achieved consensus were highlighted but not discussed further. The EAG was 
invited to discuss and recommend omitting or retaining any statement for which 
consensus had not been reached. Five capability statements that reached 74% were 
also accepted to reduce Delphi member fatigue during the next round.  
Two outcomes of the consensus meeting were to retain and share statements that 
ranked from 40% to 74% in Round Two and statements not achieving consensus at 
the end the final round would be shared and discussed with the planned Focus 
Group in Stage III. A summary was prepared for the next round, which included the 
consensus achieved, anonymous aggregated outcomes of the consensus meeting 
with the EAG and the reasoning behind decisions. 
No relevant data was written in the comments section that led to any new or 
removing any capability statements. The following section shares the results of the 
analyses periods. 
5.11. Results of Delphi survey Phase Two (Round One) 
The essential capabilities identified, and their underpinning attributes are discussed 
next. Following, the outcomes of the capability statements ranking.  
5.11.1. Capabilities required to deliver diabetes education and care 
Nine broad capabilities HCPs require to deliver diabetes education and care were 
identified and are illustrated in Figure 5.9 on page 184. Capabilities are the broad 
qualities or abilities HCPs require to support managing diabetes safely. The 
consensus process identified comprehensive assessment skills and clinical acumen, 
i.e. the knowledge and insight that allows decision-making, as the basis for the 
other capabilities to ensure quality, safe diabetes care.  
Participants listed different words to describe the basic versus advanced skills and 
knowledge needed to manage diabetes. In HCP diabetes practice levels, one to 
three, the capabilities focused on awareness and supporting diabetes care. In 
diabetes practice levels four through to seven, where the HCP roles are more 
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focused on diabetes education and care, capabilities altered to a specialised and 






Figure 5.9: Capabilities required to deliver diabetes care 
 
The EAG suggested that a HCP may not possess all the capabilities listed under their 
diabetes practice level because of their work setting. For example, a trained CDE may 
not have adequate mentoring in or exposure to diabetes technologies such as insulin 
pumps. However, when the HCP employment support, e.g. technology management, 
they are expected to exemplify statements listed below the technology capability for 
the diabetes practice level their role is currently positioned and those from preceding 
practice levels, see Table 6.3 on pages 200 to 219.  
The content analysis did not identify senior management capabilities; these were a 
minor topic listed in the data. However, capability statements do consider leadership 
within and for diabetes care. 
Technology
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Definitions for the capabilities identified from the analysis of Delphi survey feedback 
differed between the more generalist roles in diabetes care, diabetes practice levels 
1 to 3 that emphasised awareness or promotion. Compared to the more diabetes-
specific roles in diabetes education and care in diabetes practice levels, 4 to 7, 
which emphasised adept diabetes skills at an advanced level, see Table 5.4. 
 
Table 5.4: Definitions for capabilities required to deliver diabetes care 
Diabetes capabilities for practice levels one to three 
The capabilities for practice level one to three focused on awareness or promotion and are 
defined as: 
• Displays clinical assessment capacities: demonstrates foundational skills and is 
developing clinical assessment skills relevant to diabetes to assist with diagnosis 
and care and identify health status changes.  
• Supports diabetes self-management education: promotes, assists, and 
encourages self-management considering the needs, goals and life experiences of 
the person with diabetes using teaching skills and a structured decision-making 
process guided by evidence and understanding health literacy.  
• Builds therapeutic relationships: develops intentional connections focused on 
person-centeredness and shared decision-making between a healthcare 
professional and an individual requiring diabetes support; the positive relationship 
engaged for effecting a beneficial change towards an individual’s goal. 
• Communicates with influence: informs with the intention to affect behaviour 
change; to inspire, motivate, encourage, guide and advocate for people living with 
diabetes or prediabetes.  
• Supports counselling to achieve the best outcomes: uses supportive counselling 
techniques within an empowerment framework when guidance on actions is 
required and to identify mental health issues in people living with diabetes such as 
diabetes-related distress, diabetes burnout and depression. 
• Supports quality use of medicines (QUM): demonstrates QUMs in a supportive 
role and identifies potential medicine-related risks and benefits.  
• Displays quality use of diabetes technology: demonstrates a supportive role with 
individuals using diabetes technology and identifies potential risks.  
• Supports care coordination: assists in care coordination and transition as directed 
or is involved in developing and implementing a care plan for the management of 
diabetes and facilitates appropriate services in conjunction with a medical team. 
• Achieves quality: displays a supportive role within quality and research activities 
and incorporates evidence in all practice elements. 
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Table 5.4: Definitions for capabilities required to deliver diabetes care (continue) 
Diabetes capabilities for practice levels four to seven 
The capabilities for practice levels four to seven focused on diabetes healthcare 
professionals who works at an advanced practice level. They should possess adept 
diabetes skills in diabetes care and education and the capabilities are defined as: 
• Exemplifies clinical assessment capacities: advanced assessment skills and 
knowledge, clinical acumen and reflection in and on practice, to enable more 
comprehensive and individualised assessment for the person with complex 
diabetes issues and accumulative comorbidities.  
• Shapes diabetes self-management education (DSME), support and care: 
competent to design, implement, deliver and evaluate structured DSME. 
Influences the continuous development of improved diabetes care skills in 
consumers and practice to optimise DSME, support and care. Innovative and 
leads changes; promotes and develops processes to support improvement in 
health literacy. 
• Builds therapeutic relationships: adept at developing positive relationships 
between the healthcare professional and an individual requiring diabetes 
support through structured shared decision-making. Mentors others and 
incorporates evidence into local protocols, guidelines and the organisation to 
better engage with people living with diabetes and their carer’s and effect 
beneficial change.  
• Communicates with influence and leadership: proficient at communicating with 
the intention to achieve an effect: to listen, inspire, motivate and encourage 
both the consumer and other healthcare professionals. Leads with purpose and 
promotes wide-reaching advocacy for people living with diabetes.  
• Exemplifies counselling to achieve the best outcomes: adept at using 
supportive and empowering counselling techniques, and implements significant 
evidence into guidelines, protocols and the organisation. Proficient at detecting 
mental health issues early, such as diabetes-related distress, diabetes burnout 
and depression. 
• Exemplifies quality use of diabetes technology: proficient or regarded as an 
expert at teaching, operating and monitoring diabetes technology via different 
processes, i.e. providing self-management education, technology advice and 
care, and, in some cases, prescribing if the device administers a medicine.  
• Exemplifies QUMs: proficient or regarded as an expert at ensuring diabetes 
medicines are used safely when needed. Delivers comprehensive medicines 
management, including essential elements such as rigorous monitoring and de-
prescribing when indicated.  
• Leads care coordination: adeptly coordinates relevant stakeholders involved in 
the consumer’s care to deliver appropriate healthcare services promptly and 
efficiently. Aware of the specific requirements of vulnerable groups and people 
with complex diabetes issues, monitors and evaluates outcomes.  
• Cultivates quality through leadership and research: identifies, engages in, 
mentors and leads research and quality and safety improvement activities to 
identify ways to improve diabetes education and care.  
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Competence requires inherent characteristics; these health professional attributes 
are understood to support successful diabetes care delivery. 
5.11.2. Attributes underpinning diabetes capabilities 
Content analysis of participants’ responses to KSA questions in Delphi survey Phase 
One (Round one) identified three set of essential attributes that underpin the 
capabilities HCPs require to deliver safe, quality person-centred diabetes care, see 
Table 5.5.  
Table 5.5: Attributes required that underpin diabetes capabilities  
 





 Attributes to strive for 
excellence 
 
 Attributes to ensure the 
professional’s health 
and wellbeing to enable 
their adaptability to 
dynamic environments 
     
• active listener  
• caring 
• collaborative  
• compassion 
• cultural competence 
• empathy  
• inclusiveness 
• non-judgemental 
• openness  
• personable  
• willingness to learn 
from the consumer 
 • analytical  
• adaptable 
• accountability  
• confidence  
• commitment 
• creativity  
• ethical  




• life-long learner  
• open-mindedness 
• professionalism  
• reflective 
 • mindfulness 





These attributes were listed within the draft ‘Capability Framework’ in preparation 
for Stage III. They were thematically grouped into the following three categories: 
• Supporting excellent communication, collaboration and advocacy. 
• Striving for excellence. 
• Promoting the HCP’s health and wellbeing to foster their adaptability in 
dynamic environments. 
The individual attributes focus on both the HCP and their approach to consumers. It 
is hypothesised that HCPs who develop these attributes may better support the 
person living with diabetes. 
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5.11.3. Outcomes Round One questionnaire ranking 
Overall, 257 capability statements were accepted in Delphi survey Phase Two 
(Round one): see Table 6.3 on pages 200 to 219 for the statements’ ranking. All 
statements listed under practice levels four to seven reached a consensus. Five 
statements reached 74%, and they were also accepted.  
In practice level one, three capability statements were rejected, and they were 
related to supporting screening for diabetes-related complications and 
cardiovascular disease and, awareness of diabetes technologies and reporting 
problems with technology. Twenty-eight statements did not reach consensus 
derived from practice levels one to three and were neither accepted nor rejected.  
Comments under practice level one included that the framework must indicate that 
the healthcare assistants work under close supervision with guidance and direction. 
Participants were concerned that healthcare assistants might undertake activities 
better suited to a HCP. Likewise, some participant comments supported the pivotal 
roles that healthcare assistants play in the healthcare system and, that some work 
environments were highly reliant on them, e.g. residential-aged-care. 
MAD of medium (MADM) was calculated to identify the strength of disagreement 
for individual ranking scores, see Table 6.3 on page 200. The strength of agreement 
was high, i.e. MADM <48, for most capability statements in practice levels four to 
seven; the diabetes-specific roles. However, there was more disagreement related 
to capability statements for practice levels one to three, specifically in the following 
capabilities: clinical assessment capacities, DSME, counselling, technology and 
QUM, where the strength of agreement was low, i.e. MADM >75, see Table 5.6. 
Table 5.6: MAD of medium for statements under capabilities  
 CAPABILITY Tier 1 Tier 2 Tier 3 Tier 4 Tier 5 Tier 6 Tier 7 
Assessment         
DSME        
Relationships        
Communication        
Counselling        
QUM        
Technology         
Coordination         
Quality/Research         
Colour ledger for level of agreement: High-moderate   Moderate   Moderate-low   Low   Variable 
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5.12. Delphi survey Phase Two (Round Two) 
The rationale for Round two was to rank capability statements, which had not 
achieved consensus. The activity resulted in a draft Capability Framework for 
Diabetes Care: A guide to practice, ‘Capability Framework’. It included the essential 
capabilities and their statements, and the relevant attributes that underpinned the 
capability that the workforce requires, see Section 5.11.2 on page 187 and Table 6.3 
on pages 200 to 219. 
5.12.1. Process for Delphi survey Phase Two (Round Two) 
Delphi survey Phase Two (Round Two), the final Delphi survey round, opened for four-
weeks. The questionnaire was distributed via email to the remaining panel members 
who had not withdrawn via the web-based survey platform. Participants were asked 
to rank the importance of each of the remaining capability statements using the 
same process as Round one.  
It was estimated that the survey would take up to 15 minutes to complete. Due to the 
number of statements in Round One and the use of the survey platform’s ‘anonymise 
response’ feature, it was impossible to maintain records of individual responses and 
show individual participants their score from the previous round.  
A. Delphi sample  
Round Two questionnaire was forward to the Delphi participants that had 
completed Round One. Consent was implied by commencing the survey and 
participant characteristics can be seen in Table 5.2 on page 151, which remained 
representative. Further, the response rate remained high, see Figure 5.8, page 177. 
B. Delphi questionnaire content 
Phase Two (Round Two), the fourth and final Delphi survey round, presented the 
Delphi panel members with the 28 capability statements that had not reached 
consensus from practice level one to three. They were presented under their 
relevant capability and diabetes practice level, which included practice level 
descriptors, as occurred within the previous round. An aggregated summary of 
responses and consensus introduced the survey to the Delphi panel members. 
The ranking percentages achieved for capability statements in the previous round 
were not shown because the information could influence participants’, i.e. force a 
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‘middle road’. However, a question was included at the end of each diabetes 
practice level to better understand decision-making, see Figure 5.10.  
 
 
Given concerns raised about healthcare assistants in diabetes practice level 1 
undertaking activities beyond their SoP, several performance cues to demonstrate 
how the capability might be demonstrated were provided to each capability 
statement in Round two to understand the statement better. 
5.12.2. Analysis of Delphi survey Phase Two (Round Two) data 
When Round Two concluded, the results were reviewed for those capability 
statements that achieved consensus using the same criteria as Round One. The 
measure of central tendency and MAD of medium were calculated to identify the 
strength of disagreement for each capability statement, see Table 6.3 on pages 200 
to 219. Those that did not reach consensus were carried over for discussion with 
the focus group as part of the stakeholder appraisal. Delphi survey Phase Two 
(Round Two), the final round, completed the Delphi survey and Stage II. 
5.12.3. Results of Delphi survey Phase Two (Round Two) 
Nurses were those who dropped out or withdrew; all AHP participants involved in 
the Delphi survey completed both Delphi phases and all four rounds. Six capability 
statements gained consensus; four were accepted and one rejected. Following 
MADM calculations, one was removed from the list based on the strength of 
disagreement. The last 22 capability statements did not reach consensus and were 
carried over to the focus group discussions conducted in Stage III.  
In response to the reason for changes within ranking from Round two compared to 
Round one, around half indicated that it was not applicable as they did not alter 
Figure 5.10: Additional question added to Delphi Phase Two (Round Two) 
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their response. Fifty-eight to sixty-four percent indicated the behavioural indicators 
improved their understanding and one third indicated that the behavioural 
indicators made them more concerned regarding practice level one and two, see 
Table 5.7. In contrast, participants showed less concern with their change/s in 
practice level three. 
It is unclear why no participant had undertaken personal research to support 
decision-making. It is possible that the participants felt they had already committed 
significant time to the study. Although it is possible the participants felt they were 
part of the research and contributing significantly, given the level of engagement 
was higher.  
 
Table 5.7: Reasons participants provided for altering their initial ranking 
 TIER 1 TIER 2 TIER 3 
 % n % n % n 
The behavioural indicators improved my 
understanding 
64% 14 58% 11 86% 18 
My own research on the topic 0% 0 0% 0 0% 0 
The summary of other participants comments in the 
survey introduction changed my thinking on the topic 
5% 1 5% 1 0% 0 
The behavioural indicators made me more concerned 
about inherent risk to the person living with diabetes 
32% 7 37% 7 14% 3 
Sub-TOTAL  22  19  21 
Marked not applicable   17  20  18 
TOTAL  39  39  39 
 
5.13. Summary of Delphi survey  
The Delphi survey was completed by August 2019; each round lasted four to six 
weeks. The Delphi survey included two phases, each with two sequential rounds. 
Delphi panel member participation was high and maintained throughout the four 
Delphi rounds. The information gathered from Stage I and Stage II informed the 
draft Capability Framework for Diabetes Care: A guide to practice, the ‘Capability 
Framework’, developed by consensus. Once the Delphi survey was completed and 
the draft prepared, Stage III of the Delphi technique commenced. Stage III included 
an appraisal of the framework by stakeholders, including a focus group of diabetes 
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experts and a selection of health profession regulatory and training organisations to 
finalise the ‘Capability Framework’. 
5.14. Chapter summary 
In summary, Delphi survey Phase One revealed that the preferred model to describe 
the practice levels in the Australian healthcare context, which signify a change in 
the level of knowledge or skills HCPs require to deliver diabetes education and care, 
was multidisciplinary in focus.  
The model included seven diabetes practice levels in total, which altered from assistant 
healthcare roles to generalist HCPs to diabetes-specific diabetes roles. Participants 
suggested the multidisciplinary model was more transferable across the healthcare 
system and showed support for knowledge and skills transfer to different HCPs.  
Delphi survey Phase One also revealed a lack of shared understanding and 
incongruences existed for the terms ‘medicine management’ and ‘non-medical 
prescribing’, despite diabetes HCPs high level of involvement in managing medicines. 
HCPs are involved in medicine management in several ways that promote healthcare 
and access; however, terminology such as administration, prescribing and advice by 
HCPs are used interchangeably.  
Delphi survey Phase Two revealed nine essential capabilities HCPs require to deliver 
diabetes education and care. These include capabilities in clinical assessment, 
DSME, building therapeutic relationships, quality use of medicines and diabetes 
technology, care coordination and quality or research. Delphi survey Phase Two also 
developed consensus for two to 16 essential capability statements belonging to 
each capability.   
Delphi survey Phase Two also revealed that HCPs require attributes in three 
essential categories that underpin the capabilities and supported: excellent 
communication, collaboration and advocacy; striving for HCPs’ excellence and 
adaptability. 
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Chapter 6: STAGE III – Post-Delphi survey stakeholder 
appraisal 
6.1. Chapter introduction 
In Stage III, the post-Delphi survey period, the researcher consulted with two 
stakeholder groups to validate the findings from Stage II. Explicitly, the stakeholder 
consultation was undertaken to have an independent appraisal and understand 
whether the results and information gathered were well-grounded and transferable 
to the ‘real world’. It provided an opportunity to identify any issues that potentially 
impacted the applicability of the draft ‘Capability Framework’ and those impeding 
practice or not supporting safe care. Also, the researcher sought to determine how 
the draft ‘Capability Framework’ addressed the strategies of the Australian National 
Diabetes Strategy 2016-2020 (ANDS).  
6.1.1. Research questions guiding Stage III 
1. Is the identified ‘Capability Framework’ practical and how can it be used? 
2. Does the identified ‘Capability Framework’ impede practice or safe care? 
3. Does the ‘Capability Framework’ support adaptive and flexible diabetes 
healthcare to address the ANDS strategies? 
Two activities were undertaken to answer these questions, appraisals of the draft 
‘Capability Framework’ by: 
1. A focus group with expert CDEs to determine the practicality and utility of 
the framework. 
2. A survey of health profession regulatory and training organisations to 
determine whether any item in the framework impeded or affected safe 
practice and supported developing a competent and adaptive workforce for 
diabetes care. 
This chapter describes the two data activities in detail. It starts with information 
about the focus group, including a rationale for its use as a data collection method. 
Next, information about how the sample size for the group was estimated and the 
strategies adopted to recruit participants follows. Thereafter, the chapter describes 
the procedures involved in collecting and analysing data from the focus group, 
followed by the findings from the activity. Last, a description of the survey of 
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selective health profession regulatory and training organisations’ follows, including 
information about recruitment, the data collection and analysis methods, and the 
results. The final results from Stage III completed the ‘Capability Framework’ and 
finalised diabetes practice levels. The Capability Framework for Diabetes Care, 
which reached consensus, is shared in the chapter in Table 6.3 on pages 200 to 219 ; 
the capabilities guided by the attributes were shared in Chapter 5, see Table 5.5 on 
page 187. 
6.2. Focus Group appraisal of the draft ‘Capability 
Framework’  
In Stage III, a focus group followed the Delphi survey. The purpose of the focus 
group discussion was to identify: 
• The usefulness of the ‘Capability Framework’ and any unhelpful aspects. 
• The practicality of the ‘Capability Framework’ to support professional 
development and HCP training curricula in diabetes. 
Thus, it assessed the draft ‘Capability Framework’ regarding content, usability, 
relevance and soundness. The focus group also created an opportunity for peer 
debriefing with peers not involved in the study.  
6.2.1. Rationale for the focus group 
Focus groups are a standard method of collecting data in qualitative health 
research, particularly to determine competencies (Fouche et al., 2014). Focus 
groups are a form of consultation and communication among research participants 
and researchers to produce data, widely used to generate new concepts and ideas 
(Stanford, 2016). They enable the research to explore the reasoning and 
motivations behind individual participant’s comments.  
As Webb and Kevern (2001) described the focus group as a research method 
allowed the outcome, the ‘Capability Framework’, to be assessed to identify any 
limitations or gaps against the study’s aim and objectives; it was appraised for its 
completeness and practicality. Gill et al. (2008) suggest the focus group enables a 
divergence of ideas that develop through participant interactions managed by the 
researcher using a moderator.  
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6.2.2. Sample size for the focus group 
A sample size of between three to seven was agreed to allow the opinions of 
different disciplines to emerge from the discussion. Evidence informed the sample 
size for the focus group, which suggests nominal group research uses groups of 
between two and fourteen participants for brainstorming to identify problems, 
generate solutions and finalise decisions. However, a maximum of seven is 
recommended because larger group communication is more monologue and the 
dominant speaker influences participants (McMillan et al., 2016). 
Lowry et al. (2006) observed the impact of two small group sizes, three and six 
participants, on social presence on small group communication. They found smaller 
groups maintained higher levels of communication quality, recommending between 
four to six participants (Lowry et al., 2006). Suitable moderator selection was 
essential to encourage a conducive environment and manage dominant voices.  
A. Focus group recruitment  
The 2019 Australasian Diabetes Congress organising committee advertised the 
focus group to conference registrants via direct email on two occasions in mid- 
2019, see Appendix 12 on page 325. Also, the ADEA advertised the focus group 
through their fortnightly email to members in July 2019.  
A maximum of 12 places was advertised to allow for attrition. Individuals who 
responded to the Survey Monkey who met the study’s inclusion criteria were 
emailed information regarding the focus groups, i.e. a Plain Language Statement 
that included a consent form, and meeting details and venue map.  
6.2.3. Focus group process  
The focus group used a semi-structured format, given that Webb and Kevern (2001) 
suggest that responses can be explored more with less structure. An independent 
managed it because Gill et al. (2008) indicated this would reduce the researcher’s 
preconceived ideas or theories influencing participants.  
The exact process was used for conducting the focus group as the pre-Delphi 
Consultation group. Before the focus group, the researcher and moderator met to 
review the ‘Moderator Instructions’ protocol and answer any questions. The 
moderator was an academic who had performed focus groups and was familiar with 
the methodology. The moderator did not influence the study design: however, she 
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had extensive experience in diabetes education and research and was the course 
coordinator of a postgraduate diabetes course.  
After completing consent forms, the audiotaped focus group started with the 
researcher providing the participants with a rationale for: 
• Developing capabilities and a framework in diabetes for the Australian 
health workforce. 
• The Delphi technique used for the study to date. 
Also, an overview of emergent findings was shared, then the moderator facilitated 
the forum.  
The participants were provided with a document titled draft Capability Framework 
for Diabetes Care, the ‘Capability Framework’, which presented: 
• An introduction to the framework and summary of research methods. 
• Seven stages of diabetes clinical competence and their definition, inclusive of 
Section 5.7.3 on pages 174 to 176 and Figure 5.7 on page 174. 
• Nine diabetes education and care capabilities and their definition, inclusive of 
Section 5.11.1 and Table 5.4 on pages 183 to 186 and Figure 5.9 on page 184. 
• The attributes underpinning the capabilities and diabetes healthcare, 
inclusive of Section 5.11.2 and Table 5.5 on page 187. 
• Healthcare provider diabetes practice levels and a draft framework including 
the relevant statements listed under each capability within the practice 
level, inclusive of Tables 6.2 and 6.3 on page 200 and Figure 5.6 on page 173.  
• A two-page summary of diabetes-related medicine management in Australia 
and the need for consistency in practice from Section 2.9 on pages 75 to 80. 
Participants had 30 minutes to read the draft ‘Capability Framework’ and were 
encouraged to focus on its structure and definitions of critical concepts. The 
moderator then asked an opening question to start the conversation, followed by 
the five focused questions, see Table 6.1 on page 197. 
Afterwards, the focus group participants were invited to review and discuss the final 
22 capability statements that did not reach consensus after the Delphi survey 
rounds (Stage II) to determine whether to include or remove the final statements. 
The statements were added or removed from the ‘Capability Framework’ upon 
focus group participants consensus.  
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Table 6.1: Focus group questions 
Introductory 
Questions: 





• What is something right or useful about the draft ‘Capability 
Framework’ to support safe diabetes care? 
• What do you see as unhelpful or that may create barriers to practice 
about the Capability Framework? 
• Do you think the draft ‘Capability Framework’ may influence or 
support the health workforce for diabetes care?  
• The draft ‘Capability Framework’ could be used for national curricula 
development in diabetes care in Australia. If it was, do you think it 
will better prepare healthcare professionals for safe, adaptive and 
flexible diabetes healthcare? 
Exit 
Question: 




• Some competencies did not achieve consensus because their ranking 
was quite variable. Of those listed, which have not reached 
consensus, do you believe any may impede practice if not included? 
 
After the focus group, the researcher and moderator discussed the primary findings 
to determine whether another focus group was required. Given the discussion with 
the moderator and research team and the evidence, it was determined that an extra 
focus group would not be required because there had been high-quality discussion. 
6.2.4. Analyses of focus group data 
The audiotape was transcribed verbatim. The transcript of the focus group 
discussion was analysed to identify patterns that were made into categories; the 
method used was discussed in Chapter 4; see Figure 4.1 on page 119. The three 
researchers reviewed the transcript and coding to develop a consensus of issues. 
During analysis, the researcher considered the following four elements described by 
Young et al. (2015) that could support SoP expansion:  
• Patient-centred care 
• Quality and safety 
• Cost-effective services 
• Collaborative care  
Following transcript analysis, which identified how the ‘Capability Framework’ could 
be used and issues impacting practicality, relevant alterations were made to the 
framework according to the findings.  
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6.3. Results from the focus group 
The following section presents the focus group results in three sections; participant 
characteristics, findings to inform the framework, workforce or policy.  
6.3.1. Participants’ characteristics 
Four expert diabetes educators participated in the focus group: two nurses, a dietitian 
and pharmacist from different work settings. Participant characteristics are shown in 
Table 5.2. on page 151.  
6.3.2. Findings to inform the framework 
A. Guiding information about the framework for the introduction 
Focus group participants were invited to discuss the draft ‘Capability Framework’ 
practicality: its usefulness, soundness and applicability. There was agreement within 
the group that the framework should acknowledge or consider:  
• All healthcare providers have roles supporting people to live better with 
diabetes because diabetes education and care are collaborative, 
multidisciplinary activities.  
• The ‘Capability Framework’ is unique in that it recognises many of the 
healthcare providers contributing to diabetes education and care. 
• The HCP roles listed are not exhaustive and not all healthcare providers will 
engage in educational activities concerning diabetes.  
• Advanced practice generalist HCPs require a minimum level of diabetes skills 
and knowledge to support diabetes care. 
• The ‘Capability Framework’ was not a job description but a platform to guide 
training to better care for people living with diabetes. 
• Course coordinators could better prepare the healthcare workforce for the 
future healthcare needs of people living with diabetes.  
• Pharmacy assistants should be added to practice level one, given their 
increasing role in assisting people with diabetes. 
Once the EAG appraised the focus group findings, the final version of the practice 
levels that informed the ‘Capability Framework’ was finalised by consensus. The final 
agreed healthcare provider diabetes practice levels aligned with their level of diabetes 
clinical competence are shared in Table 6.2 on page 199. 
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Table 6.2: Minimum level of clinical competence in diabetes care required by roles 
Practice 
Level  1 
Practice 
Level  2 
Practice 
Level  3 
Practice 
Level  4 
Practice 
Level  5 
Practice 
Level  6 
Practice 
Level  7 
       
Foundational 








Bachelor degree ± PGC  
Certificate IV + PGC 
Advanced 
Bachelor degree + PGC 
Expert 
Bachelor degree + PGD 
Master 
Bachelor degree + PGD 
± Masters 
Masters 
• Assistant in 
Nursing 
• Personal Care 
Assistant 
• Allied Health 
Assistant 
• Personal Carer 












• Generalist AHP 
• Midwife PT 






























































*Aligned with ADEA 3 levels of competence for a CDE 
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6.3.3. The final Capability Framework for Diabetes Care 
A. Finalising of capability statements 
Focus group participants appraised and commented on the 22 statements that had 
not reached consensus by the end of the Delphi survey. Participants rejected one and 
accepted nine capability statements: 12 more were accepted after the emphasis was 
clarified. The focus of these 12 statements was altered to emphasise ‘awareness’ or 
‘promoting’ the issue to prompt action. The final agreed wording for these 
statements and the complete list of statements that gained consensus are listed in 
Table 6.3. The focus group participants indicated no statement related to disabilities 
existed; hence, one capability was added to encompass the comment in tier one. 
 
Table 6.3: Capability Framework for Diabetes Care: A guide to practice 
Consensus Outcome Scale: 
✓ = accept 
R2 = carried over to Round 2 for ranking 
FG = sent to focus group for testing 
FG* = sent to focus group on advice of EAG 
X = rejected 
FG-X = rejected by focus group 
✓* = accept by focus group with amendment as marked in italics/strikethrough 
FG-Add = additional capability statement added by focus group 









• Assistant in Nursing 
• Personal Care Assistant  
• Allied Health Assistant 
• Aged Care Worker 
• Pharmacy Assistant 
• Aboriginal and/or Torres 
Strait Islander Health 
Worker or Practitioner  
An unregulated health assistant role that require, at minimum, completing a certificate II to III at 
Technical and Further Education or equivalent level. The individual working at this level provide 
personal care under the direction and supervision of a registered healthcare professional in 
partnership with people living with diabetes as part of their work. No licensing, legislative, 
regulatory or certification requirements apply to most certificate qualifications. Health assistants 
within Tier 1 will demonstrate at minimum clinical competence in diabetes care at a foundational 
level. 
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 











  Mean 
  (Med) 
  MAD 
Out 
come 





0.74 ✓     









Support diabetes self-management education          









• Encourage early diabetes prevention and screening 70 
3.88
(4.0) 




• Reinforce Demonstrate awareness of foundational 








• Monitor for hypoglycaemia and hyperglycaemia 65 
3.78
(3.8) 









0.77 X     
• Support care of the person with established 




0.76 X     
• Promote Participate in quality diabetes care in 








• Demonstrate cultural awareness with people of 




0.55 ✓   
 
 
• Demonstrate awareness of healthcare needs of 
people living with an intellectual disability 




Build therapeutic relationships          
• Support the person living with diabetes to identify 








• Value and respect diversity 98 
4.60
(5.0) 
0.50 ✓     
• Be culturally sensitive 98 
4.68
(5.0) 
0.47 ✓     
Communicate with influence          
• Adopt the Diabetes Australia position statement 




0.67 ✓     
• Incorporate good communication skills, to listen to 




0.64 ✓     
• Support transfer of diabetes information to their 




0.63 ✓     
Support counselling to achieve agreed outcomes          
• Support implementing a self-management plan 68 
3.70
(4.0) 




• Identify psychological distress 83 
3.95
(4.0) 
0.53 ✓     
Support quality use of medicines         
• Identify and report basic issues that can impact on 









0.94 FG-✓*  
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
Display awareness of diabetes technology          









• Recognise technologies used to manage diabetes 40 
3.25
(3.0) 




• Be aware of and report basic issues that could 
impact insulin pump, CGM and Flash Glucose 




0.90 X     
Support care coordination          
• Identify internal and external relationships 65 
3.73
(4.0) 




• Listen to and understand the needs of others 90 
4.35
(4.0) 
0.59 ✓     
• Share learnings and support others 83 
4.13
(4.0) 
0.53 ✓     
Achieve quality          
• Support quality improvement 78 
3.95
(4.0) 










• Registered NursePT 
• MidwifePT  
• Allied Health Professional  
• Aboriginal and Torres Strait 
Islander Health PractitionerPT  
• Enrolled NursePT  
A registered nurse (RN), midwife or pharmacist, or registered or accredited allied health 
professional who is completing an undergraduate degree in health or is newly graduated and 
certificate IV Aboriginal and Torres Strait Islander Health Practitioner or Health Worker. They are 
regulated by the Australian Health Practitioner Regulation Agency (AHPRA) or their professional 
organisation, and they often work in the hospital setting but may be in other community or sub-
acute type settings. Their role is not diabetes-specific, but as part of their work, they will be 
involved in the care of people living with diabetes, e.g.in-hospital, residential-aged-care facility or 
community setting.  
Each capability in Tier 2 has a list of capability statements and the health professional is expected to 
meet the statements from the previous tier. Health professionals within Tier 2 will demonstrate at 
minimum clinical competence in diabetes care at a practised level. It is essential that the health 
professional work within all the following: their professional scope of practice, regulatory 
frameworks and their insurance coverage.  
* PT – Protected title used following endorsement by the Nursing and Midwifery Board of Australia 
















• Demonstrate sound clinical assessment skills 95 
4.58
(5.0) 
0.53 ✓     
• Assess for diabetes risk factors 87 
4.32
(4.0) 
0.65 ✓     
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
Support diabetes self-management education         
• Demonstrate a sound knowledge of the 








• Apply chronic conditions self-management 




0.67 ✓     
• Support diabetes prevention and early screening 76 
4.11
(4.0) 
0.71 ✓     





0.56 ✓     
• Monitor and manage glycaemic emergencies 82 
4.34
(5.0) 
0.80 ✓     
• Assess for sick day management skills 55 
3.66
(4.0) 






• Advocate for and support appropriate diabetes 
care for people undergoing surgical procedures to 




0.64 ✓     
• Guide screening for diabetes-related complications 50 
3.55
(3.5) 







When providing care in partnership with women, at risk of GDM, who are living with diabetes and 
are planning a pregnancy or are currently pregnant, the health professional: 
 





0.61 ✓     
• Support and advocate for pre-conception care and 





0.62 ✓     
• Awareness of the impact of both diabetes in 




0.64 ✓     
When providing care in partnership with women at risk of GDM, who are living with diabetes and 
are planning a pregnancy or are currently pregnant, the midwife, nurse and, Aboriginal and Torres 
Strait Islander: 
• Engage in antenatal and postnatal care related to a 









When providing care in partnership with young people living with diabetes, the health 
professional: 
 
• Assess for healthy growth and development in 




0.57 ✓     
• Promote health and wellbeing in children and 




0.62 ✓     
OTHER VULNERABLE GROUPS         
• Demonstrate awareness of and monitors and 









• Drive quality Promote improved diabetes care in 
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
Build therapeutic relationships         
• Acknowledge, understand and respond to the 




0.48 ✓     
• Respect the informed health care decision of the 




0.41 ✓     
• Incorporate cultural and diversity considerations 




0.41 ✓     





0.47 ✓     
Communicate with influence         
• Communicate clearly and promote the Diabetes 




0.62 ✓     
• Demonstrate effective communication skills, 
enabling the health professional to listen, 




0.48 ✓     
• Document precise records to support diabetes care 97 
4.68
(5.0) 
0.45 ✓     
• Recognise signs of low health literacy and advocate 




0.51 ✓     
Support counselling to achieve agreed outcomes         
• Support the person make changes to fit diabetes 




0.61 ✓     
• Identify emotional health 92 
4.32
(4.0) 
0.54 ✓     
• Demonstrate an understanding of psychosocial 




0.61 ✓     
Support quality use of medicines          
Those intending to be involved in the medicine capability should consider their professional scope 
of practice, the existence of a regulatory framework for escalation of adverse effects and insurance 
coverage: 
• Provide a description of Describes basic classes of 
glucose-lowering medicines available to manage 








• Identify insulins types and mode of action 68 
3.92
(4.0) 




• Identify and manage issues that can impact on 




0.78 ✓     
Also, when providing care in partnership with people living with diabetes, authorised registered or 
medication endorsed nurses or pharmacists within Tier 2: 
 
• Reinforce education for safe administration of 




0.70 ✓     





0.60 ✓     






0.56 ✓     
Also, when providing care in partnership with people living with diabetes authorised registered or 
medication endorsed nurses within Tier 2: 
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 




    
Display awareness of diabetes technology         





0.62 ✓     
• Show understanding Recognise technologies used 










• Recognise potential basic fundamental problems 
with insulin pump, or Continuous Glucose or Flash 










Support care coordination         





0.19 ✓     
• Engage in care coordination 97 
4.68
(5.0) 
0.45 ✓     





0.30 ✓     
• Share learning and supports others 100 
4.71
(5.0) 
0.41 ✓     
Achieve quality         
• Engage in quality improvement 92 
4.53
(5.0) 
0.57 ✓     
• Responsive to change 97 
4.58
(5.0) 
0.51 ✓     
  






• Primary Healthcare Nurse  
• Primary/Generalist Allied 
Health Professional 
• Midwife 
• Community pharmacist 
• Practice Nurse 
• Community Nurse  
A registered or accredited healthcare professional who has undertaken an undergraduate degree in 
health and is working in the primary or community health settings. Their role has a diabetes focus, 
or their workload includes a high percentage of people living with diabetes.  
Each capability in Tier 3 has a list of capability statements measured by the behavioural indicators 
listed beneath them [To be added in online version by an EAG]. Health professionals within Tier 
3 will demonstrate at minimum clinical competence in diabetes care at an experienced level. To 
meet the capabilities, it is essential that the health professional work within all the following: their 
professional scope of practice, regulatory frameworks and their insurance coverage. 
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
• Display a sound understanding of diabetes risk 
factors and impact on people of Aboriginal and 






    
Support diabetes self-management education          
• Demonstrate a sound knowledge of the 






    
• Apply chronic conditions self-management 






    
• Apply evidence-based and self-management 
education, interventions and techniques to improve 







    





    






0.69 ✓     





0.71 ✓     
• Promote sick day self-management skills 68 
3.89
(4.0) 




• Guide screening for diabetes-related complications 84 
4.24
(4.0) 
0.72 ✓     
OTHER VULNERABLE GROUPS         





0.58 ✓     
• Drive quality diabetes care in residential-aged-care 




0.75 ✓     
• Demonstrate cultural competence and advocate 





0.43 ✓     
Build therapeutic relationships          
• Recognise the emotions and unmet needs of 




0.60 ✓     
• Identify and address barriers to engagement 95 
4.45
(4.5) 
0.55 ✓     
• Promote culture and diversity in health planning 97 
4.63
(5.0) 
0.48 ✓     
Communicate with influence          
• Promote healthy conversations with and for 




0.58 ✓     
• Be aware of one’s own thoughts, emotions, 





0.43 ✓     
• Identify and draw attention to important diabetes 




0.55 ✓     
• Critically appraise health information sources and 






0.49 ✓     
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
Support counselling to achieve agreed outcomes        
• Promote implementation and monitoring of 




0.68 ✓     
• Incorporate counselling techniques and shared 




0.62 ✓     
• Monitor for emotional health 90 
4.34
(4.0) 
0.59 ✓     
• Coordinate care for people with psychosocial 




0.64 ✓     
• Advocate for peer support engagement 79 
4.05
(4.0) 
0.50 ✓     
Support quality use of medicines          
Those intending to be involved in the medicine capability should consider their professional scope 
of practice, the existence of a regulatory framework for escalation of adverse effects and 
insurance coverage: 
• Explain Recognise the action of all glucose-lowering 










• Promote therapeutic use of glucose-lowering 




0.72 ✓     
• Demonstrate understanding of insulins types and 




0.67 ✓     
• Monitor issues that can impact on use of medicines 




0.71 ✓     
When delivering care to people living with diabetes, all authorised registered or medication 
endorsed nurses, pharmacists and Diabetes Aboriginal and Torres Strait Islander health 
practitioner within Tier 3: 
• Educate the person living with diabetes or relevant 





    
In addition, when providing care in partnership with people living with diabetes, all registered or 
medication endorsed nurses or pharmacists, endorsed by their organisation within Tier 3: 




    
Display awareness of diabetes technology          





0.61 ✓     











• Encourage the consumer to apply problem-solving 
skills for insulin pump, Continuous Glucose or Flash 














• Advocate for the use of diabetes technology in 










Support care coordination          





0.62 ✓     
• Develop care plans and manage care coordination 87 
4.34
(4.0) 
0.62 ✓     
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
• Nurture relevant external relationships conducive 




0.56 ✓     
• Share learning and support others 92 
4.45
(5.0) 
0.58 ✓     
Achieve quality          
• Seek and critically review publications related to 










• Engage in quality improvement 90 
4.42
(5.0) 
0.61 ✓     
• Responsive to change 90 
4.47
(5.0) 










• Diabetes Educator (Allied 
Health Professional, 
Midwife, Nurse or 
Pharmacist)  
• ADEA Aboriginal and 
Torres Strait Islander 
Diabetes Health 
Practitioner  
A registered or accredited health professional whose role has a key focus in diabetes care and 
management, they denote themselves as a diabetes educator and they may hold a relevant 
postgraduate degree or certificate IV Aboriginal and Torres Strait Islander health practitioner  
whose role focuses on diabetes, they have completed a postgraduate degree in diabetes and the 
ADEA credentialling pathway. The AHPRA or their professional organisation regulates them.  
They have knowledge and skills in diabetes and are committed to life-long learning that would make 
them eligible for credentialling as a Credentialled Diabetes Educator™. Each capability in Tier 4 has a 
list of capability statements measured by the behavioural indicators listed beneath them [To be 
added in online version by an EAG]. Health professionals within Tier 4 will demonstrate at minimum 
clinical competence in diabetes care at a proficient level. To meet the capabilities, it is essential that 
the health professional work within all the following: their professional scope of practice, 
regulatory frameworks and their insurance coverage. 

















Shape diabetes self-management education, support and care      
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
















OTHER VULNERABLE GROUPS      






• Demonstrate an advanced understanding of the importance of managing 





Build therapeutic relationships      




Communicate with influence and leadership      










Exemplify counselling to achieve agreed outcomes      












Exemplify quality use of medicines      
Those intending to be involved in the medicine capability should consider their professional scope 
of practice, existence of a regulatory framework for escalation of adverse effects and insurance 
coverage: 
• Understand combinations of glucose-lowering medicines available to 




















Support quality use of diabetes technology      










• Promote problem-solving skills for insulin pump, Continuous or Flash 






Lead care coordination      
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
Cultivate quality through leadership and research      
























• ADEA Credentialled Diabetes Educators [Novice] (Allied Health 
Professional, Midwife, Nurse or Pharmacist)  
A CDE is a health professional who meets the requirements of the ADEA for credentialling and has 
completed the minimum 1000 hours in diabetes practice and 6-month mentoring relationship. They 
hold at minimum a Graduate Certificate in Diabetes Education or Management and are responsible 
for delivering diabetes self-management education.  
Each capability in Tier 5 has a list of capability statements measured by the behavioural indicators 
listed beneath them [To be added in online version by an EAG]. Health professionals within Tier 
5A will demonstrate at minimum clinical competence in diabetes care at an advanced level. To meet 
the capabilities, …..: their professional scope of practice, regulatory frameworks and their 
insurance coverage. 

















Shapes diabetes self-management education, support and care     
• Demonstrate an advanced understanding of the pathophysiology of the 











• Reduce the impact of diabetes on people from vulnerable groups with 











• Provide education in and promote best practice care of people living with 
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 










OTHER VULNERABLE GROUPS      
• Display advanced understanding of attributes of quality diabetes care in 





• Advise of important principles for quality care of people living with 






Build therapeutic relationships     
















Communicate with influence and leadership     














Exemplify counselling to achieve agreed outcomes     
• Consult in, develop and monitor personalised diabetes self-management 





















• Enable problem-solving by supporting the individual to identify attitudinal 






Exemplify quality use of medicines  
Those intending to be involved in the medicine capability should consider their professional 
scope of practice, the existence of a regulatory framework for escalation of adverse effects and 
insurance coverage: 
 
• Support education in and appropriate choice of glucose-lowering medicine 















Exemplify quality use of diabetes technology     
• Adeptly promote blood glucose and ketone monitoring and assessing 
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 








• Apply problem-solving skills for Continuous and Flash Glucose Monitoring 





Lead care coordination  








Cultivate quality through leadership and research     
• Support research and quality improvement to build the evidence to 
promote improvements in self-management of prediabetes and diabetes 













Roles  • ADEA Credentialled Diabetes EducatorTM [Experienced] (Allied 
Health Professional, Midwife, Nurse or Pharmacist)  
A CDE who has completed a relevant postgraduate certificate in diabetes education; however, a 
given research skills are required a postgraduate diploma is preferred. The CDE is considered 
competent with certain diabetes consumer groups, due to their work location. However, they 
should be aware of their deficits when moving from one workplace to another and work towards 
developing skills and knowledge in areas of knowledge deficit. For example, the CDE who has 
worked primarily in managing type 2 diabetes but then moves to a paediatric facility should see 
themselves as novices until they build the required skills. Health professionals within Tier 5B will 
demonstrate at minimum clinical competence in diabetes care at an advanced level. 




(Med)      MAD 
Out 
come 








Shape diabetes self-management education, support and care      
• Demonstrate a comprehensive understanding of the pathophysiology of all 
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
• Provide structured education in and consults on best practice 





















OTHER VULNERABLE GROUPS      












Build therapeutic relationships      
• Encourage more adaptive behaviours or emotional responses from a 

















Communicate with influence and leadership     
• Mentor other health professionals in healthy conversations with and for 













Exemplify counselling to achieve agreed outcomes      
• Mentor and consult health professionals to support implementing and 









• Lead care coordination for people with symptoms of psychosocial impact 





Exemplify quality use of medicines 
Those intending to be involved in the medicine capability should consider their professional scope 
of practice, the existence of a regulatory framework for escalation of adverse effects and 
insurance coverage: 




• Promote therapeutic use and monitor the impact of glucose-lowering 









Exemplify quality use of diabetes technology      
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
• Comprehend ambulatory glucose profiles and, reviews and analyses 









Lead care coordination      










Cultivate quality through leadership and research      




• Participate in research and quality improvement to build the evidence to 
promote improvements in self-management of prediabetes and diabetes 

















Roles  • Specialist Credentialled Diabetes Educator [Expert]  
The health professional within Tier 6 is a CDE who has met the requirements for credentialling by 
the ADEA. They hold a relevant postgraduate diploma in diabetes education or care, or be working 
towards a Master as an advanced practice health professional. They are an expert in diabetes care 
or within a field of diabetes care, e.g. pregnancy, paediatrics on insulin pump therapy.  
Each capability in Tier 6 has a list of capability statements measured by the behavioural indicators 
listed beneath them [To be added in online version by an EAG]. Health professionals within Tier 
6 will demonstrate at minimum clinical competence in diabetes care at an expert level. To meet the 
capabilities, it is essential that the health professional work within all the following: their 
professional scope of practice, regulatory frameworks and their insurance coverage. 






   Out 
come 
• Illustrate comprehensive assessment skills in their specialty area 97 
4.87
(5.0) 0.24 ✓ 
Shape diabetes self-management education, support and care      
• Provide education in and promote best practice management and care of 
people living with diabetes and prediabetes 
97 4.84
(5.0) 0.27 ✓ 
• Demonstrate expertise in diabetes health education to improve outcomes 
for people living with diabetes 
97 4.84
(5.0) 0.27 ✓ 
• Expertly monitor and manage glycaemic emergencies 95 
4.82
(5.0) 0.32 ✓ 
• Develop personalised diabetes care related to healthy eating and, 
recreational activity and physical activity programs 
95 4.82
(5.0) 0.32 ✓ 
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
• Expertly manage sick days in people living with diabetes 95 
4.84
(5.0) 0.28 ✓ 
• Expertly screen or direct screening for diabetes-related complications 92 
4.71
(5.0) 0.46 ✓ 
PREGNANCY 
When providing care in partnership with women, at risk of GDM, who are living with diabetes and 
are planning a pregnancy or are currently pregnant, the health professional: 
 




• Lead pre-conception care and pregnancy planning in women with 
















When providing care in partnership with young people living with diabetes, the health 
professional: 
 
• Proficiently provides care for healthy growth and development, and 





• Astute to other issues in paediatrics and youth that impact diabetes care 









OTHER VULNERABLE GROUPS      
• Coordinate and lead complex diabetes impacted by coexisting conditions 





• Provide expert advice on the care of people living with diabetes in the 











Build therapeutic relationships      








Communicate with influence and leadership      
• Integrate evidenced-based knowledge on strategies to support healthy 











• Lead change and endeavours to improve record-keeping and 





Exemplify counselling to achieve agreed outcomes      
• Integrate guidelines to support the development and quality monitoring 
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
• Incorporate measures and pathways for early screening, detection and 





Exemplify quality use of medicines      
Those intending to be involved in the medicine capability should consider their professional scope 
of practice, the existence of a regulatory framework for escalation of adverse effects and insurance 
coverage: 
• Monitor for the therapeutic use of glucose-lowering medicines available 











• Promote optimisation of diabetes to target through development of 





Exemplify quality use of diabetes technology      






• Comprehensively explain the processes and logistics required to 











• Adeptly monitor insulin pump therapy, Continuous and Flash Glucose 











Lead care coordination      












Cultivates quality through leadership and research      




• Influence research and quality improvement to build the evidence base to 
















• Advanced Management Credentialled Diabetes Educator (Non-
medical Prescriber or Prescriber in Partnership) 
• Nurse PractitionerPT (Diabetes)  
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 
A CDE who practices in advanced management in diabetes care, and is endorsed as a ‘Non-Medical 
Prescriber’ or ‘Prescriber in Partnership’, or a Nurse PractitionerPT (Diabetes)  
The health professional endorsed as a ‘Non-Medical Prescriber’ or ‘Prescriber in Partnership’ holds 
at minimum a relevant postgraduate diploma in diabetes with a preference towards a Master’s 
degree in a relevant area that includes pharmacology and pharmacotherapeutics. They hold an 
endorsement for scheduled medicines and prescribe within their level of competence and 
professional scope of practice in partnership with a partner prescriber. The health professional has 
responsibility for increased complexity of decision-making related to diabetes management and 
education, often functions autonomously, can include medicines management and prescribing and 
is a nationally recognised leader.  
The health professional endorsed as a Nurse PractitionerPT holds a Master’s degree in a relevant 
field with subjects covering comprehensive clinical assessment and decision-making, pharmacology 
and therapeutics and is registered and qualified to prescribe medicines. They are a nationally 
recognised leader and autonomous practitioner.  
Exemplify clinical assessment capacities  Round 1 
When providing care in partnership with people living with diabetes or at risk of diabetes, the 












When providing care in partnership with people living with diabetes or at risk of diabetes, the 
nurse practitioner: 








Shape diabetes self-management education, support and care      


















• Advocates for, participates in, or leads systems that support safe care, 





• Integrate and advocates for specialised knowledge to support diabetes 





PREGNANCY When providing care in partnership with women, at risk of GDM, who are living with 
diabetes  




• Lead pre-conception care and pregnancy planning in women with 
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 




PAEDIATRICS When providing care in partnership with young people living with diabetes or their 
carer – OTHER VULNERABLE GROUPS 
• Proficiently provides care for healthy growth and development, and 





• Astute to other issues in paediatrics and youth that impact diabetes care 









• Coordinate and lead complex diabetes impacted by coexisting conditions 





• Provide expert advice on the care of people living with diabetes in the 











Build therapeutic relationships      




Communicate with influence and leadership      
• Demonstrate excellent communication skills when working with people 













Exemplify counselling to achieve agreed outcomes      





• Identifies and diagnoses depression and diabetes-related distress in 




• Leads endeavours to service delivery to reduce the psychosocial impact 




Exemplifies quality use of medicines      
When involved in medicine management while caring for people living with diabetes, the health 
professional who is a ‘non-medical prescriber’ or a ‘prescriber in partnership’ considering their 
scope of practice: 
 
 










• Adeptly choose and prescribe suitable medicines within a defined scope 









When involved in medicine management while caring for people living with diabetes, the health 
professional who is a diabetes nurse practitioner: 
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Table 6.3: Capability Framework for Diabetes Care: A guide to practice (continue) 














• Monitor the impact of polypharmacy 97 
4.76
(5.0) 0.37 ✓ 
Exemplify quality use of diabetes technology      
• Be adept at interpreting ambulatory glucose profiles, and differing 






• Apply comprehensive advanced skills to manage a person living with 





Lead care coordination      








Cultivate quality through leadership and research      
• Apply research proficiently into advanced practice 95 
4.71
(5.0) 0.44 ✓ 
• Demonstrate a commitment to lifelong learning 97 
4.79
(5.0) 0.34 ✓ 
• Lead research and drive innovation 94 
4.55
(5.0) 0.59 ✓ 
6.3.4. Findings to inform workplace or policy advice 
During the focus group, when participants responded to questions to identify the 
framework’s utility: how the framework influenced the diabetes health workforce 
or guided national curricula, their responses provided some policy advice. The 
following findings were those relating to advice for healthcare organisations and 
policy. Suggestions for how the ‘Capability Framework’ should be used included by: 
• Healthcare professionals and assistants – enabling them to reflect on their 
strengths and weaknesses in diabetes education and care to align their 
professional development.  
• Managers – to discuss and plan learning and teaching improvements, staff 
career development and alignment of recruitment to the relevant skills.  
• Healthcare employers – to benchmark the current capabilities within their 
team delivering diabetes care and education. 
• Healthcare professional organisations – to identify capacity-building 
opportunities.  
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• Health organisations or state or local government – to determine the 
percentage of staff within their organisation who meet each diabetes 
practice level or their ability to access staff from other diabetes practice 
levels when they do not have any, by referral to other services, alongside 
local quality and accreditation processes. 
• Universities and colleges – to inform the design and development of 
capacity-building opportunities through constructive alignment of learning 
outcomes with the ‘Capability Framework’.  
Following consideration of focus group feedback and EAG deliberation, how the 
framework should be used was incorporated into the document’s draft version. The 
draft ‘Capability Framework’ was then forward for external review by HCP regulatory 
and training organisations, which finalised the study’s data collection period. 
6.4. Health profession regulatory and training organisations’ 
appraisal  
The draft ‘Capability Framework’ was forwarded to a selection of representatives 
from health profession training organisations and key peer organisations which 
regulated disciplines eligible for ADEA credentialling for appraisal to complete Stage 
III and the post-Delphi survey period. The purpose of the regulatory and training 
organisation survey was to invite them to comment about: 
• ‘Capability Framework’ features that could impede practice or safe care. 
• Whether the ‘Capability Framework’ could support developing a competent, 
adaptive and flexible diabetes workforce.  
Informed by evidence by Stanford (2016), to build workforce capacity, it was 
essential to ensure that capabilities statements did not limit but enabled the 
workforce to work to the SoP they are trained, experienced and credentialled to 
undertake within legislative parameters. Also, the quantity of data gathered needed 
to be manageable; therefore, a plan was devised for recruiting HCP organisations.  
6.4.1. Recruitment of stakeholders for appraisal  
A list from each role within the draft ‘Capability Framework’ and their overarching 
organisation was created to contact health profession regulatory and training 
organisations in Australia. It included the primary organisations that provided 
training to certificate level III and IV health assistants and professionals.  
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A search for course coordinators was conducted via the web Google search engine 
for each discipline, and the first two identified, which included the course 
coordinator’s email contact, were selected. The list was reviewed at the end of the 
search to ensure it included all Australian States and Territories, see Table 6.4 on 
page 222. The list included 16 Australian educational organisations providing 
training for: 
• Certificate III and IV health assistants, Aboriginal and Torres Strait Islander 
health practitioners and enrolled nurses. 
• Undergraduate nurses and allied health. 
• Postgraduate diabetes degrees. 
Three universities were chosen using the method above to provide feedback on 
nursing and midwifery, three delivering diabetes postgraduate degrees and two 
undergraduate HCP degrees from other allied health disciplines. The set number of 
organisations chosen was made to ensure the information drawn from the feedback 
would be manageable. 
6.4.2. Process taken for regulatory and training organisation review 
The selected health profession member, regulatory and training organisations were 
emailed about the opportunity to provide feedback on the draft ‘Capability 
Framework’. It contained two attachments; a letter inviting them to participate, see 
Appendix 13 on page 326, and a PDF copy of the draft ‘Capability Framework’. The 
draft ‘Capability Framework’ was a designed version of the information contained 
within the current thesis. It included an updated version of the information 
provided to the focus group, as described in Section 6.2.3 on page 195 and: 
• Additional overarching comments that guided the framework from Section 
6.3.2 on page 198. 
• A summary of how the ‘Capability Framework’ may practically be used from 
Section 6.3.4 on page 219. 
The letter provided a link to direct the respondent to an online survey using the web-
based platform to provide feedback by answering a set of questions, which are listed in 
Appendix 14 on page 328 or Table 6.6 on pages 225 to 226. The questions to guide the 
feedback focused on the draft ‘Capability Framework’s structure and its ability to meet 
the Australian National Diabetes Strategy to improve the workforce to deliver diabetes 
education and care.  




Table 6.4: Selective health profession and training organisations contacted 
Peer Health Profession member organisations 
• Allied Health Professionals Australia  
• Australian College of Midwives  
• Australian College of Nurse Practitioners  
• Australian College of Nurses   
• Australian Diabetes Educators Association   
• Australian Health Professional Regulatory Agency  
• Australian Physiotherapy Association  
• Australian Podiatry Association 
• Australian Primary Nurse Association 
• Congress of Aboriginal and Torres Strait Islander Nurses and Midwives 
• Dietetic Association of Australia 
• Exercise and Sports Science Australia 
• Indigenous Allied Health Australia  
• National Aboriginal and Torres Strait Islander Health Worker Association  
• National Aboriginal Community Controlled Health Organisation  
• Pharmacy Society of Australia  
Health Assistant and Healthcare Professional training organisations 
• Australian Skills Quality Authority – Certificate III and IV 
• Charles Darwin University, Northern Territory – Undergraduate degree in exercise 
physiology  
• Charles Sturt University, NSW – Undergraduate degree in physiotherapy  
• Curtin University, Western Australia – Postgraduate degree in diabetes  
• Deakin University, Victoria – Undergraduate degree in nursing and midwifery 
• Flinders University, South Australia – Undergraduate degree in exercise physiology 
• Monash University, Victoria – Undergraduate degree in pharmacy  
• National Prescribing Service Limited – QUM and medicine safety  
• Technical and Further Education Australia (TAFE) – Certificate III and IV, and diploma 
of nursing 
• University of Adelaide, South Australia (SA) – Undergraduate degree in dietetics 
• University of Adelaide, SA – Undergraduate degree in nursing and midwifery  
• University of Adelaide, SA – Postgraduate degree in diabetes 
• University of Canberra, Australian Capital Territory – Undergraduate degree in 
physiotherapy 
• University of South Australia, South Australia – Undergraduate degree in pharmacy 
• University of Tasmania, Tasmania – Undergraduate degree in nursing and midwifery 
• University of Technology in Sydney, NSW – Postgraduate degree in diabetes  
• University of the Sunshine Coast, Queensland – Undergraduate degree in nutrition 
and dietetics 
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A hard copy version of the questions was also available to organisations on request. 
The survey link opened for one month between September and October 2019; the 
deadline for hard copy responses was the same day. The National Prescribing 
Service could not allocate a representative to the EAG as planned; therefore, they 
were contacted by telephone and invited to participate in the review process.  
6.4.3. Analyses of stakeholder feedback data 
Following the health profession regulatory and training organisation appraisal, 
conducted to ensure no oversight of significant issues or potential impediments, the 
researcher analysed the data independently. Similar reoccurring issues were 
grouped, and the list was then forwarded to three researchers for independent 
feedback. The researchers then met to discuss any description of diabetes clinical 
competence or capability statement that could create limitations to SoP and reached 
a consensus about critical alterations. Changes were made to the draft ‘Capability 
Framework’ because of the feedback, finalising the analysis period. The categories 
identified and the data set they relate to form the basis of the discussion chapter.  
6.5. Results from health profession organisations review 
There were ten responses (30%) from the purposeful sample of 33 HCP regulatory 
and training organisations contacted; seven from HCP’s peer organisations and 
three from education provider organisations, see Table 6.5.  
Table 6.5: Stakeholders who responded to request for feedback 
Health profession regulatory and training organisations 
• Allied Health Profession Australia (health profession peer organisation [HPPO]) 
• Australian College of Midwives (HPPO) 
• Australian College of Nurse Practitioners (HPPO) 
• Australian Diabetes Educators Association (HPPO)  
• Course Accreditation and Standards of Practice Committee for ADEA (Training) 
• Dietitians Association of Australia (HPPO) 
• Exercise and Sports Science Australia (HPPO) 
• Pharmaceutical Society of Australia (HPPO) 
• University of Adelaide (Training) 
• University of Technology Sydney (Training) 
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The survey listed seven open-ended questions, see Table 6.6 on pages 225 to 226. 
The appraisal concerned ensuring that the ‘Capability Framework’ did not impede 
practice and responses by organisations were often health discipline-specific. In 
summary, most responses indicated that it was well set out, creating a consistent 
structure and set of expectations for expected capabilities and skills at the different 
diabetes practice levels identified, and its relevancy was high for their profession. 
Also, they indicated that at times some professions failed to be carried through the 
diabetes practice levels, which reduced the capacity for workforce growth.  
A specific concern raised was the inappropriate conceptualisation of the term 
‘generalists’ within the ‘Capability Framework’ because it could suggest that the 
HCP had a lower level of general competence within their discipline. Last, many 
indicated that they only saw positive impacts on safe practice through 
implementing the framework, increasing deployment and engagement. 
It is unclear whether the feedback came from a summary of a broader organisational 
group and member consultation or one person’s perspective of the document. When 
written in the first person, two responses suggested the feedback was an individual 
perspective rather than the organisation. The results from responses from the 
organisations to individual questions are summarised in Table 6.6 on pages 225 to 
226. 
The stakeholder appraisal process described in the chapter marked the end of Stage 
III data collection and the validation of the Capability Framework for Diabetes Care; 
therefore, marking the study’s end. 
6.6. A consensus Capability Framework for Diabetes Care  
The results from the pre-Delphi Consultation, the Delphi survey, and the post-Delphi 
appraisal period used in the Delphi technique culminated in the creation of a 
consensus Capability Framework for Diabetes Care to guide the future HCP training 
and practice. Informed by participant feedback through the data collection 
methods, the ‘Capability Framework’ consists of nine essential capability areas to 
inform the delivery of diabetes care, underpinned by three sets of attributes for 
seven HCP diabetes practice levels that signify a change in the HCP’s stage of 
diabetes clinical competence, the level of knowledge or skills the HCP requires. 
 




Table 6.6: Summary of stakeholder feedback 
How easy was it to read the ‘Capability Framework’? 
Consistent logical progressive structure  
8 
Difficult to navigate and not intuitive 
2 
Organisations’ responses suggested the ‘Capability Framework’:  
• Created a consistent logical structure and described the expected capabilities. 




Not relevant  
0 
Organisations’ responses suggested the ‘Capability Framework’ was:  
• Relevant to all professions and undergraduate nurses and allied health. 
• A valuable piece of work, which clearly identified the novice to the expert pathway. 
• Focused on diabetes educators and could be improved by increasing focus on other 
roles within the workforce.  
Are there items that may impede the practice? 
Framework does not impede practice 
7 
Framework impedes practice 
3 
Organisations’ responses suggested the following may impeded practice:  
• Omission of the midwife in tiers despite playing an important role in managing 
pregnancies complicated by diabetes and promoting public health messages 
during their postnatal care schedule to reduce T2D risk post-birth. 
• Required consideration be given to including the Queensland nurse or dietitian 
who has additional credentialing for ‘adjusting’ insulin doses.  
• An inappropriate conceptualisation of the term ‘generalists’: there was concern 
regarding the perceived implication within the framework that being a generalist 
implied having a lower level of competence within their chosen profession. 
• Definitions for levels of clinical competence: in particular, the clinical competence 
definitions for tier one and two because it was perceived that being a generalist 
implied a lower level of competence despite potentially advanced skills. 
Would any broad capabilities or their statements affect safe practice? 
Would not affect safe practice 
7 
Would affect safe practice 
3 
Organisations’ responses suggested the following may affect safe practice:  
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Table 6.6: Summary of stakeholder feedback (continue) 
• Unrealistic medicines competency for healthcare assistants in tier 1; particularly 
the appropriateness of pharmacy assistants’ involvement in medicine management 
due to their level of training and competency level.  
• Inadequate focus on AHPs competencies despite their role in exercise and 
nutrition. 
• Conceptualisation of generalist HCPs who may be highly-skilled and working in 
remote areas. 
Does the ‘Capability Framework’ support develop a competent, flexible and 
adaptive workforce for diabetes care? 
6 (+2 if strengthen) 2 
Organisations’ responses suggest the ‘Capability Framework’:  
• Could be strengthened by promoting more flexibility within the tiers and enabling 
progression to be better understood: linking the HCP’s development to the 
continuum of practice.  
• Sets a career pathway in diabetes: a clear pathway for developing all professions 
including novice to experts and their potential role in diabetes care.  
• Increasing specialisation may result in less flexibility and adaptability of roles.  
• Was of limited value for improving workforce because there was no imprimatur of 
an authoritative body responsible for regulating the proposed framework.  
How helpful was the structure that described the ‘Capability Framework’? 
Organisations’ responses suggested: 
• The framework was easy to follow, logical and concise, with one response indicating 
it was not straightforward. 
• Some items would benefit from professional design to improve understanding.  
• May benefit from further collapsing of practice level tiers. 
List other items that need addressing within the ‘Capability Framework’? 
Organisations’ responses suggest consideration be given to: 
• Clarifying the definition of ‘allied health professional’ as it was used broadly and 
listing the community pharmacist and midwife separately given their more specific 
roles in healthcare.  
• Grammatical and flow suggestions such as consistency with terms. 
• Clarifying where certain roles not listed may be positions in the framework, e.g. the 
intern pharmacist or PhD CDE. 
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Using the modified Delphi technique as an approach, including analysing 
knowledge, skills and attributes listed by participants into themes and the EAG’s 
validation, allowed identification of capabilities and moved away from listing 
competency statements in a more task or condition manner, promoting flexible 
care as clinically required. The approach, underpinned by theories by Benner, 
Ericsson and Sen, allowed focusing on capabilities that can be developed and builds 
workforce capacity. Moreover, the response rate was high during the Delphi survey, 
which Keeney et al. (2010) suggest, may have been enhanced as the participants 
realised and felt that they are partners in a study on a topic of personal interest. 
6.7. Chapter conclusion 
In conclusion, Chapter 6 described Stage III, the post-Delphi stakeholder appraisal 
period, which included findings from two data collection methods: a focus group 
with diabetes HCPs experts and a survey with HCP regulatory and training 
organisations. The collective results informed the final content and aspects of 
the Capability Framework for Diabetes Care. Their responses identified that the 
framework could be implemented into the real world and ways that it should be 
used to guide curricula development and workforce policy. Also, that the 
framework would support developing a flexible workforce to deliver safe care to 
meet diabetes consumer needs. Last, some minor adjustments to the inclusion of 
HCP across more practice levels and improved definition of generalism would 
enable more growth in diabetes workforce capacity. The end of Stage III finalised 
the systematic consensus method.  
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Chapter 7: Discussion – Towards diabetes competence 
7.1. Chapter introduction 
The current chapter explores the findings of the study against the research question, 
aim and objectives. It focuses on implications for enhancing the capacity of the 
healthcare workforce to deliver diabetes education and care by increasing expertise. 
Information is provided to describe ways the Capability Framework for Diabetes Care, 
the ‘Capability Framework’, should be used as a consensus approach to build 
diabetes capabilities in the healthcare workforce.  
The findings from the study resulted in a comprehensive, novel and innovative way 
to prepare HCPs to meet the needs of people living with diabetes. The ‘Capability 
Framework’ is characterised by HCP diabetes practice levels linked to minimum 
stages of diabetes clinical competence that can be used for targeted training and 
education. Nine novel capability areas support the development of HCPs, 
underpinned by three sets of attributes that clearly articulate a pathway to 
increasing expertise and excellence, which supports growth in capacity for diabetes 
care. 
The discussion considers the influence of the following theories, Benner’s stages of 
clinical competence, Ericsson’s theory of expertise and Sen’s capability approach, 
focusing on building workforce capacity. Elements drawn from these theories, which 
informed the framework concerned promoting autonomy and fostering attributes 
that make people perform and creating opportunities for deliberate practice and 
lifelong learning. Finally, the strengths and limitations of the study are described. 
7.2. Building diabetes capabilities 
Methods to increase the responsiveness and capability of the health workforce to 
meet the needs of people with diabetes is vital. Novel findings of the current study 
reveal nine capabilities that require addressing through training and education, 
underpinned by three sets of attributes to support flexibility in clinical practice and 
growth in the diabetes workforce’s capacity. Furthermore, seven different practice 
levels are linked to stages of diabetes clinical competence, which require targeting 
to increase workforce mobility to enable increased capacity in diabetes care. 
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The findings from the study are important because the application of Sen’s 
capability approach to the education setting has been found to increase flexibility 
and responsiveness, translating to increased workforce capacity (Robeyns & 
Fibieger Byskov, 2020). In contrast, competency-based training and competency 
frameworks can hinder expertise because they are limited by their ties to specific 
workplace healthcare roles and discipline requirements (Wheelahan, 2017).  
Moreover, the acquisition of expert performance comes from ongoing training, 
mentoring by others and reflection in and on practice to improve approaches to 
undertaking an activity (Ericsson et al., 2018). To move towards expertise, Benner’s 
(2004) stages of clinical competence, tested in many adult scenarios other than 
nursing, suggest that the HCP moves through stages where concepts are tested. 
Combining these theories created a framework to ensure more HCPs develop 
expertise in diabetes to meet consumer needs. 
7.2.1. Health professional diabetes practice levels 
A key study finding to inform the consensus ‘Capability Framework’ was three broad 
generalists and four diabetes-specific health professional practice levels within the 
Australian context to deliver diabetes education and care. Significantly, to 
implement the framework nationally and its overall influence, the number of 
diabetes practice levels needed to be manageable.  
Unlike the Australian Qualification Framework, where the ten levels are linked to a 
higher level of education qualification, see Figure 2.1 on page 57, the ‘Capability 
Framework’ is informed by Ericsson’s (2018) and Benner’s (2004) theories. The 
theories suggest that experience and deliberate practice develop expertise in stages, 
regardless of qualification. The ‘Capability Framework’ was comparable to other 
international frameworks focusing on diabetes or a health workforce’s competence 
regarding the number of practice levels making it feasible to implement.  
In the UK, the Employability Skills Matrix has nine career levels and includes 
mathematical and English skills requirements to support healthcare staff to identify 
the personal skills, values, attributes and behaviours required for their role; the 
information aims to develop a sustainable healthcare workforce (Skills for Health, 
2013). Similarly, the UK National Health Service Career Framework also has nine 
career levels and places advanced practice at level three, two-steps above initial 
registration; salary scales align to these levels (Cooper et al., 2019).  
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In contrast, Benner’s (2004) stages of clinical competence differ from the UK 
frameworks; the advanced practice clinician sits at level 4 of a 5-level scale, 
although her work focused on clinical expertise, see Table 3.2 on page 95. Similarly, 
the USA’s Association of Diabetes Care and Education Specialists competency 
framework aligns includes five practice levels inclusive of paraprofessionals and 
diabetes educators, see Table 2.4 on pages 46 to 48. However, unlike the ‘Capability 
framework’, the USA framework does not include the nurse practitioner or 
Indigenous-specific roles. Hence, the number of practice levels identified in the 
current research appeared reasonable to support care across the Australian health 
spectrum. 
Another key finding from the current study concerned the concept of a ‘generalist’ 
HCP. The post-Delphi survey (Stage III) feedback suggested the research had 
inappropriately conceptualised the term ‘generalist’. Services for Australian Rural 
and Remote Allied Health (2020) suggest, generalist HCPs practice at advanced 
levels within a breadth of clinical and service delivery capabilities required of their 
roles; role breadth is unrelated to the depth or complexity of practice. However, 
Ericsson’s (2018) promotes deliberate practice in the areas of expertise desired, 
suggesting a need to differentiate between the diabetes-specific and more 
generalist practice roles because the latter may not access appropriate deliberate 
practice or have adequate focus on diabetes.  
A systematic review by George et al. (2019) appraising generalism and healthcare 
delivery to rural populations by AHPs in NZ supports the inadequate access to 
diabetes practice. The authors indicated that while rural generalism could be 
considered an advanced scope of practice, maintaining competency within multiple 
specialised practice areas is time-consuming and costly, and opportunities to put 
the learnt knowledge into practice are limited (George et al., 2019).  
Ericsson’s theory supports the conceptual difference between a generalist HCPs 
versus a HCP who has more deliberate practice in diabetes, as shown by the 
distinction between diabetes practice levels within the ‘Capability Framework’. 
Ericsson (2018) indicated that merely encountering patient conditions and situations 
is not experience; experience involves HCPs reflecting on encountered circumstances 
to refine their moment-to-moment decision making at an unconscious, intuitive level.  
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However, promoting generalism is crucial internationally and in Australian rural and 
remotes areas to maximise the healthcare workforce’s effectiveness to meet 
consumer needs (Evans et al., 2020; Leary & MacLaine, 2019; NRHC, 2020a; NRHC, 
2020b). In the UK, rising multimorbidity, an aging population and increasing 
specialisation are mounting pressure on health services for increased numbers of 
doctors and advanced practice nurses with generalist skills (Evans et al., 2020; 
Rimmer, 2017).  
Similarly, in Australia, generalist nurses, allied health professionals (AHP) and GPs 
provide essential and are sometimes the only health service for rural and remote 
communities (Larkins & Evans, 2014; NRHC, 2020a; NRHC, 2020b). The National 
Rural Health Commissioner (NRHC) (2020a, 2020b) indicates that 30% of Australians 
live outside metropolitan centres in areas of increasing remoteness where access to 
health services varies drastically; however, only 12% of medical specialists live 
outside major Australian cities (NRHC, 2020a, 2020b). While the generalist HCP role 
was differentiated in the ‘Capability Framework’, it is important they have access to 
the training advised to increase equity in diabetes care.  
Diabetes practice level 2, where the term ‘generalist’ is used in the ‘Capability 
Framework’, ultimately represents the capabilities new graduate nurses, allied health, 
midwives, pharmacists and medication-endorsed Aboriginal and Torres Strait Islander 
health practitioners require. The capability statements listed in diabetes practice level 
2, inform undergraduate degrees and TAFE certificate IV curricula nationally for the 
disciplines listed in the level, see Table 6.3 on pages 202 to 203. Promoting increased 
diabetes competence in the generalist workforce aligns with NRHC policies focused on 
championing the cause of rural practice to develop a sustainable, locally trained health 
workforce to meet the needs of Australian regional, rural and remote communities 
(NRHC, 2020a, 2020b). 
Further, the ‘Capability Framework’ provides a structure to guide advanced practice 
generalists for lifelong learning in diabetes education and care. Consistent with 
Ericsson’s (2018) theory that a HCPs expertise can develop through deliberate 
practice throughout their career, the ‘Capability Framework’ is designed to 
accommodate the fact that any HCP could meet the diabetes clinical competence of 
any practice level. Hence, a proficient rural generalist nurse or AHP could meet the 
diabetes clinical competence beyond practice level two. 
Chapter 7: Discussion – Towards diabetes competence 
232 
 
Moreover, it is important to note that the ‘Capability Framework’ focuses on 
diabetes-specific competence, not a clinician’s overall competence. Within the 
framework wording included: 
The framework identifies a tiered structure to describe the minimum level of clinical 
competence in diabetes care required by different roles. While a healthcare provider 
may be working at an advanced level, they require a minimum level of competence in 
diabetes care to support appropriate care.  
The ‘Capability Framework’ accommodates the fact that any HCP can hold more in-
depth diabetes clinical competence than the minimum expected level listed in their 
practice level due to their exposure to relevant professional development in diabetes.  
Further, throughout all Delphi stages, the findings showed various opinions about 
including healthcare and pharmacy assistants in diabetes practice level 1. Participant 
feedback indicated that the assistant could undertake activities better suited to a 
HCP. Likewise, health assistants with direction and supervision provide an essential 
role in the health system, e.g. residential-aged-care settings.  
Notably, healthcare assistants have shown deficits in diabetes knowledge that 
would impact the quality of care provided, which must be addressed (Hayes & 
Cardwell, 2017). Therefore, any indicators developed for capability statements 
within the ‘Capability Framework’ need to clearly articulate the assistant’s role to 
guide appropriate training and prevent activities extending beyond what they are 
trained and educated to do. 
Diabetes practice levels at the other end of the ‘Capability Framework’ 
accommodate both a specialist CDE and a proposed CDE role with limited prescribing 
rights alongside nurse practitioners (NP). Articulating the capabilities of the specialist 
and CDE prescriber roles was important because it addresses some of the ambiguity 
about these roles. Based on a systematic review by Cooper et al. (2019), there is 
ambiguity concerning the differences between the advanced nurse practitioner and 
clinical nurse specialist (CNS) roles internationally despite both roles having an 
equally positive impact on healthcare.  
In contrast to Australia, the USA, Canada and NZ, advanced practice nurses are not 
regulated in the UK (Leary & MacLaine, 2019). However, nurses can apply for 
prescribing rights in Canada and the UK, and prescribing capabilities are entrenched 
into undergraduate degrees in the UK (Canadian Nurses Association, 2015; Nursing 
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and Midwifery Council, 2019). In contrast, CNS and CDEs in Australia do not have 
prescribing rights; thus, their medicine management capabilities differ. The only 
exclusion is the NP in Australia, who may be a CDE and manages diabetes and 
comorbidities simultaneously (ACNP, 2018). Therefore, because of these differences, 
the skills of the advanced practice nurse compared in Cooper et al. (2019) may differ; 
the CNS roles discussed were likely to have prescribing rights like the Australian NP. 
The ‘Capability Framework’ creates a pathway to building medicines capabilities. 
7.2.2. A capability framework for diabetes education and care 
The ‘Capability Framework’ that is the key outcome of the study, is unique both in 
an Australian and international context. A major strength of the framework is the 
emphasis on capability-based learning that encourages focusing on outcomes 
(Robertson, 2015). Compared to other competency-based diabetes frameworks 
currently available for CDEs, Aboriginal and Torres Strait Islander health 
practitioners and nurses in Australia and internationally, and for non-CDE AHPs 
internationally, see Table 2.4 on page 46 to 48 and Table 2.5 on page 62, the 
‘Capability Framework’ is designed to support whole workforce growth in diabetes 
and create shared understandings between disciplines about diabetes education 
and care.  
The ‘Capability Framework’ guides education on diabetes, taught by trainers or 
undertaken as self-directed learning, as evidence evolves. Consistent with Sen’s 
capability approach, the framework promotes self-efficacy, focusing on what people 
are able to do and to be: or their capabilities (Robeyns & Fibieger Byskov, 2020). 
Notably, the capability approach fosters the HCP’s capacity to adapt to clinical 
situations: rather than merely fulfilling the minimum requirements of a role, HCPs 
are encouraged to challenge their ability to reflect learnt skills (Wheelahan, 2017). 
The ‘Capability Framework’ also promotes multidisciplinary credentialling and 
recognised diversity, increasing the capacity for diabetes care in the workforce. It, 
therefore, sets a standard for diabetes education and care that would, in turn, 
reduce role boundary confusion by indicating the course requirements and 
capabilities for TAFE, undergraduate and postgraduate courses for different 
disciplines. It should guide a nationally consistent approach to training different 
health profession disciplines across Australia about diabetes, promoting safe, 
quality diabetes care and consumer engagement.  
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The overall findings from the current study can also inform the Australian National 
Diabetes Strategy action areas directed at workforce capacity (Commonwealth of 
Australia, 2015, p.13), including: 
• Upskilling the existing generalist HCP workforce in diabetes. 
• Redistributing aspects of diabetes care to different roles, community nurses. 
• Developing competencies for other HCPs involved in diabetes care, e.g. 
pharmacist and podiatrists. 
Applying the ‘Capability Framework’ promotes clinicians to work collaboratively in 
diabetes and foster a mentoring community. Adapting Sen’s capability approach to 
educating HCPs about diabetes education and care aligns with the strategy’s focus on 
building capacity because the approach promotes flexibility (Robertson, 2015; 
Robeyns & Morten, 2020). The collaborative, flexible approach supported by 
deliberate practice, including ongoing mentorship, can address the Australian 
Commission on Safety and Quality in Health Care (2020a) concerns, which suggest 
redistributing aspects of care can lead to fragmentation of care. 
The ‘Capability Framework’ may also inform HCPs to regulate their scope of practice 
through articulating training needs. Findings from the current study suggest that the 
ability of HCPs to self-determine their scope of practice is problematic because much 
confusion about scope of practice exists, particularly concerning medicines 
management. The framework provides a tool to guide HCPs consistently about SoP. 
Equally, HCPs develop their expertise by self-regulating their SoP, influenced by 
experience and life-long learning practices, and their work environment and setting 
(Ericsson, 2015, 2019; Faucher, 2016). 
To enable workforce diabetes capacity, as described in the ‘Capability Framework’, 
organisational redesign of services and governance processes is required to support 
autonomy so HCPs can move beyond merely addressing the limits of discipline-
specific expertise (Australian Public Service Commission, 2018). Social conditions 
and arrangements in organisations need to promote autonomy and initiative 
because knowledge and skills can become obsolete in a rapidly evolving world, so it 
is essential to focus on supporting traits that make people perform (Rybnicek et al., 
2019). Given that individual performance is influenced by ‘self-concept’ and 
‘motivation’, supporting autonomous practice provides more satisfaction and is 
more likely to promote these traits (Rybnicek et al., 2019).  
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Notably, capabilities may not be acquired or developed in workplaces that do not 
provide for or enable autonomous practice (Australian Public Service Commission, 
2018; Vazirani, 2011). Wheelahan (2017, p.646) hypothesised that:  
Unless the conditions for developing capabilities and the exercise of capabilities is 
considered, a capabilities approach could result in little more than the formal 
provision of opportunities without the substantive means to result in opportunities.  
Hence, such oversight would impede workforce growth in diabetes.   
A. The Delphi technique for identifying diabetes capabilities   
A rigorous process of consultation and consensus was undertaken to develop the 
‘Capability Framework’. It is unique because it is the only Delphi study identifying 
diabetes capabilities underpinned by theoretical frameworks, unlike other diabetes 
competency-based frameworks from the countries this thesis has compared. Most 
frameworks internationally and in Australia do not describe their methodology in 
detail or use a Consensus Development Conference (CDC). The latter has inherent 
limitations when involving multiple disciplines and often includes larger participant 
numbers, making it more challenging to manage dominant voices and opinions. Two 
studies used Delphi in diabetes after the current study’s data collection was 
completed: however, both captured competencies, not capabilities.  
Xing et al. (2019) used a modified Delphi technique to develop a standardised 
framework for primary nurse specialists delivering diabetes care in China. Despite 
Xing et al. presenting a systematic approach towards consensus, participants’ 
thoughts and ideas were narrowed, unlike the current study. According to Flanagan 
et al. (2016), an essential element of Delphi is to capture the experts’ intrinsic 
knowledge; however, by brainstorming ideas and basing their framework on an 
existing UK competency framework for diabetes nurses, the authors limited that 
expression. Further, Xing et al. used a Nominal Group Technique (NGT) involving 50 
participants (primary specialist nurses, physicians and consumers) and a CDC before 
their three-round Delphi technique that included 47 participants. Participant 
numbers were large in both the NGT and CDC, which Waggoner et al. (2016) suggest 
negatively influences outcomes due to dominance personality bias. Moreover, Xing 
et al. did not test their final framework with ‘end users’ for its practicality in the real 
world, given it was based on a framework with a different health system. 
Chapter 7: Discussion – Towards diabetes competence 
236 
 
Similar to the current study, Litchman et al. (2020) used a modified Delphi study 
over five rounds with varied health professional disciplines. However, unlike the 
current study, Litchman et al. used a substantial sample; 457 diabetes care and 
education specialists from across the USA. Based on systematic reviews by Foth et 
al. (2016) and Waggoner et al. (2016), due to the sample size, the breadth of data 
would create challenges with data analysis to ensure accurate interpretation. 
Furthermore, the final product was not tested or validated with ‘real users’. Instead, 
round four involved the four researchers unifying the language throughout and 
round five was a final review by the organisation’s leadership group and not 
independent of the study.  
B. Ensuring a diabetes health literate workforce   
The ‘Capability Framework’ promotes effective partnerships where everyone can 
give and receive, interpret and act on consistent information such as treatment 
choices and plans (ACSQHC, 2019). The framework is instrumental in fostering 
health literacy by promoting a diabetes health literate workforce who can help 
HCPs better partner with consumers to assist them in decision-making about their 
healthcare.  
The Australian Commission on Safety and Quality in Health Care (2019) defined 
health literacy as: “the knowledge, motivation, skills and capacity of a person to 
access, understand, appraise and apply information to make effective decisions”. To 
be enabling, health environments and the workforce must also be health literate; 
specifically, to support people living with a chronic condition due to both the 
complexity and fragmentation of the healthcare system and HCPs’ impact on 
consumer health literacy (Hendrieckx et al., 2020; Naccarella et al., 2016). 
The ‘Capability Framework’ can guide relevant under and postgraduate course 
content. The current study’s literature review suggests the health workforce may 
have limited capacity to support consumer health literacy in diabetes and to deliver 
diabetes care. An appraisal of diabetes content in undergraduate degrees for 
nursing, as previously discussed, suggest that inadequate diabetes content is taught 
in undergraduate nursing degrees (Allied Health Specialist Consultants, 2018). A 
mismatch between priorities exists because the Australian Nursing and Midwifery 
Accreditation Council does not plan to assess undergraduate nurse courses 
regarding their diabetes content, yet diabetes is a National Health Priority Area 
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(CoA, 2015). Further, PHCNs were found to have a knowledge deficit in diabetes 
(Furler et al., 2017; Hollis et al., 2014), and pre-Delphi consultation findings 
identified varying skills and knowledge levels between diabetes educators.  
Workforce health literacy must also include digital health literacy (Australian Digital 
Health Agency, 2020; WHO, 2020b). An online version of the ‘Capability Framework’ 
would be an additional resource providing an opportunity to be responsive to rapid 
change; the content changed as policy or healthcare evidence changes to guarantee 
that healthcare decisions are grounded in the best available evidence. The COVID-
19 pandemic is an example of how advice for HCPs may alter rapidly and frequently. 
The framework should be linked to ‘living’ guidelines, such as the Living Evidence for 
Diabetes Consortium (2020), which develop and update living clinical guidelines by 
reviewing and synthesising new evidence. Digital health literacy is outside the 
study’s remit but requires consideration to ensure HCPs and trainers engage 
positively with an online ‘Capability Framework’, and any online version supports 
communication and personalised care.  
C. Mentoring and practice  
The ‘Capability Framework’ promotes lifelong mentoring and deliberate practice to 
develop expertise and improve practice as informed by Ericsson’s (2018) and 
Benner’s (2004) theories. Moreover, an approach to link generalists with diabetes-
competent HCPs is considered important to increase their diabetes-related training 
(Ashton & Wynen, 2016; Burke et al., 2014; Furler et al., 2017; George et al., 2019), 
which can build capacity for diabetes care within the healthcare workforce.  
The framework can help address the inequities in access to diabetes care across 
Australia. Specifically, the geographic maldistribution and inequality in healthcare 
access in Australia require addressing (NRHC, 2020a, 2020b). The pre-Delphi 
consultation groups findings suggested HCPs have challenges with access to quality 
mentors with diverse skills; however, inequities in healthcare access warrant more 
HCPs to have access to ongoing quality mentoring in diabetes education and care. 
The ‘Capability Framework’ has the potential to build workforce capacity through 
mentorship. However, given the limited availability of mentors, as described by the 
pre-Delphi group, mentorship must also be delivered through and linked to the 
‘Capability Framework’ to promote consistency in advice. Ericsson et al. (1993) and 
Wang et al. (2016), who appraises Ericsson’s theory, suggest that creating 
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opportunities for deliberate practice, including mentoring is paramount. In parallel, 
Benner (2004) suggests that effective mentoring during the transition of stages of 
clinical competence serves to enhance experiential learning.  
Further, the ‘Capability Framework’ promotes the diversity of HCPs disciplines 
involved in diabetes care by including them in all diabetes practice levels. Findings 
from the pre-Delphi consultation group suggest that the combination of expertise, 
culture and language derived from different CDE disciplines is invaluable, which can 
add to the mentoring relationship and supports consumer engagement. Mentorship 
among disciplines Health services design would garner increased capacity for 
diabetes care by integrating different disciplines into their diabetes educator teams 
to foster close mentorship and shared learning (DoH, 2019a; Straw et al., 2019). 
i. Indigenous health workers and practitioners and mentorship  
The ‘Capability Framework’ can promote mentorship among Indigenous health 
workers and practitioners and other CDE disciplines. According to Browne et al. 
(2013), who performed a qualitative study investigating the outcomes of a 6-month 
mentorship program between 34 Aboriginal health workers and non-Indigenous 
HCPs, mentoring promoted improvement in practice by two-way learning. Browne 
et al. indicated that 18 partnerships were created, and the two-way mentoring 
relationship benefits were independent of existing working relationships, primarily 
when both parties were comfortable in their roles of either mentor or mentee. 
Two-way mentoring can enhance HCPs’ capacity to personalise care when 
delivering care to Indigenous Australians and support a better understanding of 
roles; however, it may require a means of connecting the HCPs.  
The Aboriginal and Torres Strait Islander health worker or practitioner role are 
specifically listed in three diabetes practice levels within the ‘Capability Framework’, 
levels one, two and four, which provides guidance about building the role’s capacity 
and reducing health inequities in Indigenous communities. Further, an opportunity 
to increase SoP is dependent on future work in non-medical prescribing and 
mentorship; thus, promoting increased workforce capacity. The ‘Capability 
Framework’ creates a career structure for the Aboriginal and Torres Strait Islander 
health worker and practitioner role, which through mentorship can promote 
consistent health messaging across disciplines.  
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Mentoring promotes expertise and collaboration (Benner, 2004; Ericsson, 2018), 
which increases workforce capacity (NRHC, 2020a). A study by Straw et al. (2019) 
also supports the importance of mentoring. The authors explored the lived 
experiences of Indigenous people with T2D managed by remote Aboriginal 
Community Controlled Health Services and found mentorship enabled three-way 
capacity building and collaboration between AHWs, non-Aboriginal clinicians and 
researchers. Along with thesis findings, mentorship is suggested to assist to develop 
a compassionate diabetes workforce is crucial.  
D. Promoting a compassionate diabetes workforce 
The ‘Capability Framework’ promotes a compassionate, empathetic and caring 
diabetes workforce with the concepts incorporated through several capabilities, 
including: 
• Builds therapeutic relationships. 
• Communicates with influence. 
• Counselling to achieve agreed outcomes.  
Three sets of attributes are included in the framework identified through the Delphi 
survey, suggesting that developing a compassionate diabetes workforce is essential.  
Training aligned with the ‘Capability Framework’ about communicating with 
consumers would alter HCP messaging about diabetes to be neither demeaning nor 
stigmatising. Moreover, the training would encourage HCPs to draw on their 
potential for compassion. Also, adding clinical indicators or performance cues to 
demonstrate how the capabilities might be demonstrated can strengthen 
understanding and ensure these concepts are entwined into the framework. 
Unlike other consumers with acute healthcare needs, people living with diabetes 
have life-long demands (Dunning, 2013, 2018), and experiencing social stigma is 
common for people living with diabetes (Browne et al., 2017). Therefore, it is 
essential to ensure that messaging about diabetes from HCPs is not demeaning or 
stigmatising as a caring workforce. 
A compassionate approach to diabetes care is required in order to respond to the 
high levels of depression, anxiety and severe diabetes-related distress seen in 
people with diabetes in Australia (Hendrieckx, 2020), which are associated with sup-
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optimal self-care (Browne et al., 2017; Hagger et al., 2016). Singer and Klimecki 
(2014, p.R875) described:  
Compassion is feeling for and not feeling with the other. 
In contrast to empathy, compassion does not mean sharing others’ suffering; instead, 
“it’s characterised by feelings of warmth, concern and care for others, and a strong 
motivation to improve the other’s wellbeing” (Singer & Klimecki, 2014, p.R875).  
A compassionate diabetes workforce is essential because, in periods of depressive 
states, a person living with diabetes may appear unmotivated to the healthcare 
team. However, this is when they require consistent information provided by an 
educated and compassionate diabetes workforce most (Ventura et al., 2016). For a 
healthcare workforce to support diabetes care, HCPs need to be cognisant of 
additional challenges and fears consumers experience (Singer & Klimecki, 2014) to 
better tailor, cares to consumers immediate needs. 
The ‘Capability Framework’ currently holds capability statements that draw from core 
concepts of emotional and mental health such as communication and engagement 
and facing life with diabetes and how to monitor these conditions. These capabilities 
are important because the prevalence of diabetes distress and depression is high in 
people with diabetes (Hendrieckx et al., 2020). By training the wider healthcare 
workforce consistently about diabetes, through fission-fusion dynamics, the grooming 
of interactions among a group, more HCPs will eventually talk about diabetes and to 
the consumer similarly (Ramos-Fernandez et al., 2018). HCPs learn from each other 
and through group learning, as the wider workforce learns to communicate 
appropriately with consumers living with a chronic condition, improved consumer 
engagement and communication should prevail.  
Training aligned with the ‘Capability Framework’ can enhance HCPs’ capacity to 
personalise care and feel empowered to support people with diabetes experiencing 
psychological problems. Capabilities identified guide HCP training to promote 
engagement to deliver safe, quality diabetes care. Notably, without accommodating 
conversation and education style to the person receiving the care, it is unlikely the 
HCP will effectively provide quality care (Mohn et al., 2015; Fink et al., 2019).  
Findings from the Delphi survey identified attributes HCPs require to ensure their 
wellbeing to allow adaptability to diverse environments. Core needs align with Sen’s 
capability approach theory. Similarly, West et al. (2020) interviewed nurses during 
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the COVID pandemic and found that HCPs’ wellbeing impacts their compassion and 
effectiveness; they suggest autonomy, belonging, and contribution are core needs to 
support nurses to succeed and delivering compassionate, high-quality care. However, 
layers of health service hierarchy and associated control can lessen the prospect for 
innovation and staff wellbeing (West et al., 2020), and require consideration in 
Australia. Workplaces need transformation to promote these attributes to enable a 
compassionate and effective workforce, essential for safe, quality care. 
E. Changing dimensions of Credentialled Diabetes Educator roles 
The ‘Capability Framework’ promotes the appropriate training of diabetes educators 
from different disciplines to encourage consistency and foster community. During the 
Delphi survey, the multidisciplinary model gained consensus to describe the 
Australian framework, highlighting HCPs’ willingness to embrace a multidisciplinary 
makeup to diabetes care.  
Promoting comparable capabilities across disciplines is important because it can 
enable growth in workforce capacity for diabetes care by enabling workforce 
flexibility and mobility. The ‘Capability Framework’ supports the movement from a 
nursing dominant diabetes educator workforce in Australia to a multidisciplinary 
diabetes capable workforce. However, several Delphi participants emphasised the 
importance of maintaining interprofessional role boundaries between CDEs, to 
ensure safe, quality patient care. Kislov et al. (2012) suggest that the effects of 
creating boundaries include reducing the efficiency, continuity and quality of care 
through reduced information sharing, which requires consideration within any 
framework designed to increase workforce capacity for diabetes care. 
Therefore, implementing the ‘Capability Framework’ can be eased by better 
understanding the barriers to role flexibility and the desire for discipline-specific 
role boundaries for CDEs. Information gathered from the three-staged Delphi 
technique suggests some participants perceive HCPs regulated through their 
profession’s peer organisation only and not registered under the Australian Health 
Practitioner Regulation Agency (AHPRA), do not have the same level of inquiry of 
roles. These findings related to HCPs’ involvement in certain diabetes healthcare 
activities, including medicines and technology, and the need for awareness of 
personal liability. The findings suggest that some participants perceive that HCPs 
not regulated by AHPRA may pose a risk to consumers when their scope of practice 
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extends into areas previously undertaken by a registered HCP; thus, AHPRA 
registration provided an additional level of regulation to protect the public.  
The ’Capability Framework’ can support communicating policy change such as 
the National Code of Conduct for Healthcare Workers (National Code), which sets 
the standards of conduct and practice for those HCPs who are not registered and its 
implications. The National Registration and Accreditation Scheme (NRAS) is 
delivered via AHPRA (AHPRA, 2020), and registration is restricted to certain health 
professions; however, dietitian and exercise physiologist CDEs are not registerable 
health professions Department of Health [DoH], 2019a). However, self-regulated 
CDE disciplines must abide by the ‘National Code'; thus, it provides a level of 
legislative regulation of accredited disciplines. The 'National Code' was released in 
2015 (DoH, 2019a) to deal with consumers and HCPs concerns about the risks 
associated with unregistered or unqualified practitioners who provide health 
services in Australia (COAG, 2015); local government agencies investigate ‘National 
Code’ breaches. 
The ‘Capability Framework’ can guide policy and organisations in changing 
regulations and governance processes to reduce role boundaries. Niezen and 
Mathijssen (2014), who explored task reallocation from the medical profession to 
the NP domain suggested closed communities tend to protect their ‘turf’. The 
authors described a closed community as a group with similar knowledge, expertise, 
values, and regulation that allowed professional autonomy legitimised by society’s 
acceptance of the group (Niezen & Mathijssen, 2014). The reallocation of tasks due 
to more CDEs from allied health disciplines challenges the specific knowledge and 
expertise boundaries created by the closed community, i.e. the nursing dominant 
diabetes educator workforce. However, barriers can be imposed through 
regulation, protocols and communication channels if organisations are not 
conducive to reframing professional boundaries (Niezen & Mathijssen, 2014).  
Supporting reframing professional boundaries using the ‘Capability Framework’ can 
increase diversity within the diabetes workforce. Notably, CDE status recognises 
specialty knowledge, not a profession in Australia. However, given the commitment 
to learning required by the credentialling process and lifelong learning and 
increasing complexities of diabetes management, consideration may be given to it 
becoming a profession.  
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Moreover, to ensure successful implementation of the ‘Capability Framework’ and 
increased workforce capacity for diabetes, the diabetes educator workforce must 
be seen as a collaborative community. A collaborative community is characterised 
by its dependence on ‘value rationality’, that is, “its members coordinate their 
activities through a shared commitment to a set of ultimate goals” (Noordegraaf et 
al., 2011, p.1352). Structural barriers within service design need to be removed to 
support a collaborative community, fostering shared skill development. 
Organisations need to be receptive to enabling CDEs from different disciplines to 
work in a cohesive team to become more connected and support cross-training. 
Supporting collaborative community can increase organisational and workforce 
capacities for diabetes.   
F. Health reform changing the landscape of diabetes care in Australia 
The ‘Capability Framework’ guides HCP training; however, modification of national 
diabetes-related education requires alignment with Government-driven policy 
concerning workforce and funding reforms. The literature review in this study 
suggests that policy occurs faster than regulation, creating differences in practices 
and what consumers can expect to receive. A ‘living’ ‘Capability Framework’ would 
enable responsive alteration guiding curricula nationally.  
Health reform has altered the landscape of diabetes care in Australia. Applying the 
‘Capability Framework’ can reduce the social and economic diabetes healthcare 
gaps by guiding rural and remote HCPs training to become diabetes competent. 
Moreover, the framework aligns with the Australian National Diabetes Strategy by 
guiding training to support HCPs to deliver quality primary and preventative care 
and population health initiatives (Commonwealth of Australia, 2015).  
As indicated, despite having universal health care, equitable access to care is not a 
reality in Australia (Worley et al., 2019). Essentially, the health workforce’s 
distribution and skills impede the nation’s progress toward health goals (Worley et 
al., 2019). However, the ‘Capability Framework’ can inform any Government or 
ADEA workforce planning initiative by identifying the proportion of HCPs working at 
each practice level in the region and those missing from the local diabetes 
workforce.  
Another important issue in managing diabetes is supporting medicine management.  
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7.2.3. Medicine management in diabetes care 
The ‘Capability Framework’ provides policy guidance for organisations about how 
HCPs at different practice levels can support medicine management. Further, it 
articulates a structure to describe a career-pathway for diabetes educators to 
increase their scope of practice in medicine management and towards non-medical 
prescribing (NMP). Currently, only nurse practitioners can prescribe, and limited 
prescribing can be undertaken by endorsed podiatrists and pharmacists in Australia, 
who may be a CDE.   
Developing medicine management capabilities within the diabetes workforce is 
crucial. Notably, a recent study that followed 1.2 million Australians living with T2D 
found inequities between access to newer diabetes medicines with additional 
cardiovascular benefits; those living in remote or from disadvantaged 
socioeconomic groups were less likely to access newer medicines than those in 
metropolitan areas (Morton et al., 2020).  
Promoting medicine management capabilities and non-medical prescribing 
increases access to appropriate care and produces economic benefits and improved 
patient outcomes (Courtenay et al., 2018). Findings from the Pre-Delphi 
Consultation and Delphi survey participants suggest that CDEs already work 
collaboratively with medical officers who often seek their advice about glucose-
lowering medicines. Further, that the CDE role is an underutilised expert resource 
with current diabetes medicines knowledge. 
According to the current study, CDEs do not hold a shared understanding of how 
they should be involved in medicine management because of the multidisciplinary 
nature of the profession. The findings suggest that lack of shared understanding can 
create confusion, differences in practices and what the consumer can expect to 
receive, or unsafe practices by inadequately trained HCPs. 
Notably, findings from the pre-Delphi Consultation and Delphi survey revealed that 
diabetes educators seeking to increase their scope of practice tend to focus on their 
involvement in adjusting insulin doses. The findings indicated that diabetes 
educators saw that affording insulin-using people living with diabetes easier access 
to insulin advice increases access; simultaneously, the findings suggest an 
overemphasis on insulin as a treatment option. The focus creates an unhelpful 
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situation of over-reliance on insulin to manage diabetes because the HCP skills lay 
with insulin usage rather than making appropriate medicine choices.  
The ‘Capability Framework’ can guide CDE training to align practice with QUM 
principles uniformly across disciplines. While insulin is essential for T1D, it is one of 
many treatment options for managing T2D. Pivotally, Australia is facing an obesity 
epidemic (AIHW, 2020c) and insulin is a growth hormone that may impede a 
person’s efforts at weight loss. An adverse outcome of the ‘Stepping Up Program’ 
discussed in Chapter 2, which saw practice nurses assist patients with constant 
insulin titration, was weight gain (Furler et al., 2017). Addressing QUM skills of CDEs 
can reduce a potential disproportionate focus on insulin and promote the 
appropriateness of medicine regimens (Gunton et al., 2016).  
Internationally, the BC-ADM® role in the USA requires a Masters, and in the UK, a 
postgraduate certificate is undertaken to apply for non-medical prescribing rights. 
Although TREND-UK has recommended a Masters level for their advanced role; 
however, Master’s degrees have a financial implication for HCPs and may reduce 
uptake and completion of the degree. Furthermore, the regulated NP role in 
Australia already works at an advanced level and should be promoted. 
Increasing NMP by CDEs creates a significant opportunity for increasing workforce 
capacity; however, given the diversity of disciplines, any role requires high-level 
negotiation with Government and Policy change to enable its development. 
Moreover, developing a national training program would enable a consistent 
approach to training CDEs concerning NMP, promoting QUM and reducing role 
boundaries concerns. Alternatively, a HCP may work towards prescribing 
endorsements via their profession should the option exist. However, formularies 
may not be diabetes-specific; therefore, may not result in the desired outcome, i.e. 
increased workforce capacity for diabetes. 
The ‘Capability Framework’ provides a foundation that supports advancement to 
medicine management role. According to Pre-Delphi and Delphi participants, some 
CDEs are not adequately prepared for medicine management roles. Given that CDEs 
come from different disciplines, HCPs practising in diabetes medicine management 
in Australia may benefit from formal advanced training aligned with the UK and USA 
programs.  
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National implementation of the ‘Capability Framework’ is imperative because 
diabetes consumers report receiving conflicting or contradictory advice from 
different HCPs according to a systematic literature review, including 64 studies 
(Kousoulis et al., 2014). Furthermore, an Australian study using data linkage between 
the Pharmaceutical Benefits Scheme and National Diabetes Services Scheme with 
T2D from disadvantaged socioeconomic groups had reduced access to newer 
medications (Morton et al., 2020). Using the framework supports consistency and 
competence within the diabetes workforce applying medicine management.  
A complicating factor is that different States and Territories across Australia currently 
have different Drug and Poisons Legislation. The extent to which different HCPs can 
be involved in medicine management either through prescribing, administering and 
providing advice on QUM differs across Australia (Tooms, 2017). Currently, some 
States and Territories either permit authorised registered midwives, podiatrists, 
nurses and, Aboriginal and Torres Strait Islander health practitioners to obtain, 
possess, use, sell or supply scheduled medicines such as glucose-lowering medicines 
(Aboriginal and Torres Strait Islander Health Practice Board, 2020; ADEA, 2018c). The 
‘Capability Framework’ does not accommodate these differences; however, it may 
provide a pathway to work towards consistency. 
The ‘Capability Framework’ guides relevant policy to promote the need for consistency 
in medicines legislation; standardising the training of CDEs from different disciplines 
and across the nation is currently difficult due to the differences within Drug and 
Poisons Legislation. The federated approach to Poison Acts in Australia creates 
challenges for applying QUM principles by CDEs and professional organisations that set 
standards for aspects of care, such as ambulatory insulin stabilisation. Yet, the study’s 
literature review suggest that medicines management is an important capability 
required to deliver safe, quality diabetes care, which should be supported.  
7.2.4. Private business models 
More than half of the participants from the Pre-Delphi Consultation indicated CDEs 
have inadequate financial incentives to create viable business models. In Australia, 
CDEs from nursing disciplines are financially disadvantaged compared to their allied 
health CDE counterparts who can access alternated allied health Medicare item 
numbers (DoH, 2017). Consequently, CDEs may be reluctant to practice privately, 
which reduces the workforce’s capacity to meet community diabetes needs. 
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According to Currie et al. (2019), who surveyed 73 Australian private-practice NPs, 
the current structure of the Pharmaceutical Benefits Scheme and the Medicare 
Benefits Schedule restrict the capacity of NP to deliver a complete cycle of care. 
These results align with the current study’s findings.  
Workforce distribution is essential for access (Skinner et al., 2013). The need for 
Government-funded incentives to support developing viable business models was 
raised primarily by private practice CDEs and nurse practitioners, who made up half 
of the pre-Delphi consultation group. Currently, most CDEs work in tertiary 
Government-funded services in Australia rather than primary care settings 
indicating minimal incentive to establish private services.  
An imperative exists as approximately 12% of Australian endocrinologists and diabetes 
physicians live outside of major cities (NHRC, 2020a). In contrast to Australia, the UK 
and USA diabetes educator workforce have infiltrated primary care (Hick, 2019; Rinker 
et al., 2018). Hence, Australia’s capacity for preventative care can be increased by 
supporting the growth of private sector CDEs. Growth in private sector CDEs supports 
promoting medication adherence in areas of increasing remoteness where access or 
adherence is low (Krass et al., 2015; Morton et al., 2020).   
The next section presents information about the strengths and limitations of the study. 
7.3. Study strengths and limitations 
7.3.1. Study strengths  
The study’s major strength was the systematic way of combining evidence from the 
literature with real-world experience from experts in the field and, notably the 
outcome, the ‘Capability Framework’ derived from consensus. The process was 
enhanced by applying triangulation and multiple data collection methods, sources 
and expert investigators. The multiple stages used in the Delphi technique and 
triangulation enabled repeated testing of information to enhance the data’s face 
and content validity and trustworthiness.  
Another major study strength was the high level of engagement by the Delphi expert 
participants noted by the high response rates throughout the Delphi survey rounds, 
which Hsu and Sandford (2007) indicate is essential for consensus. Further, multiple 
sampling undertaken over a prolonged period from a diverse group of diabetes 
experts from different settings supported the accuracy and soundness of the findings.  
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The Expert Advisory Group (EAG) provided another layer of validation in-
conjunction with the researcher’s supervisory team to appraise assumptions made 
and identify biases. The EAG members were very engaged in appraising the findings 
and contributing to the framework. The breadth of EAG expertise and their key 
positions in diabetes care was another study strength.    
A further study strength concerning the qualitative analysis process was how the 
researcher managed potential bias with strategies. These strategies included the 
intentional adoption of researcher reflexivity, ensuring the researcher accepted her 
place within the research by understanding the world through her interactions with 
others and acknowledging her dynamic relationship with the data (Said, 2019). EAG 
and focus group discussions supported understanding and decision-making.  
The inclusion of different disciplines suggested inherent variations and varied 
opinions. However, diabetes expert participants engaged positively in group 
formats and were respectful of differences of opinions when providing feedback, 
and the written text was considered and thoughtful, promoting transferability and 
applicability of findings to the ‘real world’. Further, detailed responses were 
received from regulatory and training organisational representatives from all States 
and Territories across Australia.  
7.3.2. Study limitations  
Despite the population sample having proportions of different disciplines aligning 
with the ADEA membership survey (ADEA, 2017a), some disciplines were not 
represented in the study. The lack of feedback from physiotherapists and Aboriginal 
and Torres Strait Islander health workers and practitioners is a limitation because 
they play an integral role in both the healthcare system and Indigenous health 
services in many parts of Australia. The two health professions’ training or 
regulatory representatives did not provide feedback in Stage III, the post-Delphi 
survey stakeholder appraisal. In 2019, ADEA only had three physiotherapist 
members and 23 Aboriginal and Torres Strait Islander health practitioners; ten were 
CDEs (Freeman, Manager Professional Services and Education, ADEA, personal 
communication, October 1, 2019). Most held CDE status no longer than two years; 
however, some may have had significant diabetes care experience. 
The Delphi technique has recognised limitations, including the purposeful selection 
of panel members, attrition rate and non-response bias (Hasson & Keeney, 2011), 
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which risks the information gathered being unrepresentative of experts opinions 
(Palinkas et al., 2015). To manage these limitations, the researcher recruited openly, 
allowing the panel to self-select. Reminder emails helped prevent attrition, and the 
characteristics of non-responders were reviewed to ensure a health discipline or 
setting were not excluded.  
Another limitation was the sheer volume of capability statements for Delphi survey 
Phase two ranking. Delphi technique requires adequate time and participant 
commitment through the whole process to ensure the data collected is truly 
representative of the expert panel (Flanagan et al., 2016). An inherent risk was the 
burden on Delphi participants to read each statement and make considered ranking 
decisions.  
However, the length of time it took to undertake the survey and differences in 
ranking within earlier diabetes practice levels and more ‘contentious’ capabilities of 
medicines management and technologies were quite diverse, implying participants 
engaged positively in the process.  
7.4. Chapter conclusion 
The chapter provided an interpretation of the study findings aligned with the study 
aim and objectives. The findings suggest that applying the ‘Capability Framework’ to 
guide HCP training can develop a more diabetes-literate and competent workforce. 
Moreover, the ‘Capability Framework’ can guide HCPs with the content and 
capabilities required through an appropriate diabetes practice level linked to an 
appropriate minimum level of diabetes clinical competence. Applying the ‘Capability 
Framework’ as a tool and supplementing education with deliberate practice such as 
diabetes-related mentoring and case studies strengthens the capacity to develop a 
compassionate and caring workforce.  
The analysis and interpretation of data led to developing a set of workforce, policy 
and research recommendations, which support implementing the findings. 
However, more consistent medicines policy and Drug and Poison’s legislation and 
better aligning workforce remuneration may increase workforce capacity in 
diabetes care by increasing equitable access to safe, quality care. Nevertheless, 
implementing the ‘Capability Framework’ derived from consensus by systematically 
combining evidence from the literature with real-world experience from experts in 
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the field, can increase in a longer-term perspective, enhanced capacity for diabetes 
education and care in Australia. 
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Chapter 8: Conclusions 
8.1. Chapter introduction  
The consensus ‘Capability Framework’ developed through the Delphi technique 
used a systematic way of combining evidence from the literature with real-world 
experience from experts in the field. The concluding chapter provides 
recommendations drawn from the study findings, and subsequent discussions 
against the research aim to enhance the capacity of the diabetes workforce to 
deliver diabetes care. Recommendations are made focused on areas of education, 
workforce and policy and future research directions. The chapter concludes with a 
thesis summary and conclusion. 
8.2. Study recommendations  
The following section makes recommendations regarding the study findings and 
their application to practice. Moreover, rethinking skills and moving from 
competency-based to capability-based learning promotes developing capacity by 
removing barriers created by role boundaries within the diabetes workforce. 
8.2.1. Capability Framework recommendation 
That the ‘Capability Framework’ is implemented online, promoted and used to 
guide national curricula to support consistency in training about diabetes across 
disciplines for undergraduate and graduate nurses, midwives, pharmacists, 
allied health and Aboriginal and/or Torres Strait Islander health workers and 
practitioners. 
All healthcare providers play an integral role in supporting people to live better with 
diabetes. Diabetes education and care is a collaborative, multidisciplinary activity, 
and the ‘Capability Framework’ is unique in that it recognises many healthcare 
providers contributing to the care. The list of healthcare providers identified within 
the diabetes practice levels is not exhaustive, and not all healthcare providers will 
engage in all activities. Placing the ‘Capability Framework’ online promotes a novel 
way of learning. 
The ‘Capability Framework’ supports developing an agile, responsive diabetes 
workforce by: 
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• Informing national curricula by Universities and TAFE colleges to standardise 
under- and postgraduate training across HCP disciplines supporting the 
diabetes workforce. 
• Promoting better consumer engagement through consistent recommendations 
and advice from HCPs to consumers by providing consistency in training. 
• Reducing HCP role boundary concerns by clarifying how different CDE 
disciplines can participate in diabetes care activities.  
• Articulating a recommended career pathway in diabetes education and care 
from generalist or novice to expert HCP.  
• Better preparing the local rural and remote health workforce for diabetes care 
through training and mentorship.  
• Informing employers about how their employees can deliver diabetes 
education and care and promoting the appropriate assignment of 
responsibilities according to the clinician’s competence.  
• Assisting HCPs to identify their knowledge deficits to strategize relevant 
professional development. 
By applying the ‘Capability Framework’ nationally it creates a single portal for 
current information about HCP training in diabetes education and care to support 
consistency in advice and care delivered by compassionate competent HCPs, 
promoting consumer engagement. 
Once implemented, that efforts are made to make the ‘Capability Framework’ 
a ‘living’ framework.  
A process for ongoing updates to the ‘Capability Framework’ supporting a ‘living’ 
framework to guide national curricula should be considered. For example, an expert 
panel assigned by the ADEA could update the ‘Capability Framework’ as evidence 
emerges and include a major review each 3-5 years in a consensus manner to 
identify any new or changes to capabilities.  
The concept and its financial implications have merit; however, it can assist 
universities or TAFEs that may be individually updating their course content 
annually. A ‘living’ ‘Capability Framework’ can guide curricula to train the future 
healthcare workforce for diabetes care in the most contemporary manner.  
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8.2.2. Workforce recommendation 
A. Non-medical prescribing role in diabetes 
That a secondary advanced diabetes educator role with a limited non-medical 
prescribing endorsement is implemented into the workforce. 
Equitable diabetes healthcare access can be increased by creating a new advanced 
CDE role that focuses on complex care and medicine management in diabetes with 
prescribing rights against a glucose-lowering medicines formulary. 
The advanced CDE role is: 
• Irrespective of the disciplines eligible for CDE, when training appropriately 
aligned to the role.  
• Regulated by the Australian Health Practitioner Regulation Agency if 
appropriate 
• Prepared with appropriate training in pharmacotherapy, Quality Use of 
Medicines (QUM) and assessment, and have access to ongoing professional 
development and mentoring, including at minimum a postgraduate diploma 
degree.  
• Developed as a workforce solution to improve medication adherence and 
access to manage diabetes, particularly in remote areas of Australia where 
the poor geographical distribution of communities and different HCP 
disciplines exist.  
B. Mentoring portal to support strengthening connections 
That a semi-living mentoring portal is incorporated into the online ‘Capability 
Framework’. 
• The online ‘Capability Framework’ can be enhanced and assist in developing 
a mentoring portal that includes case studies allowing remote and rural 
diabetes HCPs access to mentors and deliberate practice.  
• Promoting working relationships between Indigenous and non-Indigenous 
clinicians is essential. A mentoring portal will support two-way mentoring 
between Aboriginal and Torres Strait Islander health workers and 
practitioners and non-Indigenous clinicians, enabling them to meet their 
identified learning needs through the partnership.  
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• The online platform should be linked to ‘living’ evidence-based guidelines to 
ensure contemporary evidence-based practice to support optimal decisions 
by HCP and patients.  
C. Workforce planning. 
That the ‘Capability Framework’ be used as a tool to guide workforce 
planning for diabetes care by identifying the numbers of staff working at each 
practice level in the region. 
The diabetes practice levels described in the ‘Capability Framework’ can assist 
workforce planning by identifying staff working at each practice level in the 
organisation or region. Undertaking analyses of diabetes-competent staffing levels 
can help in identifying workforce deficits and determining the type and level of 
roles required locally. 
That different disciplines are integrated into diabetes teams in all workplaces. 
The ‘Capability Framework’ can promote more comprehensive quality care by 
promoting diversity by integrating individuals from different disciplines interested in 
diabetes. Expertise requires an openness to learning opportunities, mentoring and 
reflecting in and on practice. Integrating different disciplines into the educator 
teams combined with capability-based training supports a collaborative community 
and promotes more in-depth diabetes clinical reasoning from cross-learning. 
8.2.3. Policy recommendation  
A. Medicines management 
That Drug and Poisons Legislation is modified nationally to include 
information explaining whether and by whom a prescriber’s order can be 
amended once the medication is prescribed and dispensed and that a 
consistent term is established to describe these medication amendments. 
There is a need for greater clarity about how registered and non-registered non-
medical HCPs (accredited health professions) can be involved in medicines 
management to support consistency and quality of diabetes care across the nation. 
A consistent nationwide Drugs and Poisons Legislation rather than multiple versions 
across the nation would enhance understanding.   
The ‘Capability Framework’ contributes to the training and mentoring of CDEs to 
support medicine management nationwide, which promotes adherence and 
Chapter 8: Conclusions 
255 
 
medicine management access. Drug and Poisons Legislation is required to not only 
describe prescribing activities, i.e. the possession, prescribing and dispensing of the 
medication but also medicines management, and QUM principles that encompass 
many activities that HCPs can support. National consistency in Drug and Poisons 
Legislation, including terminology, can better enable the diabetes workforce across 
Australia by enabling consistency in HCP training and reducing confusion among 
different disciplines.   
B. Orientating healthcare organisations for capability-based learning 
That policy is developed to promote capability-based learning in healthcare 
services and organisations. 
Capability-based learning will help to increase workforce capacity in healthcare 
organisations and enable compassionate, high-quality healthcare. To enable 
capability-based learning, healthcare organisations’ need to promote HCP autonomy, 
which fosters innovation. Supporting social conditions for increased autonomy, 
meaning reducing regulatory and communication channel barriers in workplaces 
that enable capability-based learning will increase capacity for diabetes care.  
C. Developing diabetes healthcare business models 
That financial incentives for private practice CDEs and nurse practitioners are 
reviewed. 
The ‘Capability Framework’ can guide training to ensure consistency in practice, and 
that practice is evidence-based. An online delivery mode will connect more CDEs 
and NPs working in private practice and help them to develop their expertise 
continually. To enable the sustainability of services and to build capacity in the 
diabetes workforce, financial incentives need to be appropriate for supporting the 
viability of private CDE and NP business models, particularly for CDEs and NPs 
working in rural and remote areas. 
Providing NPs with incentives to undertake activities such as GP Management Plans 
has utility for increasing equitable diabetes healthcare access. Nurse practitioners  
are appropriately trained in assessing, diagnosing, prescribing, and coordinating 
safe, quality care. Economic benefits of diabetes educators and non-medical 
prescribing roles can offset improved financial incentives to enable more CDEs and 
NPs to move from the tertiary to primary care setting by establishing viable private 
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businesses. Financial incentives may require consideration of infrastructure, and 
travel costs and telehealth options.  
8.2.4. Recommendations for further research  
A. Capability Framework evaluation 
Implementation of the ‘Capability Framework’s and its impact on workforce training 
should be evaluated. The researcher successfully received a competitive grant to 
design, implement and evaluate an online version of the ‘Capability Framework’ 
nationally in 2021/22. The evaluation will consider process, outcome and impact. 
The project will include an online survey, a semi-structured focus group targeting 
course coordinators for diabetes undergraduate programs and a review of 
engagement and interaction with the site. 
B. Indigenous capabilities to promote diabetes care  
Research is needed to identify any specific capability required to better tailor care 
to Indigenous people. The ADEA Indigenous pathway is due for review in 2021, 
which creates an excellent opportunity to determine whether a different or 
additional capability is required within the ‘Capability Framework’. The funding 
grant mentioned creates an opportunity to engage Indigenous researchers and 
health experts to tailor the ‘Capability Framework’ to Indigenous health workers 
and practitioners to promote improved health outcomes.  
C. Nurse practitioner management plans for chronic conditions 
The viability of nurse practitioners (NP) involvement in completing and reviewing 
General Practice(GP) Management Plans in Australia via a pilot project should be 
considered. NPs working in diabetes create an opportunity; they are generalist 
advanced practice nurses with expertise in diabetes. As the title suggests, chronic 
conditions Medicare item numbers using GP Management Plans with referral to 
Team Care Arrangements are only available to GPs in Australia.  
Allowing NPs to prepare and review GP Management Plans autonomously with 
diabetes consumers creates a workforce solution, particularly increasing healthcare 
access in rural and remote areas of Australia where medical shortages exist, and 
comorbidities are high. Evaluating whether the NP can produce management plans 
which promote wellbeing, reduce adverse health outcomes and increase healthcare 
access can identify a workforce solution increasing capacity for diabetes care.  
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8.3. Thesis conclusion and summary  
The prevalence of people living with diabetes is high throughout Australia, more so 
in areas of remoteness. Many people with diabetes rely on medicines in-
conjunction with modification to their diet and physical activity to manage their 
diabetes. The high prevalence of diabetes in Australian communities requires all 
HCPs to support the care required, diabetes care is everyone’s business. The 
geographical nuances of Australia and reduced healthcare access require means to 
build HCP diabetes skills while also supporting consistency in training to improve 
health outcomes in people living with diabetes. 
The diabetes workforce is an enabler of evidence-based, timely care. Ensuring that 
the whole workforce is prepared and can deliver safe, high-quality diabetes care is 
imperative. The ‘Capability Framework’ developed from this research program 
identifies how HCPs from different disciplines and workplace settings can work 
together. The ‘Capability Framework’ can guide the professional development of 
different HCPs across the healthcare spectrum in Australia to deliver quality 
diabetes care. 
The study addressed the aims and identified a novel way to educate and prepare the 
Australian health workforce to deliver diabetes education and care through: 
• A consensus diabetes capability-based framework for the healthcare 
professional workforce delivering care across the healthcare system that 
includes nine capabilities underpinned by three sets of attributes to promote 
workforce agility and flexibility. 
• Seven different healthcare professional diabetes practice levels to deliver 
diabetes education and care in Australia, which are linked to an appropriate 
stage of diabetes clinical competence and align relevant training.  
By describing and defining the capabilities required at different levels of practice 
within the healthcare workforce, the Capability Framework for Diabetes Care 
provides a comprehensive evidence-informed mechanism to build workforce 
capacity and promote an agile and flexible workforce to meet the growing 
complexity of the needs of people living with diabetes. It can support consistency in 
practice and strengthen connections within the workforce. A focus on capability-
based learning, combined with connections to mentoring help to support 
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Appendix 2: Plain language statement for consultation group 
ADC 2018 
PLAIN LANGUAGE STATEMENT AND CONSENT 
FORM 
 
TO:                                   Participant  
Date:    24 July 2018 
Full Project Title: A Competency-Base Approach to Expanding the Diabetes 
Care Workforce  
Principal Researcher:       Professor Trisha Dunning  
Student Researcher:       Giuliana Murfet 
Associate Researcher(s): Dr Joan Ostaszkiewicz 
 
You are invited to take part in a Consultation Group to inform the ‘Competency-Base 
Approach to Expanding the Diabetes Care Workforce’ study. To be involved you need to be 
a registered healthcare professional (HCP) and either:  
• Credentialed as a Credentialled Diabetes Educator (CDE) for five years or more.  
• Employment for the past five years or more in diabetes-focused education or research.  
 
What is the project about? 
The study aims to develop a draft consensus-based competency framework for HCPs 
involved in diabetes education and care. The ‘framework’ will be for generalist to expert 
HCPs, both nursing and allied health, except for medical officers. The study ultimately aims 
to improve healthcare for people who live with diabetes and its complications.  
Diabetes and other chronic conditions are becoming more prevalent in our society. Further, 
there is a move from hospital-based specialist care to more primary prevention and 
management in the community. Combined these changes will present significant workforce 
challenges in delivering and access to safe, quality healthcare in the future.  
From research we understand a range of health disciplines with varying levels of 
experience, skills and knowledge now provide diabetes education in multiple settings. 
Some feel ill-equipped to undertake diabetes education and care, while others have 
demonstrated gaps in important basic understanding. Also, skills and knowledge alone are 
inadequate to support diabetes education and care; HCPs have indicated their need to be 
assisted in developing skills to form therapeutic relationships. Further, consumers have 
raised concerns about some HCPs lack of interpersonal and self-management skills and 




Diabetes education improves clinical outcomes and quality of life; therefore, the person 
with diabetes should have access to quality diabetes self-management education from 
appropriately trained HCPs. The ‘framework’ may assist in informing a national HCP 
curriculum for diabetes care. Also, it may support developing targeted training and 
professional development programs for HCPs working with people who have diabetes. 
Further, to develop standards for education and program accreditation for HCPs 
preparation for a career in diabetes education.  
How will the study be conducted? 
The proposed research will be conducted using a Delphi technique with several rounds of a 
questionnaire to gain group consensus. The Consultation Group is an audio-taped small 
group session of less than 20 individuals. A moderator with a pre-defined script of semi-
structured interview questions will facilitate the session. Feedback from the Consultation 
Group will inform questions in the Delphi survey planned for the study.  
What will I be asked to do? 
You will be invited to contribute to a discussion which involves opened ended questions; to 
share your thoughts and ideas. The session aims to explore key concepts with the 
participants regarding diabetes education competencies required not only by diabetes 
educators but by the entire non-medical healthcare workforce and for non-medical 
prescribing (NMP).  
Initially, the consultation group participants will be provided with a summary of the 
rationale for developing competencies for the non-medical healthcare workforce in 
Australia and the Delphi technique planned for the study. The moderator will then facilitate 
the forum. The participants will be encouraged to be involved in exploring the topic of 
competencies and discussing the issues associated with NMP for people with diabetes.  
The consultation group discussion will be opened with several key questions that focus on 
areas such as: 
• Training needs for non-medical healthcare professionals working in differing settings. 
• Potential factors that should be considered as they could be helpful or not so helpful 
in developing the HCP workforce to better care for people with diabetes.  
• NMP – the risks, benefits and what people need to know and be skilled at in 
the current climate. 
Information will be fed-back to the group during the activity to ensure validity through 
accuracy in meaning. 
How much time will the group take? 
The Consultation Group will run over one hour. Should you arrive early to settle in, the full 




Are there any risks associated with participating in this project? 
No foreseeable risks to participating in the study exist. As a Public Consultation group 
member, you will need to give some of your valuable time to participate. For those 
participants wishing to have their names acknowledged, individual responses and opinions 
will not be identifiable from the information generated by the study. If you do feel 
distressed by any component of the study please seek support by contacting either: 
• Beyond Blue on 1300 22 4636 or via their chat line at 
https://www.beyondblue.org.au/ 
• Your personal counsellor 
What are the benefits of the research project? 
The findings could benefit people living with diabetes and diabetes educator practice 
because the outcomes may support developing a national curriculum, which identifies 
appropriate professional development to optimise the diabetes healthcare delivered by 
HCPs. The study ultimately aims to improve healthcare for people living with diabetes and 
reduce diabetes-related complications.  
You will not derive any immediate direct benefit from participating in the study. If required, 
a certificate of participation to meet requirements for ongoing professional development 
with your relevant Board or credentialing body can be provided. 
Who is undertaking the project? 
Giuliana Murfet is completing the study in partial fulfilment of a Doctor of Philosophy degree 
under the supervision of Professor Trisha Dunning at Deakin University and Dr Joan 
Ostaszkiewicz, the associate supervisor to the study. 
Privacy and confidentiality: How will anonymity and data storage be managed? 
All electronic copies of data will be stored on the Deakin University computer network 
system; the data will be password protected. Deakin University’s system offers high-level 
security management for maintenance of data integrity and disaster recovery should a 
large-scale incident occur.  
Written transcripts of the audiotape will not include any names or identifying features; if 
needed individuals will be listed with a letter from the alphabet. Any printed copies of data 
used in the process of undertaking the study will be locked in a filing cabinet in the 
researcher’s private office. Data will be held for five years following publications of the 






Dissemination of Results: Will anyone else know the results of the project? 
The findings of the study will be disseminated through presentations and publications. In 
any dissemination, the study investigators will make sure that the results of the study are 
de-identified before presentation or publication and only aggregated group data are 
presented. Any potential identifying data will not be shared with anyone outside the study.  
Will I be able to find out the results of the project? 
A summarised report of the findings will be available for participants to read at the study’s 
completion. The study findings will also be presented at conferences and published in peer-
reviewed journals that you can access.  
Can I withdraw from the Public Consultation Group? 
Your participation in the study is voluntary. If you do not wish to take part, there is no 
obligation. If you decide to take part and later change your mind, you are free to withdraw 
your participation and leave the consultation group at any time. There will be no adverse 
consequences should you wish to withdraw. Deletion of any of your personal comments 
during the consultation group may be deleted on request. However, please keep in mind 
this may be difficult as no names are associated with the feedback. 
What if I have a complaint or any concerns? 
If you have any complaints about any aspect of the project, the way it is conducted or any 
questions about your rights as a research participant, then you may contact:  
The Human Research Ethics Office,  
Deakin University,  
221 Burwood Highway,  
Burwood Victoria 3125  
+61 3 9251 7129  email research-ethics@deakin.edu.au   
Please quote the Human Research Ethics Committee approval number HEAG-H 102_2018.  
 
Who do I contact if I have questions about the project? 
If you have any questions about the project, please contact Giuliana Murfet. Contact details: 
Giuliana Murfet 
PhD Candidate 
School of Nursing and Midwifery 
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The moderators’ role aims to create an environment that is conducive to the sharing of 
diverse opinions on the topic in question and manage discussions to minimise dominance, 
shyness or acquaintance bias.  
Schedule 
3:30  Introduction of moderator and topic 
3:45 Review of topic 1 
4.10 Feedback to the group about key concepts 
4:20 Review of topic 2 
4:45 Feedback to the group about key concepts 
4:55 Final comments 







The session will be run in a semi-structured format by the moderator. It is essential that the 
moderator follows the suggested questions or prompt but does not engage in the 
conversation to reduce the impact of preconceived ideas or theories being placed on the 
participants by the moderator. The protocol will include desired results of the forum and 
delineation of participant responses to minimise dominance, shyness or acquaintance bias. 
The moderator will encourage the audience to be involved in addressing each question. 
There are no wrong or right answers; the purpose is to obtain opinions and understand the 
reasoning behind the thinking or position. 
You may use prompting questions to keep the conversation going such as: 
• Does anyone have a different view? 
• Can you provide an example? 
• Let’s hear from some of the others that have not spoken yet? 
• Does anyone have a different view? 
 
Topics 
There are two main topics: (1) competencies for healthcare professionals (HCP) involved in 
diabetes education and care, (2) non-medical prescribing (NMP). Allow 20 minutes for each 
topic. 
Why is the topic important? 
Diabetes and other chronic conditions are becoming more prevalent in our society. Further, 
there is a move from hospital-based specialist care to more primary prevention and 
management in the community. These changes will present significant workforce 
challenges in delivering and access to safe, quality healthcare in the future. 
What we hope to achieve in the next hour? 
The opinions and views of participants on the issues of competencies for diabetes 
education and NMP; the responses from the session will help to shape the questions in the 
Delphi survey. 
Introduction 
Briefly introduce yourself and your roles in diabetes education and care and thank the 






Ensure that each participant has reviewed the PLS and signed the consent form before 
proceeding. Encourage the audience to take their seats and to silence their phones to 
assure no disturbances.  
Provide a brief overview of the public consultation session; what is planned and how it will 
be facilitated.  
  
Address confidentiality and remind participants that they are being audiotaped and that it 
is important that they always speak loudly and clearly. 
  
Sit with the group to support the general discussion but remember the moderator is not a 
group member. Brief introduction of individuals and their role. Acknowledge the diverse 
group of HCP disciplines within the room. 
Thank you for volunteering your time this afternoon. I am [NAME] and I am [role]. I will 
be moderating the discussion today. It is essential that you know and understand that 
you can withdraw from the consultation group at any stage.  
We estimate the discussion will last one hour. During this time, we will be asking you to 
contribute to a discussion about the health professional workforce caring for people with 
diabetes and NMP. 
I am here to facilitate the focus group this afternoon and you should feel free to express 
your thoughts and feelings on the topic. We are interested in hearing your opinions and 
points of view even if they differ from those, which others express in the group. However, if 
you feel distressed at any stage during the discussion, please free to leave at any time. 
I will be making every effort to keep the discussion on track and within our time frame. If 
we are spending too much time on one topic, I may park the conversation so that we can 
move on. I will make sure that everyone gets a chance to discuss their thoughts. If we have 
enough time, we will revisit parked thoughts in the order of their listing. I will write parked 
items in a list format on the board. 
At the end of each of the two topics, we will feedback to you the key concepts that have 
been raised by the group to ensure we are accurate in understanding the meaning. 
The discussion will be audio-recorded because we do not want to miss your 
comments. We will be using first names only today, however, no names will be 
attached to any comment on the written transcript of the discussion. The discussion 
and your comments will be treated with strict confidentiality. It is best if one person 




Discussion topics / Questions 
 
Feedback 
Following each of the two topics, main concepts drawn out of the discussion by the 
transcriber will be fed back to the consultation group to ensure the validity of key concepts 
by ensuring accuracy in meaning. 
• Do you think this captures the discussion well? 
• Are there any comments? 
Closing 
Thank everyone for their input and offer an opportunity for short final comments 
participants would like to make.  
Advise the participants that the information they provided will inform the Delphi survey 
tool planned for the study and note that their identity will always remain confidential.  
Advise that if they wish to contact the researcher about the research, to take a copy of the 





Appendix 4: Delphi survey Phase One (Round one) questions 
A Competency-based approach to 
expanding the diabetes healthcare 
workforce 
 




As a valued member of the workforce who supports managing people with diabetes, you 
are invited to participate as a Delphi Group Member in the research project – ‘A 
Competency-Based Approach to Expanding the Diabetes Healthcare Workforce’.  
The survey should take you 30-60 minutes to complete depending on the level of detail you 
wish to provide. You can come back to the survey as needed before submitting.  
As you are aware, the prevalence of diabetes is increasing exponentially. Consequently, 
every healthcare professional (HCP) will need to be involved in diabetes care at some level 
to ensure timely safe quality care. Further, health reform has moved diabetes management 
from hospital-based specialist care to more primary prevention and management in the 
community.  
Research reports that some HCPs in the primary care setting do not feel they are equipped 
to undertake the tasks requested of them and have gaps in relevant basic knowledge about 
diabetes and its care. Certain HCPs are under-resourced to provide care safely. Also, those 
who already hold diabetes-related credentials want to increase their scope of practice: 
often in medicines management and technology. It is essential that those training our HCPs 
understand the skills and knowledge all levels of HCPs require to deliver diabetes education 
and care to ensure that all people with diabetes have access to quality safe care.  
Delphi Survey Phase 1 will collect demographic data related to your experience and 
training. The survey itself then consists of three questions. The first is designed to identify 
appropriate 'Diabetes HCP Practice Levels’ for diabetes education and care that exist in the 
Australian context. ‘Diabetes Practice Levels’ describe levels of HCPs competence, work 
experience and skills, and scope of practice in diabetes care. It may encompass the 
healthcare support worker and generalist HCP to the expert diabetes educator. In some 
work settings, some HCPs may require only basic knowledge about diabetes care to assist 




and skills given the nature of the care they provide to people with diabetes to provide safe 
quality care. In the study, the focus is HCPs who are carers, nurses or allied health 
disciplines NOT medical officers.  
The second question asks you to list the basic or fundamental and advanced Knowledge, 
skills, and attitudes (KSAs) required by an HCP or diabetes educator working with people 
with diabetes. The third question has three parts to it and asks you to define medicines 
management and list the important skills and knowledge required by diabetes HCPs to be 
involved in medicines management.  
Please note, several participants are generating both lists and, you will have another 
opportunity to add and remove items with each round until agreement.  
 
Thank you in advance for participating, 
Giuliana Murfet, Professor Trisha Dunning and Dr Joan Ostaszkiewicz  
 
If you have any questions about the study, please contact: Giuliana Murfet, PhD  
Candidate Email: gmurfet@deakin.edu.au  
 
Participant Information: Before you proceed, please indicate that you have read and 
understood the Plain Language Statement for the study.  
  
  
o I have read and understood the participant information statement (1)  
 
 





Basic Demographic Questions 
 
Are you currently employed in a role with a diabetes focus and held this or similar work 
for at least the past 5 years? 
▼ Yes (1) ... No (2) 
 
 
How many years have you worked as a health professional? 
▼ 5 years (1) ... > 30 years (6) 
 
 
In which state or territory of Australia do you practice in? 
▼ ACT (1) ... Northern Territory (9) 
 
 
What is your gender? 
▼ Male (1) ... Rather not say (3) 
 
 
What is your age group? 
▼ < 30 years (1) >30 – 50 years (2) > 50 years (3) 
 
 
 What is your primary discipline? 
o Dietitian (1)  
o Exercise Physiologist (2)  
o Midwife (3)  
o Nurse (4)  
o Pharmacist (5)  
o Physiotherapist (6)  
o Podiatrist (7)  






What is your current profession? (Mark all boxes that are relevant) 
▢   Aboriginal and Torres Strait Islander Health Practitioner  
▢   Academic  
▢   Accredited Exercise Physiologist  
▢   Advanced / Accredited Practising Dietitian  
▢   Accredited Pharmacist  
▢   Community Nurse - Primary Health Care Nurse  
▢   Credentialled Diabetes Educator  
▢   Diabetes Educator  
▢   Enrolled Nurse  
▢   Midwife  
▢   Nurse Practitioner  
▢   Practice Nurse - Primary Health Care Nurse  
▢   Psychologist  
▢   Registered Nurse  
▢   Registered Physiotherapist  
▢   Registered Podiatrist  
▢   Other (please specify) ________________________________________________ 
 
 
Please explain why you chose not to pursue credentialing as a Credentialled Diabetes 









Which diabetes-related employment sector do you currently work in? (Mark all the boxes 
that are relevant) 
▢  Primary (including community health if not attached to a tertiary service) (1)  
▢  Tertiary/Hospital (including specialist outpatients services if attached to tertiary service) (2)  
▢  Research/University (3)  
▢  Other (please specify) (4) ________________________________________________ 
 
 
What is the highest qualification you have attained?  
▢ General nurse training (Hospital/TAFE) (1)  
▢ Bachelor degree (2)  
▢ Postgraduate Degree (3)  
▢ Clinical Masters (Course Work) (4)  
▢ Masters (Research) (5)  
▢ PhD or Doctorate (6)  
 
 Do you have a postgraduate degree in diabetes? 
▼ Yes (1) ... No (2) 
 
Page Break  
 
Are you involved in medicines management?  
o No (1)  
o Maybe (2)  
o Yes (3)  








Delphi Survey Questions  
Question 1  
What ‘Diabetes HCP Practice Levels’ for diabetes education and care currently exist 
within the Australian healthcare system? Provide a rationale for your answer. 
  
In your response ensure you provide details for each of the Practice Levels that you list. 
Consider whether each practice level needs a basic or in-depth understanding of diabetes 
care by the HCPs that fall within that 'level'. Consider topics such as registration or non-
registration, credentialling, the clinical or academic level of the health professional, years of 
experience, their discipline, expertise or non-expertise in diabetes education, generalist 
HCPs and various work settings. 
  








Page Break  
Question 2  
List the basic or fundamental and advanced knowledge, skills and attributes (KSA) 
required to enable a non-medical healthcare professional to support diabetes education 
and care for people with diabetes?  
 
List under BASIC and ADVANCED and provide a brief description of any KSA that could be 
ambiguous. 
There will be another opportunity to add and remove items during each Delphi round until 
consensus is gained. Also, a group of participants will generate the list therefore another 
participant may capture items you have missed.  
 














Page Break  
 
End of Block: Default Question Block 
 
Start of Block: Block 2 
 
Question 3 







B) What essential knowledge and skills do you think non-medical healthcare professionals 

























Appendix 6: Plain Language Statement for Delphi study 
 
 




Plain Language Statement (PLS) 
Date 31 July 2018  
Full Project Title A competency-based approach to expanding the diabetes care 
workforce 
Principle Researcher Professor Trisha Dunning  
Student Researcher Giuliana Murfet 
Associate 
Research(s) 
Dr Joan Ostaszkiewicz 
  
You are invited to take part in the ‘Competency-Base Approach to Expanding the Diabetes 
Care Workforce’ study if you are a registered healthcare professional (HCP) and either:  
• Credentialed as a Credentialled Diabetes Educator (CDE) for five years or more.  
• The focus of your employment for the past five years or more was diabetes 
education or research.  
 What is the project about?  
As per Appendix 2 wording  
How will the study be conducted?  
The proposed research will be conducted using a Delphi technique and consists of two 
phases. A Delphi technique uses several rounds of a questionnaire to gain group 
consensus. The study will bring together a virtual expert group of diabetes educators to 
allow for examination of diverse opinions. We will seek agreement in two areas:  
(i) Diabetes HCP Practice Levels.  
(ii) The knowledge, skills and attitudes required by HCPs working in diabetes care for 
medicines management.  
The study will be conducted using email communication and an online survey tool.  
What will I be asked to do?  
You are invited to participate as a member of the expert Delphi group for the study. The 
initial questionnaire will be forwarded to you for completion. Thereafter you will receive a 




rank each response. As a Delphi group member, you will be able to adjust your answers in 
subsequent rounds; the rounds continue until consensus is achieved.  
In the first phase of the study, each member of the Delphi group will be asked to identify 
the varying levels of expertise in diabetes education and care that exist in the Australian 
healthcare system; fundamental or basic to specialist care. These will become known as 
‘Diabetes HCP Practice Levels’. You will also be asked to list the basic and advanced 
knowledge, skills and attributes (KSAs) required of HCPs working with people who have 
diabetes including, the essential knowledge and skills needed to be involved in medicines 
management in people with diabetes.  
In each round following, a summary of the feedback from the previous round and a 
revised version of the ‘Diabetes HCP Practice Levels’ identified will be provided to you. 
You will be asked to rank your preferred sample that best describes the Australian 
healthcare system. We expect that it will need another 1 to 2 rounds to achieve 
consensus. You can perform the questionnaire at your convenience within a structured 
timeframe for each round.  
During the data analysis period, in-between the two phases, you will be invited to be part 
of a smaller virtual ‘member checking’ group. If you are interested, a sample of similar but 
anonymous responses will be provided to you with the researchers’ definition. You will be 
asked to indicate whether you generally agree with the researchers’ interpretation and to 
provide any additional comments if you have any. 
The second phase of the study will seek confirmation of the KSAs required for diabetes 
HCPs for each of the agreed ‘Diabetes HCP Practice Levels’. The KSAs isolated in the first 
phase will be presented to you under the ‘Diabetes HCP Practice Levels’ that ultimately 
gained consensus; under domains identified during the analysis period. You will also be 
provided with an amalgamated summary of the knowledge and skills identified for 
participation in medicines management in people with diabetes.  
Each member of the Delphi group will be asked to rank a set of draft competency 
standards for each of the ‘Diabetes HCP Practice Levels’. In each round, along with the 
summary of the feedback from the previous round, a revised version of the competency 
standards is shared. We expect that it will need 3 rounds to achieve consensus.  
How much time will the project take?  
In each round, the amount of time that each Delphi group member will need to spend will 
be between 15 and 60 minutes, becoming shorter with each round. We expect up to 3 




process of developing and reviewing the ‘Diabetes HCP Practice Levels’ and draft 
competency standards will take place over 6 to 9 months.  
Are there any risks associated with participating in this project?  
As per Appendix 2 wording  
What are the benefits of the research project?  
As per Appendix 2 wording  
Who is undertaking the project?  
As per Appendix 2 wording  
Privacy and confidentiality: How will anonymity and data storage be managed?  
As per Appendix 2 wording first paragraph  
Unique identification numbers are assigned to each participant’s email address to 
protect anonymity. ‘Anonymize responses’ will be then selected in Qualtrics, the survey 
software, to disassociate the participant’s email address from each of the responses. Any 
printed copies of data used in the process of undertaking the study will be locked in a 
filing cabinet in the researcher’s private office. Data will be held for at least five years 
following publications of results at completion of the study, and then it will be securely 
shredded.  
The online survey platform will be stored by Qualtrics within a secure data centre in 
Utah, USA. The surveys and the data remain the ownership of the user, i.e. Deakin 
University. The data cannot be sold to a third party. After the Delphi rounds add data 
collected in Qualtrics will be exported from Qualtrics to excel and stored on the Deakin 
server. The account in Qualtrics will be deleted after the study. For further information, 
refer to the Qualtrics Security Privacy Statement http://qualtrics.com/privacy-
statement/.  
Dissemination of Results: Will anyone else know the results of the project?  
The findings of the study will be disseminated through presentations and publications. 
The study investigators will ensure that the results of the study are de-identified prior to 
any presentation or publication. Only aggregated group data will be presented and only 
the research staff will have access to the de-identified data.  
All the feedback about the proposed ‘Diabetes HCP Practice Levels’ and draft competency 




staff will have access to the feedback. Only de-identified aggregated feedback from the 
Delphi group members will be shared. Identifying data will not be shared with anyone 
outside the study.  
 
Will I be able to find out the results of the project?  
As per Appendix 2 wording  
Can I withdraw from the study?  
Your participation in the study is voluntary. If you do not wish to take part, there is no 
obligation. If you decide to take part and later change your mind, you are free to 
withdraw your participation from the study at any time. There will be no adverse 
consequences should you wish to withdraw. Deletion of your information from the data 
can occur up until the data is de-identified and aggregated. As we will be using the 
Qualtrics ‘anonymise responses’ feature information from surveys is de-identified as it 
comes in.  
Choosing not to participate or withdrawing from the study will not affect your 
employment, your relationship with your professional organisation or Deakin University. 
Should any of the researchers withdraw from the study, you will be notified.  
What if I have a complaint or any concerns?  




















Appendix 9: Delphi survey Phase One (Round two) questions  
Diabetes Competency Survey - Phase 1 Round 2 
 
Survey Flow 
Block: Default Question Block (5 Questions) 
Standard: Block 1 (2 Questions) 
Standard: Block 3 (0 Questions) 
 
 
Start of Block: Default Question Block  
Introduction: Thank you for contributing to the study that focuses on developing a national 
competency framework for health professionals, excluding medical doctors, involved in 
diabetes education and care.  
The current survey should take you up to 10 minutes to complete and aims to gain 
consensus of the model, derived from your feedback, to be used for the competency 
framework. You can come back to the survey as needed before submitting. The summary 
below will also provide you with some definitions.  
In summary of the last round, we have a Delphi panel of 48 members, made up of nurses 
(80%) and allied health (20%). These proportions are similar to the ADEA membership 
distribution of disciplines. The Delphi panel members were mature with 98.1% indicating 
that they are within >30 to 50 years or >50 years age categories. The panel had significant 
experience in diabetes care with 86.6% overall having greater than 15 years’ experience; 
57.7% have greater than 30 years’ experience. The panel has representation from tertiary, 
primary care and academia from nurses, dietitians, podiatrists, pharmacists, exercise 
physiologist and psychology. Also, the panel has representation from each of the States and 
Territories across Australia.  
Many participants (86.2%) indicated that they were or may be involved in medicines 
management. Involvement in medicines management was listed primarily as, providing 
advice and support on different classes of oral or injectable therapies to both the consumer 
and medical staff, insulin titration according to algorithms, deprescribing and education to 
other healthcare professionals. A small proportion of panel members indicated that 
medicine management and assessment for its use formed part of certain undergraduate 
degrees, nursing and pharmacy. Noting that consequently these healthcare professionals 
may be better prepared for involvement in medicine management. 
In round one of the Delphi study, a proportion of participants indicated that they did not 




people’ proving advice on CAM and exercise prescription. ‘NMP’ is a widely used term in 
contemporary Australian and international documentation to describe the act of 
prescribing - assessing and providing a patient with a prescription following a differential 
diagnosis or altering the dosage of medication - by healthcare professionals who are not 
medical doctors.  
Also, a proportion of the participants indicated that they did not understand the term 
‘Diabetes Healthcare Processional Practice Levels’. In the introduction to Round 1, the term 
was used to “describe levels of health professionals (HP) competence, work experience and 
skills, and scope of practice in diabetes care. It may encompass the healthcare support 
worker and generalist HP to the expert diabetes educator. In some work settings, some HPs 
may require only basic knowledge about diabetes care to assist people with diabetes. In 
other work settings, the HP may need more in-depth knowledge and skills because of the 
nature of the care they provide to people with diabetes to provide safe quality care“ (Round 
1). Given, we do not have consensus for the term it will be explored in the current round.  
The panel members described 34 models to designate diabetes healthcare professional 
practice levels. A proportion of the Delphi members indicated that any framework was 
dependent on the setting where the care was being provided, such as tertiary versus 
private practice or primary care within the general practice setting. Also, the remoteness of 
the service was considered an important consideration. For example, some noted that 
regional areas often offer diabetes care to all patient groups such as pregnancy, paediatrics 
and inpatients. Most panel members were more likely to describe the framework as roles 
and settings; clinical, educational and professional. A large proportion believed that most 
diabetes educators should have time in a tertiary environment and acknowledged the 
tertiary setting as a place to build expertise and skills.  
The 34 models were merged into six due to minor differences or with the addition of 
another layer to the model. The four significant models are listed in the current survey that 
aims to gain consensus on the preferred model to be used for the competency framework.  
 
Kind regards,  
Giuliana Murfet, Professor Trisha Dunning and Dr Joan Ostaszkiewicz  
 




Page Break  
QUESTION 1: 




remoteness do you currently provide care to people living with diabetes? Pick as many as 
are relevant.  
Map of the 2016 Remoteness Areas of Australia 
 
  
▢  Major cities of Australia (1)  
▢  Inner regional Australia (2)  
▢  Outer regional Australia (3)  
▢  Remote Australia (4)  
▢  Very remote Australia (5)  
Page Break  
 
QUESTION 2:  
Given the term ‘NMP’ is widely used nationally and internationally the research team has 
decided to continue to use the term to describe medicine management by health 
professionals who are not medical doctors. Do you agree with this decision?  
o Yes (1)  






Display This Question: 
If QUESTION 2: Given the term ‘NMP’ is widely used nationally and internationally... = No 
 








Different health professionals within the workforce can provide a range of care to people 
with diabetes that may be either generalist advice to expert or specialised care. What term 
would you use to describe a structure to denote changes in the essential skills and 
knowledge required of health professionals to perform their role safely? 
o Healthcare Professionals Diabetes Practice Levels (1)  




Page Break  
 
End of Block: Default Question Block 
 
Start of Block: Block 1 
 
QUESTION 4: Below are 4 ‘models’ derived from the feedback of the Delphi panel 
members. They are listed in no particular order. The final model that gains consensus will 
be used to form the framework; to determine relevant fundamental skills and knowledge in 
diabetes care and education for each of the roles listed. Further, small adjustments can be 
made to the chosen model according to your feedback. 
A) Indicate your preferred option by ranking in order of preference, with 1 being your 
first choice for a proposed model for the competency framework. 
______ Model 1 (1) 
______ Model 2 (2) 
______ Model 3 (3) 

































B) For the Model that you ranked 1 what were the main reasons that you selected it 
as your preferred option? Any further comments?  
______________________________________________________________ 




Appendix 10: Summary forward to Delphi panel members 
following Phase One  
Dear Delphi Panel member, 
 
Thank you for participating in Phase 1 of the Delphi Survey titled 'A Competency Base 
Approach to Expanding the Diabetes Care Workforce’.  
 
In summary 
Participant ranking varied and Models 1, 2 and 3 were equally ranked in the number one 
position by most panel members. Model 4 was the less preferred option with 86.1% of 
panel members ranking it in the third or fourth position. 
 
Model 3 was identified as the preferred option as it was more often ranked as the second 
preferred option. Over 79% of panel members ranked Model 3 in the first or second 
position, so we will move forward with Model 3 to develop the Framework. 
 
Feedback from panel members that ranked Model 3 as the preferred option for the 
Framework included that the option: 
• Encompassed other disciplines without being exclusive. 
• Applied to both metro and remote areas. 
• Best describes what was currently happening in practice. 
• Included all diabetes team members who would better address the needs of all people 
living with diabetes. 
• Accommodated a broad range of health professionals involved in diabetes care. 
• Acknowledge that vast differences between practice levels and expertise in diabetes 
management dependent on workplace exposure to all types of diabetes care. 
• Recognises that the ability to manage certain levels of diabetes care with competence 
requires consistent exposure and mentoring regularly. 
• Recognised the multiple disciplines and settings that diabetes can occur in, including 
aged care, remote and community. 
 
The inclusion and importance of roles such as Assistant in Nursing, Primary Care Assistant 
and Allied Health Assistant were often recorded in panel member’s feedback regardless of 
which model they chose. Given the importance of these roles, they will be added as the 
initial practice level tier to Model 3. 
 
Non-medical prescribing was accepted by 91.3% of participants as the term to describe 
prescribing by a health professional who is not a medical doctor. Also, 84.4% of panel 
participants agreed to the term ‘Healthcare Professional Diabetes Practice Levels’ to denote 
changes in the scope of practice for a health professional. 
 
Participant feedback highlighted that it was important that the Framework allowed for an 
appreciation that diabetes care is provided in many settings across Australia including rural 





Practice Nurse or Primary Healthcare Nurse (PHCN) were considered to require more 
knowledge and skills than the Community Nurse by respondents who requested the role be 
moved up a tier.  
 
As you are aware, the models were drawn from panel members’ initial feedback. Therefore, 
I have reviewed the Australian National Diabetes Strategy (ANDS) 2016-2020 for some 
guidance. ANDS listed ‘improving workforce capacity’ under potential areas of 
improvement. The following dot point was included: 
• Consider redistributing some aspects of diabetes care to different roles (e.g. 
community nurses delivering diabetes education, credentialled diabetes 
educators taking on expanded roles in diabetes management) 
 
The research team will continue to review whether the Community Nurse should sit within 
the same tier as the Practice Nurse/PHCN or be left within its current position. The tier may 
alter with focus group testing of the completed draft Framework. 
 
Lastly, a few panel members provided feedback to indicate that the Advanced CDE and 
Nurse Practitioner should not be in the same tier but separated. Also, that differences 
between the NP working in chronic disease compared to the NP who has diabetes expertise 
or is a CDE exists. Again, the research team will explore whether changes need to be made. 
Ultimately, the Framework identifies the expected competencies and capabilities the health 
professional requires to be working at that practice level or within that scope of practice to 
drive change to diabetes educational curricula. 
  
What happens now? 
We will now be working at placing the basic and advanced skills, knowledge and attributes 
that you provided previously, under each of the ‘practice levels’ identified. An external 
Expert Advisory Group will provide oversight of the process. In 4 to 6 weeks I will be 
emailing the second phase of the Delphi survey, the draft Framework. I will be asking you to 
rank the importance of each of the competency statements listed for each practice level 
within the framework. 
  





PhD Candidate | Deakin University | School of Nursing and Midwifery | Faculty of Health 









Appendix 11: Summary forward to Delphi participants at 
completion of Phase 2, Round one  
All competency statement listed under Tiers 4 through to 7 gained consensuses and were 
retained. As five other competency statements reached 74%, they were also accepted. In Tier 
1, three were rejected, related to supporting screening for diabetes-related complications 
and cardiovascular disease, and awareness of diabetes technologies and reporting problems. 
  
In Tier 1 through to 3, some competency statements were not rejected as they did not gain 
consensus to be removed or accepted because their score was not high enough to be 
accepted in the Framework. Comments by participants involved in the survey below Tier 1, 
related to the importance of the healthcare assistant working under the guidance of their 
immediate supervisor. Recognition of supervision and direction will appear in the 
introduction. There were also concerns that healthcare assistants in Tier 1 may undertake 
activities better suited by a health professional. Simultaneously, some comments supported 
the essential roles that the Tier 1 healthcare assistants provide in our health system. In 
addition, some work environments are highly reliant on healthcare assistants, in particular, 
residential-aged-care settings. The more extensive curricula will include ‘performance cues’ 
as an elaboration of the competencies aimed to prevent misinterpretation. 
  
Other comments listed under the higher Tiers, by survey participants, indicated that the 
health professional might be working with a particular patient population and therefore may 
not maintain their skills in another area, e.g. pregnancy. Please note the caveats to these in 
the Framework, e.g. ‘when providing care in partnership with women at risk of gestational 
diabetes mellitus’. Further, discussions from the Expert Advisory Group suggest, in 
developing the workforce for the future, we need to keep the following in mind: 
• What are the minimum skills and knowledge required by the specific health 
professionals to provide equitable and safe quality care in all parts of Australia 
including rural, regional areas, to people living with diabetes? 
• The increasing methods to maintain skills through webinars and online mentoring 
via, e.g. Zoom or Skype. 
• Government has made changes to legislation to encourage interprofessional training 
and collaboration, and non-medical prescribing; for example, future podiatrists 
completing an undergraduate degree will shortly graduate with non-medical 
prescribing competencies, as it will form part of their course. 
In addition, primarily from Tier 4 through to Tier 7, there were some comments regarding 




comments have not altered the competency statements within the Framework at this point. 
However, the Framework included a delineation, when supported by evidence, for example, 
the medicine’s capability. Also, a caveat will be included in the introduction of the ‘Capability 
Framework’ with consideration that the Framework is designed to train the workforce for the 
future to provide equitable, safe and quality diabetes care. Some Capability areas, e.g. 
‘Medicines’, have a range of relevant awards and Acts, unlike other Capability areas, e.g. 
‘Counselling’ or ‘Technology’.  
Once completed, the ‘Capability Framework’ for healthcare providers providing care to 
people living with diabetes will support developing educational curricula.  
 
As a refresher, Capabilities within the ‘Framework’ are the qualities and abilities of a health 
professional that can be used or developed. Consider it in terms of ‘the potential’ or ‘areas of 
growth’. Competencies are observable evidence of ability, skill or qualification. 
 
For Round 2 of Phase Two of Delphi, please rank the importance of each competency for the 
specific health professional tier. Those competency statements that do not achieve 
consensus following this round but are not rejected will be discussed at a Focus Group with 
experts planned in August. 
In summary of Round One: 
We are writing to thank you for supporting the research studies into this important piece of 
work. Your ongoing support and contribution have been paramount to ensuring the 
consensus around the 'A competency-based approach to expanding the diabetes 
healthcare workforce' study.  
 
We appreciate that some of the surveys were lengthy. The competency statements and 
survey questions were drawn from your feedback. A large amount of information captured 
through the surveys is a testament to the advancements in diabetes care and the vast 
amount of knowledge that is required to manage people living with diabetes safely. 
 
Two more consultative processes planned over August and October to review the final draft 
‘Capability Framework’. These will ensure that the Framework neither affects safety and 
quality nor impede clinical practice. We hope that the Framework will be used to drive 
curricula development nationally. Further, we will look for opportunities for implementation 





Appendix 12: Advertisement for focus group at the 2019 ADC  
 
A Competency-Base Approach to Expanding the 
Workforce for Diabetes Care
If you are an allied health or nursing healthcare professional, or academic who 
has worked primarily in diabetes care for the past 5 years you may be interested 
in being involved in this review. Particularly, health professionals who are 
interested in the expansion of diabetes competencies for the entire healthcare 
workforce to support developing future training curricula should attend.
Background
At the ADC in 2018, a Consultation Group informed the development of a Delphi 
survey to identify essential knowledge, skills and attributes (KSA) required by 
health professionals across the health spectrum to support care in people living 
with diabetes.
The Delphi survey was administered to 57 expert diabetes health professionals, 
who created a tier of ‘practice levels’ and a list of the relevant KSAs for health 
professionals. These included knowledge, skills and attributes for care, counselling 
and medicines management. The data gathered was developed into competency 
statements within a Capability Framework, and the Delphi panel ranked each 
according to importance. Competency statements with 75% agreement were 
retained.
How can I be involved?
The Focus Group will review the final draft of the Capability Framework for health 
professional’s providing care to people with diabetes. The focus is to understand 
whether any components within the Capability Framework that may be difficult to 
implement or impede practice for each of the health assistant or health 
professional tiers.
How do I register?
Focus Group spaces are limited; please complete the online registration to 
indicate your interest: https://www.surveymonkey.com/r/9GJ6PYP
Once your registration has been accepted your attendance to the Focus Group 
implies that you have consented to be involved in the Focus Group and are aware 
that it will be audiotaped. The session will run for one and a half hours, and the 
group will be asked broad, open-ended questions on the functionality of the 
'Framework'.
No names, including Christian names, will be recorded in the written transcript 
from audiotapes. You can leave at any time during the session; should you leave 
your discipline will be recorded and time of departure.
For further information or a copy of the Plain Language Statement and Consent 
Form please contact Giuliana Murfet on gmurfet@deakin.edu.au




Appendix 13: Letter requesting feedback from health 










School of Nursing and Midwifery 
Deakin University  
Monday, 30 September 2019 
 
Dear health professional organisation, 
Public consultation opens on proposed Capability Framework for Diabetes Care 
Deakin University is inviting feedback on a proposed framework to guide Australian 
health professional curricula to prepare them for diabetes care better.  
Today we open public consultation on the proposed ‘Capability Framework for 
Diabetes Care: A guide for practice for nurse and allied health professionals, 
Aboriginal and Torres Strait Islander health practitioners and health assistants’ 
(the Framework). Health professional organisations and course coordinators are 
encouraged to provide feedback through an online survey, which is open until 
Friday 25 October 2019.  
Questions related to why and how the Framework was developed, and how it 
should be used, are addressed within the draft Framework. 
We are seeking high-level responses that mainly address whether the Framework 
may impede clinical practice. Our preference is for one accumulated response per 
organisation to understand better the overarching themes. The survey can be 
accessed by the link below: 
https://researchsurveys.deakin.edu.au/jfe/form/SV_8kAq1WI5cf2lSwB 
Hard copy replies will be accepted if not able to undertake the online survey. A 






Appendix 14: Qualtrics Survey to collect stakeholder 
feedback about the Framework 
 
Framework for public consultation 
  
Deakin University is seeking your feedback on the Capability Framework 
for Diabetes Care: A guide for practice for nurses, allied health 
professionals, Aboriginal and Torres Strait Islander health practitioners 
and health assistants 
  
Please ensure you have read the Framework before providing feedback, as 
the questions are specific to the Framework. 
Making a submission 
We welcome feedback from health professional and training organisations, 
and consumers. 
 
We encourage you to use the online survey to make your submission. 
However, if this is not possible, you may make a written submission using the 
Word templates provided. Email submissions to: gmurfet@deakin.edu.au 
The questions in the online survey and the Word response templates are the 
same. 
Privacy 





Giuliana Murfet is conducting the consultation in part fulfilment for a Doctor of 
Philosophy degree. It is hosted on a third-party website, provided by 
Qualtrics. The researchers will use the information collected to evaluate the 
Framework. The information will be handled with privacy and confidentiality 






About your response 
Are you responding on behalf of an organisation? 
Yes 
No 
Which of the following best describes your organisation? 
Health services provider 
Professional indemnity insurer 
Legal services provider 





Please write the name of your organisation. 
 
 
Before you answer questions about the Framework 
 
Please ensure you have read the Framework, as the questions are specific to the 
Framework. 
 
The following questions will help us to gather feedback about the Framework. 
 
How easy was it to read the Framework?  
 
 















Do you think any broad capabilities, or their competency statements 
may affect safe practice? 
Yes 
No 




How helpful is the structure that describes the Framework? 
 
 
How helpful is the structure that describes the Framework? 
 
 
Is there anything else that needs addressing in the final Framework? 
 
 
Please add any other comments for the Framework. 
 
 
Thank you for participating in the consultation. 
 
